Processing 00000000.tx.1: Genetically Corrected Autologous Stem Cells Engraft, But Host Immune Responses Limit Their Utility in Canine -L-iduronidase Deficiency By Carolyn Lutzko, Stephen Kruth, Anthony C.G. 

Phrase: "Genetically"

Phrase: "Corrected"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205202:Corrected [Qualitative Concept]
   966 E C2349182:Correct [Qualitative Concept]

Phrase: "Autologous Stem Cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C0038250:Stem cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0242767:Stem [Plant]
   827   C1186763:Stem [Body Part, Organ, or Organ Component]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "Engraft"

Phrase: ","

Phrase: "But"

Phrase: "Host"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1167395:Host [Organism]

Phrase: "Immune Responses"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0301872:immune responses [Organ or Tissue Function]
   861   C0439662:Immune [Functional Concept]
   861   C0871261:responses [Organism Attribute]
   827 E C1704632:Response [Finding]
   827 E C1706817:Response [Intellectual Product]
   827 E C2911692:Response [Mental Process]

Phrase: "Limit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439801:limit [Functional Concept]
  1000   C1549649:Limit [Idea or Concept]
  1000   C2349209:Limit [Conceptual Entity]

Phrase: "Their Utility in Canine -L-iduronidase Deficiency"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0582205:utility [Organization]

Phrase: "By Carolyn Lutzko,"

Phrase: "Stephen Kruth,"

Phrase: "Anthony C.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.2: Abrams-Ogg, Kathy Lau, Liheng Li, Brian R. 

Phrase: "Abrams-Ogg,"

Phrase: "Kathy Lau,"

Phrase: "Liheng Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "Brian R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.3: Clark, Christine Ruedy, Shaherose Nanji, Robert Foster, Donald Kohn, Robert Shull, and Ian D. 

Phrase: "Clark,"

Phrase: "Christine Ruedy,"

Phrase: "Shaherose Nanji,"

Phrase: "Robert Foster,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0242298:foster [Daily or Recreational Activity]
   861   C0344349:foster [Family Group]

Phrase: "Donald Kohn,"

Phrase: "Robert Shull,"

Phrase: "and"

Phrase: "Ian D."
Processing 00000000.tx.4: Dub From the Department of Laboratory Medicine, Sunnybrook Health Science Centre, and the Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; 

Phrase: "Dub From the Department of Laboratory Medicine,"

Phrase: "Sunnybrook Health Science Centre,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C0475309:Health center [Health Care Related Organization,Manufactured Object]
   812   C0205099:Center [Spatial Concept]

Phrase: "and"

Phrase: "the Department of Laboratory Medicine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Pathobiology,"

Phrase: "University of Toronto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Toronto,"

Phrase: "Ontario,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029040:Ontario [Geographic Area]

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ";"
Processing 00000000.tx.5: the Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada; 

Phrase: "the Department of Clinical Studies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "Ontario Veterinary College,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0557806:College [Manufactured Object]

Phrase: "University of Guelph,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Guelph,"

Phrase: "Ontario,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029040:Ontario [Geographic Area]

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ";"
Processing 00000000.tx.6: the Oncology Research Program, Toronto Hospital, Toronto, Ontario, Canada; 

Phrase: "the Oncology Research Program,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0683935:research program [Research Activity]
   827   C1709697:Program [Conceptual Entity]
   827   C2728259:Program [Pharmacologic Substance]
   827   C3484370:Program [Functional Concept]

Phrase: "Toronto Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "Toronto,"

Phrase: "Ontario,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029040:Ontario [Geographic Area]

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ";"
Processing 00000000.tx.7: Research Immunology and Bone Marrow Transplantation, Childrens Hospital Los Angeles, Los Angeles, CA; 

Phrase: "Research Immunology"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0152036:Immunology [Biomedical Occupation or Discipline]
   861   C1522005:immunology [Qualitative Concept]
   789 E C0205470:Immunological [Functional Concept]

Phrase: "and"

Phrase: "Bone Marrow Transplantation,"
Meta Candidates (Total=19; Excluded=5; Pruned=0; Remaining=14)
  1000   C0005961:Bone Marrow Transplantation [Therapeutic or Preventive Procedure]
           Marrow Transplantation
   913   C0005976:Bone Transplantation [Therapeutic or Preventive Procedure]
   901   C0005953:Bone Marrow [Tissue]
   827   C0029216:Transplantation [Therapeutic or Preventive Procedure]
   827   C0040732:Transplantation [Therapeutic or Preventive Procedure]
   827   C0040733:transplantation [Functional Concept]
   827   C0086590:Marrow [Food]
   827   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   827   C0376152:Marrow [Body Part, Organ, or Organ Component]
   827   C0391978:Bone [Tissue]
   827   C1266908:Bone [Body Part, Organ, or Organ Component]
   827   C1266909:Bone [Body System]
   827   C1546708:Marrow [Intellectual Product]
   771 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   771 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   771 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   755 E C0443157:Bony [Functional Concept]
   743 E C0330477:Marrows [Plant]

Phrase: "Childrens Hospital Los Angeles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024015:Los Angeles [Geographic Area]

Phrase: "Los Angeles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024015:Los Angeles [Geographic Area]

Phrase: "CA"

Phrase: ";"
Processing 00000000.tx.8: and the Department of Pathology, College of Veterinary Medicine, University of Tennessee, Knoxville, TN.  

Phrase: "and"

Phrase: "the Department of Pathology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0587487:Pathology department [Health Care Related Organization]
   770   C1704729:Department [Organization]

Phrase: "College of Veterinary Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0557806:College [Manufactured Object]

Phrase: "University of Tennessee,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0039514:Tennessee [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Knoxville,"

Phrase: "TN."
Processing 00000000.tx.9: ABSTRACT TOP ABSTRACT INTRODUCTION REFERENCES Canine -L-iduronidase (-ID) deficiency, a model of the human storage disorder mucopolysaccharidosis type I (MPS I), is an ideal system in which to evaluate the clinical benefit of genetically corrected hematopoietic stem cells. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1293116:Introduction [Health Care Activity]
   812   C1875307:INTRODUCTION [Manufactured Object]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Canine -L-iduronidase (-ID) deficiency,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0011155:Deficiency [Functional Concept]
   812   C0162429:Deficiency [Disease or Syndrome]
   812   C1623416:deficiency [Qualitative Concept]
   741 E C1636779:% deficient [Quantitative Concept]

Phrase: "a model of the human storage disorder mucopolysaccharidosis type I (MPS I),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0684309:disorder model [Experimental Model of Disease]
   739   C3161035:Model [Intellectual Product]

Phrase: "is"

Phrase: "an ideal system in which to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0449913:System [Functional Concept]
   753   C1553451:System [Manufactured Object]
   753   C1704459:System [Medical Device]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the clinical benefit of genetically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0814225:Benefit [Quantitative Concept]

Phrase: "corrected"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205202:Corrected [Qualitative Concept]
   966 E C2349182:Correct [Qualitative Concept]

Phrase: "hematopoietic stem cells."
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0018956:Hematopoietic stem cells [Cell]
   901   C0038250:Stem cells [Cell]
   896   C2323499:Hematopoietic cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0018957:Haematopoietic [Body System]
   827   C0229601:Hematopoietic [Functional Concept]
   827   C0242767:Stem [Plant]
   827   C1186763:Stem [Body Part, Organ, or Organ Component]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0018951:Haematopoiesis [Organ or Tissue Function]
Processing 00000000.tx.10: We performed adoptive transfer of genetically corrected autologous hematopoietic cells in dogs with -ID deficiency. 

Phrase: "We"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "adoptive transfer of genetically"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0376518:Adoptive Transfer [Therapeutic or Preventive Procedure]
   770   C0040671:Transfer [Mental Process]
   770   C1705822:Transfer [Activity]

Phrase: "corrected"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205202:Corrected [Qualitative Concept]
   966 E C2349182:Correct [Qualitative Concept]

Phrase: "autologous hematopoietic cells in dogs"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C2323499:Hematopoietic cell [Cell]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "with -ID deficiency."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0011155:Deficiency [Functional Concept]
   861   C0162429:Deficiency [Disease or Syndrome]
   861   C1623416:deficiency [Qualitative Concept]
   789 E C1636779:% deficient [Quantitative Concept]
Processing 00000000.tx.11: Large volume marrow collections were performed on five -ID-deficient dogs. 

Phrase: "Large volume marrow collections"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0600644:Collections [Intellectual Product]
   812   C1516698:Collection [Functional Concept]
   812   C1704814:Collection [Idea or Concept]
   729 E C1516695:Collected [Idea or Concept]

Phrase: "were"

Phrase: "performed on five -ID-deficient dogs."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0011155:Deficient [Functional Concept]
   753   C0012984:Dogs [Mammal]
   753   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0205451:Five [Quantitative Concept]
   753   C0884358:Performed [Functional Concept]
   753   C1280551:Dogs [Mammal]
   753   C1636779:% deficient [Quantitative Concept]
   719 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.12: Marrow mononuclear cells in long-term marrow cultures (LTMCs) were exposed on three occasions during 3weeks of culture to retroviral vectors bearing the normal canine -ID cDNA. 

Phrase: "Marrow mononuclear cells in long-term marrow cultures (LTMCs)"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0806987:Mononuclear cells [Cell]
   767   C0007585:cells cultures [Laboratory Procedure]
   744   C0007634:Cells [Cell]
   744   C1513475:Mononuclear [Clinical Attribute]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "exposed on three occasions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205449:Three [Quantitative Concept]
   770   C0332157:Exposed [Clinical Attribute]

Phrase: "during 3weeks"

Phrase: "of culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "to retroviral vectors"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1514926:retroviral vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0035366:Retroviral [Virus]
   861   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vectors [Spatial Concept]
   827 E C1705099:Vector [Idea or Concept]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "the normal canine -ID cDNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.13: Transduced LTMC cells from deficient dogs expressed enzymatically active -ID at 10to 200times the levels seen in normal dogs. 

Phrase: "Transduced LTMC cells from deficient dogs"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "expressed"

Phrase: "enzymatically active -ID at 10to 200times"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "the levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "seen in normal dogs."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0012984:Dogs [Mammal]
   770   C0205307:Normal [Qualitative Concept]
   770   C0205397:Seen [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C1280551:Dogs [Mammal]
   770   C2347086:% Normal [Quantitative Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]
Processing 00000000.tx.14: An average of 32% of LTMC-derived clonogenic hematopoietic cells were provirus positive by polymerase chain reaction and about half of these expressed -ID. 

Phrase: "An average of 32% of LTMC-derived clonogenic hematopoietic cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1510992:Average [Quantitative Concept]
   739   C2825518:AVERAGE [Quantitative Concept]

Phrase: "were"

Phrase: "provirus positive by polymerase chain reaction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0439178:% Positive [Quantitative Concept]
   753   C1446409:Positive [Qualitative Concept]
   753   C1514241:Positive [Finding]
   753   C2825490:Positive [Qualitative Concept]

Phrase: "and"

Phrase: "about half of these expressed -ID."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C2825407:Half [Quantitative Concept]
Processing 00000000.tx.15: Approximately 107 autologous gene-modified LTMC cells/kg were infused into nonmyeloablated recipients. 

Phrase: "Approximately 107 autologous gene-modified LTMC cells/kg"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0022718:KG [Geographic Area]
   793   C0439209:kg [Quantitative Concept]

Phrase: "were"

Phrase: "infused into nonmyeloablated recipients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1709854:Recipient [Human]
Processing 00000000.tx.16: Proviral DNA was detected in up to 10% of individual marrow-derived hematopoietic colonies and in 0.01% to 1% of blood and marrow leukocytes at up to 2to 3years postinfusion. 

Phrase: "Proviral DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "detected in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0442726:Detected [Finding]
   833   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "up to 10%"

Phrase: "of individual marrow-derived hematopoietic colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0439158:colonies [Quantitative Concept]
   771 E C1947989:Colony [Cell]

Phrase: "and in 0.01%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515981:And [Idea or Concept]

Phrase: "to 1%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "of blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "marrow leukocytes at"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   866   C0023516:Marrow leukocyte [Cell]
           Leukocytes

Phrase: "up to 2to 3years postinfusion."
Processing 00000000.tx.17: Despite good evidence for engraftment of provirally marked cells, neither -ID enzyme nor -ID transcripts were detected in any dog. 

Phrase: "Despite good evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "for engraftment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0301944:Engraftment [Physiologic Function]

Phrase: "of provirally marked cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "neither -ID enzyme nor -ID transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "detected in any dog."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0012984:Dog [Mammal]
   770   C0442726:Detected [Finding]
   770   C1280551:Dog [Mammal]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.18: We evaluated immune responses against -ID and transduced cells. 

Phrase: "We"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "immune responses against -ID"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0301872:immune responses [Organ or Tissue Function]
   770   C0439662:Immune [Functional Concept]
   770   C0871261:responses [Organism Attribute]
   737 E C1704632:Response [Finding]
   737 E C1706817:Response [Intellectual Product]
   737 E C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "transduced cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.19: Humoral responses to -ID and serum components of the culture media (fetal bovine and horse sera and bovine serum albumin) were identified by enzyme-linked immunosorbent assay. 

Phrase: "Humoral responses to -ID"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "serum components of the culture media"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0449432:Components [Manufactured Object]
   719 E C1705248:Component [Conceptual Entity]

Phrase: "(fetal bovine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0007452:Bovine [Mammal]
   861   C1140701:bovine [Mammal]

Phrase: "and"

Phrase: "horse sera"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   966   C1518416:Serum, Horse [Immunologic Factor]
   861   C0019944:Horse [Mammal]
   861   C0229671:Sera [Body Substance]
   861   C0242616:Horse [Mammal]
   861   C1151254:SerA [Molecular Function]
   861   C1265527:Horse [Mammal]
   827 E C1546774:Serum [Intellectual Product]
   827 E C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "bovine serum albumin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   901   C0728877:serum albumin [Laboratory or Test Result]
   827   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0007452:Bovine [Mammal]
   827   C0229671:Serum [Body Substance]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: ")"

Phrase: "were"

Phrase: "identified by enzyme-linked immunosorbent assay."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   882   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   783   C2717977:Enzyme Assay [Laboratory Procedure]
   753   C0005507:Assay [Laboratory Procedure]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   753   C0205396:Identified [Qualitative Concept]
   753   C0243073:assay [Qualitative Concept]
   753   C1510438:Assay [Laboratory Procedure]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]
   719   C1517892:Link [Intellectual Product]
   719   C1704666:Link [Intellectual Product]
Processing 00000000.tx.20: Cellular immune responses to autologous -ID but not neor transduced cells were demonstrated by lymphocyte proliferation assays. 

Phrase: "Cellular immune responses to autologous -ID"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C1817908:Immune Responses, Cellular [Cell Function]
   790   C0301872:immune responses [Organ or Tissue Function]
   753   C0007634:Cellular [Cell]
   753   C0178539:Cellular [Functional Concept]
   753   C0439662:Immune [Functional Concept]
   753   C0871261:responses [Organism Attribute]
   719 E C1704632:Response [Finding]
   719 E C1706817:Response [Intellectual Product]
   719 E C2911692:Response [Mental Process]

Phrase: "but"

Phrase: "not neor transduced cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "demonstrated by lymphocyte proliferation assays."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   828   C0201614:Lymphocyte Proliferation Assay [Laboratory Procedure]
   806   C0596873:lymphocyte proliferation [Cell Function]
   760   C0024264:Lymphocyte [Cell]
   760   C0334094:Proliferation [Pathologic Function]
   760   C1514485:Proliferation [Functional Concept]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.21: To abrogate potential immune phenomena, four affected dogs received posttransplant cyclosporine A.

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "abrogate"

Phrase: "potential immune phenomena,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1882365:Phenomena [Phenomenon or Process]

Phrase: "four affected dogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0012984:Dogs [Mammal]
   827   C1280551:Dogs [Mammal]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "posttransplant cyclosporine A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0010592:Cyclosporin A [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Ciclosporin
Processing 00000000.tx.22: Whereas immune responses were dampened in these dogs, -ID activity remained undetectable. 

Phrase: "Whereas"

Phrase: "immune responses"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0301872:immune responses [Organ or Tissue Function]
   861   C0439662:Immune [Functional Concept]
   861   C0871261:responses [Organism Attribute]
   827 E C1704632:Response [Finding]
   827 E C1706817:Response [Intellectual Product]
   827 E C2911692:Response [Mental Process]

Phrase: "were"

Phrase: "dampened in these dogs, -ID activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0012984:Dogs [Mammal]
   753   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1280551:Dogs [Mammal]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "remained"

Phrase: "undetectable."
Processing 00000000.tx.23: In none of the dogs engrafted with genetically corrected cells was there evidence for clinical improvement. 

Phrase: "In none"

Phrase: "of the dogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012984:Dogs [Mammal]
  1000   C1280551:Dogs [Mammal]

Phrase: "engrafted with genetically corrected cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   760   C0007634:Cells [Cell]
   760   C0205202:Corrected [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   726 E C2349182:Correct [Qualitative Concept]

Phrase: "was"

Phrase: "there evidence for clinical improvement."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]
Processing 00000000.tx.24: Our data suggest that, whereas the -ID cDNA may be transferred and maintained in approximately 5% of hematopoietic progenitors, the potential of this approach appears limited by the levels of provirally derived enzyme that are expressed in vivo and by the host's response to cultured and transduced hematopoietic cells expressing foreign proteins.  

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that,"

Phrase: "whereas"

Phrase: "the -ID cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "may"

Phrase: "be"

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "and"

Phrase: "maintained in approximately 5% of hematopoietic progenitors,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0018957:Haematopoietic [Body System]
   748   C0229601:Hematopoietic [Functional Concept]
   748   C0332232:Approximately [Qualitative Concept]
   748   C1314677:Maintained [Functional Concept]
   714 E C0024501:Maintain [Activity]
   714   C0870134:Progenitor [Family Group]

Phrase: "the potential of this approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3245505:Potential [Qualitative Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "limited by the levels of provirally derived enzyme"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   767   C0014440:enzyme levels [Laboratory Procedure]
   767   C1287349:enzyme levels [Laboratory or Test Result]
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0439801:Limited [Functional Concept]
   744   C0441889:Levels [Qualitative Concept]
   744   C1441547:Derived [Qualitative Concept]
   744   C3245521:derived [Idea or Concept]
   744   C3542948:Limited [Intellectual Product]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C1549649:Limit [Idea or Concept]
   711 E C2349209:Limit [Conceptual Entity]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "that"

Phrase: "are"

Phrase: "expressed"

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and by the host's response"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0301872:Host response [Organ or Tissue Function]
   760   C0871261:Response [Organism Attribute]
   760   C1167395:Host [Organism]
   760   C1515981:And [Idea or Concept]
   760   C1704632:Response [Finding]
   760   C1706817:Response [Intellectual Product]
   760   C2911692:Response [Mental Process]

Phrase: "to cultured"

Phrase: "and"

Phrase: "transduced hematopoietic cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   884   C2323499:Hematopoietic cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "foreign proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.25: 1999 by The American Society of Hematology.  

Phrase: "1999 by The American Society of Hematology."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C1515949:American Society of Hematology [Professional Society]
   748   C0018943:Haematology NOS [Biomedical Occupation or Discipline]
   748   C0037455:society [Organization]
   748   C0200627:HEMATOLOGY [Laboratory Procedure]
   748   C0596070:American [Population Group]
Processing 00000000.tx.26: INTRODUCTION TOP ABSTRACT INTRODUCTION REFERENCES GENE THERAPIES DELIVERED by hematopoietic stem cells (HSCs) offer several theoretical advantages over other methods of drug delivery. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "GENE THERAPIES"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0017296:gene therapies [Therapeutic or Preventive Procedure]
   861   C0017337:Gene [Gene or Genome]
   861   C0087111:therapies [Therapeutic or Preventive Procedure]
   827 E C0039798:therapy [Functional Concept]
   827 E C1363945:Therapy [Finding]

Phrase: "DELIVERED by hematopoietic stem cells (HSCs)"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   862   C0018956:Hematopoietic stem cells [Cell]
   806   C0038250:Stem cells [Cell]
   781   C2323499:Hematopoietic cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0018957:Haematopoietic [Body System]
   760   C0229601:Hematopoietic [Functional Concept]
   760   C0242767:Stem [Plant]
   760   C1186763:Stem [Body Part, Organ, or Organ Component]
   760   C1705822:Delivered [Activity]
   760   C3282337:Cells [Cell]
   726 E C0308779:DELIVER [Organic Chemical,Pharmacologic Substance]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1874964:DELIVER [Pharmacologic Substance]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "offer"

Phrase: "several theoretical advantages over other methods of drug delivery."
Processing 00000000.tx.27: These include long-term, regulated, in vivo production of a wide variety of therapeutic agents derived from DNA permanently integrated into the genomes of cells with life-long capacities for extensive proliferation and multilineage differentiation.1 Recent progress towards this goal has been tenuous, with apparent advances generally followed by the identification of largely unforeseen obstacles. 

Phrase: "These"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "long-term,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0443252:Long-term [Temporal Concept]
   861   C0205166:Long [Qualitative Concept]
   861   C1515273:Term [Temporal Concept]
   861   C1705313:Term [Idea or Concept]
   861   C1706317:Long [Qualitative Concept]
   861   C2826302:TERM [Intellectual Product]

Phrase: "regulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: ","

Phrase: "in vivo production of a wide variety of therapeutic agents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0033268:production [Occupational Activity]

Phrase: "derived from DNA permanently"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]

Phrase: "integrated into the genomes of cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   753   C0007634:Cells [Cell]
   753   C0017428:Genomes [Gene or Genome]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
   719 E C2338314:Genome [Conceptual Entity]

Phrase: "with life-long capacities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1516240:Capacity [Quantitative Concept]

Phrase: "for extensive proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0334094:Proliferation [Pathologic Function]
   861   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "multilineage differentiation.1 Recent progress towards this goal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1272688:progress [Functional Concept]
   744   C1280477:Progress [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "tenuous,"

Phrase: "with apparent advances generally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0725066:Advance [Medical Device]

Phrase: "followed by the identification of largely unforeseen obstacles."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0332283:Followed by [Temporal Concept]
           followed
   744   C0020792:Identification [Mental Process]
   744   C0205396:Identification [Qualitative Concept]
   711 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.28: To date there is limited evidence that genetically modified HSCs can actually be of therapeutic benefit in human disease or in large animal models.2-4 Over the last decade, several approaches have been taken to develop HSCs as efficient vehicles for gene delivery. 

Phrase: "To date there"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011008:Date [Temporal Concept]
   861   C2348077:Date [Food]

Phrase: "is"

Phrase: "limited"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0439801:Limited [Functional Concept]
  1000   C3542948:Limited [Intellectual Product]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that genetically"

Phrase: "modified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]

Phrase: "HSCs"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0018956:Hematopoietic stem cells [Cell]
   901   C0038250:Stem cells [Cell]
   896   C2323499:Hematopoietic cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0018957:Haematopoietic [Body System]
   827   C0229601:Hematopoietic [Functional Concept]
   827   C0242767:Stem [Plant]
   827   C1186763:Stem [Body Part, Organ, or Organ Component]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0018951:Haematopoiesis [Organ or Tissue Function]

Phrase: "can"

Phrase: "actually"

Phrase: "be of therapeutic benefit"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039796:Therapeutic [Therapeutic or Preventive Procedure]
   770   C0302350:Therapeutic [Functional Concept]
   770   C0814225:Benefit [Quantitative Concept]
   770   C2987476:Be [Conceptual Entity]

Phrase: "in human disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "or in large animal models.2-4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0599779:Models, Animal [Animal]
   748   C0003062:Animal [Animal]
   748   C0549177:Large [Quantitative Concept]
   748   C3161035:Models [Intellectual Product]

Phrase: "Over the last decade,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2981279:Decade [Quantitative Concept]

Phrase: "several approaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449445:Approaches [Spatial Concept]
   861   C1292724:Approaches [Functional Concept]

Phrase: "have"

Phrase: "been"

Phrase: "taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "develop"

Phrase: "HSCs as efficient vehicles"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   833   C0018956:Hematopoietic stem cells [Cell]
   790   C0038250:Stem cells [Cell]
   767   C2323499:Hematopoietic cell [Cell]
   753   C0007634:Cells [Cell]
   753   C0018957:Haematopoietic [Body System]
   753   C0229601:Hematopoietic [Functional Concept]
   753   C0242767:Stem [Plant]
   753   C1186763:Stem [Body Part, Organ, or Organ Component]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "for gene delivery."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0872177:gene delivery [Genetic Function]
  1000   C1524066:Gene Delivery [Conceptual Entity]
   861   C0011209:Delivery [Therapeutic or Preventive Procedure]
   861   C0559563:delivery [Finding]
   861   C1705822:Delivery [Activity]
Processing 00000000.tx.29: These include the use of HSC-enriched cell target populations5 and methods for selecting gene-modified HSCs.6 One recurring concern is that HSCs, in contrast to their committed progeny, appear to express low levels of the receptor required for successful gene transfer mediated by the retroviral vectors used in most applications.7 Another problem limiting practical applications of HSC gene transfer is that the vast majority of HSCs are likely to be quiescent8 and consequently resistant to stable gene transfer. 

Phrase: "These"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the use of HSC-enriched cell target populations5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1524063:Use of [Functional Concept]
   744   C0042153:use [Functional Concept]
   744   C0457083:Use [Functional Concept]
   744   C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "methods for selecting gene-modified HSCs.6 One recurring concern"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   736   C0025663:Methods [Intellectual Product]
   736   C0025664:methods [Intellectual Product]
   736   C0449851:Methods [Functional Concept]
   703 E C0871511:METHOD [Intellectual Product]

Phrase: "is"

Phrase: "that HSCs,"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0018956:Hematopoietic stem cells [Cell]
   901   C0038250:Stem cells [Cell]
   896   C2323499:Hematopoietic cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0018957:Haematopoietic [Body System]
   827   C0229601:Hematopoietic [Functional Concept]
   827   C0242767:Stem [Plant]
   827   C1186763:Stem [Body Part, Organ, or Organ Component]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0018951:Haematopoiesis [Organ or Tissue Function]

Phrase: "in contrast to their committed progeny,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0680063:Progeny [Family Group]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "express"

Phrase: "low levels of the receptor"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "required for successful gene transfer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1517499:Gene Transfer [Molecular Biology Research Technique]
   760   C0017337:Gene [Gene or Genome]
   760   C0040671:Transfer [Mental Process]
   760   C1272703:Successful [Qualitative Concept]
   760   C1514873:Required [Functional Concept]
   760   C1705822:Transfer [Activity]

Phrase: "mediated by the retroviral vectors"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C1514926:retroviral vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0035366:Retroviral [Virus]
   760   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0442335:Vectors [Spatial Concept]
   726 E C1705099:Vector [Idea or Concept]

Phrase: "used in most applications.7"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
   760   C0185125:applications [Health Care Activity]
   760   C1273517:used [Finding]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947919:Application [Intellectual Product]
   726 E C1947944:Use [Intellectual Product]
   726 E C2347934:Application [Intellectual Product]
   726 E C3539080:APPLICATION [Quantitative Concept]

Phrase: "Another problem"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033213:Problem [Finding]

Phrase: "limiting"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0439801:limiting [Functional Concept]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]

Phrase: "practical applications of HSC gene transfer"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0185125:applications [Health Care Activity]
   719 E C1947919:Application [Intellectual Product]
   719 E C2347934:Application [Intellectual Product]
   719 E C3539080:APPLICATION [Quantitative Concept]

Phrase: "is"

Phrase: "that"

Phrase: "the vast majority of HSCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0680220:majority [Social Behavior]

Phrase: "are"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "quiescent8"

Phrase: "and"

Phrase: "consequently resistant to stable gene transfer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332325:Resistant to [Functional Concept]
           Resistant
   753   C2827757:RESISTANT [Laboratory or Test Result]
Processing 00000000.tx.30: Furthermore, the likelihood that any given gene-modified HSC would be among the small minority that actually undergo expansion in vivo under steady-state conditions seems remote.9 We focused on gene transfer to candidate HSCs in in vitro hematopoietic microenvironments, because it seemed logical that under the correct culture conditions HSCs may be induced to exit quiescence and enter the cell cycle. 

Phrase: "Furthermore,"

Phrase: "the likelihood"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0033204:Likelihood [Quantitative Concept]
   928 E C0332148:Likely [Qualitative Concept]
   928 E C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "any given gene-modified HSC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1523748:HSC [Cell Component]
   812   C1705576:HSC [Therapeutic or Preventive Procedure]

Phrase: "would"

Phrase: "be among the small minority"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0026192:Minority [Population Group]
   760   C0700321:Small [Quantitative Concept]
   760   C2987476:Be [Conceptual Entity]

Phrase: "that actually"

Phrase: "undergo"

Phrase: "expansion"

Phrase: "in vivo under steady-state conditions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "seems"

Phrase: "remote.9"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205157:Remote [Spatial Concept]
   861   C0443203:Remote [Spatial Concept]
   861   C1550013:remote [Idea or Concept]

Phrase: "We"

Phrase: "focused on gene transfer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1517499:Gene Transfer [Molecular Biology Research Technique]
   770   C0017337:Gene [Gene or Genome]
   770   C0040671:Transfer [Mental Process]
   770   C0205234:Focused [Spatial Concept]
   770   C1285542:focused [Functional Concept]
   770   C1705822:Transfer [Activity]

Phrase: "to candidate HSCs"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   923   C0018956:Hematopoietic stem cells [Cell]
   861   C0038250:Stem cells [Cell]
   858   C2323499:Hematopoietic cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0018957:Haematopoietic [Body System]
   812   C0229601:Hematopoietic [Functional Concept]
   812   C0242767:Stem [Plant]
   812   C1186763:Stem [Body Part, Organ, or Organ Component]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   741 E C0018951:Haematopoiesis [Organ or Tissue Function]

Phrase: "in in vitro hematopoietic microenvironments,"

Phrase: "because"

Phrase: "it"

Phrase: "seemed"

Phrase: "logical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0023963:Logic [Idea or Concept]

Phrase: "that under the correct culture"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0010453:Culture [Idea or Concept]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C2242979:Culture [Laboratory Procedure]
   760   C2349182:Correct [Qualitative Concept]

Phrase: "conditions"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   944 E C0040607:Training [Educational Activity]
   944 E C0220931:Training [Educational Activity]
   944 E C0336809:Train [Manufactured Object]
   944 E C1552514:Train [Manufactured Object]
   944 E C2673163:training [Qualitative Concept]
   916 E C0009647:Conditioned [Mental Process]

Phrase: "HSCs"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0018956:Hematopoietic stem cells [Cell]
   901   C0038250:Stem cells [Cell]
   896   C2323499:Hematopoietic cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0018957:Haematopoietic [Body System]
   827   C0229601:Hematopoietic [Functional Concept]
   827   C0242767:Stem [Plant]
   827   C1186763:Stem [Body Part, Organ, or Organ Component]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0018951:Haematopoiesis [Organ or Tissue Function]

Phrase: "may"

Phrase: "be"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0337094:Exit [Spatial Concept]
  1000   C1550550:exit [Temporal Concept]

Phrase: "quiescence"

Phrase: "and"

Phrase: "enter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522196:ENTER [Functional Concept]

Phrase: "the cell cycle."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007586:Cell Cycle [Cell Function]
  1000   C1155839:Cell Cycle [Cell Function]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1511572:Cycle [Temporal Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.31: Data from our studies10,11 and from others12-14 demonstrated that exposure of hematopoietic cells to retroviral vectors in the presence of marrow-derived stromal cells facilitated reporter gene transfer into a high proportion of committed progenitors. 

Phrase: "Data from our studies10,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]

Phrase: "11"

Phrase: "and from others12-14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515981:And [Idea or Concept]

Phrase: "demonstrated"

Phrase: "that exposure of hematopoietic cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0274281:Exposure, NOS [Injury or Poisoning]
   760   C0332157:Exposure [Clinical Attribute]

Phrase: "to retroviral vectors"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1514926:retroviral vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0035366:Retroviral [Virus]
   861   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vectors [Spatial Concept]
   827 E C1705099:Vector [Idea or Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of marrow-derived stromal cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   861   C0162597:Stromal Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   808 E C0596291:stroma cell [Cell Component]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   741   C0927195:Stroma [Body Part, Organ, or Organ Component]

Phrase: "facilitated"

Phrase: "reporter gene transfer into a high proportion of committed progenitors."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0206414:Reporter Gene [Gene or Genome]
   760   C1517499:Gene Transfer [Molecular Biology Research Technique]
   739   C0017337:Gene [Gene or Genome]
   739   C0040671:Transfer [Mental Process]
   739   C1705822:Transfer [Activity]
Processing 00000000.tx.32: In a canine model system, autologous marrow transduced by multiple exposures to retroviral vectors in long-term marrow cultures (LTMCs) engrafted in the absence of myeloablative conditioning and gave rise to reporter gene-marked committed progeny that were maintained at approximately 5% levels for up to 2years.11 Similar results were more recently obtained from a human clinical trial of LTMC stem cell gene marking in multiple myeloma.15 These studies suggested that, although the goal of achieving large populations of genetically modified hematopoietic cells in vivo remains elusive, the levels of gene transfer achievable using current technology may alleviate disease symptoms in certain deficiency disorders. 

Phrase: "In a canine model system,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0026339:Model System [Intellectual Product,Research Device]
   901   C3161035:Model System [Intellectual Product]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "autologous marrow"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0086590:Marrow [Food]
   861   C0376152:Marrow [Body Part, Organ, or Organ Component]
   861   C1546708:Marrow [Intellectual Product]
   805 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   805 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   805 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   777 E C0330477:Marrows [Plant]

Phrase: "transduced by multiple exposures"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0274281:exposures [Injury or Poisoning]
   770   C0439064:Multiple [Quantitative Concept]
   770   C0728853:exposures [Phenomenon or Process]
   737 E C0332157:Exposure [Clinical Attribute]

Phrase: "to retroviral vectors"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1514926:retroviral vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0035366:Retroviral [Virus]
   861   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vectors [Spatial Concept]
   827 E C1705099:Vector [Idea or Concept]

Phrase: "in long-term marrow cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0010453:Cultures [Idea or Concept]
   779 E C0220814:culture [Functional Concept]
   779 E C0430400:Culture [Laboratory Procedure]
   779 E C2242979:Culture [Laboratory Procedure]

Phrase: "(LTMCs"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0010453:Cultures [Idea or Concept]
   779 E C0220814:culture [Functional Concept]
   779 E C0430400:Culture [Laboratory Procedure]
   779 E C2242979:Culture [Laboratory Procedure]

Phrase: ")"

Phrase: "engrafted in the absence of myeloablative conditioning"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0009647:Conditioning [Mental Process]
   748   C0332197:absence [Quantitative Concept]
   748   C1689985:Absence [Anatomical Abnormality]

Phrase: "and"

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "rise to reporter gene-"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: "committed progeny"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0680063:Progeny [Family Group]

Phrase: "that"

Phrase: "were"

Phrase: "maintained at approximately 5% levels"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   781   C0456951:Level 5 [Qualitative Concept]
   760   C0332232:Approximately [Qualitative Concept]
   760   C0441889:Levels [Qualitative Concept]
   760   C1314677:Maintained [Functional Concept]
   726 E C0024501:Maintain [Activity]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "for"

Phrase: "up to 2years.11 Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C1274040:Result [Functional Concept]
   779   C1546471:Result [Idea or Concept]
   779   C2825142:Result [Finding]

Phrase: "were"

Phrase: "more recently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0332185:Recently [Temporal Concept]

Phrase: "obtained from a human clinical trial of LTMC stem cell gene marking"
Meta Candidates (Total=19; Excluded=1; Pruned=0; Remaining=18)
   753   C0008976:Clinical Trial [Research Activity]
           Trial
   753   C0038250:Stem cell [Cell]
   753   C1096775:Clinical Trial [Intellectual Product]
   753   C1861886:CELL Gene [Gene or Genome]
   751   C0314604:Human gene [Gene or Genome]
   751   C0427861:cell human [Laboratory or Test Result]
   736   C0007634:Cell [Cell]
   736   C0017337:Gene [Gene or Genome]
   736   C0086418:Human [Human]
   736   C0205210:Clinical [Qualitative Concept]
   736   C0242767:Stem [Plant]
   736   C0522501:marking [Qualitative Concept]
   736   C1186763:Stem [Body Part, Organ, or Organ Component]
   736   C1269647:Cell [Cell]
   736   C1301820:Obtained [Functional Concept]
   736   C1704653:Cell [Medical Device]
   736   C1948049:Cell [Spatial Concept]
   703 E C1706701:Obtain [Activity]

Phrase: "in multiple myeloma.15"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   827   C0439064:Multiple [Quantitative Concept]
   827   C3538749:Myeloma [Intellectual Product]

Phrase: "These studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that,"

Phrase: "although"

Phrase: "the goal of achieving large populations of genetically"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0018017:Goal [Intellectual Product]
   744   C1571704:Goal [Idea or Concept]

Phrase: "modified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]

Phrase: "hematopoietic cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C2323499:Hematopoietic cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "remains"

Phrase: "elusive,"

Phrase: "the levels of gene transfer"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "achievable"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "current technology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:Technology [Occupation or Discipline]

Phrase: "may"

Phrase: "alleviate"

Phrase: "disease symptoms in certain deficiency disorders."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0683368:symptoms [Functional Concept]
   753   C1457887:Symptoms [Sign or Symptom]
Processing 00000000.tx.33: To evaluate the therapeutic benefit of low and sustained levels of genetically modified hematopoietic cells, we attempted gene therapy for canine -L-iduronidase (-ID) deficiency. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the therapeutic benefit of low"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0814225:Benefit [Quantitative Concept]

Phrase: "and"

Phrase: "sustained levels of genetically"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "modified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]

Phrase: "hematopoietic cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C2323499:Hematopoietic cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "we"

Phrase: "attempted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1516084:Attempt [Event]

Phrase: "gene therapy for canine -L-iduronidase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0017296:gene therapy [Therapeutic or Preventive Procedure]
   753   C0017337:Gene [Gene or Genome]
   753   C0039798:therapy [Functional Concept]
   753   C0087111:Therapy [Therapeutic or Preventive Procedure]
   753   C1363945:Therapy [Finding]

Phrase: "(-ID"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "deficiency."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0011155:Deficiency [Functional Concept]
  1000   C0162429:Deficiency [Disease or Syndrome]
  1000   C1623416:deficiency [Qualitative Concept]
   928 E C1636779:% deficient [Quantitative Concept]
Processing 00000000.tx.34: In this autosomal recessive disorder there is a complete deficiency of -ID due to a single base substitution in the -ID gene that disrupts intron I splicing and gives rise to a stop codon.16,17 Dogs homozygous for the -ID mutation do not have any -ID enzyme as determined by either -ID activity or immunoprecipitation.18 The -ID deficiency results in lysosomal storage of large amounts of the glycosaminoglycans (GAGs) heparan and dermatan sulfate in many tissues, including the central nervous system.16,19 -ID-deficient dogs are clinically similar to human patients with the Hurler/Scheie phenotype of mucopolysaccharidosis type I (MPS I) and exhibit progressive cardiac abnormalities, corneal clouding, stunted growth, and degenerative joint disease, all of which progress to severe states within 2to 3years.16,19 We hypothesized that canine -ID deficiency would be an ideal model system to evaluate the potential clinical benefit of low numbers of genetically corrected hematopoietic cells for the following reasons: the disorder is a single gene defect for which the canine cDNA is cloned; 

Phrase: "In this autosomal recessive disorder there"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0012634:Disorder [Disease or Syndrome]

Phrase: "is"

Phrase: "a complete deficiency of -ID due to a single base substitution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in the -ID gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "that"

Phrase: "disrupts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "intron I splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035687:Splicing [Genetic Function]
   827   C2610186:splicing [Genetic Function]

Phrase: "and"

Phrase: "gives"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "rise to a stop codon.16,"

Phrase: "17 Dogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0012984:Dogs [Mammal]
   861   C1280551:Dogs [Mammal]

Phrase: "homozygous for the -ID mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0019904:Homozygous [Organism Attribute]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "any -ID enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "as"

Phrase: "determined by either -ID activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "or"

Phrase: "immunoprecipitation.18"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "The -ID deficiency"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0011155:Deficiency [Functional Concept]
   861   C0162429:Deficiency [Disease or Syndrome]
   861   C1623416:deficiency [Qualitative Concept]
   789 E C1636779:% deficient [Quantitative Concept]

Phrase: "results in lysosomal storage of large amounts of the glycosaminoglycans (GAGs) heparan"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   738   C0017973:Glycosaminoglycans [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   738   C0337174:Storage [Spatial Concept]
   738   C0521450:Lysosomal [Body Location or Region]
   738   C0549177:Large [Quantitative Concept]
   738   C1265611:amounts [Quantitative Concept]
   738   C1274040:Result [Functional Concept]
   738   C1546471:Result [Idea or Concept]
   738   C1698986:Storage [Functional Concept]
   738   C1753314:storage [Cell Component]
   738   C2327880:Heparan [Biologically Active Substance]
   738   C2825142:Result [Finding]
   704 E C3536869:Glycosaminoglycan [Pharmacologic Substance]

Phrase: "and"

Phrase: "dermatan sulfate in many tissues,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0011602:Dermatan Sulfate [Biologically Active Substance,Carbohydrate]
           Dermatan
   760   C0038720:Sulfate [Inorganic Chemical]
   760   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   760   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the central nervous system.16,"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   923   C0927232:Central Nervous System [Body System]
   923   C1269563:Central nervous system [Body System]
   861   C0027763:Nervous System [Body System]
   861   C0422837:NERVOUS SYSTEM [Finding]
   861   C1269560:Nervous system [Body System]
   812   C0027769:Nervous [Sign or Symptom]
   812   C0205099:Central [Spatial Concept]
   812   C0449913:System [Functional Concept]
   812   C0599851:Nervous [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   812   C1879652:Central - [Laboratory Procedure]
   805 E C0205494:Neurologic [Qualitative Concept]
   768 E C0027855:Neurology [Biomedical Occupation or Discipline]
   750 E C2707261:Neurological [Clinical Attribute]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "19 -ID-deficient dogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0012984:Dogs [Mammal]
   812   C1280551:Dogs [Mammal]

Phrase: "are"

Phrase: "clinically similar to human patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "with the Hurler/Scheie phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031437:Phenotype [Organism Attribute]
   827   C1285572:Phenotype [Laboratory Procedure]

Phrase: "of mucopolysaccharidosis type I"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0023786:Mucopolysaccharidosis Type I [Disease or Syndrome]
           Mucopolysaccharidosis I
   901   C0441729:Type I [Classification]
   827   C0021966:I- [Inorganic Chemical]
   827   C0026703:Mucopolysaccharidosis [Disease or Syndrome]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(MPS I"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0023786:Mucopolysaccharidosis Type I [Disease or Syndrome]
           Mucopolysaccharidosis I
   901   C0441729:Type I [Classification]
   827   C0021966:I- [Inorganic Chemical]
   827   C0026703:Mucopolysaccharidosis [Disease or Syndrome]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "progressive cardiac abnormalities,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   901   C0018798:Cardiac abnormalities [Congenital Abnormality]
   827   C0000768:Abnormalities [Congenital Abnormality]
   827   C0000769:abnormalities [Functional Concept]
   793 E C1704258:Abnormality [Finding]
   743 E C0205161:Abnormal [Qualitative Concept]
   743 E C2347472:% Abnormal [Quantitative Concept]
   743 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "corneal clouding,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0010038:Corneal clouding [Finding]
   861   C0010031:Corneal [Body Part, Organ, or Organ Component]
   789 E C1278889:Cornea [Body Part, Organ, or Organ Component]

Phrase: "stunted"

Phrase: "growth,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018270:'growth' NOS [Organism Function]
  1000   C0220844:growth [Physiologic Function]
  1000   C1621966:Growth [Organ or Tissue Function]
  1000   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "degenerative joint disease,"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
  1000   C0029408:Degenerative joint disease [Disease or Syndrome]
   913   C1285162:Degenerative Disease [Disease or Syndrome]
   901   C0022408:Joint disease [Disease or Syndrome]
   827   C0011164:Degenerative [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0022417:Joint [Body Space or Junction]
   827   C0392905:Joint, NOS [Body System]
   827   C1269611:Joint [Body Space or Junction]
   827   C1706309:Joint [Medical Device]
   827   C1880269:Degenerative [Functional Concept]
   771 E C0521339:Articular [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "all of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0444868:All [Quantitative Concept]
   790   C3539085:All [Idea or Concept]

Phrase: "progress to severe states"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0205082:Severe [Qualitative Concept]
   770   C1272688:progress [Functional Concept]
   770   C1280477:Progress [Functional Concept]
   770   C1301808:states [Geographic Area]
   737 E C1442792:State [Functional Concept]
   737 E C3148680:State [Geographic Area]

Phrase: "within 2to 3years.16,"

Phrase: "19"

Phrase: "We"

Phrase: "hypothesized"

Phrase: "that canine -ID deficiency"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0011155:Deficiency [Functional Concept]
   827   C0162429:Deficiency [Disease or Syndrome]
   827   C1623416:deficiency [Qualitative Concept]
   755 E C1636779:% deficient [Quantitative Concept]

Phrase: "would"

Phrase: "be"

Phrase: "an ideal model system to"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0026339:Model System [Intellectual Product,Research Device]
   861   C3161035:Model System [Intellectual Product]
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the potential clinical benefit of low numbers of genetically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0814225:Benefit [Quantitative Concept]

Phrase: "corrected"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205202:Corrected [Qualitative Concept]
   966 E C2349182:Correct [Qualitative Concept]

Phrase: "hematopoietic cells for the following reasons"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   773   C2323499:Hematopoietic cell [Cell]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "the disorder"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012634:Disorder [Disease or Syndrome]

Phrase: "is"

Phrase: "a single gene defect for which"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0037176:Single gene defect [Disease or Syndrome]
   783   C0079429:A Gene [Gene or Genome]
   753   C0017337:Gene [Gene or Genome]
   753   C0037179:Single [Population Group]
   753   C0087136:single [Finding]
   753   C0205171:Single [Quantitative Concept]
   753   C1457869:Defect [Functional Concept]
   753   C1861101:DEFECT [Disease or Syndrome]

Phrase: "the canine cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: ";"
Processing 00000000.tx.35: there is a wide range of enzyme levels compatible with a normal or mild phenotype; 

Phrase: "there"

Phrase: "is"

Phrase: "a wide range of enzyme levels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1514721:Range [Quantitative Concept]
   753   C2348147:Range [Quantitative Concept]
   753   C3542016:Range [Intellectual Product]

Phrase: "compatible with a normal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332290:compatible [Idea or Concept]
   770   C1524057:Compatible [Qualitative Concept]

Phrase: "or"

Phrase: "mild phenotype"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1855585:Mild phenotype [Finding]
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.36: matched, related bone marrow transplantation is of known clinical benefit in affected dogs20; 

Phrase: "matched"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150103:matched [Research Activity]
  1000   C1708943:Matched [Qualitative Concept]

Phrase: ","

Phrase: "related bone marrow transplantation"
Meta Candidates (Total=19; Excluded=5; Pruned=0; Remaining=14)
   923   C0005961:Bone Marrow Transplantation [Therapeutic or Preventive Procedure]
           Marrow Transplantation
   875   C0005976:Bone Transplantation [Therapeutic or Preventive Procedure]
   861   C0005953:Bone Marrow [Tissue]
   812   C0029216:Transplantation [Therapeutic or Preventive Procedure]
   812   C0040732:Transplantation [Therapeutic or Preventive Procedure]
   812   C0040733:transplantation [Functional Concept]
   812   C0086590:Marrow [Food]
   812   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   812   C0376152:Marrow [Body Part, Organ, or Organ Component]
   812   C0391978:Bone [Tissue]
   812   C1266908:Bone [Body Part, Organ, or Organ Component]
   812   C1266909:Bone [Body System]
   812   C1546708:Marrow [Intellectual Product]
   756 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   756 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   756 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   741 E C0443157:Bony [Functional Concept]
   729 E C0330477:Marrows [Plant]

Phrase: "is of known clinical benefit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205210:Clinical [Qualitative Concept]
   760   C0205309:Known [Qualitative Concept]
   760   C0814225:Benefit [Quantitative Concept]

Phrase: "in affected dogs20"

Phrase: ";"
Processing 00000000.tx.37: and enzyme replacement using a human recombinant product is of clinical benefit, despite the development of complement-activating antibodies.21,22 In this study we infused five homozygous affected -ID-deficient pups with autologous marrow genetically corrected to express high levels of functional -ID. 

Phrase: "and"

Phrase: "enzyme replacement"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035139:Replacement [Therapeutic or Preventive Procedure]
   861   C0559956:Replacement [Functional Concept]
   861   C1555302:Replacement [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a human recombinant product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1514468:product [Entity]
   827   C1704444:Product [Quantitative Concept]

Phrase: "is of clinical benefit,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205210:Clinical [Qualitative Concept]
   770   C0814225:Benefit [Quantitative Concept]

Phrase: "despite the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of complement-activating antibodies.21,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0009498:Complement [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C1879547:activating [Activity]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   779 E C1515877:Activate [Functional Concept]

Phrase: "22 In this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "infused"

Phrase: "five homozygous affected -ID-deficient pups with autologous marrow genetically"

Phrase: "corrected"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205202:Corrected [Qualitative Concept]
   966 E C2349182:Correct [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "express"

Phrase: "high levels of functional -ID."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.38: Our results demonstrate that long-lived hematopoietic progenitor cells, genetically modified ex vivo, engraft and are maintained in vivo at levels thought to be clinically relevant. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that long-lived hematopoietic progenitor cells,"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   884   C0018956:Progenitor Cells, Hematopoietic [Cell]
   840   C0038250:Progenitor Cells [Cell]
   836   C2323499:Hematopoietic cell [Cell]
   804   C0007634:Cells [Cell]
   804   C0018957:Haematopoietic [Body System]
   804   C0229601:Hematopoietic [Functional Concept]
   804   C0870134:Progenitor [Family Group]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   733 E C0018951:Haematopoiesis [Organ or Tissue Function]

Phrase: "genetically"

Phrase: "modified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]

Phrase: "ex vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2348480:ex vivo [Functional Concept]
   861   C1515655:vivo [Spatial Concept]

Phrase: "engraft"

Phrase: "and"

Phrase: "are"

Phrase: "maintained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1314677:Maintained [Functional Concept]
   966 E C0024501:Maintain [Activity]

Phrase: "in vivo at levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "clinically relevant."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347946:Relevant [Qualitative Concept]
Processing 00000000.tx.39: However, their utility in gene therapy for deficiency states is likely limited by both the low expression level of the transgene and normal host immune responses to foreign proteins and cultured transduced cells. 

Phrase: "However,"

Phrase: "their utility in gene therapy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0582205:utility [Organization]

Phrase: "for deficiency states"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   983   C0162429:Deficiency state [Disease or Syndrome]
   861   C1301808:states [Geographic Area]
   827 E C1442792:State [Functional Concept]
   827 E C3148680:State [Geographic Area]

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "limited by both"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0439801:Limited [Functional Concept]
   790   C3542948:Limited [Intellectual Product]
   756 E C1549649:Limit [Idea or Concept]
   756 E C2349209:Limit [Conceptual Entity]

Phrase: "the low expression level of the transgene"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C3244092:expression level [Idea or Concept]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "normal host immune responses to foreign proteins"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   793   C2611460:response to host [Cell Function]
   778   C0301872:immune responses [Organ or Tissue Function]
           Host response
   748   C0439662:Immune [Functional Concept]
   748   C0871261:responses [Organism Attribute]
   714 E C1704632:Response [Finding]
   714 E C1706817:Response [Intellectual Product]
   714 E C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "cultured"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0010453:Culture [Idea or Concept]
   966   C0220814:culture [Functional Concept]
   966   C0430400:Culture [Laboratory Procedure]
   966   C2242979:Culture [Laboratory Procedure]

Phrase: "transduced cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.40: Such responses may be exacerbated when gene-modified autografts contain large numbers of antigen-presenting cells and their precursors, such as cultured marrow cells.  

Phrase: "Such responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0871261:responses [Organism Attribute]
   966 E C1704632:Response [Finding]
   966 E C1706817:Response [Intellectual Product]
   966 E C2911692:Response [Mental Process]

Phrase: "may"

Phrase: "be"

Phrase: "exacerbated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0436331:Exacerbated [Finding]
  1000   C1444749:Exacerbated [Qualitative Concept]

Phrase: "when"

Phrase: "gene-modified autografts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0040736:autografts [Therapeutic or Preventive Procedure]
   827   C0559189:Autografts [Biomedical or Dental Material]
   734   C1517476:Gene-Modified [Qualitative Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "large numbers of antigen-presenting cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0007584:Cell Number [Laboratory Procedure]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "their precursors,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1709634:Precursor [Idea or Concept]

Phrase: "such as cultured marrow cells."
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
   913   C0007600:cultured cells [Cell]
   913   C0007635:Cultured Cells [Cell]
   913   C3282338:Cells, Cultured [Cell]
   827   C0007634:Cells [Cell]
   827   C0086590:Marrow [Food]
   827   C0376152:Marrow [Body Part, Organ, or Organ Component]
   827   C1546708:Marrow [Intellectual Product]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   771 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   771 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   771 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   743 E C0330477:Marrows [Plant]
Processing 00000000.tx.41: MATERIALS AND METHODS Dogs and marrow harvests.  

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS Dogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0012984:Dogs [Mammal]
   861   C1280551:Dogs [Mammal]

Phrase: "and"

Phrase: "marrow harvests."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1512335:Harvest [Health Care Activity]
Processing 00000000.tx.42: The MPS I dogs used in this study were bred and maintained at the University of Guelph's Central Animal Facility (Guelph, Ontario, Canada) and were not treated with -ID enzyme before this study. 

Phrase: "The MPS I dogs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0012984:Dogs [Mammal]
   812   C1280551:Dogs [Mammal]
   756   C0023786:Mucopolysaccharidosis Type I [Disease or Syndrome]
           Mucopolysaccharidosis I

Phrase: "used in this study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "bred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0006159:breed [Organism Function]
   966   C1704650:Breed [Classification]

Phrase: "and"

Phrase: "maintained at the University of Guelph's Central Animal Facility"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   764   C0872329:animal facility [Manufactured Object]
   742   C0003062:Animal [Animal]
   742   C0041740:University [Manufactured Object,Organization]
   742   C0205099:Central [Spatial Concept]
   742   C1314677:Maintained [Functional Concept]
   742   C1547538:Facility [Idea or Concept]
   742   C1879652:Central - [Laboratory Procedure]
   708 E C0024501:Maintain [Activity]

Phrase: "(Guelph,"

Phrase: "Ontario,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029040:Ontario [Geographic Area]

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "treated with -ID enzyme"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0014442:Enzyme [Enzyme,Organic Chemical]
   770   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "before this study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]
Processing 00000000.tx.43: The animal care and bioethics committees of the Universities of Toronto and Guelph approved all protocols. 

Phrase: "The animal care"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0178478:animal care [Occupation or Discipline]
   861   C1947933:Care [Activity]

Phrase: "and"

Phrase: "bioethics committees of the Universities of Toronto"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2699414:Committee [Group]

Phrase: "and"

Phrase: "Guelph"

Phrase: "approved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205540:Approved [Qualitative Concept]

Phrase: "all protocols."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0442711:Protocols [Intellectual Product]
   966 E C1507394:Protocol [Intellectual Product]
   966 E C1522729:Protocol [Intellectual Product]
   966 E C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.44: Large-scale marrow harvests were performed on 2-to 12-month-old dogs from either the iliac crest or proximal humeri and femora under general anesthesia. 

Phrase: "Large-scale marrow harvests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1512335:Harvest [Health Care Activity]

Phrase: "were"

Phrase: "performed on 2-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "to 12-month-old dogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0012984:Dogs [Mammal]
   812   C1280551:Dogs [Mammal]

Phrase: "from either"

Phrase: "the iliac crest"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0223651:Iliac crest [Body Part, Organ, or Organ Component]
  1000   C1279104:Iliac crest [Body Part, Organ, or Organ Component]
   861   C0020889:Iliac [Body Part, Organ, or Organ Component]
   861   C0332243:crest [Functional Concept]
   861   C1947915:Crest [Spatial Concept]
   861   C2948667:Crest [Pharmacologic Substance]
   768 E C0229465:cristae [Body Part, Organ, or Organ Component]
   768 E C0230844:cristae [Cell Component]

Phrase: "or"

Phrase: "proximal humeri"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0020164:Humerus [Body Part, Organ, or Organ Component]
   827   C1279075:Humerus [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "femora under general anesthesia."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0015811:Femur [Body Part, Organ, or Organ Component]
   737   C1279112:Femur [Body Part, Organ, or Organ Component]
Processing 00000000.tx.45: Marrow, equivalent in volume to up to 10% of total blood volume, was collected at each large-scale harvest (range, 100to 300mL), whereas approximately 10mL marrow was collected at each follow-up time point for analysis. 

Phrase: "Marrow,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0086590:Marrow [Food]
  1000   C0376152:Marrow [Body Part, Organ, or Organ Component]
  1000   C1546708:Marrow [Intellectual Product]
   944 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   944 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   944 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   916 E C0330477:Marrows [Plant]

Phrase: "equivalent in volume"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205163:Equivalent [Qualitative Concept]
   790   C0439185:equivalent [Quantitative Concept]

Phrase: "to"

Phrase: "up to 10%"

Phrase: "of total blood volume,"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0429890:Total blood volume [Finding]
   913   C0449468:Total Volume [Quantitative Concept]
           *Volume
   901   C0005850:Blood Volume [Organism Attribute]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0229664:Blood [Body Substance]
   827   C0439175:% total [Quantitative Concept]
   827   C0439810:Total [Qualitative Concept]
   827   C1690016:% volume [Qualitative Concept]
   827   C1705102:Volume [Intellectual Product]
   827   C2700258:Volume [Laboratory Procedure]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "was"

Phrase: "collected at each large-scale harvest"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0175659:Scale [Medical Device]
   753   C0349674:Scale [Intellectual Product]
   753   C0549177:Large [Quantitative Concept]
   753   C1512335:Harvest [Health Care Activity]
   753   C1516695:Collected [Idea or Concept]
   753   C1516698:Collected [Functional Concept]
   753   C1947916:Scale [Activity]
   753   C3536777:Scale [Manufactured Object]

Phrase: "(range,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1514721:Range [Quantitative Concept]
  1000   C2348147:Range [Quantitative Concept]
  1000   C3542016:Range [Intellectual Product]

Phrase: "100to 300mL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0470462:300ml [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "approximately 10mL marrow"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0086590:Marrow [Food]
   827   C0376152:Marrow [Body Part, Organ, or Organ Component]
   827   C1546708:Marrow [Intellectual Product]
   771 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   771 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   771 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   743 E C0330477:Marrows [Plant]

Phrase: "was"

Phrase: "collected at each follow-up time point"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   778   C0589120:Follow-up [Finding]
   778   C1522577:follow-up [Health Care Activity]
   778   C1704685:FOLLOW-UP [Intellectual Product]
   778   C2348792:Time Point [Temporal Concept]
   778   C3274571:FOLLOW-UP [Health Care Activity]
   748   C0040223:Time [Temporal Concept]
   748   C0332283:follow [Temporal Concept]
   748   C1516695:Collected [Idea or Concept]
   748   C1516698:Collected [Functional Concept]
   748   C1552961:Point [Quantitative Concept]
   748   C1719822:Follow [Intellectual Product]
   748   C2347617:point [Quantitative Concept]
   748   C3541383:Time [Temporal Concept]

Phrase: "for analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]
Processing 00000000.tx.46: Light-density marrow cells (<1.075 g/mL) were recovered after Percoll (Pharmacia, Uppsala, Sweden) density gradient separation and washing, as previously described.10,11 Retroviral vectors.  

Phrase: "Light-density marrow cells"
Meta Candidates (Total=13; Excluded=7; Pruned=0; Remaining=6)
   886   C1517881:Light Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0086590:Marrow [Food]
   812   C0376152:Marrow [Body Part, Organ, or Organ Component]
   812   C1546708:Marrow [Intellectual Product]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   756 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   756 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   729 E C0330477:Marrows [Plant]

Phrase: "("

Phrase: "<1.075 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "mL)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "were"

Phrase: "recovered after Percoll"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0070386:Percoll [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   790   C0521108:recovered [Qualitative Concept]
   756 E C2004454:recover [Organism Function]

Phrase: "(Pharmacia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331955:Pharmacia [Health Care Related Organization]

Phrase: "Uppsala,"

Phrase: "Sweden"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: ")"

Phrase: "density gradient separation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0036679:Separation [Pathologic Function]
   827   C0237868:Separation [Social Behavior]
   827   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "and"

Phrase: "washing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "as"

Phrase: "previously"

Phrase: "described.10,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552738:described [Idea or Concept]

Phrase: "11 Retroviral vectors."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C1514926:retroviral vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0035366:Retroviral [Virus]
   827   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vectors [Spatial Concept]
   793 E C1705099:Vector [Idea or Concept]
Processing 00000000.tx.47: Two Moloney-based retroviral vectors were used in this study (Fig 1). 

Phrase: "Two Moloney-based retroviral vectors"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   840   C1514926:retroviral vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0035366:Retroviral [Virus]
   804   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0442335:Vectors [Spatial Concept]
   771 E C1705099:Vector [Idea or Concept]

Phrase: "were"

Phrase: "used in this study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "(Fig 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.48: The M48ID vector has extended viral gag sequences23 upstream of an internal murine phosphoglycerate kinase-1 promoter,24 which directs expression of the normal canine -ID cDNA.25 The LCIDSN vector, based on LXSN,26 has the normal canine -ID cDNA25 expressed from the viral LTR and neor from the SV40 promoter and was packaged by PA317.27 The M48ID vector is produced by CRIP28 and was provided by Drs A.

Phrase: "The M48ID vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: "has"

Phrase: "extended viral gag sequences23"

Phrase: "upstream of an internal murine phosphoglycerate kinase-1 promoter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "24"

Phrase: "which"

Phrase: "directs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "expression of the normal canine -ID cDNA.25"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1515563:cDNA Expression [Molecular Biology Research Technique]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "The LCIDSN vector,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: "based on LXSN,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C1527178:Based [Functional Concept]
   790   C1705938:Based [Idea or Concept]
   756 E C0002055:base [Inorganic Chemical]
   756 E C0178499:Base [Chemical Viewed Functionally]
   756 E C1880279:Base [Biomedical or Dental Material]

Phrase: "26"

Phrase: "has"

Phrase: "the normal canine -ID cDNA25"

Phrase: "expressed from the viral LTR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0023978:LTR [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0521026:Viral [Functional Concept]

Phrase: "and"

Phrase: "neor from the SV40 promoter"

Phrase: "and"

Phrase: "was"

Phrase: "packaged by PA317.27"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0030176:packaged [Human-caused Phenomenon or Process]
   737 E C0013194:Package [Medical Device]
   737 E C2700580:Package [Manufactured Object]

Phrase: "The M48ID vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: "is"

Phrase: "produced by CRIP28"

Phrase: "and"

Phrase: "was"

Phrase: "provided by Drs A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1999230:Provided [Activity]
Processing 00000000.tx.49: Salvetti and O.Danos (Paris, France). 

Phrase: "Salvetti"

Phrase: "and"

Phrase: "O.Danos"

Phrase: "(Paris,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030561:Paris [Geographic Area]
  1000   C0331677:Paris [Plant]
  1000   C1824032:PARIS [Gene or Genome]
   966 E C1824369:PARI [Gene or Genome]

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: ")."
Processing 00000000.tx.50: View larger version (10K): [in this window] [in a new window]  Fig 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(10K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig 1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]
Processing 00000000.tx.51: Illustration of retroviral vectors. 

Phrase: "Illustration of retroviral vectors."
Processing 00000000.tx.52: Abbreviations: LTR, long terminal repeats; 

Phrase: "Abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: ":"

Phrase: "LTR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023978:LTR [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "long terminal repeats"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0023978:Terminal Repeats, Long [Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0039551:Terminal Repeats [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0205088:Terminal [Temporal Concept]
   827   C0205341:repeats [Functional Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   827   C1705914:Repeats [Conceptual Entity]
   793 E C1547730:Repeat [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.53: +, packaging signal; 

Phrase: "+,"

Phrase: "packaging signal"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0013194:Packaging [Medical Device]
   861   C0030176:Packaging [Human-caused Phenomenon or Process]
   861   C1710082:Signal [Phenomenon or Process]
   861   C2828395:Packaging [Activity]
   827 E C2700580:Package [Manufactured Object]

Phrase: ";"
Processing 00000000.tx.54: gag, gag sequences; 

Phrase: "gag,"

Phrase: "gag sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.55: SV, SV40 promoter; 

Phrase: "SV,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0013754:SV [Geographic Area]
  1000   C0560132:Sv [Quantitative Concept]
  1000   C1704677:SV [Idea or Concept]

Phrase: "SV40 promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ";"
Processing 00000000.tx.56: neor, neomycin phosphotransferase; 

Phrase: "neor,"

Phrase: "neomycin phosphotransferase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0064230:Neomycin Phosphotransferase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0027603:Neomycin [Antibiotic,Carbohydrate]
   861   C0031727:Phosphotransferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.57: muPGK, murine phosphoglycerate kinase-1 promoter. 

Phrase: "muPGK,"

Phrase: "murine phosphoglycerate kinase-1 promoter."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   717   C1418508:PHOSPHOGLYCERATE KINASE 1 [Gene or Genome]
Processing 00000000.tx.58: The titers of all producer lines were approximately 1to 5105 colony-forming units (CFU)/mL determined on NIH3T3 as previously described.29 To ensure that stocks were free of replication competent retrovirus (RCR), supernatants from all producer cell lines were routinely assayed by a sensitive marker rescue assay.30 Marrow cultures, transductions, and infusions.  

Phrase: "The titers of all producer lines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0475208:Titer [Quantitative Concept]

Phrase: "were"

Phrase: "approximately 1to 5105 colony-forming units (CFU)/mL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   801   C2945590:unit/mL [Quantitative Concept]
   795   C0439526:/mL [Quantitative Concept]

Phrase: "determined on NIH3T3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1257739:NIH/3T3 [Cell]

Phrase: "as"

Phrase: "previously"

Phrase: "described.29 To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1552738:described [Idea or Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "that stocks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710198:Stock [Idea or Concept]

Phrase: "were"

Phrase: "free of replication competent retrovirus (RCR),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0332296:free [Functional Concept]
   760   C1880497:Free [Qualitative Concept]
   760   C1996904:Free [Qualitative Concept]

Phrase: "supernatants from all producer cell lines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "routinely"

Phrase: "assayed by a sensitive marker rescue assay.30 Marrow cultures,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   739   C0005516:Marker [Clinical Attribute]
   739   C0010453:Cultures [Idea or Concept]
   739   C0086590:Marrow [Food]
   739   C0332324:Sensitive [Functional Concept]
   739   C0376152:Marrow [Body Part, Organ, or Organ Component]
   739   C1546708:Marrow [Intellectual Product]
   739   C1550474:sensitive [Idea or Concept]
   706   C0005507:Assay [Laboratory Procedure]
   706 E C0220814:culture [Functional Concept]
   706   C0243073:assay [Qualitative Concept]
   706 E C0430400:Culture [Laboratory Procedure]
   706   C1510438:Assay [Laboratory Procedure]
   706 E C2242979:Culture [Laboratory Procedure]

Phrase: "transductions,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1160185:transduction [Organism Function]

Phrase: "and"

Phrase: "infusions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0574032:infusions [Therapeutic or Preventive Procedure]
   966 E C1827465:Infusion [Functional Concept]
Processing 00000000.tx.59: Marrow was set up in LTMCs and transduced as described previously,10,31 with minor modifications. 

Phrase: "Marrow"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0086590:Marrow [Food]
  1000   C0376152:Marrow [Body Part, Organ, or Organ Component]
  1000   C1546708:Marrow [Intellectual Product]
   944 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   944 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   944 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   916 E C0330477:Marrows [Plant]

Phrase: "was"

Phrase: "set up in LTMCs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0036849:Set [Mental Process]
   748   C1442518:Set [Functional Concept]
   748   C1705195:Set [Conceptual Entity]

Phrase: "and"

Phrase: "transduced"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously,"

Phrase: "10,"

Phrase: "31 with minor modifications."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0026193:Minor [Population Group]
   770   C0205165:Minor [Qualitative Concept]
   770   C0450355:31 [Intellectual Product]
   737   C0392747:Modification [Functional Concept]
   737   C1554963:modification [Qualitative Concept]
Processing 00000000.tx.60: Briefly, 1108 cells were seeded in 150-cm2 tissue culture flasks (Corning, Corning, NY) in LTMC media consisting of 10% fetal bovine serum (FBS) and 15% horse serum (HS) in McCoy's 5A media supplemented as described.29 Control flasks were initiated and maintained with LTMC media alone and transduced cultures were initiated in a 50:50 mix of fresh LTMC media and retroviral supernatant. 

Phrase: "Briefly,"

Phrase: "1108 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "seeded in 150-cm2 tissue culture flasks"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   797   C0492793:FLASK, TISSUE CULTURE [Medical Device]
   778   C0040284:Tissue culture [Laboratory Procedure]
   748   C0010453:Culture [Idea or Concept]
   748   C0040300:Tissue [Tissue]
   748   C0220814:culture [Functional Concept]
   748   C0430400:Culture [Laboratory Procedure]
   748   C0439479:cm2 [Quantitative Concept]
   748   C0555206:CM2 [Congenital Abnormality]
   748   C0872171:flasks [Medical Device]
   748   C1547928:Tissue [Intellectual Product]
   748   C2242979:Culture [Laboratory Procedure]
   714   C0036563:Seed [Plant]
   714   C1705192:Seed [Laboratory Procedure]
   714   C1882540:{Seed} [Quantitative Concept]
   714   C2346495:Seed [Conceptual Entity]

Phrase: "(Corning,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0010046:corning [Acquired Abnormality]
   966 E C0010028:Corn [Plant]
   966 E C0087179:Corn [Plant]
   966 E C1095906:corn [Pharmacologic Substance]
   966 E C1138842:Corn [Food]

Phrase: "Corning,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0010046:corning [Acquired Abnormality]
   966 E C0010028:Corn [Plant]
   966 E C0087179:Corn [Plant]
   966 E C1095906:corn [Pharmacologic Substance]
   966 E C1138842:Corn [Food]

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")"

Phrase: "in LTMC media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0009458:Media [Intellectual Product]
   861   C0162867:Media [Tissue]
   861   C1254021:Media [Tissue]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]

Phrase: "consisting of 10% fetal bovine serum (FBS)"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0007452:Bovine [Mammal]
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0521457:Fetal [Functional Concept]
   753   C1140701:bovine [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0332529:CONSIST [Qualitative Concept]

Phrase: "and"

Phrase: "15% horse serum (HS) in McCoy's 5A media"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1518416:Serum, Horse [Immunologic Factor]
   748   C0019944:Horse [Mammal]
   748   C0229671:Serum [Body Substance]
   748   C0242616:Horse [Mammal]
   748   C1265527:Horse [Mammal]
   748   C1546774:Serum [Intellectual Product]
   748   C1550100:Serum [Body Substance]

Phrase: "supplemented"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0242295:Supplement [Food]
   966   C1947943:Supplement [Intellectual Product]
   966   C2348609:Supplement [Functional Concept]

Phrase: "as"

Phrase: "described.29 Control flasks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0872171:flasks [Medical Device]

Phrase: "were"

Phrase: "initiated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1548602:Initiate [Idea or Concept]
   966   C1704686:Initiate [Functional Concept]

Phrase: "and"

Phrase: "maintained with LTMC media"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C1254021:Media [Tissue]
   770   C1314677:Maintained [Functional Concept]
   737 E C0024501:Maintain [Activity]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737 E C3244283:medium [Intellectual Product]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "and"

Phrase: "transduced cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0010453:Cultures [Idea or Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "initiated in a 50"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1548602:Initiate [Idea or Concept]
   737   C1704686:Initiate [Functional Concept]

Phrase: ":"

Phrase: "50 mix of fresh LTMC media"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205430:Mix [Functional Concept]
   753   C1421951:MIX [Gene or Genome]
   753   C1720722:Mix [Qualitative Concept]

Phrase: "and"

Phrase: "retroviral supernatant."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550101:Supernatant [Body Substance]
Processing 00000000.tx.61: Retroviral supernatant was prepared by conditioning LTMC media on confluent retroviral producer cells for 18to 24hours at 33C. 

Phrase: "Retroviral supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "prepared by conditioning LTMC media"
Meta Candidates (Total=12; Excluded=6; Pruned=0; Remaining=6)
   760   C0009458:Media [Intellectual Product]
   760   C0009647:Conditioning [Mental Process]
   760   C0162867:Media [Tissue]
   760   C1254021:Media [Tissue]
   751   C0162518:Conditioned Media [Indicator, Reagent, or Diagnostic Aid]
   726 E C0012634:condition [Disease or Syndrome]
   726 E C0348080:Condition [Qualitative Concept]
   726 E C0439536:Medium [Quantitative Concept]
   726   C1521827:Prepare [Functional Concept]
   726 E C1705217:Medium [Substance]
   726 E C1705253:Condition [Conceptual Entity]
   726 E C3244283:medium [Intellectual Product]

Phrase: "on confluent retroviral producer cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "for 18to 24hours"

Phrase: "at 33C."
Processing 00000000.tx.62: Viral supernatants were filtered through a 0.45-m filter and either used directly or stored at 70C until use. 

Phrase: "Viral supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "filtered through a 0.45-m filter"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441923:M+ [Intellectual Product]
   714   C0180860:Filter [Manufactured Object]
   714   C0581406:Filter [Medical Device]
   714   C1522664:Filter [Intellectual Product]
   714   C1704449:Filter [Conceptual Entity]
   714   C1704684:Filter [Medical Device]
   714   C1875155:FILTER [Medical Device]

Phrase: "and"

Phrase: "either"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "or"

Phrase: "stored at 70C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1698986:Store [Functional Concept]

Phrase: "until use."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]
Processing 00000000.tx.63: All cultures were incubated in a humidified environment at 33C and 5% CO2 in air for 21days. 

Phrase: "All cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "incubated in a humidified environment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0014406:Environment [Spatial Concept]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 33C"

Phrase: "and"

Phrase: "5% CO2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347816:Co2+ [Element, Ion, or Isotope]

Phrase: "in air for 21days."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0001861:Air [Substance]
   770   C3536832:Air [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.64: LTMCs were maintained by removal of half of the nonadherent cells and media at weeks 1and 2and replenishment with fresh LTMC media. 

Phrase: "LTMCs"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0010453:Cultures [Idea or Concept]
   779 E C0220814:culture [Functional Concept]
   779 E C0430400:Culture [Laboratory Procedure]
   779 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "maintained by removal of half of the nonadherent cells"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   742   C0007634:Cells [Cell]
   742   C0015252:Removal [Therapeutic or Preventive Procedure]
   742   C0728940:Removal [Therapeutic or Preventive Procedure]
   742   C1314677:Maintained [Functional Concept]
   742   C2825407:Half [Quantitative Concept]
   742   C3282337:Cells [Cell]
   708 E C0024501:Maintain [Activity]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "media at weeks 1and 2and replenishment"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0009458:Media [Intellectual Product]
   753   C0162867:Media [Tissue]
   753   C1254021:Media [Tissue]
   719 E C0439536:Medium [Quantitative Concept]
   719 E C1705217:Medium [Substance]
   719 E C3244283:medium [Intellectual Product]

Phrase: "with fresh LTMC media."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0009458:Media [Intellectual Product]
   827   C0162867:Media [Tissue]
   827   C1254021:Media [Tissue]
   793 E C0439536:Medium [Quantitative Concept]
   793 E C1705217:Medium [Substance]
   793 E C3244283:medium [Intellectual Product]
Processing 00000000.tx.65: Twenty-four hours after feeding, half of the nonadherent cells and media were again removed and replaced with retroviral supernatant. 

Phrase: "Twenty-four hours after feeding,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0439227:hours [Temporal Concept]
   726 E C0564385:/hour [Quantitative Concept]

Phrase: "half of the nonadherent cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2825407:Half [Quantitative Concept]

Phrase: "and"

Phrase: "media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "again"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "replaced with retroviral supernatant."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0035366:Retroviral [Virus]
   770   C0559956:Replaced [Functional Concept]
   770   C1299987:replaced [Functional Concept]
   770   C1550101:Supernatant [Body Substance]
   737 E C1554078:Replace [Idea or Concept]
Processing 00000000.tx.66: The adherent LTMC cells were harvested by enzymatic digestion with 0.25% trypsin and 1mmol/L EDTA (GIBCO, Grand Island, NY) and washed twice with Hank's buffered saline. 

Phrase: "The adherent LTMC cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested by enzymatic digestion"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0012238:Digestion [Organism Function]
   770   C2349986:Digestion [Research Activity]
   737   C1512335:Harvest [Health Care Activity]
   715 E C0443277:Peptic [Functional Concept]

Phrase: "with 0.25% trypsin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "and"

Phrase: "1mmol/L EDTA (GIBCO,"

Phrase: "Grand Island,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022130:Island [Geographic Area]

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with Hank's buffered saline."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0036082:Saline [Substance]
   760   C1423529:HANK [Gene or Genome]
   760   C1720725:Twice [Intellectual Product]
   760   C1948050:Twice [Quantitative Concept]
Processing 00000000.tx.67: Aliquots of cells were set aside for molecular assays, histology, and marker rescue assay for RCR. 

Phrase: "Aliquots of cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "set aside for molecular assays,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0036849:Set [Mental Process]
   760   C1442518:Set [Functional Concept]
   760   C1705195:Set [Conceptual Entity]

Phrase: "histology,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0019638:Histology [Biomedical Occupation or Discipline]
  1000   C0205462:histology [Functional Concept]
  1000   C0344441:Histology [Laboratory Procedure]

Phrase: "and"

Phrase: "marker rescue assay for RCR."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0005507:Assay [Laboratory Procedure]
   748   C0243073:assay [Qualitative Concept]
   748   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.68: The remaining cells were either cryopreserved until use or infused directly as previously described.32 Where dogs received multiple large-scale infusions, time points postinfusion for polymerase chain reaction (PCR) analysis were calculated from the first infusion. 

Phrase: "The remaining cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "either"

Phrase: "cryopreserved until use"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0010405:Cryopreserved [Laboratory Procedure]
   790   C0042153:use [Functional Concept]
   790   C0457083:Use [Functional Concept]
   790   C1947944:Use [Intellectual Product]

Phrase: "or"

Phrase: "infused"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "as"

Phrase: "previously"

Phrase: "described.32 Where dogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0012984:Dogs [Mammal]
   812   C1280551:Dogs [Mammal]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "multiple large-scale infusions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0574032:infusions [Therapeutic or Preventive Procedure]
   779 E C1827465:Infusion [Functional Concept]

Phrase: "time points postinfusion for polymerase chain reaction (PCR) analysis"

Phrase: "were"

Phrase: "calculated from the first infusion."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0205435:First [Quantitative Concept]
   760   C0444686:Calculated [Functional Concept]
   760   C0574032:Infusion [Therapeutic or Preventive Procedure]
   760   C1279901:First [Qualitative Concept]
   760   C1441506:Calculated [Activity]
   760   C1443182:Calculated [Laboratory Procedure]
   760   C1827465:Infusion [Functional Concept]
Processing 00000000.tx.69: Tissues at postmortem examination were prepared for histopathologic analysis.19 In vitro assays of gene transfer.  

Phrase: "Tissues at postmortem examination"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   802   C0444184:Postmortem tissue [Tissue]
   770   C0040300:Tissues [Tissue]
   737 E C1547928:Tissue [Intellectual Product]

Phrase: "were"

Phrase: "prepared for histopathologic analysis.19 In vitro assays of gene transfer."
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   756   C0021135:In Vitro [Intellectual Product]
   756   C1517499:Gene Transfer [Molecular Biology Research Technique]
   756   C1533691:in vitro [Qualitative Concept]
           vitro
   756   C2827718:In Vitro [Functional Concept]
   742   C1515653:In Vitro Assay [Research Activity]
   738   C0002778:Analysis [Laboratory Procedure]
   738   C0017337:Gene [Gene or Genome]
   738   C0040671:Transfer [Mental Process]
   738   C0677043:Histopathologic [Biomedical Occupation or Discipline]
   738   C0936012:Analysis [Research Activity]
   738   C1524024:analysis [Functional Concept]
   738   C1705822:Transfer [Activity]
   704   C0005507:Assay [Laboratory Procedure]
   704   C0243073:assay [Qualitative Concept]
   704   C1510438:Assay [Laboratory Procedure]
   704   C1521827:Prepare [Functional Concept]
Processing 00000000.tx.70: Proviral marking in hematopoietic progenitors was evaluated by PCR amplification of proviral specific sequences in individual colony-forming unit-granulocyte-macrophage (CFU-GM) and burst-forming unit-erythroid (BFU-E) colonies. 

Phrase: "Proviral marking in hematopoietic progenitors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0522501:marking [Qualitative Concept]

Phrase: "was"

Phrase: "evaluated by PCR amplification of proviral specific sequences"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   782   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   739   C0162326:Sequences [Nucleotide Sequence]
   739   C0205369:Specific [Qualitative Concept]
   739   C0220825:Evaluated [Functional Concept]
   739   C0337112:Chain [Manufactured Object]
   739   C0443286:Reaction [Functional Concept]
   739   C1114821:Reaction [Clinical Attribute]
   739   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C1517480:Amplification [Molecular Biology Research Technique]
   739   C1521871:Amplification [Phenomenon or Process]
   739   C1524075:Chain [Idea or Concept]
   739   C1552740:specific [Intellectual Product]
   739   C1705759:Amplification [Cell or Molecular Dysfunction]
   706 E C0004793:Sequence [Nucleotide Sequence]
   706 E C0162327:Sequence [Nucleotide Sequence]
   706 E C1519249:Sequence [Functional Concept]

Phrase: "in individual colony-forming unit-granulocyte-macrophage (CFU-GM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0024432:macrophage [Cell]

Phrase: "and"

Phrase: "burst-forming unit-erythroid (BFU-E) colonies."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0439158:colonies [Quantitative Concept]
   771   C1257771:Burst-forming unit erythroid [Cell]
   771 E C1947989:Colony [Cell]
Processing 00000000.tx.71: Adherent layer cells were plated in quadruplicate at a density of 1105 cells/mL in complete methylcellulose with either recombinant human or murine cytokines (MethoCult GF M3434 or H4435; Stem Cell Technologies, Vancouver, British Columbia, Canada) and supplemented with 10% canine phytohemagglutinin (PHA)-stimulated leukocyte conditioned media. 

Phrase: "Adherent layer cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated in quadruplicate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205175:Quadruplicate [Quantitative Concept]
   756   C0005971:Plate [Medical Device]
   756   C1139930:plate [Medical Device]
   756   C3537155:Plate [Manufactured Object]

Phrase: "at a density"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0178587:density [Quantitative Concept]
   928 E C0439794:Dense [Qualitative Concept]

Phrase: "of 1105 cells/mL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2699156:Cells/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "in complete methylcellulose"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0025729:Methyl Cellulose [Carbohydrate,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   805 E C0699455:Methocel [Carbohydrate,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "with either recombinant human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0086418:Human [Human]

Phrase: "or"

Phrase: "murine cytokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(MethoCult GF M3434"

Phrase: "or"

Phrase: "H4435"

Phrase: "; Stem Cell Technologies,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0039421:technologies [Occupation or Discipline]
   734   C0038250:Stem cell [Cell]

Phrase: "Vancouver,"

Phrase: "British Columbia,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0006193:British Columbia [Geographic Area]
   861   C1551442:Columbia [Population Group]
   861   C3245499:Columbia [Health Care Related Organization]
   789 E C1551955:Columbian [Language]

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "supplemented with 10% canine phytohemagglutinin (PHA)-stimulated leukocyte conditioned media."
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   764   C0162518:Conditioned Media [Indicator, Reagent, or Diagnostic Aid]
   742   C0009458:Media [Intellectual Product]
   742   C0009647:Conditioned [Mental Process]
   742   C0012984:Canine, NOS [Mammal]
   742   C0023516:Leucocyte [Cell]
   742   C0031858:Phytohaemagglutinin [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   742   C0162867:Media [Tissue]
   742   C1254021:Media [Tissue]
   742   C1280551:Canine [Mammal]
   742   C1948023:Stimulated [Natural Phenomenon or Process]
   708   C0242295:Supplement [Food]
   708 E C0439536:Medium [Quantitative Concept]
   708 E C1705217:Medium [Substance]
   708   C1947943:Supplement [Intellectual Product]
   708   C2348609:Supplement [Functional Concept]
   708 E C3244283:medium [Intellectual Product]
Processing 00000000.tx.72: The colonies were assessed using standard criteria on days 10to 12of culture.33 Up to 100well-isolated colonies and 10methylcellulose only controls were plucked from each sample. 

Phrase: "The colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0439158:colonies [Quantitative Concept]
   966 E C1947989:Colony [Cell]

Phrase: "were"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "standard criteria on days 10to 12of culture.33"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   750   C0150109:CRITERION STANDARD [Qualitative Concept]
   744   C0243161:criteria [Intellectual Product]

Phrase: "Up to 100well-isolated colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439158:colonies [Quantitative Concept]
   793 E C1947989:Colony [Cell]

Phrase: "and"

Phrase: "10methylcellulose only"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "plucked from each sample."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0370003:Sample [Substance]
   770   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.73: Individual colonies and background methylcellulose controls were placed into 40L of lysis buffer (0.5% NP-40, 0.5% tween-20, and 0.9mg/mL proteinase-K), incubated at 56C for 1to 2hours, and boiled for 10minutes to inactivate the proteinase-K. 

Phrase: "Individual colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439158:colonies [Quantitative Concept]
   827 E C1947989:Colony [Cell]

Phrase: "and"

Phrase: "background methylcellulose controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0243148:control [Qualitative Concept]
   793   C1550141:Control [Substance]
   793   C1882979:Control [Conceptual Entity]
   793   C2587213:Control [Functional Concept]
   793   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "placed into 40L of lysis buffer"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0024348:Lysis [Pathologic Function]
   753   C1536403:lysis [Cell Function]
   719   C0442504:Place [Spatial Concept]
   719   C1704765:Place [Functional Concept]
   719   C1882509:Place [Activity]
   719   C3496241:place [Disease or Syndrome]

Phrase: "(0.5% NP-40,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0068941:NP-40 [Organic Chemical,Pharmacologic Substance]
   861   C0444499:0/5 [Quantitative Concept]
   812   C0439509:/40 [Temporal Concept]
   812   C1706141:NP [Gene or Genome]

Phrase: "0.5% tween-20,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   861   C0444499:0/5 [Quantitative Concept]
   833 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   812   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   756 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.9mg/mL proteinase-K"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0059256:Proteinase K [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   804   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   804   C1622131:proteinase [Molecular Function]
   804   C1708601:K' [Quantitative Concept]
   804   C1947941:Proteinase [Enzyme]

Phrase: ")"

Phrase: ","

Phrase: "incubated at 56C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 1to 2hours,"

Phrase: "and"

Phrase: "boiled for 10minutes to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0242301:Boil [Disease or Syndrome]
   737   C1546559:Boil [Intellectual Product]

Phrase: "inactivate"

Phrase: "the proteinase-K."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0059256:Proteinase K [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1622131:proteinase [Molecular Function]
   861   C1708601:K' [Quantitative Concept]
   861   C1947941:Proteinase [Enzyme]
Processing 00000000.tx.74: Five microliters of each sample was used per PCR amplification. 

Phrase: "Five microliters of each sample"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439243:microliter [Quantitative Concept]

Phrase: "was"

Phrase: "used per PCR amplification."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   833   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0337112:Chain [Manufactured Object]
   753   C0443286:Reaction [Functional Concept]
   753   C1114821:Reaction [Clinical Attribute]
   753   C1273517:used [Finding]
   753   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1517480:Amplification [Molecular Biology Research Technique]
   753   C1521871:Amplification [Phenomenon or Process]
   753   C1524075:Chain [Idea or Concept]
   753   C1705759:Amplification [Cell or Molecular Dysfunction]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.75: Proviral -ID sequences were detected by PCR amplification of a 422-bp amplicon from the -ID cDNA sequence (the amplicon from -ID genomic DNA is ~1 kb). 

Phrase: "Proviral -ID sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "were"

Phrase: "detected by PCR amplification of a 422-bp amplicon"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   775   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   738   C0337112:Chain [Manufactured Object]
   738   C0442726:Detected [Finding]
   738   C0443286:Reaction [Functional Concept]
   738   C1114821:Reaction [Clinical Attribute]
   738   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C1511790:Detected [Therapeutic or Preventive Procedure]
   738   C1517480:Amplification [Molecular Biology Research Technique]
   738   C1521871:Amplification [Phenomenon or Process]
   738   C1524075:Chain [Idea or Concept]
   738   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "from the -ID cDNA sequence"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "("

Phrase: "the amplicon from -ID genomic DNA is ~1 kb"

Phrase: ")."
Processing 00000000.tx.76: The -ID sense primer was derived from exon 3(cID3S; 

Phrase: "The -ID sense primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "derived from exon 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]

Phrase: "(cID3S"

Phrase: ";"
Processing 00000000.tx.77: 5'-CAAGGCCTGAGCTACAACTTC-3') and the antisense primer from exon 6(cID6AS; 

Phrase: "5'-CAAGGCCTGAGCTACAACTTC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "the antisense primer from exon 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(cID6AS"

Phrase: ";"
Processing 00000000.tx.78: 5'-GTGCCGTTGTGACAATGCTCC-3'). 

Phrase: "5'-GTGCCGTTGTGACAATGCTCC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.79: Proviral -ID PCR was performed with denaturation at 94C for 3minutes, followed by 40cycles of amplification: denaturation at 94C for 25seconds, annealing at 60C for 25seconds, and extension at 72C for 30seconds. 

Phrase: "Proviral -ID PCR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   804   C0337112:Chain [Manufactured Object]
   804   C0443286:Reaction [Functional Concept]
   804   C1114821:Reaction [Clinical Attribute]
   804   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1524075:Chain [Idea or Concept]

Phrase: "was"

Phrase: "performed with denaturation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0301642:Denaturation [Molecular Function]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "at 94C"

Phrase: "for 3minutes,"

Phrase: "followed by 40cycles of amplification"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C1517480:Amplification [Molecular Biology Research Technique]
   760   C1521871:Amplification [Phenomenon or Process]
   760   C1705759:Amplification [Cell or Molecular Dysfunction]
   726 E C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "denaturation at 94C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0301642:Denaturation [Molecular Function]

Phrase: "for 25seconds,"

Phrase: "annealing at 60C"

Phrase: "for 25seconds,"

Phrase: "and"

Phrase: "extension at 72C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0231448:Extension [Functional Concept]
   790   C1880641:Extension [Conceptual Entity]

Phrase: "for 30seconds."
Processing 00000000.tx.80: The neor PCR used in these studies amplifies a 471-bp fragment with a sense primer N1 (5'-GAACAAGATGGATTGCACGCAG-3') and the anti-sense primer YJR2 (5'-GTCCAGATCATCCTGATCGACAAG-3'). 

Phrase: "The neor PCR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0337112:Chain [Manufactured Object]
   812   C0443286:Reaction [Functional Concept]
   812   C1114821:Reaction [Clinical Attribute]
   812   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1524075:Chain [Idea or Concept]

Phrase: "used in these studies"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   802   C0869040:Use studies [Research Activity]
   770   C0947630:studies [Laboratory Procedure]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C0557651:Study [Manufactured Object]
   737 E C1947944:Use [Intellectual Product]
   737 E C2603343:Study [Research Activity]

Phrase: "amplifies"

Phrase: "a 471-bp fragment with a sense primer N1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0332255:fragment [Functional Concept]
   742   C1708096:Fragment [Qualitative Concept]

Phrase: "(5'-GAACAAGATGGATTGCACGCAG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "the anti-sense primer YJR2"

Phrase: "(5'-GTCCAGATCATCCTGATCGACAAG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.81: The quality of DNA was assessed by PCR amplification of the canine dystrophin gene with the sense primer (5'-ACAGTCCTCTACTTCTTC CCACCA-3') and the antisense primer (5'-AATTCACAGAGCTTGCCATGC-3'). 

Phrase: "The quality of DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332306:Quality [Qualitative Concept]

Phrase: "was"

Phrase: "assessed by PCR amplification of the canine dystrophin gene"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   775   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   754   C0017256:Gene Amplification [Genetic Function]
   754   C1335440:Polymerase Gene [Gene or Genome]
   754   C1705759:Gene Amplification [Cell or Molecular Dysfunction]
           Amplification
   738   C0012984:Canine, NOS [Mammal]
   738   C0017337:Gene [Gene or Genome]
   738   C0079259:Dystrophin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0337112:Chain [Manufactured Object]
   738   C0443286:Reaction [Functional Concept]
   738   C1114821:Reaction [Clinical Attribute]
   738   C1280551:Canine [Mammal]
   738   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C1414083:DYSTROPHIN [Gene or Genome]
   738   C1516048:Assessed [Activity]
   738   C1517480:Amplification [Molecular Biology Research Technique]
   738   C1521871:Amplification [Phenomenon or Process]
   738   C1524075:Chain [Idea or Concept]

Phrase: "with the sense primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(5'-ACAGTCCTCTACTTCTTC CCACCA-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439084:>5 [Quantitative Concept]
   812   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "the antisense primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(5'-AATTCACAGAGCTTGCCATGC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.82: PCR reactions were performed in Stratagene Buffer 10(Stratagene, La Jolla, CA), with 10pmol of each primer in a 25L reaction. 

Phrase: "PCR reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C0032520:Reactions, Polymerase Chain [Laboratory Procedure,Molecular Biology Research Technique]
           Polymerase Chain Reaction

Phrase: "were"

Phrase: "performed in Stratagene Buffer 10"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0884358:Performed [Functional Concept]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Stratagene,"

Phrase: "La Jolla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555265:La Jolla [Population Group]

Phrase: "CA),"

Phrase: "with 10pmol"

Phrase: "of each primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in a 25L reaction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]
Processing 00000000.tx.83: The cycling conditions for these PCR reactions start with a denaturation at 94C for 3minutes, followed by 42cycles of amplification: denaturation at 94C for 20seconds, annealing at 61C for 25seconds, and extension at 72C for 30seconds. 

Phrase: "The cycling conditions for these PCR reactions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   708   C0012634:condition [Disease or Syndrome]
   708   C0348080:Condition [Qualitative Concept]
   708   C1705253:Condition [Conceptual Entity]

Phrase: "start with a denaturation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0301642:Denaturation [Molecular Function]
   770   C0439659:Start [Temporal Concept]

Phrase: "at 94C"

Phrase: "for 3minutes,"

Phrase: "followed by 42cycles of amplification"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C1517480:Amplification [Molecular Biology Research Technique]
   760   C1521871:Amplification [Phenomenon or Process]
   760   C1705759:Amplification [Cell or Molecular Dysfunction]
   726 E C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "denaturation at 94C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0301642:Denaturation [Molecular Function]

Phrase: "for 20seconds,"

Phrase: "annealing at 61C"

Phrase: "for 25seconds,"

Phrase: "and"

Phrase: "extension at 72C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0231448:Extension [Functional Concept]
   790   C1880641:Extension [Conceptual Entity]

Phrase: "for 30seconds."
Processing 00000000.tx.84: PCR amplification products of colonies were routinely transferred onto nylon membrane (Hybond N+; Amersham, Arlington Heights, IL), hybridized with an end-labeled radioactive oligonucleotide specific for each PCR product, and analyzed by autoradiography. 

Phrase: "PCR amplification products of colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1514468:Products [Entity]
   714 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "routinely"

Phrase: "transferred onto nylon membrane"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0025255:Membrane [Tissue]
   770   C0028736:Nylon [Biomedical or Dental Material,Organic Chemical]
   770   C0348011:transferred [Functional Concept]
   770   C0596901:Membrane [Cell Component]
   770   C0740034:Nylon [Biomedical or Dental Material]
   770   C1706182:Membrane [Manufactured Object]
   737 E C0040671:Transfer [Mental Process]
   737 E C1705822:Transfer [Activity]

Phrase: "(Hybond N+"

Phrase: "; Amersham,"

Phrase: "Arlington Heights,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0489786:heights [Organism Attribute]
   777 E C0205250:High [Qualitative Concept]
   777 E C1299351:High [Qualitative Concept]
   777 E C1522410:Highest [Qualitative Concept]
   777 E C2700149:HIGH [Intellectual Product]

Phrase: "IL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "hybridized with an end-labeled radioactive oligonucleotide"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   757   C2986808:Radioactive Label [Indicator, Reagent, or Diagnostic Aid]
   748   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0034553:radioactive [Natural Phenomenon or Process]
   748   C0444930:End [Spatial Concept]
   748   C1708632:Labeled [Qualitative Concept]
   748   C2746065:End [Temporal Concept]
   714 E C0181496:Label [Manufactured Object]
   714 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "specific for each PCR product,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205369:Specific [Qualitative Concept]
   748   C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "analyzed by autoradiography."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0004400:Autoradiography [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.85: The sequences of the neor and -ID probes used are as follows: neor, 5'-CGACCTGTCCGGTGCCCTGAATGAACTGG-3'; 

Phrase: "The sequences of the neor"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0162326:Sequences [Nucleotide Sequence]
   726 E C0004793:Sequence [Nucleotide Sequence]
   726 E C0162327:Sequence [Nucleotide Sequence]
   726 E C1519249:Sequence [Functional Concept]

Phrase: "and -ID probes"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0182400:Probes [Medical Device]
   827   C1515981:And [Idea or Concept]
   793 E C1704681:Probe [Gene or Genome]
   793 E C2347609:Probe [Chemical Viewed Functionally]
   793 E C3536729:Probe [Manufactured Object]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "neor,"

Phrase: "5'-CGACCTGTCCGGTGCCCTGAATGAACTGG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.86: and -ID, 5'-CCAGGCTGACCGCTATGACC-3'. 

Phrase: "and -ID,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1515981:And [Idea or Concept]

Phrase: "5'-CCAGGCTGACCGCTATGACC-3'."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.87: Assays for proviral -ID expression.  

Phrase: "Assays for proviral -ID expression."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.88: -ID activity was assessed in duplicate by the 4-methylumbelliferyl -iduronide (4MUID) fluorimetric assay.21,22 In brief, samples were homogenized in 10mmol/L phosphate buffer pH 5.8,containing 0.1mmol/L dithiothreitol and 0.01% triton-X 100,and lysed by either 4cycles of freeze-thawing (for assessment of individual CFU) or sonication (blood, marrow, and LTMC samples). 

Phrase: "-ID activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "assessed in duplicate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205173:Duplicate [Functional Concept]
   790   C1516048:Assessed [Activity]
   790   C3539942:Duplicate [Intellectual Product]

Phrase: "by the 4-methylumbelliferyl -iduronide (4MUID) fluorimetric assay.21,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0048509:4-methylumbelliferyl iduronide [Organic Chemical]
   799   C0005507:Assay [Laboratory Procedure]
   799   C0243073:assay [Qualitative Concept]
   799   C1510438:Assay [Laboratory Procedure]
   727   C0016352:Fluorimetry [Laboratory Procedure]

Phrase: "22 In brief, samples"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1282927:brief [Qualitative Concept]
   770   C1879313:Brief [Temporal Concept]
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "homogenized in 10mmol/L phosphate buffer pH 5.8,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   762   C0492253:PH BUFFER [Medical Device]
   742   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   742   C0020283:[pH] [Quantitative Concept]
   742   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   742   C0031701:phosphate [Organophosphorus Compound]
   742   C0450407:ph+ [Finding]
   742   C0450408:ph++ [Finding]
   742   C0450409:ph+++ [Finding]
   742   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.1mmol/L dithiothreitol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.01% triton-X 100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: "and"

Phrase: "lysed by either 4cycles of freeze-thawing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0016701:Freeze [Natural Phenomenon or Process]
   748   C0024348:lysed [Pathologic Function]
   714   C1710378:Thaw [Laboratory Procedure]

Phrase: "("

Phrase: "for assessment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1261322:Assessment [Health Care Activity]
  1000   C1516048:Assessment [Activity]

Phrase: "of individual CFU"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   923   C0553561:Colony-Forming Units [Quantitative Concept]
   812   C0205431:Forming [Functional Concept]
   812   C0439148:Units [Quantitative Concept]
   812   C0439158:colony [Quantitative Concept]
   812   C1519795:Units [Quantitative Concept]
   812   C1522492:Forming [Functional Concept]
   812   C1947989:Colony [Cell]
   779 E C0348078:Form [Qualitative Concept]
   779 E C0376315:Form [Manufactured Object]
   779 E C1704753:Unit [Manufactured Object]
   779 E C1880519:Unit [Quantitative Concept]

Phrase: ")"

Phrase: "or"

Phrase: "sonication"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037680:Sonication [Research Activity]

Phrase: "(blood,"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: "marrow,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0086590:Marrow [Food]
  1000   C0376152:Marrow [Body Part, Organ, or Organ Component]
  1000   C1546708:Marrow [Intellectual Product]
   944 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   944 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   944 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   916 E C0330477:Marrows [Plant]

Phrase: "and"

Phrase: "LTMC samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.89: The reaction was performed in 0.2mol/L formate, pH 3.5,with 25mol/L 4MUID (Sigma, St Louis, MO) at 37C for 1to 24hours. 

Phrase: "The reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "performed in 0.2mol/L formate,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0016572:formate [Organic Chemical]
   753   C0220832:formate [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0884358:Performed [Functional Concept]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "pH 3.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0601906:PH 3 [Pharmacologic Substance]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "with 25mol/L 4MUID"

Phrase: "(Sigma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "St Louis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: "MO) at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3538743:MO [Idea or Concept]

Phrase: "for 1to 24hours."
Processing 00000000.tx.90: Serial dilutions of 4-methylumbelliferone (4MU) were used to calibrate the fluorimeter. 

Phrase: "Serial dilutions of 4-methylumbelliferone (4MU)"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0031082:serial [Intellectual Product,Manufactured Object]
   760   C0079240:dilutions [Laboratory Procedure]
   726 E C1948037:Dilution [Functional Concept]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "calibrate"

Phrase: "the fluorimeter."
Processing 00000000.tx.91: Negative controls included pretreatment samples, tissue blanks, and reagent controls. 

Phrase: "Negative controls included pretreatment samples,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0370003:Sample [Substance]
   771   C2347026:Sample [Conceptual Entity]

Phrase: "tissue blanks,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0750479:blanks [Finding]

Phrase: "and"

Phrase: "reagent controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.92: Positive controls consisted of matched tissues from normal dogs. 

Phrase: "Positive controls"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   966   C1883676:Positive Control [Conceptual Entity]
   861   C0439178:% Positive [Quantitative Concept]
   861   C1446409:Positive [Qualitative Concept]
   861   C1514241:Positive [Finding]
   861   C2825490:Positive [Qualitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "consisted of matched tissues"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C2985123:Matched Tissues [Body Substance]
   770   C0040300:Tissues [Tissue]
   770   C0150103:matched [Research Activity]
   770   C1708943:Matched [Qualitative Concept]
   737   C0332529:CONSIST [Qualitative Concept]
   737 E C1547928:Tissue [Intellectual Product]

Phrase: "from normal dogs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0012984:Dogs [Mammal]
   861   C1280551:Dogs [Mammal]
Processing 00000000.tx.93: Liberated 4MU was detected fluorimetrically with 365nm excitation and 440emission filters (assay sensitivity ~1% of normal levels) in either a Turner Diagnostics cuvette reader (Sunnyvale, CA) for tissue samples or the Fluoroskan II 96well reader (Labsystems, Helsinki, Finland) for CFU. 

Phrase: "Liberated"

Phrase: "4MU"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020411:4-Methylumbelliferone [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
           Methylumbelliferone

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "fluorimetrically with 365nm excitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0549255:Excitation [Activity]

Phrase: "and"

Phrase: "440emission filters"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0180860:Filters [Manufactured Object]
   827 E C0581406:Filter [Medical Device]
   827 E C1522664:Filter [Intellectual Product]
   827 E C1704449:Filter [Conceptual Entity]
   827 E C1704684:Filter [Medical Device]
   827 E C1875155:FILTER [Medical Device]

Phrase: "(assay sensitivity ~1% of normal levels"
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   767   C0456947:Level 1 [Intellectual Product]
   753   C0005507:Assay [Laboratory Procedure]
   753   C0036667:Sensitivity [Quantitative Concept]
   753   C0205307:Normal [Qualitative Concept]
   753   C0243073:assay [Qualitative Concept]
   753   C0312418:Sensitivity [Mental Process]
   753   C0427965:Sensitivity [Finding]
   753   C0439166:% normal [Quantitative Concept]
   753   C0441889:Levels [Qualitative Concept]
   753   C1510438:Assay [Laboratory Procedure]
   753   C1511883:Sensitivity [Quantitative Concept]
   753   C1522640:Sensitivity [Qualitative Concept]
   753   C2346484:SENSITIVITY [Phenomenon or Process]
   753   C2347086:% Normal [Quantitative Concept]
   753   C2349185:Sensitivity [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: ")"

Phrase: "in either"

Phrase: "a Turner Diagnostics cuvette reader"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1514743:Reader [Professional or Occupational Group]
   812   C1706461:Reader [Manufactured Object]

Phrase: "(Sunnyvale,"

Phrase: "CA) for tissue samples"

Phrase: "or"

Phrase: "the Fluoroskan II 96well reader"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1514743:Reader [Professional or Occupational Group]
   812   C1706461:Reader [Manufactured Object]

Phrase: "(Labsystems,"

Phrase: "Helsinki,"

Phrase: "Finland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016132:Finland [Geographic Area]

Phrase: ")"

Phrase: "for CFU."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
  1000   C0553561:Colony-Forming Units [Quantitative Concept]
   827   C0205431:Forming [Functional Concept]
   827   C0439148:Units [Quantitative Concept]
   827   C0439158:colony [Quantitative Concept]
   827   C1519795:Units [Quantitative Concept]
   827   C1522492:Forming [Functional Concept]
   827   C1947989:Colony [Cell]
   793 E C0348078:Form [Qualitative Concept]
   793 E C0376315:Form [Manufactured Object]
   793 E C1704753:Unit [Manufactured Object]
   793 E C1880519:Unit [Quantitative Concept]
Processing 00000000.tx.94: One unit of ID activity was determined to correspond to the release of 1nmol of 4MUID substrate per milligram of protein per hour at 37C. 

Phrase: "One unit of ID activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439148:Unit [Quantitative Concept]
   760   C1519795:Unit [Quantitative Concept]
   760   C1704753:Unit [Manufactured Object]
   760   C1880519:Unit [Quantitative Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "correspond to the release of 1nmol of 4MUID substrate"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   738   C0030685:Release [Health Care Activity]
   738   C0391871:Release [Functional Concept]
   738   C0439180:% release [Quantitative Concept]
   738   C0680255:release [Health Care Activity]
   738   C1283071:Release [Functional Concept]
   738   C1710236:Substrate [Manufactured Object]
   738   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "per milligram"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439210:milligram [Quantitative Concept]

Phrase: "of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "per hour"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439227:Hour [Temporal Concept]
  1000   C0564385:/hour [Quantitative Concept]

Phrase: "at 37C."
Processing 00000000.tx.95: For analysis of -ID activity from CFU-GM, individual colonies were plucked in 3to 5L methylcellulose and resuspended in 25L buffer. 

Phrase: "For analysis of -ID activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "from CFU-GM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0024432:macrophage [Cell]
   717   C0553561:Colony-forming unit [Quantitative Concept]

Phrase: "individual colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439158:colonies [Quantitative Concept]
   827 E C1947989:Colony [Cell]

Phrase: "were"

Phrase: "plucked in 3to 5L methylcellulose"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0025729:Methyl Cellulose [Carbohydrate,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   704 E C0699455:Methocel [Carbohydrate,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "and"

Phrase: "resuspended in 25L buffer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.96: The whole colony was used for the assay. 

Phrase: "The whole colony"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439158:colony [Quantitative Concept]
   861   C1947989:Colony [Cell]

Phrase: "was"

Phrase: "used for the assay."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0243073:assay [Qualitative Concept]
   770   C1273517:used [Finding]
   770   C1510438:Assay [Laboratory Procedure]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.97: Background methylcellulose and reagent controls were included for each sample as negative controls. 

Phrase: "Background methylcellulose"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0025729:Methyl Cellulose [Carbohydrate,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   805 E C0699455:Methocel [Carbohydrate,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "and"

Phrase: "reagent controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "included for each sample"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0332257:included [Functional Concept]
   770   C0370003:Sample [Substance]
   770   C2347026:Sample [Conceptual Entity]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]

Phrase: "as negative controls."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   966   C1639518:% negative control [Quantitative Concept]
   966   C1947986:Negative Control [Conceptual Entity]
   861   C0205160:Negative [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.98: Reverse transcriptase-PCR (RT-PCR) was performed to detect proviral -ID transcripts. 

Phrase: "Reverse transcriptase-PCR (PCR)"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0599161:Reverse Transcriptase Polymerase Chain Reaction [Molecular Biology Research Technique]
   884   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   840   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0337112:Chain [Manufactured Object]
   804   C0443286:Reaction [Functional Concept]
   804   C1114821:Reaction [Clinical Attribute]
   804   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1524075:Chain [Idea or Concept]
   804   C1555029:Reverse [Idea or Concept]
   804   C2257077:transcriptase [Genetic Function]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "proviral -ID transcripts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.99: RNA was prepared from blood and marrow leukocytes, treated with RNase-free DNase, and phenol-chloroform extracted. 

Phrase: "RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "prepared from blood"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   790   C0005767:Blood [Tissue]
   790   C0005768:blood [Body Substance]
   790   C0229664:Blood [Body Substance]
   756   C1521827:Prepare [Functional Concept]
   718 E C0333275:Bloody [Qualitative Concept]
   706 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   706 E C0392895:Bloods [Population Group]
   706 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   706 E C1511228:VESSEL, BLOOD [Tissue]

Phrase: "and"

Phrase: "marrow leukocytes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0023516:Marrow leukocyte [Cell]
           Leukocytes

Phrase: "treated with RNase-free DNase,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0011519:DNase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0011522:DNAase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0014241:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0035541:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0035542:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0332296:free [Functional Concept]
   760   C1522326:Treated [Functional Concept]
   760   C1880497:Free [Qualitative Concept]
   760   C1996904:Free [Qualitative Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "phenol-chloroform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008238:Chloroform [Hazardous or Poisonous Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "extracted."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]
Processing 00000000.tx.100: -ID cDNA was synthesized using an antisense primer derived from exon 7(5'-GGTCCGCCTCGTCGTTGTAA-3') and Superscript II reverse transcriptase (GIBCO). 

Phrase: "-ID cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "synthesized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883254:Synthesized [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an antisense primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "derived from exon 7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]

Phrase: "(5'-GGTCCGCCTCGTCGTTGTAA-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "Superscript II reverse transcriptase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1555029:Reverse [Idea or Concept]
   812   C2257077:transcriptase [Genetic Function]

Phrase: "(GIBCO"

Phrase: ")."
Processing 00000000.tx.101: The mutation in the -ID gene in MPS I dogs eliminates the splice site in intron 1and thus endogenous transcripts from the mutant gene contain intron 1and are 450bp longer than transcripts from the normal canine -ID cDNA present in the provirus. 

Phrase: "The mutation in the -ID gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0596611:Gene Mutation [Genetic Function]
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in MPS I dogs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0012984:Dogs [Mammal]
   812   C1280551:Dogs [Mammal]
   756   C0023786:Mucopolysaccharidosis Type I [Disease or Syndrome]
           Mucopolysaccharidosis I

Phrase: "eliminates"

Phrase: "the splice site in intron 1and thus endogenous transcripts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0205145:Site [Spatial Concept]
   742   C1515974:Site [Body Location or Region]
   742   C2825164:Site [Spatial Concept]

Phrase: "from the mutant gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0678941:mutant gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "intron 1and"

Phrase: "are"

Phrase: "450bp"

Phrase: "longer than transcripts"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   756   C0205166:Long [Qualitative Concept]
   756   C1706317:Long [Qualitative Concept]
   706 E C1444754:Length [Quantitative Concept]
   706 E C1706316:LENGTH [Research Activity]

Phrase: "from the normal canine -ID cDNA present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0150312:Present [Quantitative Concept]
   804   C0449450:Present [Idea or Concept]

Phrase: "in the provirus."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033755:Provirus [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1527278:provirus [Cell Component]
Processing 00000000.tx.102: PCR amplification of the cDNA with a forward primer from exon 1(primer CA-1 from Menon et al17; 

Phrase: "PCR amplification of the cDNA"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0337112:Chain [Manufactured Object]
   748   C0443286:Reaction [Functional Concept]
   748   C1114821:Reaction [Clinical Attribute]
   748   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1517480:Amplification [Molecular Biology Research Technique]
   748   C1521871:Amplification [Phenomenon or Process]
   748   C1524075:Chain [Idea or Concept]
   748   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "with a forward primer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1953382:Forward primer [Cell]
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "from exon 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(primer CA-1 from Menon et al17"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   774   C0079281:ET-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.103: 5'-CGCTGCGGCCCCTGCGG CCCTTCT-3') and the reverse primer cID6AS described above were used for amplification. 

Phrase: "5'-CGCTGCGGCCCCTGCGG CCCTTCT-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439084:>5 [Quantitative Concept]
   812   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "the reverse primer cID6AS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1953384:Reverse primer [Amino Acid, Peptide, or Protein]

Phrase: "described above"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1552738:described [Idea or Concept]

Phrase: "were"

Phrase: "used for amplification."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C1273517:used [Finding]
   790   C1517480:Amplification [Molecular Biology Research Technique]
   790   C1521871:Amplification [Phenomenon or Process]
   790   C1705759:Amplification [Cell or Molecular Dysfunction]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.104: This reaction unambiguously distinguishes transcripts derived from the provirus (618bp) and those from the endogenous mutant gene (1,068bp). 

Phrase: "This reaction unambiguously"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "distinguishes"

Phrase: "transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "derived from the provirus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033755:Provirus [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1441547:Derived [Qualitative Concept]
   770   C1527278:provirus [Cell Component]
   770   C3245521:derived [Idea or Concept]

Phrase: "(618bp"

Phrase: ")"

Phrase: "and"

Phrase: "those from the endogenous mutant gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0678941:mutant gene [Gene or Genome]
   753   C0017337:Gene [Gene or Genome]
   753   C0205227:Endogenous [Functional Concept]
   753   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "068bp"

Phrase: ")."
Processing 00000000.tx.105: The PCR reaction and cycling conditions were the same described above. 

Phrase: "The PCR reaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "and"

Phrase: "cycling conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "were"

Phrase: "the same described above."
Processing 00000000.tx.106: The quality of the cDNA samples was assessed by PCR amplification of the exon 3-6of the -ID gene that provides the same size fragment from both the normal and the MPS I genomic transcripts. 

Phrase: "The quality of the cDNA samples"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332306:Quality [Qualitative Concept]

Phrase: "was"

Phrase: "assessed by PCR amplification of the exon 3-6of"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   775   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   738   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0337112:Chain [Manufactured Object]
   738   C0443286:Reaction [Functional Concept]
   738   C1114821:Reaction [Clinical Attribute]
   738   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C1516048:Assessed [Activity]
   738   C1517480:Amplification [Molecular Biology Research Technique]
   738   C1521871:Amplification [Phenomenon or Process]
   738   C1524075:Chain [Idea or Concept]
   738   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "the -ID gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "that"

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "the same size fragment from both"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332255:fragment [Functional Concept]
   753   C1708096:Fragment [Qualitative Concept]

Phrase: "the normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "the MPS I genomic transcripts."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]
   717   C0023786:Mucopolysaccharidosis Type I [Disease or Syndrome]
Processing 00000000.tx.107: Controls without reverse transcriptase enzyme were included for each sample in all experiments. 

Phrase: "Controls without reverse transcriptase enzyme"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "included for each sample"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0332257:included [Functional Concept]
   770   C0370003:Sample [Substance]
   770   C2347026:Sample [Conceptual Entity]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]

Phrase: "in all experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.108: For RT-PCR amplification of proviral specific transcripts, primers were chosen that span intron 1. 

Phrase: "For RT-PCR amplification"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C1517480:Amplification [Molecular Biology Research Technique]
   799   C1521871:Amplification [Phenomenon or Process]
   799   C1705759:Amplification [Cell or Molecular Dysfunction]
   780   C0599161:Reverse Transcriptase Polymerase Chain Reaction [Molecular Biology Research Technique]

Phrase: "of proviral specific transcripts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "chosen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:Chosen [Activity]

Phrase: "that span intron 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1711300:Span [Conceptual Entity]
   827   C2700613:Span [Quantitative Concept]
Processing 00000000.tx.109: Immunoassays.  

Phrase: "Immunoassays."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0020980:Immunoassays [Laboratory Procedure]
   966 E C0021060:immunoassay [Laboratory Procedure]
Processing 00000000.tx.110: Sera from dogs were tested for the presence of IgG antibodies directed against -ID, HS, FBS, and bovine serum albumin by enzyme-linked immunosorbent assay (ELISA). 

Phrase: "Sera from dogs"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0229671:Sera [Body Substance]
   790   C1151254:SerA [Molecular Function]
   756 E C1546774:Serum [Intellectual Product]
   756 E C1550100:Serum [Body Substance]

Phrase: "were"

Phrase: "tested for the presence of IgG antibodies"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   762   C2754943:IgG antibody [Cell Component]
   757   C0580327:antibodies test [Laboratory Procedure]
   748   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C0392366:tested [Intellectual Product]
   714 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   714 E C0022885:Test [Laboratory Procedure]
   714 E C0039593:Test [Functional Concept]

Phrase: "directed against -ID,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]
   756   C0439851:Direct [Qualitative Concept]
   756   C1947931:Direct [Qualitative Concept]

Phrase: "HS,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1518416:Serum, Horse [Immunologic Factor]
   861   C0019944:Horse [Mammal]
   861   C0229671:Serum [Body Substance]
   861   C0242616:Horse [Mammal]
   861   C1265527:Horse [Mammal]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "FBS,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0007452:Bovine [Mammal]
   827   C0015965:Fetal [Embryonic Structure]
   827   C0229671:Serum [Body Substance]
   827   C0521457:Fetal [Functional Concept]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "bovine serum albumin by enzyme-linked immunosorbent assay (ELISA)."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   800   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   770   C0728877:serum albumin [Laboratory or Test Result]
   767 E C0523465:Albumin - serum [Laboratory Procedure]
   744   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0007452:Bovine [Mammal]
   744   C0229671:Serum [Body Substance]
   744   C1140701:bovine [Mammal]
   744   C1546774:Serum [Intellectual Product]
   744   C1550100:Serum [Body Substance]
Processing 00000000.tx.111: Serum samples were collected at 1-to 3-month intervals postinfusion. 

Phrase: "Serum samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0444266:Serum sample [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "at 1-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: "to 3-month intervals postinfusion."
Processing 00000000.tx.112: Preinfusion serum was collected from each dog and used as individual baseline controls. 

Phrase: "Preinfusion serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "was"

Phrase: "collected from each dog"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0012984:Dog [Mammal]
   770   C1280551:Dog [Mammal]
   770   C1516695:Collected [Idea or Concept]
   770   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "used as individual baseline controls."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   760   C0027361:Individual [Population Group]
   760   C0168634:baseline [Biomedical or Dental Material]
   760   C0237401:Individual [Human]
   760   C1273517:used [Finding]
   760   C1442488:Baseline [Quantitative Concept]
   726 E C0042153:use [Functional Concept]
   726   C0243148:control [Qualitative Concept]
   726 E C0457083:Use [Functional Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726 E C1947944:Use [Intellectual Product]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.113: ELISA was performed as described21; 

Phrase: "ELISA"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   902   C2717977:Enzyme Assay [Laboratory Procedure]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
   779   C1517892:Link [Intellectual Product]
   779   C1704666:Link [Intellectual Product]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "performed as described21"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.114: however, wells were blocked with 0.1% tween-20. 

Phrase: "however,"

Phrase: "wells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205170:Well [Qualitative Concept]
   966   C3146287:Well [Manufactured Object]

Phrase: "were"

Phrase: "blocked with 0.1% tween-20."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   790   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   762 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   753   C0028778:Blocked [Pathologic Function]
   753   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   753   C0332206:Blocked [Functional Concept]
   753   C2983591:BLOCKED [Research Activity]
   719 E C1533157:Block [Substance]
   719 E C1706084:Block [Geographic Area]
   719 E C2828370:Block [Quantitative Concept]
Processing 00000000.tx.115: For the detection of antibodies against serum or serum components, wells were coated with 100L antigen solution containing either 0.2g recombinant -ID (kindly provided by Dr E.Kakkis, University of California San Francisco, San Francisco, CA) or a 2.5% solution of either bovine serum albumin, HS, or FBS in phosphate-buffered saline. 

Phrase: "For the detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "of antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "against serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "or"

Phrase: "serum components,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449432:Components [Manufactured Object]
   827 E C1705248:Component [Conceptual Entity]

Phrase: "wells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205170:Well [Qualitative Concept]
   966   C3146287:Well [Manufactured Object]

Phrase: "were"

Phrase: "coated with 100L antigen solution"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0003320:Antigen [Immunologic Factor]
   760   C0037633:Solution [Substance]
   760   C0525069:Solution [Biomedical or Dental Material]
   760   C1522408:Coated [Qualitative Concept]
   726 E C0453946:Coat [Manufactured Object]
   726 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "either 0.2g recombinant -ID"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(kindly"

Phrase: "provided by Dr E.Kakkis,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0031831:DR [Professional or Occupational Group]
   760   C1707664:DR [Biomedical or Dental Material]
   760   C1999230:Provided [Activity]
   760   C2348314:Dr. [Conceptual Entity]
   760   C3540849:DR [Idea or Concept]

Phrase: "University of California San Francisco,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0036152:San Francisco [Geographic Area]
   804   C0006754:California [Geographic Area]
   804   C0041740:University [Manufactured Object,Organization]
   804   C1826357:San [Gene or Genome]
   804   C3146274:California [Plant]

Phrase: "San Francisco,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036152:San Francisco [Geographic Area]
   861   C1826357:San [Gene or Genome]

Phrase: "CA)"

Phrase: "or"

Phrase: "a 2.5% solution of either bovine serum albumin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0359180:Albumin solution [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   742   C0037633:Solution [Substance]
   742   C0525069:Solution [Biomedical or Dental Material]

Phrase: "HS,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1518416:Serum, Horse [Immunologic Factor]
   861   C0019944:Horse [Mammal]
   861   C0229671:Serum [Body Substance]
   861   C0242616:Horse [Mammal]
   861   C1265527:Horse [Mammal]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "or"

Phrase: "FBS in phosphate-buffered saline."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   774   C0036820:phosphate serum [Laboratory Procedure]
   748   C0007452:Bovine [Mammal]
   748   C0015965:Fetal [Embryonic Structure]
   748   C0229671:Serum [Body Substance]
   748   C0521457:Fetal [Functional Concept]
   748   C1140701:bovine [Mammal]
   748   C1546774:Serum [Intellectual Product]
   748   C1550100:Serum [Body Substance]
Processing 00000000.tx.116: The secondary antibody used was alkaline phosphatase-conjugated goat anticanine IgG (Chemicon, Temecula, CA). 

Phrase: "The secondary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "was"

Phrase: "alkaline phosphatase-conjugated goat anticanine IgG"

Phrase: "(Chemicon,"

Phrase: "Temecula,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555271:Temecula [Population Group]

Phrase: "CA)."
Processing 00000000.tx.117: The optical density was read on a microtiter plate reader at 405nm (Molecular Devices, Sunnyvale, CA). 

Phrase: "The optical density"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0439164:Optical density [Quantitative Concept]
  1000   C1268822:Optical density [Clinical Attribute]
   861   C0178587:density [Quantitative Concept]
   805   C0042789:Vision [Organism Function]
   805   C2707266:Vision [Clinical Attribute]
   789 E C0439794:Dense [Qualitative Concept]

Phrase: "was"

Phrase: "read on a microtiter plate reader"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1709027:Microtiter Plate [Research Device]
   753   C0005971:Plate [Medical Device]
   753   C0034754:Read [Daily or Recreational Activity]
   753   C1139930:plate [Medical Device]
   753   C1514743:Reader [Professional or Occupational Group]
   753   C1705179:read [Finding]
   753   C1706461:Reader [Manufactured Object]
   753   C3537155:Plate [Manufactured Object]

Phrase: "at 405nm"

Phrase: "(Molecular Devices,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025080:DEVICES [Medical Device]
   861   C0220819:devices [Manufactured Object]
   861   C0699733:Devices [Manufactured Object]

Phrase: "Sunnyvale,"

Phrase: "CA)."
Processing 00000000.tx.118: The titer was reported as the greatest dilution of serum that had an optical density of greater than twice that of the preimmune serum. 

Phrase: "The titer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0475208:Titer [Quantitative Concept]

Phrase: "was"

Phrase: "reported as the greatest dilution of serum"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   748   C0079240:Dilution [Laboratory Procedure]
   748   C0205393:Greatest [Quantitative Concept]
   748   C0229671:Serum [Body Substance]
   748   C0684224:Reported [Intellectual Product]
   748   C0700287:Reported [Health Care Activity]
   748   C1546774:Serum [Intellectual Product]
   748   C1550100:Serum [Body Substance]
   748   C1948037:Dilution [Functional Concept]
   748   C3496591:Reported [Clinical Attribute]
   714 E C0549177:Great [Quantitative Concept]
   714 E C1704243:Great [Quantitative Concept]
   714 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "had"

Phrase: "an optical density of greater"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0439164:Optical density [Quantitative Concept]
   806   C1268822:Optical density [Clinical Attribute]
   760   C0178587:density [Quantitative Concept]
   704   C0042789:Vision [Organism Function]
   704   C2707266:Vision [Clinical Attribute]

Phrase: "than twice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720725:Twice [Intellectual Product]
  1000   C1948050:Twice [Quantitative Concept]

Phrase: "that of the preimmune serum."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0229671:Serum [Body Substance]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
Processing 00000000.tx.119: A cellular immune response was assessed by evaluating the proliferation of peripheral blood mononuclear cells in response to transduced autologous stroma. 

Phrase: "A cellular immune response"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C1817908:Cellular Immune Response [Cell Function]
   901   C0301872:Immune response [Organ or Tissue Function]
   827   C0007634:Cellular [Cell]
   827   C0178539:Cellular [Functional Concept]
   827   C0439662:Immune [Functional Concept]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]
   755 E C1516377:Cellularity [Qualitative Concept]

Phrase: "was"

Phrase: "assessed by evaluating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1516048:Assessed [Activity]
   756   C0220825:Evaluate [Functional Concept]

Phrase: "the proliferation of peripheral blood mononuclear cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   863   C2246305:peripheral blood mononuclear cell proliferation [Cell Function]
   788   C2246303:mononuclear cell proliferation [Cell Function]
   757   C0596290:Cell Proliferation [Cell Function]
   748   C0334094:Proliferation [Pathologic Function]
   748   C1514485:Proliferation [Functional Concept]
   724   C0700080:Vascular proliferation [Pathologic Function]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to transduced autologous stroma."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0927195:Stroma [Body Part, Organ, or Organ Component]
Processing 00000000.tx.120: Marrow stroma was grown similarly to LTMCs, except that 4to 24hours after culture initiation the nonadherent fraction was removed and replaced with fresh LTMC media. 

Phrase: "Marrow stroma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0927195:Stroma [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "grown"

Phrase: "similarly to LTMCs,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   790   C0443252:Long-term [Temporal Concept]
   753   C0010453:Cultures [Idea or Concept]
   753   C0086590:Marrow [Food]
   753   C0205166:Long [Qualitative Concept]
   753   C0376152:Marrow [Body Part, Organ, or Organ Component]
   753   C1515273:Term [Temporal Concept]
   753   C1546708:Marrow [Intellectual Product]
   753   C1705313:Term [Idea or Concept]
   753   C1706317:Long [Qualitative Concept]
   753   C2826302:TERM [Intellectual Product]
   719 E C0220814:culture [Functional Concept]
   719 E C0430400:Culture [Laboratory Procedure]
   719 E C2242979:Culture [Laboratory Procedure]

Phrase: "except"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332300:except [Functional Concept]

Phrase: "that 4to 24hours after culture initiation"

Phrase: "the nonadherent fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "replaced with fresh LTMC media."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   760   C0009458:Media [Intellectual Product]
   760   C0162867:Media [Tissue]
   760   C0443224:Fresh [Qualitative Concept]
   760   C0559956:Replaced [Functional Concept]
   760   C1254021:Media [Tissue]
   760   C1299987:replaced [Functional Concept]
   760   C2827486:Fresh [Body Substance]
   726 E C0439536:Medium [Quantitative Concept]
   726 E C1554078:Replace [Idea or Concept]
   726 E C1705217:Medium [Substance]
   726 E C3244283:medium [Intellectual Product]
Processing 00000000.tx.121: The stromal cultures were maintained in LTMC media by twice weekly half volume media changes. 

Phrase: "The stromal cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0010453:Cultures [Idea or Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "maintained in LTMC media"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C1254021:Media [Tissue]
   770   C1314677:Maintained [Functional Concept]
   737 E C0024501:Maintain [Activity]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737 E C3244283:medium [Intellectual Product]

Phrase: "by twice weekly half volume media changes."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   799   C0392747:changes [Functional Concept]
   799   C0443172:changes [Quantitative Concept]
   766 E C1705241:Change [Quantitative Concept]
Processing 00000000.tx.122: At confluence (10to 14days), the stroma was trypsinized and replated at a 1:3 dilution. 

Phrase: "At confluence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0205200:Confluent [Qualitative Concept]

Phrase: "(10to 14days"

Phrase: ")"

Phrase: ","

Phrase: "the stroma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0927195:Stroma [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "trypsinized"

Phrase: "and"

Phrase: "replated at a 1"

Phrase: ":"

Phrase: "3 dilution."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]
Processing 00000000.tx.123: Twenty-four hours later, the stroma was transduced by replacing the media with retroviral supernatant twice daily for 2days. 

Phrase: "Twenty-four hours later,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0439227:hours [Temporal Concept]
   779 E C0564385:/hour [Quantitative Concept]

Phrase: "the stroma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0927195:Stroma [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "transduced by replacing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1299987:replacing [Functional Concept]
   756 E C1554078:Replace [Idea or Concept]

Phrase: "the media with retroviral supernatant twice daily"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   748   C0009458:Media [Intellectual Product]
   748   C0162867:Media [Tissue]
   748   C1254021:Media [Tissue]
   714 E C0439536:Medium [Quantitative Concept]
   714 E C1705217:Medium [Substance]
   714 E C3244283:medium [Intellectual Product]

Phrase: "for 2days."
Processing 00000000.tx.124: Control untransduced stroma was manipulated similarly to transduced stroma; 

Phrase: "Control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "untransduced stroma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0927195:Stroma [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "manipulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0947647:Manipulate [Therapeutic or Preventive Procedure]

Phrase: "similarly to transduced stroma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0927195:Stroma [Body Part, Organ, or Organ Component]

Phrase: ";"
Processing 00000000.tx.125: however, fresh LTMC media was used instead of retroviral supernatant. 

Phrase: "however,"

Phrase: "fresh LTMC media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0009458:Media [Intellectual Product]
   827   C0162867:Media [Tissue]
   827   C1254021:Media [Tissue]
   793 E C0439536:Medium [Quantitative Concept]
   793 E C1705217:Medium [Substance]
   793 E C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "used instead of retroviral supernatant."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   781   C1524063:Use of [Functional Concept]
   760   C0035366:Retroviral [Virus]
   760   C1273517:used [Finding]
   760   C1550101:Supernatant [Body Substance]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.126: Stroma was maintained by 1:3 dilutions once confluent. 

Phrase: "Stroma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0927195:Stroma [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "maintained by 1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1314677:Maintained [Functional Concept]
   756 E C0024501:Maintain [Activity]

Phrase: ":"

Phrase: "3 dilutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0079240:dilutions [Laboratory Procedure]
   827 E C1948037:Dilution [Functional Concept]

Phrase: "once confluent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205200:Confluent [Qualitative Concept]

Phrase: "."
Processing 00000000.tx.127: At passage 3to 4,the stromal cells were plated in 100L of Iscove's modified Dulbecco's medium (IMDM) with 15% FBS in 96-well plates. 

Phrase: "At passage 3to 4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439799:Passage [Spatial Concept]

Phrase: "the stromal cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0162597:Stromal Cells [Cell]
   947 E C0596291:stroma cell [Cell Component]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789   C0927195:Stroma [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "plated in 100L of Iscove's modified Dulbecco's medium"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0009458:Medium [Intellectual Product]
   744   C0392747:Modified [Functional Concept]
   744   C0439536:Medium [Quantitative Concept]
   744   C1705217:Medium [Substance]
   744   C3244283:medium [Intellectual Product]
   711   C0005971:Plate [Medical Device]
   711   C1139930:plate [Medical Device]
   711   C3537155:Plate [Manufactured Object]

Phrase: "(IMDM"

Phrase: ")"

Phrase: "with 15% FBS"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0007452:Bovine [Mammal]
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0521457:Fetal [Functional Concept]
   812   C1140701:bovine [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: "in 96-well plates."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1139930:plates [Medical Device]
   793 E C0005971:Plate [Medical Device]
   793 E C3537155:Plate [Manufactured Object]
Processing 00000000.tx.128: Responder cells were fresh or cryopreserved autologous, ficoll gradient-separated peripheral blood mononuclear cells and were resuspended in IMDM with 15% FBS and either 5% canine or 10% murine leukocyte-conditioned media. 

Phrase: "Responder cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "fresh"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443224:Fresh [Qualitative Concept]
  1000   C2827486:Fresh [Body Substance]

Phrase: "or"

Phrase: "cryopreserved autologous, ficoll gradient-separated peripheral blood mononuclear cells"
Meta Candidates (Total=23; Excluded=10; Pruned=0; Remaining=13)
   874   C1511548:Cryopreserved Cell [Cell]
   849   C1321301:Peripheral Blood Mononuclear Cells [Cell]
   817   C0005773:Blood Cells [Cell]
           Peripheral blood cell
   807   C0229664:peripheral blood [Body Substance]
           Blood
   807   C0806987:Mononuclear cells [Cell]
   791   C0005767:Blood [Tissue]
   791   C0005768:blood [Body Substance]
   791   C0007634:Cells [Cell]
   791   C0205100:Peripheral [Spatial Concept]
   791   C1513475:Mononuclear [Clinical Attribute]
   791   C3282337:Cells [Cell]
   773 E C2328697:Hemal cell [Cell]
   766 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   758 E C1269647:Cell [Cell]
   758 E C1704653:Cell [Medical Device]
   758 E C1948049:Cell [Spatial Concept]
   720 E C0333275:Bloody [Qualitative Concept]
   708 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   708 E C0392895:Bloods [Population Group]
   708 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   708 E C1511228:VESSEL, BLOOD [Tissue]

Phrase: "and"

Phrase: "were"

Phrase: "resuspended in IMDM"

Phrase: "with 15% FBS"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0007452:Bovine [Mammal]
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0521457:Fetal [Functional Concept]
   812   C1140701:bovine [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "either 5% canine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0012984:Canine, NOS [Mammal]
   827   C1280551:Canine [Mammal]

Phrase: "or"

Phrase: "10% murine leukocyte-conditioned media."
Meta Candidates (Total=19; Excluded=13; Pruned=0; Remaining=6)
   840   C0162518:Conditioned Media [Indicator, Reagent, or Diagnostic Aid]
   804   C0009458:Media [Intellectual Product]
   804   C0009647:Conditioned [Mental Process]
   804   C0023516:Leucocyte [Cell]
   804   C0162867:Media [Tissue]
   804   C1254021:Media [Tissue]
   771 E C0439536:Medium [Quantitative Concept]
   771 E C1705217:Medium [Substance]
   771 E C3244283:medium [Intellectual Product]
   733 E C0012634:condition [Disease or Syndrome]
   733 E C0040607:Training [Educational Activity]
   733 E C0220931:Training [Educational Activity]
   733 E C0336809:Train [Manufactured Object]
   733 E C0348080:Condition [Qualitative Concept]
   733 E C1552514:Train [Manufactured Object]
   733 E C1705253:Condition [Conceptual Entity]
   733 E C2673163:training [Qualitative Concept]
   704 E C1701901:Conditional [Qualitative Concept]
   704 E C1963686:Conditional [Functional Concept]
Processing 00000000.tx.129: One hundred microliters of responder cells was added at a ratio of 1:10 stimulator to responder cells in triplicate to each transduced and control stroma sample. 

Phrase: "One hundred microliters of responder cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0439378:cells/microliter [Quantitative Concept]
   753   C0439243:microliter [Quantitative Concept]

Phrase: "was"

Phrase: "added at a ratio of 1"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   767   C0945818:Add 1 [Quantitative Concept]
   753   C0456603:Ratio [Quantitative Concept]
   753   C1524062:Added [Functional Concept]
   753   C1547037:Ratio [Intellectual Product]
   719 E C1883712:Add [Functional Concept]

Phrase: ":"

Phrase: "10 stimulator to responder cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0175727:Stimulator [Medical Device]

Phrase: "in triplicate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205174:Triplicate [Quantitative Concept]

Phrase: "to each"

Phrase: "transduced"

Phrase: "and"

Phrase: "control stroma sample."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.130: The positive control wells received 2% PHA, whereas blank wells, peripheral blood cells alone, and stroma alone served as negative controls. 

Phrase: "The positive control wells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0205170:Well [Qualitative Concept]
   793   C3146287:Well [Manufactured Object]
   734   C1883676:Positive Control [Conceptual Entity]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "2% PHA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031858:Phytohaemagglutinin [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]

Phrase: "whereas"

Phrase: "blank wells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205170:Well [Qualitative Concept]
   827   C3146287:Well [Manufactured Object]

Phrase: "peripheral blood cells"
Meta Candidates (Total=21; Excluded=12; Pruned=0; Remaining=9)
   966   C0005773:Peripheral blood cell [Cell]
           Blood Cells
   901   C0229664:peripheral blood [Body Substance]
           Blood
   859 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   856 E C2328697:Hemal cell [Cell]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0007634:Cells [Cell]
   827   C0205100:Peripheral [Spatial Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "alone,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "and"

Phrase: "stroma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0927195:Stroma [Body Part, Organ, or Organ Component]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "served as negative controls."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   799   C1639518:% negative control [Quantitative Concept]
   799   C1947986:Negative Control [Conceptual Entity]
   770   C0205160:Negative [Qualitative Concept]
   770   C1513916:Negative [Finding]
   770   C2825415:Negative [Conceptual Entity]
   770   C2825491:Negative [Qualitative Concept]
   737   C0243148:control [Qualitative Concept]
   737   C1550141:Control [Substance]
   737   C1882979:Control [Conceptual Entity]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.131: Cells were incubated at 37C for 6days and during the last 18-hour cells were pulsed with [3H]-thymidine. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 6days"

Phrase: "and during the last 18-hour cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   748   C0007634:Cells [Cell]
   748   C0439227:Hour [Temporal Concept]
   748   C0564385:/hour [Quantitative Concept]
   748   C1515981:And [Idea or Concept]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "pulsed with"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   833   C1947910:Pulsed [Phenomenon or Process]
   799 E C0232117:PULSE [Clinical Attribute]
   799 E C0391850:Pulse [Physiologic Function]

Phrase: "[3H]-thymidine."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040077:Thymidine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1442460:3H [Temporal Concept]
Processing 00000000.tx.132: Thymidine incorporation was analyzed on a Wallac 1205Betaplate counter (Wallac, Gaithersburg, MD) and reported as the mean cpm (SD) for triplicate measurements.  

Phrase: "Thymidine incorporation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0243126:incorporation [Functional Concept]

Phrase: "was"

Phrase: "analyzed on a Wallac 1205Betaplate counter"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0677601:Counter [Manufactured Object]
   753   C0936012:Analyzed [Research Activity]
   753   C1705206:Counter [Medical Device]

Phrase: "(Wallac,"

Phrase: "Gaithersburg,"

Phrase: "MD)"

Phrase: "and"

Phrase: "reported as the mean"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0444504:Mean [Quantitative Concept]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C2347634:Mean [Quantitative Concept]
   770   C2348143:Mean [Quantitative Concept]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "cpm"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0392412:Count per Minute [Quantitative Concept]
           Count/Minute
   790   C0439157:counts [Quantitative Concept]
   790   C0439232:minute [Temporal Concept]
   790   C0700321:minute [Quantitative Concept]
   790   C0702093:/minute [Temporal Concept]
   790   C0750480:Count [Activity]
   790   C1282918:Minute [Quantitative Concept]
   790   C1705566:Count [Quantitative Concept]
   790   C2347166:Minute [Quantitative Concept]

Phrase: "(SD) for triplicate measurements."
Processing 00000000.tx.133: RESULTS Autografts.  

Phrase: "RESULTS Autografts."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040736:autografts [Therapeutic or Preventive Procedure]
   861   C0559189:Autografts [Biomedical or Dental Material]
Processing 00000000.tx.134: Large volume marrow harvests were performed on five MPS I-affected dogs. 

Phrase: "Large volume marrow harvests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1512335:Harvest [Health Care Activity]

Phrase: "were"

Phrase: "performed on five MPS I-affected dogs."
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   800   C0023786:Mucopolysaccharidosis Type I [Disease or Syndrome]
           Mucopolysaccharidosis I
   770   C0441729:Type I [Classification]
   744   C0012984:Dogs [Mammal]
   744   C0021966:I- [Inorganic Chemical]
   744   C0026703:Mucopolysaccharidosis [Disease or Syndrome]
   744   C0205451:Five [Quantitative Concept]
   744   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0332307:Type [Qualitative Concept]
   744   C0392760:Affected [Functional Concept]
   744   C0884358:Performed [Functional Concept]
   744   C1280551:Dogs [Mammal]
   744   C1314939:Affected [Functional Concept]
   744   C1547052:*Type [Quantitative Concept]
   711 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.135: When yields of marrow mononuclear cell were less than 2108 cells/kg, dogs underwent multiple marrow harvests. 

Phrase: "When"

Phrase: "yields of marrow mononuclear cell"

Phrase: "were"

Phrase: "less than 2108 cells/kg,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0439092:Less Than [Intellectual Product]
           less
   760   C0007634:Cells [Cell]
   760   C0022718:KG [Geographic Area]
   760   C0439209:kg [Quantitative Concept]
   760   C0547044:Less [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "dogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012984:Dogs [Mammal]
  1000   C1280551:Dogs [Mammal]

Phrase: "underwent"

Phrase: "multiple marrow harvests."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1512335:Harvest [Health Care Activity]
Processing 00000000.tx.136: The time intervals between collections ranged from 1to 3months and in all cases subsequent harvests were performed after blood cells counts had normalized. 

Phrase: "The time intervals between collections"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   797   C0552379:Collection Time [Temporal Concept]
   773   C0872291:Time Interval [Temporal Concept]
   760   C0040223:Time [Temporal Concept]
   760   C1272706:intervals [Temporal Concept]
   760   C3541383:Time [Temporal Concept]
   726 E C1552654:Interval [Idea or Concept]
   726 E C1552713:Interval [Intellectual Product]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "ranged from 1to 3months"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1514721:Range [Quantitative Concept]
   737   C2348147:Range [Quantitative Concept]
   737   C3542016:Range [Intellectual Product]

Phrase: "and in all cases subsequent harvests"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0332282:Subsequent [Temporal Concept]
   753   C0868928:Cases [Functional Concept]
   753   C1515981:And [Idea or Concept]
   753   C1533148:Cases [Quantitative Concept]
   719   C1512335:Harvest [Health Care Activity]
   719 E C1706255:CASE [Medical Device]
   719 E C1706256:Case [Conceptual Entity]

Phrase: "were"

Phrase: "performed after blood cells"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   833   C0005773:Blood Cells [Cell]
   788 E C2328697:Hemal cell [Cell]
   770   C0005767:Blood [Tissue]
   770   C0005768:blood [Body Substance]
   770   C0007634:Cells [Cell]
   770   C0229664:Blood [Body Substance]
   770   C0884358:Performed [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "counts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439157:counts [Quantitative Concept]
  1000   C0750480:Count [Activity]
  1000   C1705566:Count [Quantitative Concept]

Phrase: "had"

Phrase: "normalized."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalized [Research Activity]
Processing 00000000.tx.137: Three dogs (M3, M5, and M6) underwent one marrow harvest, whereas dogs M4 and M2 underwent two and three marrow aspirations, respectively. 

Phrase: "Three dogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0012984:Dogs [Mammal]
   861   C1280551:Dogs [Mammal]

Phrase: "(M3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1300554:m3 [Quantitative Concept]
  1000   C3484373:M3 [Intellectual Product]

Phrase: "M5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1550079:M5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
  1000   C1561481:M5 [Intellectual Product]

Phrase: "and"

Phrase: "M6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412828:M6 [Gene or Genome]
  1000   C2986885:M6 [Gene or Genome]

Phrase: ")"

Phrase: "underwent"

Phrase: "one marrow harvest,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1512335:Harvest [Health Care Activity]

Phrase: "whereas"

Phrase: "dogs M4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1550077:M4 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C1561479:M4 [Intellectual Product]

Phrase: "and"

Phrase: "M2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0457242:m2 [Quantitative Concept]

Phrase: "underwent"

Phrase: "two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "and"

Phrase: "three marrow aspirations,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   827   C0004056:Aspirations [Mental Process]
   793 E C0220787:Aspiration [Health Care Activity]
   793 E C0349707:Aspiration [Therapeutic or Preventive Procedure]
   793 E C0700198:Aspiration [Pathologic Function]
   793 E C2827071:Aspiration [Finding]

Phrase: "respectively."
Processing 00000000.tx.138: On average, 1.0108 (standard error [SE]: 1.6107) mononuclear cells and 5.4104 (SE: 4.2103) CFU-GM/kg were obtained from each marrow sample after density gradient separation and washing. 

Phrase: "On average,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1510992:Average [Quantitative Concept]
  1000   C2825518:AVERAGE [Quantitative Concept]

Phrase: "1.0108"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "(standard error [SE]"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1710181:Standard Error [Quantitative Concept]
   861   C0743559:error [Qualitative Concept]
   861   C1442989:Standard [Qualitative Concept]
   861   C1608199:Error [Functional Concept]
   861   C2828392:Standard [Intellectual Product]

Phrase: ":"

Phrase: "1.6107"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "mononuclear cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0806987:Mononuclear cells [Cell]
   861   C0007634:Cells [Cell]
   861   C1513475:Mononuclear [Clinical Attribute]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "5.4104"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: "(SE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1710181:Standard Error [Quantitative Concept]
   861   C0743559:error [Qualitative Concept]
   861   C1442989:Standard [Qualitative Concept]
   861   C1608199:Error [Functional Concept]
   861   C2828392:Standard [Intellectual Product]

Phrase: ":"

Phrase: "4.2103"

Phrase: ")"

Phrase: "CFU-GM/kg"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C1300561:unit/kg [Quantitative Concept]
   799   C0022718:KG [Geographic Area]
   799   C0439209:kg [Quantitative Concept]

Phrase: "were"

Phrase: "obtained from each marrow sample"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   797   C1277697:Sample obtained [Finding]
   760   C0086590:Marrow [Food]
   760   C0370003:Sample [Substance]
   760   C0376152:Marrow [Body Part, Organ, or Organ Component]
   760   C1301820:Obtained [Functional Concept]
   760   C1546708:Marrow [Intellectual Product]
   760   C2347026:Sample [Conceptual Entity]
   726 E C1706701:Obtain [Activity]
   704 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   704 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   704 E C1550278:Medullary [Body Part, Organ, or Organ Component]

Phrase: "after density gradient separation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0036679:Separation [Pathologic Function]
   827   C0237868:Separation [Social Behavior]
   827   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "and"

Phrase: "washing."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]
Processing 00000000.tx.139: LTMCs from MPS I dogs were transduced by three exposures to retroviral vectors bearing the canine -ID cDNA. 

Phrase: "LTMCs"
Meta Candidates (Total=17; Excluded=4; Pruned=0; Remaining=13)
   861   C0443252:Long-term [Temporal Concept]
   812   C0010453:Culture [Idea or Concept]
   812   C0086590:Marrow [Food]
   812   C0205166:Long [Qualitative Concept]
   812   C0220814:culture [Functional Concept]
   812   C0376152:Marrow [Body Part, Organ, or Organ Component]
   812   C0430400:Culture [Laboratory Procedure]
   812   C1515273:Term [Temporal Concept]
   812   C1546708:Marrow [Intellectual Product]
   812   C1705313:Term [Idea or Concept]
   812   C1706317:Long [Qualitative Concept]
   812   C2242979:Culture [Laboratory Procedure]
   812   C2826302:TERM [Intellectual Product]
   756 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   756 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   756 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   729 E C0330477:Marrows [Plant]

Phrase: "from MPS I dogs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0012984:Dogs [Mammal]
   812   C1280551:Dogs [Mammal]
   756   C0023786:Mucopolysaccharidosis Type I [Disease or Syndrome]
           Mucopolysaccharidosis I

Phrase: "were"

Phrase: "transduced by three exposures"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0205449:Three [Quantitative Concept]
   770   C0274281:exposures [Injury or Poisoning]
   770   C0728853:exposures [Phenomenon or Process]
   737 E C0332157:Exposure [Clinical Attribute]

Phrase: "to retroviral vectors"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1514926:retroviral vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0035366:Retroviral [Virus]
   861   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vectors [Spatial Concept]
   827 E C1705099:Vector [Idea or Concept]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "the canine -ID cDNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.140: During 3weeks of culture, LTMCs from dogs M3, M4, and M5 were transduced with M48ID (Fig 1). 

Phrase: "During 3weeks"

Phrase: "of culture,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "LTMCs"
Meta Candidates (Total=17; Excluded=4; Pruned=0; Remaining=13)
   861   C0443252:Long-term [Temporal Concept]
   812   C0010453:Culture [Idea or Concept]
   812   C0086590:Marrow [Food]
   812   C0205166:Long [Qualitative Concept]
   812   C0220814:culture [Functional Concept]
   812   C0376152:Marrow [Body Part, Organ, or Organ Component]
   812   C0430400:Culture [Laboratory Procedure]
   812   C1515273:Term [Temporal Concept]
   812   C1546708:Marrow [Intellectual Product]
   812   C1705313:Term [Idea or Concept]
   812   C1706317:Long [Qualitative Concept]
   812   C2242979:Culture [Laboratory Procedure]
   812   C2826302:TERM [Intellectual Product]
   756 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   756 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   756 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   729 E C0330477:Marrows [Plant]

Phrase: "from dogs M3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1300554:m3 [Quantitative Concept]
   861   C3484373:M3 [Intellectual Product]

Phrase: "M4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1550077:M4 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
  1000   C1561479:M4 [Intellectual Product]

Phrase: "and"

Phrase: "M5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1550079:M5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
  1000   C1561481:M5 [Intellectual Product]

Phrase: "were"

Phrase: "transduced with M48ID"

Phrase: "(Fig 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.141: For the remaining two dogs, LTMCs from the first two marrow harvests from dog M2 were transduced with M48ID and the third with LCIDSN, whereas for dog M6, approximately one half of the LTMCs were transduced with each vector. 

Phrase: "For the remaining two dogs,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0012984:Dogs [Mammal]
   827   C1280551:Dogs [Mammal]

Phrase: "LTMCs"
Meta Candidates (Total=17; Excluded=4; Pruned=0; Remaining=13)
   861   C0443252:Long-term [Temporal Concept]
   812   C0010453:Culture [Idea or Concept]
   812   C0086590:Marrow [Food]
   812   C0205166:Long [Qualitative Concept]
   812   C0220814:culture [Functional Concept]
   812   C0376152:Marrow [Body Part, Organ, or Organ Component]
   812   C0430400:Culture [Laboratory Procedure]
   812   C1515273:Term [Temporal Concept]
   812   C1546708:Marrow [Intellectual Product]
   812   C1705313:Term [Idea or Concept]
   812   C1706317:Long [Qualitative Concept]
   812   C2242979:Culture [Laboratory Procedure]
   812   C2826302:TERM [Intellectual Product]
   756 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   756 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   756 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   729 E C0330477:Marrows [Plant]

Phrase: "from the first two marrow"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0086590:Marrow [Food]
   827   C0376152:Marrow [Body Part, Organ, or Organ Component]
   827   C1546708:Marrow [Intellectual Product]
   771 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   771 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   771 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   743 E C0330477:Marrows [Plant]

Phrase: "harvests from dog M2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0012984:Dog [Mammal]
   770   C0457242:m2 [Quantitative Concept]
   770   C1280551:Dog [Mammal]
   770   C1512335:Harvest [Health Care Activity]

Phrase: "were"

Phrase: "transduced with M48ID"

Phrase: "and"

Phrase: "the third with LCIDSN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205437:Third [Quantitative Concept]

Phrase: "whereas for dog M6,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0012984:Dog [Mammal]
   770   C1280551:Dog [Mammal]
   770   C1412828:M6 [Gene or Genome]
   770   C2986885:M6 [Gene or Genome]

Phrase: "approximately one half of the LTMCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C2825407:Half [Quantitative Concept]

Phrase: "were"

Phrase: "transduced with each vector."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0442335:Vector [Spatial Concept]
   770   C1705099:Vector [Idea or Concept]
Processing 00000000.tx.142: The cell and progenitor recoveries at the end of the 3-week LTMC and transduction period were 1.5107 cells (SE: 5.2107) and 9.2103 CFU-GM (SE: 4.8103) per kilogram, corresponding to 15% and 17% recovery of cells and CFU-GM. 

Phrase: "The cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "progenitor recoveries at the end of the 3-week LTMC"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   739   C0237820:recoveries [Activity]
   706 E C1555688:recovery [Idea or Concept]
   706 E C2004454:Recovery [Organism Function]

Phrase: "and"

Phrase: "transduction period"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0439531:/period [Temporal Concept]
   861   C1948053:Period [Temporal Concept]
   789 E C0332182:Periodic [Temporal Concept]
   789 E C1706381:PERIODIC [Intellectual Product]
   761 E C0031084:Periodicities [Temporal Concept]

Phrase: "were"

Phrase: "1.5107 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(SE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1710181:Standard Error [Quantitative Concept]
   861   C0743559:error [Qualitative Concept]
   861   C1442989:Standard [Qualitative Concept]
   861   C1608199:Error [Functional Concept]
   861   C2828392:Standard [Intellectual Product]

Phrase: ":"

Phrase: "5.2107"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "9.2103 CFU-GM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0024432:macrophage [Cell]

Phrase: "(SE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1710181:Standard Error [Quantitative Concept]
   861   C0743559:error [Qualitative Concept]
   861   C1442989:Standard [Qualitative Concept]
   861   C1608199:Error [Functional Concept]
   861   C2828392:Standard [Intellectual Product]

Phrase: ":"

Phrase: "4.8103"

Phrase: ")"

Phrase: "per kilogram,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439209:Kilogram [Quantitative Concept]

Phrase: "corresponding to 15%"

Phrase: "and"

Phrase: "17% recovery of cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0237820:Recovery [Activity]
   770   C1555688:recovery [Idea or Concept]
   770   C2004454:Recovery [Organism Function]

Phrase: "and"

Phrase: "CFU-GM."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0024432:macrophage [Cell]
   717   C0553561:Colony-forming unit [Quantitative Concept]
Processing 00000000.tx.143: Gene transfer and -ID expression in transduced LTMCs.  

Phrase: "Gene transfer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1517499:Gene Transfer [Molecular Biology Research Technique]
   861   C0017337:Gene [Gene or Genome]
   861   C0040671:Transfer [Mental Process]
   861   C1705822:Transfer [Activity]

Phrase: "and -ID expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   827   C1515981:And [Idea or Concept]

Phrase: "in transduced LTMCs."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   804   C0010453:Cultures [Idea or Concept]
   771 E C0220814:culture [Functional Concept]
   771 E C0430400:Culture [Laboratory Procedure]
   771 E C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.144: Successful transduction of LTMC cells was confirmed by PCR detection of proviral DNA in cells from all adherent layers (Fig 2A and Table 1). 

Phrase: "Successful transduction of LTMC cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1160185:transduction [Organism Function]

Phrase: "was"

Phrase: "confirmed by PCR detection of proviral DNA"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   790   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   764   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   762   C0012892:DNA Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0337112:Chain [Manufactured Object]
   742   C0443286:Reaction [Functional Concept]
   742   C0750484:Confirmed [Idea or Concept]
   742   C1114821:Reaction [Clinical Attribute]
   742   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C1511790:Detection [Therapeutic or Preventive Procedure]
   742   C1524075:Chain [Idea or Concept]
   708 E C1456348:Confirm [Qualitative Concept]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "from all adherent layers"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0934502:layers [Body Part, Organ, or Organ Component]
   827 E C1522408:Layer [Qualitative Concept]
   827 E C1561599:Layer [Intellectual Product]

Phrase: "(Fig 2A"

Phrase: "and"

Phrase: "Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.145: Transduced LTMCs were assayed for proviral -ID expression. 

Phrase: "Transduced LTMCs"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   804   C0010453:Cultures [Idea or Concept]
   771 E C0220814:culture [Functional Concept]
   771 E C0430400:Culture [Laboratory Procedure]
   771 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "assayed for proviral -ID expression."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.146: LTMC cells from transduced MPS I cultures had -ID enzyme activities of between 10and 198U (nanomoles per milligram of protein per hour; Table 1), corresponding to approximately 10to 200times normal enzyme levels. 

Phrase: "LTMC cells from transduced MPS I cultures"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   782   C1519720:Type I Cell [Cell]
   767   C0007585:cells cultures [Laboratory Procedure]
   767   C0449475:cells type [Intellectual Product]
   750 E C0007634:Cell Type [Cell]
           Cells
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "had -ID enzyme activities"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   827   C0243102:enzyme activity [Molecular Function]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0062074:HAD [Therapeutic or Preventive Procedure]
   812   C0441655:Activities [Activity]
   812   C1415458:HAD [Gene or Genome]
   812   C3539897:Had [Qualitative Concept]
   779 E C0205177:Activity [Functional Concept]
   779 E C0439167:% activity [Quantitative Concept]
   779 E C1561536:*Activity [Idea or Concept]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "of"

Phrase: "between 10and 198U"

Phrase: "(nanomoles per milligram of protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1881965:Nanomole per Milligram of Protein [Quantitative Concept]
           Nanomole/Milligram of Protein
   862   C0439291:Nanomole per Milligram [Quantitative Concept]
   760   C0439191:Nanomole [Quantitative Concept]

Phrase: "per hour"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439227:Hour [Temporal Concept]
  1000   C0564385:/hour [Quantitative Concept]

Phrase: "; Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "corresponding"

Phrase: "to approximately 10to 200times normal enzyme levels."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   818   C0014440:enzyme levels [Laboratory Procedure]
   818   C1287349:enzyme levels [Laboratory or Test Result]
   795   C0014442:Enzyme [Enzyme,Organic Chemical]
   795   C0441889:Levels [Qualitative Concept]
   762 E C0456079:Level [Classification]
   762 E C1547707:Level [Geographic Area]
   762 E C2946261:Level [Pharmacologic Substance]
   712 E C0014445:enzymes [Functional Concept]
Processing 00000000.tx.147: There was no activity detected in untransduced MPS I control LTMC adherent layer cells. 

Phrase: "There"

Phrase: "was"

Phrase: "no activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "detected in untransduced MPS I control LTMC adherent layer cells."
Meta Candidates (Total=29; Excluded=4; Pruned=0; Remaining=25)
   775   C0023786:Mucopolysaccharidosis Type I [Disease or Syndrome]
           Mucopolysaccharidosis I
   761   C1519720:Type I Cell [Cell]
   756   C0441729:Type I [Classification]
   754   C0449475:cells type [Intellectual Product]
   754   C1707504:Control Type [Research Activity]
   754   C1879930:Control Type [Intellectual Product]
   738   C0007634:Cells [Cell]
       E   Cell Type
   738   C0021966:I- [Inorganic Chemical]
   738   C0026703:Mucopolysaccharidosis [Disease or Syndrome]
   738   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   738   C0243148:control [Qualitative Concept]
   738   C0332307:Type [Qualitative Concept]
   738   C0334154:Adherent [Functional Concept]
   738   C0442726:Detected [Finding]
   738   C0934502:Layer [Body Part, Organ, or Organ Component]
   738   C1511790:Detected [Therapeutic or Preventive Procedure]
   738   C1522408:Layer [Qualitative Concept]
   738   C1547052:*Type [Quantitative Concept]
   738   C1550141:Control [Substance]
   738   C1561599:Layer [Intellectual Product]
   738   C1882979:Control [Conceptual Entity]
   738   C2587213:Control [Functional Concept]
   738   C3274648:Control [Qualitative Concept]
   738   C3282337:Cells [Cell]
   704 E C1269647:Cell [Cell]
   704 E C1704653:Cell [Medical Device]
   704 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.148: All transduced LTMCs were also positive for proviral -ID transcripts by RT-PCR (Fig 3A and Table 1). 

Phrase: "All transduced LTMCs"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   804   C0010453:Cultures [Idea or Concept]
   771 E C0220814:culture [Functional Concept]
   771 E C0430400:Culture [Laboratory Procedure]
   771 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "also positive for proviral -ID transcripts"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0439178:% Positive [Quantitative Concept]
   753   C1446409:Positive [Qualitative Concept]
   753   C1514241:Positive [Finding]
   753   C2825490:Positive [Qualitative Concept]

Phrase: "by RT-PCR"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0599161:Reverse Transcriptase Polymerase Chain Reaction [Molecular Biology Research Technique]
   884   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   840   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0337112:Chain [Manufactured Object]
   804   C0443286:Reaction [Functional Concept]
   804   C1114821:Reaction [Clinical Attribute]
   804   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1524075:Chain [Idea or Concept]
   804   C1555029:Reverse [Idea or Concept]
   804   C2257077:transcriptase [Genetic Function]

Phrase: "(Fig 3A"

Phrase: "and"

Phrase: "Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.149: View larger version (59K): [in this window] [in a new window]  Fig 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(59K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig 2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]
Processing 00000000.tx.150: Detection of proviral sequences in MPS I tissues. 

Phrase: "Detection of proviral sequences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "in MPS I tissues."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0040300:Tissues [Tissue]
   779 E C1547928:Tissue [Intellectual Product]
   756   C0023786:Mucopolysaccharidosis Type I [Disease or Syndrome]
           Mucopolysaccharidosis I
Processing 00000000.tx.151: (A) Proviral -ID and genomic control dystrophin (MD) PCR on day 21transduced adherent layer LTMC cells from dogs M2 through M6. 

Phrase: "(A) Proviral -ID"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "genomic control dystrophin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0079259:Dystrophin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1414083:DYSTROPHIN [Gene or Genome]

Phrase: "(MD) PCR on day 21transduced adherent layer LTMC cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   775   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   738   C0337112:Chain [Manufactured Object]
   738   C0443286:Reaction [Functional Concept]
   738   C1114821:Reaction [Clinical Attribute]
   738   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C1524075:Chain [Idea or Concept]

Phrase: "from dogs M2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0457242:m2 [Quantitative Concept]

Phrase: "through M6."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412828:M6 [Gene or Genome]
  1000   C2986885:M6 [Gene or Genome]
Processing 00000000.tx.152: The vectors used for each culture were M-M48ID and L-LCIDSN. 

Phrase: "The vectors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vectors [Spatial Concept]
   966 E C1705099:Vector [Idea or Concept]

Phrase: "used for each culture"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0010453:Culture [Idea or Concept]
   770   C0220814:culture [Functional Concept]
   770   C0430400:Culture [Laboratory Procedure]
   770   C1273517:used [Finding]
   770   C2242979:Culture [Laboratory Procedure]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "M-"

Phrase: "M48ID"

Phrase: "and"

Phrase: "L-LCIDSN."
Processing 00000000.tx.153: Positive controls were 10% M48ID producer cell line DNA mixed with 90% untransduced MPS I canine DNA and 1% M48ID producer cell line DNA mixed with 99% untransduced MPS I canine DNA. 

Phrase: "Positive controls"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   966   C1883676:Positive Control [Conceptual Entity]
   861   C0439178:% Positive [Quantitative Concept]
   861   C1446409:Positive [Qualitative Concept]
   861   C1514241:Positive [Finding]
   861   C2825490:Positive [Qualitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "10% M48ID producer cell line DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "mixed with 90% untransduced MPS I canine DNA"
Meta Candidates (Total=18; Excluded=2; Pruned=0; Remaining=16)
   790   C0023786:Mucopolysaccharidosis Type I [Disease or Syndrome]
           Mucopolysaccharidosis I
   764   C0441729:Type I [Classification]
   762   C0079247:type dna [Molecular Biology Research Technique]
   742   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0012984:Canine, NOS [Mammal]
   742   C0021966:I- [Inorganic Chemical]
   742   C0026703:Mucopolysaccharidosis [Disease or Syndrome]
   742   C0205430:Mixed [Functional Concept]
   742   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0332307:Type [Qualitative Concept]
   742   C0439083:>90 [Quantitative Concept]
   742   C0439087:<90 [Quantitative Concept]
   742   C1280551:Canine [Mammal]
   742   C1547052:*Type [Quantitative Concept]
   742   C3160715:Mixed [Finding]
   708 E C1421951:MIX [Gene or Genome]
   708 E C1720722:Mix [Qualitative Concept]

Phrase: "and"

Phrase: "1% M48ID producer cell line DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "mixed with 99% untransduced MPS I canine DNA."
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   790   C0023786:Mucopolysaccharidosis Type I [Disease or Syndrome]
           Mucopolysaccharidosis I
   764   C0441729:Type I [Classification]
   762   C0079247:type dna [Molecular Biology Research Technique]
   742   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0012984:Canine, NOS [Mammal]
   742   C0021966:I- [Inorganic Chemical]
   742   C0026703:Mucopolysaccharidosis [Disease or Syndrome]
   742   C0205430:Mixed [Functional Concept]
   742   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0332307:Type [Qualitative Concept]
   742   C1280551:Canine [Mammal]
   742   C1547052:*Type [Quantitative Concept]
   742   C3160715:Mixed [Finding]
   708 E C1421951:MIX [Gene or Genome]
   708 E C1720722:Mix [Qualitative Concept]
Processing 00000000.tx.154: All samples and control DNA mixes were positive for dystrophin sequences, and all transduced LTMCs were positive for proviral -ID. 

Phrase: "All samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "control DNA mixes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0205430:Mix [Functional Concept]
   793   C1421951:MIX [Gene or Genome]
   793   C1720722:Mix [Qualitative Concept]

Phrase: "were"

Phrase: "positive for dystrophin sequences,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439178:% Positive [Quantitative Concept]
   770   C1446409:Positive [Qualitative Concept]
   770   C1514241:Positive [Finding]
   770   C2825490:Positive [Qualitative Concept]

Phrase: "and"

Phrase: "all transduced LTMCs"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   804   C0010453:Cultures [Idea or Concept]
   771 E C0220814:culture [Functional Concept]
   771 E C0430400:Culture [Laboratory Procedure]
   771 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "positive for proviral -ID."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439178:% Positive [Quantitative Concept]
   770   C1446409:Positive [Qualitative Concept]
   770   C1514241:Positive [Finding]
   770   C2825490:Positive [Qualitative Concept]
Processing 00000000.tx.155: Untransduced LTMC DNA from dog M6 (UM6) and reagent controls were negative for proviral sequences. 

Phrase: "Untransduced LTMC DNA from dog M6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(UM6"

Phrase: ")"

Phrase: "and"

Phrase: "reagent controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "negative for proviral sequences."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205160:Negative [Qualitative Concept]
   770   C1513916:Negative [Finding]
   770   C2825415:Negative [Conceptual Entity]
   770   C2825491:Negative [Qualitative Concept]
Processing 00000000.tx.156: (B) Semiquantitative neor and genomic control dystrophin PCR on LTMCs transduced with M48ID (L1) and LCIDSN (L2); 

Phrase: "(B) Semiquantitative neor"

Phrase: "and"

Phrase: "genomic control dystrophin PCR on LTMCs"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   775   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   738   C0337112:Chain [Manufactured Object]
   738   C0443286:Reaction [Functional Concept]
   738   C1114821:Reaction [Clinical Attribute]
   738   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C1524075:Chain [Idea or Concept]

Phrase: "transduced with M48ID"

Phrase: "(L1)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441918:L1 [Finding]
  1000   C1179698:L1 [Body Location or Region]
  1000   C1416177:L1 [Gene or Genome]

Phrase: "and"

Phrase: "LCIDSN"

Phrase: "(L2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1179699:L2 [Body Location or Region]
  1000   C1418789:L2 [Gene or Genome]
  1000   C1825810:L2 [Gene or Genome]
  1000   C3538854:L2 [Gene or Genome]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.157: postinfusion blood (PB) and marrow (BM) cells from M2 with 0.01%, 0.1%, 1%, and 10% positive control mixed with untransduced canine DNA; 

Phrase: "postinfusion blood (PB)"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "marrow"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0086590:Marrow [Food]
  1000   C0376152:Marrow [Body Part, Organ, or Organ Component]
  1000   C1546708:Marrow [Intellectual Product]
   944 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   944 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   944 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   916 E C0330477:Marrows [Plant]

Phrase: "(BM) cells from M2"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   819   C2985212:cells/m2 [Quantitative Concept]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "with 0.01%,"

Phrase: "0.1%,"

Phrase: "1%,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "10% positive control"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   901   C1883676:Positive Control [Conceptual Entity]
   827   C0243148:control [Qualitative Concept]
   827   C0439178:% Positive [Quantitative Concept]
   827   C1446409:Positive [Qualitative Concept]
   827   C1514241:Positive [Finding]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C2825490:Positive [Qualitative Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "mixed with untransduced canine DNA"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0012984:Canine, NOS [Mammal]
   760   C0205430:Mixed [Functional Concept]
   760   C1280551:Canine [Mammal]
   760   C3160715:Mixed [Finding]
   726 E C1421951:MIX [Gene or Genome]
   726 E C1720722:Mix [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.158: and negative untransduced control (0). 

Phrase: "and"

Phrase: "negative untransduced control"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   913   C1639518:% negative control [Quantitative Concept]
   913   C1947986:Negative Control [Conceptual Entity]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "(0"

Phrase: ")."
Processing 00000000.tx.159: (C) PCR amplification and Southern blot analysis of 10CFU from M2 at 1year postinfusion; 

Phrase: "(C) PCR amplification"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   804   C0337112:Chain [Manufactured Object]
   804   C0443286:Reaction [Functional Concept]
   804   C1114821:Reaction [Clinical Attribute]
   804   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1517480:Amplification [Molecular Biology Research Technique]
   804   C1521871:Amplification [Phenomenon or Process]
   804   C1524075:Chain [Idea or Concept]
   804   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "Southern blot analysis of 10CFU"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0005862:Southern blot analysis [Molecular Biology Research Technique]
           Southern Blot
   862   C1148472:southern blot analysis [Laboratory or Test Result]
           Blot, Southern
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1710133:Southern [Spatial Concept]

Phrase: "from M2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0457242:m2 [Quantitative Concept]

Phrase: "at 1year postinfusion"

Phrase: ";"
Processing 00000000.tx.160: dystrophin genomic control (MD), proviral -ID (ID), and neor (neo) PCR analysis. 

Phrase: "dystrophin genomic control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "(MD),"

Phrase: "proviral -ID"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(ID"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600091:ID [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "neor (neo) PCR analysis."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   937   C0200931:Polymerase chain reaction analysis [Laboratory Procedure]
   884   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   804   C0002778:Analysis [Laboratory Procedure]
   804   C0337112:Chain [Manufactured Object]
   804   C0443286:Reaction [Functional Concept]
   804   C0936012:Analysis [Research Activity]
   804   C1114821:Reaction [Clinical Attribute]
   804   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1524024:analysis [Functional Concept]
   804   C1524075:Chain [Idea or Concept]
Processing 00000000.tx.161: This sample demonstrates 10CFU positive for genomic DNA (MD) and 1of 10CFU positive for both -ID and neor sequences (CFU 5). 

Phrase: "This sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "demonstrates"

Phrase: "10CFU positive for genomic DNA (MD)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0439178:% Positive [Quantitative Concept]
   753   C1446409:Positive [Qualitative Concept]
   753   C1514241:Positive [Finding]
   753   C2825490:Positive [Qualitative Concept]

Phrase: "and"

Phrase: "1of 10CFU positive for both -ID"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0439178:% Positive [Quantitative Concept]
   753   C1446409:Positive [Qualitative Concept]
   753   C1514241:Positive [Finding]
   753   C2825490:Positive [Qualitative Concept]

Phrase: "and"

Phrase: "neor sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "(CFU 5"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   923   C0553561:Colony-Forming Units [Quantitative Concept]
   812   C0205431:Forming [Functional Concept]
   812   C0439148:Units [Quantitative Concept]
   812   C0439158:colony [Quantitative Concept]
   812   C1519795:Units [Quantitative Concept]
   812   C1522492:Forming [Functional Concept]
   812   C1947989:Colony [Cell]
   779 E C0348078:Form [Qualitative Concept]
   779 E C0376315:Form [Manufactured Object]
   779 E C1704753:Unit [Manufactured Object]
   779 E C1880519:Unit [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.162: Abbreviations: M, marker lane; 

Phrase: "Abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: ":"

Phrase: "M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "marker lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.163: MC, methylcellulose control; 

Phrase: "MC,"

Phrase: "methylcellulose control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.164: RC, reagent control; 

Phrase: "RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419366:RC [Gene or Genome]

Phrase: "reagent control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.165: +C, positive control DNA.  

Phrase: "+C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "positive control DNA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1883676:Positive Control [Conceptual Entity]
Processing 00000000.tx.166: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.167: Evaluation of Gene Transfer and Proviral Gene Expression Into Canine MPS I LTMC Adherent Layers and Individual CFU-GM Derived From Transduced LTMCs View larger version (34K): [in this window] [in a new window]  Fig 3. 

Phrase: "Evaluation of Gene Transfer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0220825:Evaluation [Functional Concept]
   770   C1261322:Evaluation [Health Care Activity]

Phrase: "and"

Phrase: "Proviral Gene Expression Into Canine MPS I LTMC Adherent Layers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0017262:Gene Expression [Genetic Function]
   754   C0314611:Gene type [Genetic Function]
   738   C0017337:Gene [Gene or Genome]
   738   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Individual CFU-GM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0024432:macrophage [Cell]

Phrase: "Derived From Transduced LTMCs"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   778   C0443252:Long-term [Temporal Concept]
   748   C0010453:Cultures [Idea or Concept]
   748   C0086590:Marrow [Food]
   748   C0205166:Long [Qualitative Concept]
   748   C0376152:Marrow [Body Part, Organ, or Organ Component]
   748   C1441547:Derived [Qualitative Concept]
   748   C1515273:Term [Temporal Concept]
   748   C1546708:Marrow [Intellectual Product]
   748   C1705313:Term [Idea or Concept]
   748   C1706317:Long [Qualitative Concept]
   748   C2826302:TERM [Intellectual Product]
   748   C3245521:derived [Idea or Concept]
   714 E C0220814:culture [Functional Concept]
   714 E C0430400:Culture [Laboratory Procedure]
   714 E C2242979:Culture [Laboratory Procedure]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(34K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig 3."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]
Processing 00000000.tx.168: -ID expression evaluated by RT-PCR. 

Phrase: "-ID expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "evaluated by RT-PCR."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   897   C0599161:Reverse Transcriptase Polymerase Chain Reaction [Molecular Biology Research Technique]
   814   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   778   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0220825:Evaluated [Functional Concept]
   748   C0337112:Chain [Manufactured Object]
   748   C0443286:Reaction [Functional Concept]
   748   C1114821:Reaction [Clinical Attribute]
   748   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1524075:Chain [Idea or Concept]
   748   C1555029:Reverse [Idea or Concept]
   748   C2257077:transcriptase [Genetic Function]
Processing 00000000.tx.169: (A) LTMC adherent layers from all dogs and (B) blood (PB) and marrow (BM) leukocytes from M2 at 1to 3months postinfusion. 

Phrase: "(A) LTMC adherent layers from all dogs"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0934502:layers [Body Part, Organ, or Organ Component]
   714 E C1522408:Layer [Qualitative Concept]
   714 E C1561599:Layer [Intellectual Product]

Phrase: "and ("

Phrase: "B) blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "(PB"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "marrow"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0086590:Marrow [Food]
  1000   C0376152:Marrow [Body Part, Organ, or Organ Component]
  1000   C1546708:Marrow [Intellectual Product]
   944 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   944 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   944 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   916 E C0330477:Marrows [Plant]

Phrase: "(BM) leukocytes from M2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0023516:Leukocytes [Cell]

Phrase: "at 1to 3months postinfusion."
Processing 00000000.tx.170: PCR amplification of a 618-bp proviral specific -ID transcript (proviral transcript) was performed. 

Phrase: "PCR amplification of a 618-bp proviral specific -ID transcript"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   736   C0337112:Chain [Manufactured Object]
   736   C0443286:Reaction [Functional Concept]
   736   C1114821:Reaction [Clinical Attribute]
   736   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   736   C1517480:Amplification [Molecular Biology Research Technique]
   736   C1521871:Amplification [Phenomenon or Process]
   736   C1524075:Chain [Idea or Concept]
   736   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "(proviral transcript"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "was"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.171: PCR amplification of the 422-bp transcript arising from either the normal or mutant genomic -ID cDNA (endogenous transcript) was performed to confirm the presence of amplifiable cDNA in these tissues. 

Phrase: "PCR amplification of the 422-bp transcript arising"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   782   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   739   C0337112:Chain [Manufactured Object]
   739   C0443286:Reaction [Functional Concept]
   739   C1114821:Reaction [Clinical Attribute]
   739   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C1517480:Amplification [Molecular Biology Research Technique]
   739   C1521871:Amplification [Phenomenon or Process]
   739   C1524075:Chain [Idea or Concept]
   739   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "from either"

Phrase: "the normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "or"

Phrase: "mutant genomic -ID cDNA (endogenous transcript"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the presence of amplifiable cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in these tissues."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.172: A control for each sample was not treated with reverse transcriptase (RT) to ensure that there was not genomic DNA contamination of samples. 

Phrase: "A control for each sample"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "treated with reverse transcriptase (RT) to"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1522326:Treated [Functional Concept]
   760   C1555029:Reverse [Idea or Concept]
   760   C2257077:transcriptase [Genetic Function]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "that there"

Phrase: "was"

Phrase: "not genomic DNA contamination of samples."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C2936628:DNA Contamination [Human-caused Phenomenon or Process]
   753   C0259846:contamination [Human-caused Phenomenon or Process]
   753   C1881659:CONTAMINATION [Event]
   753   C2349974:Contamination [Idea or Concept]
Processing 00000000.tx.173: Abbreviations: ULTMC, untransduced LTMC control from M2; 

Phrase: "Abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: ":"

Phrase: "ULTMC,"

Phrase: "untransduced LTMC control from M2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.174: RC, reagent control; 

Phrase: "RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419366:RC [Gene or Genome]

Phrase: "reagent control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.175: +C, positive control DNA. 

Phrase: "+C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "positive control DNA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1883676:Positive Control [Conceptual Entity]
Processing 00000000.tx.176: To evaluate the levels of gene transfer and expression in the hematopoietic progenitor subpopulation of LTMCs, individual hematopoietic colonies were assayed. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the levels of gene transfer"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "expression in the hematopoietic progenitor subpopulation of LTMCs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "individual hematopoietic colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439158:colonies [Quantitative Concept]
   793 E C1947989:Colony [Cell]

Phrase: "were"

Phrase: "assayed."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.177: The average percentage of LTMC-derived CFU-GM positive for provirus was 32.8% (range, 20% to 62%; Table 1). 

Phrase: "The average percentage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439165:Percentage [Quantitative Concept]
   861   C1549488:Percentage [Idea or Concept]
   861   C1561533:Percentage [Idea or Concept]

Phrase: "of LTMC-derived CFU-GM positive"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0439178:% Positive [Quantitative Concept]
   793   C1446409:Positive [Qualitative Concept]
   793   C1514241:Positive [Finding]
   793   C2825490:Positive [Qualitative Concept]

Phrase: "for provirus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033755:Provirus [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1527278:provirus [Cell Component]

Phrase: "was"

Phrase: "32.8%"

Phrase: "(range,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1514721:Range [Quantitative Concept]
  1000   C2348147:Range [Quantitative Concept]
  1000   C3542016:Range [Intellectual Product]

Phrase: "20% to 62%"

Phrase: "; Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.178: Proviral -ID expression was assayed in CFU-GM from dogs M2 through M5 and on average 15% (range, 8% to 20%) of CFU-GM from transduced LTMCs had proviral -ID activity. 

Phrase: "Proviral -ID expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "assayed in CFU-GM"
Meta Candidates (Total=24; Excluded=2; Pruned=0; Remaining=22)
   912   C0201610:Colony forming unit-granulocyte/macrophage assay [Laboratory Procedure]
   870   C0314589:Colony-forming unit, granulocyte-macrophage [Cell]
   868   C0201608:Colony forming unit-granulocyte assay [Laboratory Procedure]
   855   C0201609:Colony forming unit-macrophage assay [Laboratory Procedure]
   840   C0314587:Colony-forming unit, granulocyte [Cell]
   840   C0314592:Colony-forming unit, macrophage [Cell]
   823   C0009385:Colony forming unit assay [Laboratory Procedure]
   814   C0553561:Colony-forming unit [Quantitative Concept]
   757   C2346864:Assay Unit [Quantitative Concept]
   748   C0018183:granulocyte [Cell]
   748   C0024432:macrophage [Cell]
   748   C0205431:Forming [Functional Concept]
   748   C0439148:Unit [Quantitative Concept]
   748   C0439158:colony [Quantitative Concept]
   748   C1519795:Unit [Quantitative Concept]
   748   C1522492:Forming [Functional Concept]
   748   C1704753:Unit [Manufactured Object]
   748   C1880519:Unit [Quantitative Concept]
   748   C1947989:Colony [Cell]
   714   C0005507:Assay [Laboratory Procedure]
   714   C0243073:assay [Qualitative Concept]
   714 E C0348078:Form [Qualitative Concept]
   714 E C0376315:Form [Manufactured Object]
   714   C1510438:Assay [Laboratory Procedure]

Phrase: "from dogs M2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0457242:m2 [Quantitative Concept]

Phrase: "through M5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1550079:M5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
  1000   C1561481:M5 [Intellectual Product]

Phrase: "and on average 15%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1510992:Average [Quantitative Concept]
   770   C1515981:And [Idea or Concept]
   770   C2825518:AVERAGE [Quantitative Concept]

Phrase: "(range,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1514721:Range [Quantitative Concept]
  1000   C2348147:Range [Quantitative Concept]
  1000   C3542016:Range [Intellectual Product]

Phrase: "8% to 20%"

Phrase: ")"

Phrase: "of CFU-GM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0024432:macrophage [Cell]
   717   C0553561:Colony-forming unit [Quantitative Concept]

Phrase: "from transduced LTMCs"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   804   C0010453:Cultures [Idea or Concept]
   771 E C0220814:culture [Functional Concept]
   771 E C0430400:Culture [Laboratory Procedure]
   771 E C2242979:Culture [Laboratory Procedure]

Phrase: "had"

Phrase: "proviral -ID activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.179: These data indicate that on average half of the progenitors carrying proviral sequences expressed the transgene. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that on average half of the progenitors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C1510992:Average [Quantitative Concept]
   748   C2825407:Half [Quantitative Concept]
   748   C2825518:AVERAGE [Quantitative Concept]
   714   C0870134:Progenitor [Family Group]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "proviral sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "expressed"

Phrase: "the transgene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282641:Transgene [Gene or Genome]
Processing 00000000.tx.180: The in vitro gene transfer efficiencies obtained in this study were comparable with results obtained in other canine and human gene transfer studies in our laboratory.11,15 Infusion of transduced LTMCs.  

Phrase: "The in vitro gene transfer efficiencies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0013682:efficiencies [Quantitative Concept]
   721 E C0442799:Efficient [Qualitative Concept]

Phrase: "obtained in this study"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0557651:Study [Manufactured Object]
   770   C1301820:Obtained [Functional Concept]
   770   C2603343:Study [Research Activity]
   737 E C1706701:Obtain [Activity]

Phrase: "were"

Phrase: "comparable with results"

Phrase: "obtained in other canine"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0012984:Canine, NOS [Mammal]
   770   C1280551:Canine [Mammal]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "human gene transfer studies in our laboratory.11,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   767   C0178693:human studies [Research Activity]
   767   C0681827:Laboratory studies [Laboratory Procedure]
   767   C1273305:Gene studies [Laboratory Procedure]
   744   C0947630:studies [Laboratory Procedure]
   711 E C0557651:Study [Manufactured Object]
   711 E C2603343:Study [Research Activity]

Phrase: "15 Infusion of transduced LTMCs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0574032:Infusion [Therapeutic or Preventive Procedure]
   744   C1827465:Infusion [Functional Concept]
Processing 00000000.tx.181: An average of 1.67107 (range, 9.6106 to 3.1107) LTMC cells per kilogram were infused into unconditioned autologous recipient dogs that had not received any type of -ID enzyme therapy (Fig 4). 

Phrase: "An average of 1.67107"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1510992:Average [Quantitative Concept]
   760   C2825518:AVERAGE [Quantitative Concept]

Phrase: "(range,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1514721:Range [Quantitative Concept]
  1000   C2348147:Range [Quantitative Concept]
  1000   C3542016:Range [Intellectual Product]

Phrase: "9.6106 to 3.1107"

Phrase: ")"

Phrase: "LTMC cells per kilogram"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "infused into unconditioned autologous recipient dogs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0012984:Dogs [Mammal]
   753   C0439859:Autologous [Qualitative Concept]
   753   C1280551:Dogs [Mammal]
   753   C1709854:Recipient [Human]

Phrase: "that"

Phrase: "had"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "any type of -ID enzyme therapy"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   840   C0596530:Enzyme Therapy [Therapeutic or Preventive Procedure]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0039798:therapy [Functional Concept]
   804   C0087111:Therapy [Therapeutic or Preventive Procedure]
   804   C1363945:Therapy [Finding]
   721 E C0014445:enzymes [Functional Concept]

Phrase: "(Fig 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.182: Dogs were not myeloablated or otherwise preconditioned. 

Phrase: "Dogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012984:Dogs [Mammal]
  1000   C1280551:Dogs [Mammal]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "myeloablated"

Phrase: "or"

Phrase: "otherwise"

Phrase: "preconditioned."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0871117:precondition [Mental Process]
   966   C1709632:Precondition [Conceptual Entity]
Processing 00000000.tx.183: Three dogs (M3, M5, and M6) each received one infusion. 

Phrase: "Three dogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0012984:Dogs [Mammal]
   861   C1280551:Dogs [Mammal]

Phrase: "(M3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1300554:m3 [Quantitative Concept]
  1000   C3484373:M3 [Intellectual Product]

Phrase: "M5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1550079:M5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
  1000   C1561481:M5 [Intellectual Product]

Phrase: "and"

Phrase: "M6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412828:M6 [Gene or Genome]
  1000   C2986885:M6 [Gene or Genome]

Phrase: ")"

Phrase: "each"

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "one infusion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0574032:Infusion [Therapeutic or Preventive Procedure]
   861   C1827465:Infusion [Functional Concept]
Processing 00000000.tx.184: M4 received two infusions of ID-transduced LTMC cells. 

Phrase: "M4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1550077:M4 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
  1000   C1561479:M4 [Intellectual Product]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "two infusions of ID-transduced LTMC cells."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0574032:infusions [Therapeutic or Preventive Procedure]
   714 E C1827465:Infusion [Functional Concept]
Processing 00000000.tx.185: After M2 had received three infusions of transduced cells, he was placed on cyclosporine A immunosuppressive therapy and two more infusions of 5106 LTMC cells/kg were administered. 

Phrase: "After M2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0457242:m2 [Quantitative Concept]

Phrase: "had"

Phrase: "received three infusions of transduced cells,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0574032:infusions [Therapeutic or Preventive Procedure]
   719 E C1827465:Infusion [Functional Concept]

Phrase: "he"

Phrase: "was"

Phrase: "placed on cyclosporine A immunosuppressive therapy"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0010592:Cyclosporin A [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Ciclosporin
   790   C0021079:Immunosuppressive therapy [Therapeutic or Preventive Procedure]
   753   C0021081:immunosuppressive [Immunologic Factor,Pharmacologic Substance]
   753   C0039798:therapy [Functional Concept]
   753   C0087111:Therapy [Therapeutic or Preventive Procedure]
   753   C1363945:Therapy [Finding]
   719   C0442504:Place [Spatial Concept]
   719   C1704765:Place [Functional Concept]
   719   C1882509:Place [Activity]
   719   C3496241:place [Disease or Syndrome]

Phrase: "and"

Phrase: "two more infusions of 5106 LTMC cells/kg"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0574032:infusions [Therapeutic or Preventive Procedure]
   711 E C1827465:Infusion [Functional Concept]

Phrase: "were"

Phrase: "administered."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521801:Administered [Functional Concept]
   966 E C1621583:Administer [Functional Concept]
Processing 00000000.tx.186: Dogs M3 through M6 received immediate posttransplant cyclosporine A and dog M6 received, in addition, methotrexate (0.2mg/kg) intravenously on days 1,3,6,and 11and weekly thereafter.34 The dose of cyclosporine A used was 10to 30mg/kg (cyclosporine A was kindly provided by Sandoz Canada, Dorval, Quebec, Canada) and adjusted to maintain a whole blood cyclosporine A level of 400to 500ng/mL. 

Phrase: "Dogs M3 through M6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1300554:m3 [Quantitative Concept]
   770   C3484373:M3 [Intellectual Product]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "immediate posttransplant cyclosporine A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010592:Cyclosporin A [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Ciclosporin

Phrase: "and"

Phrase: "dog M6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1412828:M6 [Gene or Genome]
   861   C2986885:M6 [Gene or Genome]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: ","

Phrase: "in addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "methotrexate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025677:Methotrexate [Organic Chemical,Pharmacologic Substance]

Phrase: "(0.2mg/kg) intravenously on days 1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0439418:kg/day [Quantitative Concept]
   748   C0022718:KG [Geographic Area]
   748   C0439209:kg [Quantitative Concept]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "6,"

Phrase: "and"

Phrase: "11and weekly thereafter.34"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0332174:Weekly [Temporal Concept]

Phrase: "The dose of cyclosporine A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0366433:Cyclosporin Dose [Clinical Attribute]
   760   C0178602:Dose [Quantitative Concept]
   760   C0869039:Dose [Quantitative Concept]
   760   C1114758:Dose # [Clinical Attribute]

Phrase: "used"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]

Phrase: "was"

Phrase: "10to 30mg/kg (cyclosporine A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0010592:Cyclosporin A [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Ciclosporin

Phrase: "was"

Phrase: "kindly"

Phrase: "provided by Sandoz Canada,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006823:Canada [Geographic Area]
   770   C0331892:Sandoz [Health Care Related Organization]
   770   C1999230:Provided [Activity]

Phrase: "Dorval,"

Phrase: "Quebec,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034390:Quebec [Geographic Area]

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "adjusted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456081:Adjusted [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "a whole blood cyclosporine A level of 400to 500ng/mL."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   777   C1278100:Blood cyclosporin level [Laboratory Procedure]
   739   C0441889:Level [Qualitative Concept]
   739   C0456079:Level [Classification]
   739   C1547707:Level [Geographic Area]
   739   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.187: LTMC cells were adminstered intravenously in 50mL Hank's buffered saline over 15to 30minutes. 

Phrase: "LTMC cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "adminstered intravenously in 50mL Hank's buffered saline"

Phrase: "over 15to 30minutes."
Processing 00000000.tx.188: The injections were well tolerated and there were no late complications. 

Phrase: "The injections"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0021485:injections [Therapeutic or Preventive Procedure]
  1000   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
  1000   C1828121:Injections [Functional Concept]
   966 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "were"

Phrase: "well tolerated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205170:Well [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "and"

Phrase: "there"

Phrase: "were"

Phrase: "no late complications."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0009566:Complications [Pathologic Function]
   861   C1171258:complications [Pathologic Function]
   827 E C2362589:Complication [Idea or Concept]
   777 E C0231242:Complicated [Functional Concept]
Processing 00000000.tx.189: View larger version (8K): [in this window] [in a new window]  Fig 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(8K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig 4."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]
Processing 00000000.tx.190: Summary of LTMC cells infused per kilogram into MPS I dogs. 

Phrase: "Summary of LTMC cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552616:summary [Intellectual Product]
   770   C1706244:Summary [Intellectual Product]

Phrase: "infused per kilogram"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439209:Kilogram [Quantitative Concept]

Phrase: "into MPS I dogs."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0012984:Dogs [Mammal]
   812   C1280551:Dogs [Mammal]
   756   C0023786:Mucopolysaccharidosis Type I [Disease or Syndrome]
           Mucopolysaccharidosis I
Processing 00000000.tx.191: Multiple infusions in M2 and M4 were separated by 3to 4weeks. 

Phrase: "Multiple infusions in M2"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0574032:infusions [Therapeutic or Preventive Procedure]
   737 E C1827465:Infusion [Functional Concept]

Phrase: "and"

Phrase: "M4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1550077:M4 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
  1000   C1561479:M4 [Intellectual Product]

Phrase: "were"

Phrase: "separated by 3to 4weeks."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
Processing 00000000.tx.192: Cell doses administered in multiple infusions are indicated by different shading patterns. 

Phrase: "Cell doses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0178602:Doses [Quantitative Concept]
   827 E C0869039:Dose [Quantitative Concept]
   827 E C1114758:Dose # [Clinical Attribute]
   827 E C1428722:DOS [Gene or Genome]

Phrase: "administered in multiple infusions"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0439064:Multiple [Quantitative Concept]
   770   C0574032:infusions [Therapeutic or Preventive Procedure]
   770   C1521801:Administered [Functional Concept]
   737 E C1621583:Administer [Functional Concept]
   737 E C1827465:Infusion [Functional Concept]

Phrase: "are"

Phrase: "indicated by different shading patterns."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0449774:Patterns [Spatial Concept]
   760   C1444656:Indicated [Finding]
   760   C1705242:Different [Qualitative Concept]
Processing 00000000.tx.193: Gene transfer into in vivo repopulating cells.  

Phrase: "Gene transfer into in vivo repopulating cells."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1517499:Gene Transfer [Molecular Biology Research Technique]
   757   C1861886:CELL Gene [Gene or Genome]
   748   C0017337:Gene [Gene or Genome]
   748   C0040671:Transfer [Mental Process]
   748   C1705822:Transfer [Activity]
Processing 00000000.tx.194: To assess the presence of transduced, long-lived, hematopoietic cells and progenitors, PCR analyses for proviral specific neor and -ID sequences were performed on samples at up to 36months postinfusion. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the presence of transduced, long-lived, hematopoietic cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0427850:Presence of cells [Laboratory or Test Result]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "progenitors,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0870134:Progenitor [Family Group]

Phrase: "PCR analyses for proviral specific neor"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   800   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   799   C0200931:Polymerase chain reaction analysis [Laboratory Procedure]
   744   C0337112:Chain [Manufactured Object]
   744   C0443286:Reaction [Functional Concept]
   744   C1114821:Reaction [Clinical Attribute]
   744   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1524075:Chain [Idea or Concept]
   711   C0002778:Analysis [Laboratory Procedure]
   711   C0936012:Analysis [Research Activity]
   711   C1524024:analysis [Functional Concept]

Phrase: "and -ID sequences"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   827   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0162326:Sequences [Nucleotide Sequence]
   827   C1515981:And [Idea or Concept]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "were"

Phrase: "performed on samples"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0884358:Performed [Functional Concept]
   756   C0370003:Sample [Substance]
   756   C2347026:Sample [Conceptual Entity]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "at"

Phrase: "up to 36months postinfusion."
Processing 00000000.tx.195: Semiquantitative neor PCR analysis was performed on blood and marrow leukocytes from the two dogs (M2 and M6) that received the neor containing vector, LCIDSN. 

Phrase: "Semiquantitative neor PCR analysis"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   901   C0200931:Polymerase chain reaction analysis [Laboratory Procedure]
   861   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   799   C0002778:Analysis [Laboratory Procedure]
   799   C0337112:Chain [Manufactured Object]
   799   C0443286:Reaction [Functional Concept]
   799   C0936012:Analysis [Research Activity]
   799   C1114821:Reaction [Clinical Attribute]
   799   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C1524024:analysis [Functional Concept]
   799   C1524075:Chain [Idea or Concept]

Phrase: "was"

Phrase: "performed on blood"
Meta Candidates (Total=10; Excluded=6; Pruned=0; Remaining=4)
   790   C0005767:Blood [Tissue]
   790   C0005768:blood [Body Substance]
   790   C0229664:Blood [Body Substance]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]
   718 E C0333275:Bloody [Qualitative Concept]
   706 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   706 E C0392895:Bloods [Population Group]
   706 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   706 E C1511228:VESSEL, BLOOD [Tissue]

Phrase: "and"

Phrase: "marrow leukocytes from the two dogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   773   C0023516:Marrow leukocyte [Cell]
           Leukocytes

Phrase: "(M2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0457242:m2 [Quantitative Concept]

Phrase: "and"

Phrase: "M6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412828:M6 [Gene or Genome]
  1000   C2986885:M6 [Gene or Genome]

Phrase: ")"

Phrase: "that"

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "the neor containing vector,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vector [Spatial Concept]
   827   C1705099:Vector [Idea or Concept]

Phrase: "LCIDSN."
Processing 00000000.tx.196: The proportion of neor-positive cells from both dogs was similar and data from M2 are shown in Fig 2B. 

Phrase: "The proportion of neor-positive cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709707:Proportion [Quantitative Concept]

Phrase: "from both dogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012984:Dogs [Mammal]
  1000   C1280551:Dogs [Mammal]

Phrase: "was"

Phrase: "similar"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "data from M2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1511726:Data [Idea or Concept]
   790   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "shown in Fig 2B."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0349966:Fig [Food]
   770   C0450354:2b [Intellectual Product]
   770   C1337208:FIG [Food]
   770   C1706096:2B [Research Activity]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.197: The proportion of blood and marrow leukocytes carrying the proviral genome was between 0.1% and 1% at time points up to 26months postinfusion (Fig 2B). 

Phrase: "The proportion of blood"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709707:Proportion [Quantitative Concept]

Phrase: "and"

Phrase: "marrow leukocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0023516:Marrow leukocyte [Cell]
           Leukocytes

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "the proviral genome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017428:Genome [Gene or Genome]
   861   C2338314:Genome [Conceptual Entity]

Phrase: "was between 0.1%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1421478:WAS [Gene or Genome]

Phrase: "and"

Phrase: "1% at time points"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   799   C2348792:Time Point [Temporal Concept]
   770   C0040223:Time [Temporal Concept]
   770   C2827734:1+ [Quantitative Concept]
   770   C2981698:1+ [Classification]
   770   C3541383:Time [Temporal Concept]
   737   C1552961:Point [Quantitative Concept]
   737   C2347617:point [Quantitative Concept]
   715 E C0442043:Temporal [Spatial Concept]
   715 E C2362314:Temporal [Temporal Concept]

Phrase: "up to 26months postinfusion"

Phrase: "(Fig 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.198: The levels generally decreased to approximately 0.01% at 28months postinfusion and were undetectable by 36months. 

Phrase: "The levels generally"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "to approximately 0.01% at 28months postinfusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332232:Approximately [Qualitative Concept]
   748   C1883351:To [Qualitative Concept]

Phrase: "and"

Phrase: "were"

Phrase: "undetectable by 36months."
Processing 00000000.tx.199: The proportion of hematopoietic progenitors carrying the proviral -ID cDNA was evaluated by PCR amplification of proviral DNA in marrow-derived hematopoietic colonies (CFU-GM and BFU-E) at time points after adoptive transfer. 

Phrase: "The proportion of hematopoietic progenitors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709707:Proportion [Quantitative Concept]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "the proviral -ID cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "evaluated by PCR amplification of proviral DNA"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   762   C0012892:DNA Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   762   C0683230:DNA amplification [Genetic Function]
   742   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0220825:Evaluated [Functional Concept]
   742   C0337112:Chain [Manufactured Object]
   742   C0443286:Reaction [Functional Concept]
   742   C1114821:Reaction [Clinical Attribute]
   742   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C1517480:Amplification [Molecular Biology Research Technique]
   742   C1521871:Amplification [Phenomenon or Process]
   742   C1524075:Chain [Idea or Concept]
   742   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "in marrow-derived hematopoietic colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0439158:colonies [Quantitative Concept]
   779 E C1947989:Colony [Cell]

Phrase: "(CFU-GM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0024432:macrophage [Cell]
   717   C0553561:Colony-forming unit [Quantitative Concept]

Phrase: "and"

Phrase: "BFU-E"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1257771:Burst-forming unit erythroid [Cell]
   812   C0205431:Forming [Functional Concept]
   812   C0439148:Unit [Quantitative Concept]
   812   C0439818:burst [Qualitative Concept]
   812   C1516960:Erythroid [Qualitative Concept]
   812   C1519795:Unit [Quantitative Concept]
   812   C1522492:Forming [Functional Concept]
   812   C1704753:Unit [Manufactured Object]
   812   C1880519:Unit [Quantitative Concept]
   812   C1881705:BURST [Phenomenon or Process]
   779 E C0348078:Form [Qualitative Concept]
   779 E C0376315:Form [Manufactured Object]

Phrase: ")"

Phrase: "at time points"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   966   C2348792:Time Point [Temporal Concept]
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   827   C1552961:Point [Quantitative Concept]
   827   C2347617:point [Quantitative Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "after adoptive transfer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0376518:Adoptive Transfer [Therapeutic or Preventive Procedure]
   861   C0040671:Transfer [Mental Process]
   861   C1705822:Transfer [Activity]
Processing 00000000.tx.200: A representative CFU PCR analysis comparing endogenous control of dystrophin PCR, neor PCR, and -ID PCR from M2 at 12months postinfusion is shown in Fig 2C. 

Phrase: "A representative CFU PCR analysis"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0200931:Polymerase chain reaction analysis [Laboratory Procedure]
   835   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0337112:Chain [Manufactured Object]
   793   C0443286:Reaction [Functional Concept]
   793   C0936012:Analysis [Research Activity]
   793   C1114821:Reaction [Clinical Attribute]
   793   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   793   C1524024:analysis [Functional Concept]
   793   C1524075:Chain [Idea or Concept]

Phrase: "comparing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707455:Compare [Activity]

Phrase: "endogenous control of dystrophin PCR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0243148:control [Qualitative Concept]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]

Phrase: "neor PCR,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0337112:Chain [Manufactured Object]
   812   C0443286:Reaction [Functional Concept]
   812   C1114821:Reaction [Clinical Attribute]
   812   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1524075:Chain [Idea or Concept]

Phrase: "and -ID PCR"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   884   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   804   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0337112:Chain [Manufactured Object]
   804   C0443286:Reaction [Functional Concept]
   804   C1114821:Reaction [Clinical Attribute]
   804   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1515981:And [Idea or Concept]
   804   C1524075:Chain [Idea or Concept]

Phrase: "from M2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0457242:m2 [Quantitative Concept]

Phrase: "at 12months postinfusion"

Phrase: "is"

Phrase: "shown in Fig 2C."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0349966:Fig [Food]
   770   C1337208:FIG [Food]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.201: There was good evidence for the presence of committed progenitors bearing proviral DNA in all dogs, and all had provirus positive CFU at all time points tested (at least 1year postinfusion). 

Phrase: "There"

Phrase: "was"

Phrase: "good evidence for the presence of committed progenitors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "proviral DNA in all dogs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "all"

Phrase: "had"

Phrase: "provirus positive CFU at all time points"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   790   C0553561:Colony-Forming Units [Quantitative Concept]
   745   C0439221:Time Unit [Temporal Concept]
   742   C0205431:Forming [Functional Concept]
   742   C0439148:Units [Quantitative Concept]
   742   C0439158:colony [Quantitative Concept]
   742   C1519795:Units [Quantitative Concept]
   742   C1522492:Forming [Functional Concept]
   742   C1947989:Colony [Cell]
   708 E C0348078:Form [Qualitative Concept]
   708 E C0376315:Form [Manufactured Object]
   708 E C1704753:Unit [Manufactured Object]
   708 E C1880519:Unit [Quantitative Concept]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "("

Phrase: "at least 1year postinfusion"

Phrase: ")."
Processing 00000000.tx.202: Dog M5, for example, maintained between 2% and 3% provirally marked CFU throughout the 12-month period postinfusion. 

Phrase: "Dog M5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1550079:M5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C1561481:M5 [Intellectual Product]

Phrase: "for example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "maintained between 2%"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1314677:Maintained [Functional Concept]
   756 E C0024501:Maintain [Activity]

Phrase: "and"

Phrase: "3% provirally marked CFU"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   861   C0553561:Colony-Forming Units [Quantitative Concept]
   799   C0205431:Forming [Functional Concept]
   799   C0439148:Units [Quantitative Concept]
   799   C0439158:colony [Quantitative Concept]
   799   C1519795:Units [Quantitative Concept]
   799   C1522492:Forming [Functional Concept]
   799   C1947989:Colony [Cell]
   766 E C0348078:Form [Qualitative Concept]
   766 E C0376315:Form [Manufactured Object]
   766 E C1704753:Unit [Manufactured Object]
   766 E C1880519:Unit [Quantitative Concept]

Phrase: "throughout the 12-month period postinfusion."
Processing 00000000.tx.203: Other dogs generally had a peak of 5% to 10% positive CFU in the first 6months postinfusion and then a gradual decrease to 2% to 5% at time points greater than 1year (Table 2 and Fig 5). 

Phrase: "Other dogs generally"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0012984:Dogs [Mammal]
   861   C1280551:Dogs [Mammal]

Phrase: "had"

Phrase: "a peak of 5%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0444505:Peak [Quantitative Concept]

Phrase: "to 10% positive CFU"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   884   C0553561:Colony-Forming Units [Quantitative Concept]
   804   C0205431:Forming [Functional Concept]
   804   C0439148:Units [Quantitative Concept]
   804   C0439158:colony [Quantitative Concept]
   804   C1519795:Units [Quantitative Concept]
   804   C1522492:Forming [Functional Concept]
   804   C1947989:Colony [Cell]
   771 E C0348078:Form [Qualitative Concept]
   771 E C0376315:Form [Manufactured Object]
   771 E C1704753:Unit [Manufactured Object]
   771 E C1880519:Unit [Quantitative Concept]

Phrase: "in the first 6months postinfusion"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "a gradual decrease to 2%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "to 5%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "at time points"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   966   C2348792:Time Point [Temporal Concept]
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   827   C1552961:Point [Quantitative Concept]
   827   C2347617:point [Quantitative Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "greater than 1year"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0439093:Greater Than [Quantitative Concept]
   790   C0443228:greater [Quantitative Concept]
   790   C1704243:Greater [Quantitative Concept]
   756 E C0549177:Great [Quantitative Concept]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "and"

Phrase: "Fig 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.204: Dog M2 was observed the longest and maintained levels of up to 6% provirus positive CFU between 12and 24months and 2% to 5% at up to 24to 36months postinfusion. 

Phrase: "Dog M2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0457242:m2 [Quantitative Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "the longest"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C1522425:Longest [Qualitative Concept]
   966 E C0205166:Long [Qualitative Concept]
   966 E C1706317:Long [Qualitative Concept]
   916 E C1444754:Length [Quantitative Concept]
   916 E C1706316:LENGTH [Research Activity]

Phrase: "and"

Phrase: "maintained levels of"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0441889:Levels [Qualitative Concept]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]

Phrase: "up to 6% provirus positive CFU"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   861   C0553561:Colony-Forming Units [Quantitative Concept]
   799   C0205431:Forming [Functional Concept]
   799   C0439148:Units [Quantitative Concept]
   799   C0439158:colony [Quantitative Concept]
   799   C1519795:Units [Quantitative Concept]
   799   C1522492:Forming [Functional Concept]
   799   C1947989:Colony [Cell]
   766 E C0348078:Form [Qualitative Concept]
   766 E C0376315:Form [Manufactured Object]
   766 E C1704753:Unit [Manufactured Object]
   766 E C1880519:Unit [Quantitative Concept]

Phrase: "between 12and 24months"

Phrase: "and"

Phrase: "2% to 5%"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   858   C0450346:2 5 [Quantitative Concept]
   790   C0740116:+2 [Quantitative Concept]
   790   C2827735:2+ [Quantitative Concept]
   790   C2981700:2+ [Classification]

Phrase: "at"

Phrase: "up to 24to 36months postinfusion."
Processing 00000000.tx.205: Generally, the level of progenitors carrying provirus in the MPS I dogs in this study were similar to those observed in normal dogs used in previous marker gene studies from our center.11 For negative controls, background methylcellulose from each plate and colonies from three marrow samples from control, untreated dogs were harvested, plucked, and analyzed by PCR. 

Phrase: "Generally,"

Phrase: "the level of progenitors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "provirus in the MPS I dogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0033755:Provirus [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C1527278:provirus [Cell Component]

Phrase: "in this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "similar to those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "observed in normal dogs"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0012984:Dogs [Mammal]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C1280551:Dogs [Mammal]
   770   C1441672:Observed [Functional Concept]
   770   C2347086:% Normal [Quantitative Concept]

Phrase: "used in previous marker gene"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0005516:Marker [Clinical Attribute]
   760   C0017337:Gene [Gene or Genome]
   760   C0205156:Previous [Temporal Concept]
   760   C1273517:used [Finding]
   760   C1552607:previous [Temporal Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "studies from our center.11"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205099:Center [Spatial Concept]
   760   C0557651:Study [Manufactured Object]
   760   C0947630:studies [Laboratory Procedure]
   760   C2603343:Study [Research Activity]

Phrase: "For negative controls,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   966   C1639518:% negative control [Quantitative Concept]
   966   C1947986:Negative Control [Conceptual Entity]
   861   C0205160:Negative [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "background methylcellulose from each plate"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0025729:Methyl Cellulose [Carbohydrate,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   704 E C0699455:Methocel [Carbohydrate,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "and"

Phrase: "colonies from three marrow samples"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0439158:colonies [Quantitative Concept]
   726 E C1947989:Colony [Cell]

Phrase: "from control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "untreated dogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0012984:Dogs [Mammal]
   861   C1280551:Dogs [Mammal]

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: ","

Phrase: "plucked"

Phrase: ","

Phrase: "and"

Phrase: "analyzed by PCR."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0337112:Chain [Manufactured Object]
   760   C0443286:Reaction [Functional Concept]
   760   C0936012:Analyzed [Research Activity]
   760   C1114821:Reaction [Clinical Attribute]
   760   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1524075:Chain [Idea or Concept]
Processing 00000000.tx.206: A total of 139colonies from untransduced control dogs and 177background methylcellulose plucking controls from treated dogs underwent neor and/or -ID PCR analysis and all were negative.  

Phrase: "A total of 139colonies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439175:% total [Quantitative Concept]
   770   C0439810:Total [Qualitative Concept]

Phrase: "from untransduced control dogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0012984:Dogs [Mammal]
   827   C1280551:Dogs [Mammal]

Phrase: "and"

Phrase: "177background methylcellulose plucking controls from treated dogs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   714   C0243148:control [Qualitative Concept]
   714   C1550141:Control [Substance]
   714   C1882979:Control [Conceptual Entity]
   714   C2587213:Control [Functional Concept]
   714   C3274648:Control [Qualitative Concept]

Phrase: "underwent"

Phrase: "neor"

Phrase: "and/or -ID PCR analysis"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   877   C0200931:Polymerase chain reaction analysis [Laboratory Procedure]
   845   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   818   C1706528:And/Or [Conceptual Entity]
   795   C0002778:Analysis [Laboratory Procedure]
   795   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0337112:Chain [Manufactured Object]
   795   C0443286:Reaction [Functional Concept]
   795   C0936012:Analysis [Research Activity]
   795   C1114821:Reaction [Clinical Attribute]
   795   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C1515981:And [Idea or Concept]
   795   C1524024:analysis [Functional Concept]
   795   C1524075:Chain [Idea or Concept]

Phrase: "and"

Phrase: "all"

Phrase: "were"

Phrase: "negative."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205160:Negative [Qualitative Concept]
  1000   C1513916:Negative [Finding]
  1000   C2825415:Negative [Conceptual Entity]
  1000   C2825491:Negative [Qualitative Concept]
Processing 00000000.tx.207: View this table: [in this window] [in a new window]  Table 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.208: Detection of Proviral-Specific Sequences in Marrow-Derived Hematopoietic Colonies (CFU-GM and BFU-E) From MPS I Dogs at Time Points Postinfusion View larger version (13K): [in this window] [in a new window]  Fig 5. 

Phrase: "Detection of Proviral-Specific Sequences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "in Marrow-Derived Hematopoietic Colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0439158:colonies [Quantitative Concept]
   779 E C1947989:Colony [Cell]

Phrase: "(CFU-GM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0024432:macrophage [Cell]
   717   C0553561:Colony-forming unit [Quantitative Concept]

Phrase: "and"

Phrase: "BFU-E"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1257771:Burst-forming unit erythroid [Cell]
   812   C0205431:Forming [Functional Concept]
   812   C0439148:Unit [Quantitative Concept]
   812   C0439818:burst [Qualitative Concept]
   812   C1516960:Erythroid [Qualitative Concept]
   812   C1519795:Unit [Quantitative Concept]
   812   C1522492:Forming [Functional Concept]
   812   C1704753:Unit [Manufactured Object]
   812   C1880519:Unit [Quantitative Concept]
   812   C1881705:BURST [Phenomenon or Process]
   779 E C0348078:Form [Qualitative Concept]
   779 E C0376315:Form [Manufactured Object]

Phrase: ")"

Phrase: "From MPS I Dogs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0012984:Dogs [Mammal]
   812   C1280551:Dogs [Mammal]
   756   C0023786:Mucopolysaccharidosis Type I [Disease or Syndrome]
           Mucopolysaccharidosis I

Phrase: "at Time Points Postinfusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   701   C2348792:Time Point [Temporal Concept]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(13K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig 5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]
Processing 00000000.tx.209: Percentage of provirus-positive progenitors in five MPSI (M2 through M6) dogs observed for 1to 2years postinfusion. 

Phrase: "Percentage of provirus-positive progenitors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439165:Percentage [Quantitative Concept]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]

Phrase: "in five MPSI"

Phrase: "(M2 through M6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0457242:m2 [Quantitative Concept]

Phrase: ")"

Phrase: "dogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012984:Dogs [Mammal]
  1000   C1280551:Dogs [Mammal]

Phrase: "observed for 1to 2years postinfusion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1441672:Observed [Functional Concept]
Processing 00000000.tx.210: At each time point, up to 100colonies (CFU-GM and/or BFU) and 10methylcellulose controls were plucked from methylcellulose plates and subject to -ID or neor PCR. 

Phrase: "At each time point,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C2348792:Time Point [Temporal Concept]
   861   C0040223:Time [Temporal Concept]
   861   C1552961:Point [Quantitative Concept]
   861   C2347617:point [Quantitative Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "up to 100colonies"

Phrase: "(CFU-GM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0024432:macrophage [Cell]
   717   C0553561:Colony-forming unit [Quantitative Concept]

Phrase: "and/or"

Phrase: "BFU)"

Phrase: "and"

Phrase: "10methylcellulose controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "plucked from methylcellulose plates"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0025729:Methyl Cellulose [Carbohydrate,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C1139930:plates [Medical Device]
   737 E C0005971:Plate [Medical Device]
   737 E C3537155:Plate [Manufactured Object]
   715 E C0699455:Methocel [Carbohydrate,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "and subject to -ID"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0681850:Subject [Group]
   770   C1515981:And [Idea or Concept]
   770   C1550501:{Subject} [Idea or Concept]
   770   C1706203:Subject [Idea or Concept]
   770   C2349001:Subject [Human]
   770   C2697811:Subject [Functional Concept]

Phrase: "or"

Phrase: "neor PCR."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0337112:Chain [Manufactured Object]
   812   C0443286:Reaction [Functional Concept]
   812   C1114821:Reaction [Clinical Attribute]
   812   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1524075:Chain [Idea or Concept]
Processing 00000000.tx.211: Proviral -ID expression in vivo.  

Phrase: "Proviral -ID expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.212: Peripheral blood and marrow leukocytes from all five dogs were assayed for expression by -ID enzyme activity and RT-PCR on multiple occasions after adoptive transfer. 

Phrase: "Peripheral blood"
Meta Candidates (Total=13; Excluded=8; Pruned=0; Remaining=5)
  1000   C0229664:peripheral blood [Body Substance]
           Blood
   958 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0205100:Peripheral [Spatial Concept]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "marrow leukocytes from all five dogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   773   C0023516:Marrow leukocyte [Cell]
           Leukocytes

Phrase: "were"

Phrase: "assayed for expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]
   756   C0005507:Assay [Laboratory Procedure]
   756   C0243073:assay [Qualitative Concept]
   756   C1510438:Assay [Laboratory Procedure]

Phrase: "by -ID enzyme activity"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0243102:enzyme activity [Molecular Function]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "RT-PCR on multiple occasions"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   869   C0599161:Reverse Transcriptase Polymerase Chain Reaction [Molecular Biology Research Technique]
   800   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0337112:Chain [Manufactured Object]
   744   C0443286:Reaction [Functional Concept]
   744   C1114821:Reaction [Clinical Attribute]
   744   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1524075:Chain [Idea or Concept]
   744   C1555029:Reverse [Idea or Concept]
   744   C2257077:transcriptase [Genetic Function]

Phrase: "after adoptive transfer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0376518:Adoptive Transfer [Therapeutic or Preventive Procedure]
   861   C0040671:Transfer [Mental Process]
   861   C1705822:Transfer [Activity]
Processing 00000000.tx.213: -ID enzyme activity was not detected in either blood or marrow mononuclear cells from any dog (sensitivity ~1%). 

Phrase: "-ID enzyme activity"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0243102:enzyme activity [Molecular Function]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected in either blood"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0005767:Blood [Tissue]
   770   C0005768:blood [Body Substance]
   770   C0229664:Blood [Body Substance]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "marrow mononuclear cells from any dog"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0806987:Mononuclear cells [Cell]
   753   C0007634:Cells [Cell]
   753   C1513475:Mononuclear [Clinical Attribute]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(sensitivity ~1%"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0036667:Sensitivity [Quantitative Concept]
   861   C0312418:Sensitivity [Mental Process]
   861   C0427965:Sensitivity [Finding]
   861   C1511883:Sensitivity [Quantitative Concept]
   861   C1522640:Sensitivity [Qualitative Concept]
   861   C2346484:SENSITIVITY [Phenomenon or Process]
   861   C2349185:Sensitivity [Qualitative Concept]
   789 E C0332324:Sensitive [Functional Concept]
   789 E C1550474:sensitive [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.214: Proviral specific RT-PCR on blood and marrow mononuclear cells collected during the first 3months postinfusion from all dogs were consistently negative (data from dog M2 shown in Fig 3B). 

Phrase: "Proviral specific RT-PCR on blood"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   849   C0599161:Reverse Transcriptase Polymerase Chain Reaction [Molecular Biology Research Technique]
   790   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   764   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0337112:Chain [Manufactured Object]
   742   C0443286:Reaction [Functional Concept]
   742   C1114821:Reaction [Clinical Attribute]
   742   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C1524075:Chain [Idea or Concept]
   742   C1555029:Reverse [Idea or Concept]
   742   C2257077:transcriptase [Genetic Function]

Phrase: "and"

Phrase: "marrow mononuclear cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0806987:Mononuclear cells [Cell]
   827   C0007634:Cells [Cell]
   827   C1513475:Mononuclear [Clinical Attribute]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "collected during the first 3months postinfusion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205435:First [Quantitative Concept]
   753   C1279901:First [Qualitative Concept]
   753   C1516695:Collected [Idea or Concept]
   753   C1516698:Collected [Functional Concept]

Phrase: "from all dogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012984:Dogs [Mammal]
  1000   C1280551:Dogs [Mammal]

Phrase: "were"

Phrase: "consistently negative"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205160:Negative [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]

Phrase: "(data from dog M2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]

Phrase: "shown in Fig 3B"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0349966:Fig [Food]
   770   C0450365:3b [Intellectual Product]
   770   C1337208:FIG [Food]
   770   C1706097:3B [Research Activity]
   737   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.215: Expression data from two dogs (M2 and M5) are summarized in Table 3. 

Phrase: "Expression data from two dogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1511726:Data [Idea or Concept]
   760   C3245479:data [Medical Device]

Phrase: "(M2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0457242:m2 [Quantitative Concept]

Phrase: "and"

Phrase: "M5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1550079:M5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
  1000   C1561481:M5 [Intellectual Product]

Phrase: ")"

Phrase: "are"

Phrase: "summarized in Table 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
Processing 00000000.tx.216: Proviral -ID expression was also assessed in hematopoietic progenitors, because this population of hematopoietic cells had higher levels of provirus (2% to 10%) than the total blood and marrow leukocytes (<1%). 

Phrase: "Proviral -ID expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "also"

Phrase: "assessed in hematopoietic progenitors,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0018957:Haematopoietic [Body System]
   770   C0229601:Hematopoietic [Functional Concept]
   770   C1516048:Assessed [Activity]
   737   C0870134:Progenitor [Family Group]

Phrase: "because"

Phrase: "this population of hematopoietic cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0032659:Population [Quantitative Concept]
   760   C1257890:Population [Population Group]

Phrase: "had"

Phrase: "higher levels of provirus"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "(2% to 10%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0740116:+2 [Quantitative Concept]
   790   C2827735:2+ [Quantitative Concept]
   790   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "than the total blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "marrow leukocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0023516:Marrow leukocyte [Cell]
           Leukocytes

Phrase: "("

Phrase: "<1%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.217: The -ID activity assay was performed on individual CFU-GM from M2 and M5 at various time points postinfusion. 

Phrase: "The -ID activity assay"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0205177:Activity [Functional Concept]
   827   C0243073:assay [Qualitative Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1510438:Assay [Laboratory Procedure]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "performed on individual CFU-GM"
Meta Candidates (Total=20; Excluded=3; Pruned=0; Remaining=17)
   848   C0314589:Colony-forming unit, granulocyte-macrophage [Cell]
   822   C0314587:Colony-forming unit, granulocyte [Cell]
   822   C0314592:Colony-forming unit, macrophage [Cell]
   800   C0553561:Colony-forming unit [Quantitative Concept]
   744   C0018183:granulocyte [Cell]
   744   C0024432:macrophage [Cell]
   744   C0027361:Individual [Population Group]
   744   C0205431:Forming [Functional Concept]
   744   C0237401:Individual [Human]
   744   C0439148:Unit [Quantitative Concept]
   744   C0439158:colony [Quantitative Concept]
   744   C0884358:Performed [Functional Concept]
   744   C1519795:Unit [Quantitative Concept]
   744   C1522492:Forming [Functional Concept]
   744   C1704753:Unit [Manufactured Object]
   744   C1880519:Unit [Quantitative Concept]
   744   C1947989:Colony [Cell]
   711 E C0348078:Form [Qualitative Concept]
   711 E C0376315:Form [Manufactured Object]
   711 E C2947996:Perform [Pharmacologic Substance]

Phrase: "from M2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0457242:m2 [Quantitative Concept]

Phrase: "and"

Phrase: "M5 at various time points postinfusion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1550079:M5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C1561481:M5 [Intellectual Product]
Processing 00000000.tx.218: A total of 399CFU-GM from 1to 24months were assayed from M2. 

Phrase: "A total of 399CFU-GM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]

Phrase: "from 1to 24months"

Phrase: "were"

Phrase: "assayed from M2."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0457242:m2 [Quantitative Concept]
   756   C0005507:Assay [Laboratory Procedure]
   756   C0243073:assay [Qualitative Concept]
   756   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.219: One CFU-GM of 155was positive for -ID activity at 1month, whereas 244CFU-GM from time points up to 24months were negative. 

Phrase: "One CFU-GM of 155was positive"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   832   C0314589:Colony-forming unit, granulocyte-macrophage [Cell]
   810   C0314592:Colony-forming unit, macrophage [Cell]
   742   C0024432:macrophage [Cell]

Phrase: "for -ID activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "at 1month,"

Phrase: "whereas"

Phrase: "244CFU-GM from time points"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: "up to 24months"

Phrase: "were"

Phrase: "negative."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205160:Negative [Qualitative Concept]
  1000   C1513916:Negative [Finding]
  1000   C2825415:Negative [Conceptual Entity]
  1000   C2825491:Negative [Qualitative Concept]
Processing 00000000.tx.220: In dog M5, -ID activity was not detected in any of 193CFU-GM from 1to 4months postinfusion (Table 3). 

Phrase: "In dog M5, -ID activity"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   804   C0012984:Dog [Mammal]
   804   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0150312:In [Quantitative Concept]
   804   C0205177:Activity [Functional Concept]
   804   C0332285:In [Spatial Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1280551:Dog [Mammal]
   804   C1550079:M5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   804   C1561481:M5 [Intellectual Product]
   804   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected in any of 193CFU-GM"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0442726:Detected [Finding]
   753   C0546866:GM [Antibiotic,Carbohydrate]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "from 1to 4months postinfusion"

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.221: Controls from these experiments included CFU-GM from normal dogs as positive controls and reagent and tissue negative controls.  

Phrase: "Controls from these experiments"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   802   C0009932:control experiments [Group]
   737   C0243148:control [Qualitative Concept]
   737   C1550141:Control [Substance]
   737   C1882979:Control [Conceptual Entity]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "CFU-GM from normal dogs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   848   C0314589:Colony-forming unit, granulocyte-macrophage [Cell]
   822   C0314592:Colony-forming unit, macrophage [Cell]
   744   C0024432:macrophage [Cell]

Phrase: "as positive controls"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   966   C1883676:Positive Control [Conceptual Entity]
   861   C0439178:% Positive [Quantitative Concept]
   861   C1446409:Positive [Qualitative Concept]
   861   C1514241:Positive [Finding]
   861   C2825490:Positive [Qualitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "reagent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "tissue negative controls."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   867   C1639518:% negative control [Quantitative Concept]
   867   C1947986:Negative Control [Conceptual Entity]
   827   C0205160:Negative [Qualitative Concept]
   827   C1513916:Negative [Finding]
   827   C2825415:Negative [Conceptual Entity]
   827   C2825491:Negative [Qualitative Concept]
   793   C0243148:control [Qualitative Concept]
   793   C1550141:Control [Substance]
   793   C1882979:Control [Conceptual Entity]
   793   C2587213:Control [Functional Concept]
   793   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.222: View this table: [in this window] [in a new window]  Table 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.223: -ID Activity in Blood and Marrow Leukocytes and Individual CFU-GM Postinfusion Immune response assays.  

Phrase: "-ID Activity in Blood"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "Marrow Leukocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0023516:Marrow leukocyte [Cell]
           Leukocytes

Phrase: "and"

Phrase: "Individual CFU-GM Postinfusion Immune response assays."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   895   C0201610:Colony forming unit-granulocyte/macrophage assay [Laboratory Procedure]
   885   C0201608:Colony forming unit-granulocyte assay [Laboratory Procedure]
   878   C0201609:Colony forming unit-macrophage assay [Laboratory Procedure]
   872   C0009385:Colony forming unit assay [Laboratory Procedure]
   756   C0005507:Assay [Laboratory Procedure]
   756   C0243073:assay [Qualitative Concept]
   756   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.224: Immune responses against provirally marked cells, proviral gene products, and sera components were evaluated. 

Phrase: "Immune responses against provirally marked cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0301872:immune responses [Organ or Tissue Function]
   753   C0439662:Immune [Functional Concept]
   753   C0871261:responses [Organism Attribute]
   719 E C1704632:Response [Finding]
   719 E C1706817:Response [Intellectual Product]
   719 E C2911692:Response [Mental Process]

Phrase: "proviral gene products,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   867   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   867   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017337:Gene [Gene or Genome]
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]

Phrase: "and"

Phrase: "sera components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449432:Components [Manufactured Object]
   827 E C1705248:Component [Conceptual Entity]

Phrase: "were"

Phrase: "evaluated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]
Processing 00000000.tx.225: Specific IgG antibodies against -ID enzyme were detected by ELISA in sera from dog M2 at all time points postinfusion. 

Phrase: "Specific IgG antibodies against -ID enzyme"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   773   C2754943:IgG antibody [Cell Component]
   767   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "detected by ELISA"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   882   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   783   C2717977:Enzyme Assay [Laboratory Procedure]
   753   C0005507:Assay [Laboratory Procedure]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   753   C0243073:assay [Qualitative Concept]
   753   C0442726:Detected [Finding]
   753   C1510438:Assay [Laboratory Procedure]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   719   C1517892:Link [Intellectual Product]
   719   C1704666:Link [Intellectual Product]

Phrase: "in sera"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0229671:Sera [Body Substance]
  1000   C1151254:SerA [Molecular Function]
   966 E C1546774:Serum [Intellectual Product]
   966 E C1550100:Serum [Body Substance]

Phrase: "from dog M2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0457242:m2 [Quantitative Concept]

Phrase: "at all time points postinfusion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   701   C2348792:Time Point [Temporal Concept]
Processing 00000000.tx.226: The titer peaked after the third infusion (~2 months postinfusion) at 1:3,200 and decreased to 1:800 to 1:1,600 after initiation of treatment with cyclosporine A at approximately 4months postinfusion (Table 4). 

Phrase: "The titer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0475208:Titer [Quantitative Concept]

Phrase: "peaked after the third infusion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205437:Third [Quantitative Concept]
   760   C0444505:peaked [Quantitative Concept]
   760   C0574032:Infusion [Therapeutic or Preventive Procedure]
   760   C1827465:Infusion [Functional Concept]

Phrase: "(~2 months postinfusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1442456:2 Months [Temporal Concept]

Phrase: ")"

Phrase: "at 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: ":"

Phrase: "3,200"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "decreased to 1"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   756 E C0547047:Decrease [Quantitative Concept]

Phrase: ":"

Phrase: "800 to 1"

Phrase: ":"

Phrase: "1,600 after initiation of treatment"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C0589507:Initiation [Mental Process]
   753   C1158830:Initiation [Genetic Function]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1704686:Initiation [Functional Concept]
   753   C1705169:Treatment [Conceptual Entity]
   753   C2827734:1+ [Quantitative Concept]
   753   C2981698:1+ [Classification]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "with cyclosporine A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010592:Cyclosporin A [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Ciclosporin

Phrase: "at approximately 4months postinfusion"

Phrase: "(Table 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.227: Humoral immune responses against FBS, HS, and bovine serum albumin were assayed after the third infusion and demonstrated IgG titers of 1:3,200 to 1:6,400 (Fig 6). 

Phrase: "Humoral immune responses against FBS,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   814   C1155229:Immune Responses, Humoral [Cell Function]
   797 E C0020967:Humoral Immune Response [Organism Function]
   778   C0301872:immune responses [Organ or Tissue Function]
   774   C0020960:immune serum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0439662:Immune [Functional Concept]
   748   C0871261:responses [Organism Attribute]
   714 E C1704632:Response [Finding]
   714 E C1706817:Response [Intellectual Product]
   714 E C2911692:Response [Mental Process]

Phrase: "HS,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1518416:Serum, Horse [Immunologic Factor]
   861   C0019944:Horse [Mammal]
   861   C0229671:Serum [Body Substance]
   861   C0242616:Horse [Mammal]
   861   C1265527:Horse [Mammal]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "bovine serum albumin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   901   C0728877:serum albumin [Laboratory or Test Result]
   827   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0007452:Bovine [Mammal]
   827   C0229671:Serum [Body Substance]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "were"

Phrase: "assayed after the third infusion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205437:Third [Quantitative Concept]
   760   C0574032:Infusion [Therapeutic or Preventive Procedure]
   760   C1827465:Infusion [Functional Concept]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]

Phrase: "and"

Phrase: "demonstrated IgG titers of 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0475208:Titer [Quantitative Concept]

Phrase: ":"

Phrase: "3,200 to 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439086:<3 [Quantitative Concept]
   770   C2827736:3+ [Quantitative Concept]
   770   C2981702:3+ [Classification]

Phrase: ":"

Phrase: "6,400"

Phrase: "(Fig 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.228: The anti-fetal bovine and anti-horse sera antibodies observed were maintained in the serum of M2 for at least 1year after the infusion of transduced cells at titers of 1:1,600 to 1:3,200. 

Phrase: "The anti-fetal bovine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0007452:Bovine [Mammal]
   827   C1140701:bovine [Mammal]

Phrase: "and"

Phrase: "anti-horse sera antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   902   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   886 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "were"

Phrase: "maintained in the serum of M2"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0229671:Serum [Body Substance]
   753   C0457242:m2 [Quantitative Concept]
   753   C1314677:Maintained [Functional Concept]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719 E C0024501:Maintain [Activity]

Phrase: "for"

Phrase: "at least 1year"

Phrase: "after the infusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0574032:Infusion [Therapeutic or Preventive Procedure]
  1000   C1827465:Infusion [Functional Concept]

Phrase: "of transduced cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "at titers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0475208:Titer [Quantitative Concept]

Phrase: "of 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1,600 to 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C2827734:1+ [Quantitative Concept]
   770   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "3,200."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]
Processing 00000000.tx.229: The highest anti--ID titer was observed in M2 after the third infusion of gene modified cells. 

Phrase: "The highest anti"

Phrase: "--ID titer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0475208:Titer [Quantitative Concept]

Phrase: "was"

Phrase: "observed in M2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0457242:m2 [Quantitative Concept]
   790   C1441672:Observed [Functional Concept]

Phrase: "after the third infusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0574032:Infusion [Therapeutic or Preventive Procedure]
   861   C1827465:Infusion [Functional Concept]

Phrase: "of gene modified cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C1517476:Gene-Modified [Qualitative Concept]
Processing 00000000.tx.230: The other dogs with lower anti--ID antibody titers received only one or two infusions of gene-modified cells.  

Phrase: "The"

Phrase: "other dogs with lower anti"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0012984:Dogs [Mammal]
   760   C1280551:Dogs [Mammal]

Phrase: "--ID antibody titers"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0474643:antibody titers [Laboratory Procedure]
   901   C1287242:antibody titers [Laboratory or Test Result]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   793   C0475208:Titer [Quantitative Concept]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "only one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205447:One [Quantitative Concept]

Phrase: "or"

Phrase: "two infusions of gene-modified cells."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0574032:infusions [Therapeutic or Preventive Procedure]
   719 E C1827465:Infusion [Functional Concept]
Processing 00000000.tx.231: View this table: [in this window] [in a new window]  Table 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 4."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.232: Serum Anti--ID IgG Titer Detected by ELISA in Serum Samples From MPS I Dogs Postinfusion View larger version (21K): [in this window] [in a new window]  Fig 6. 

Phrase: "Serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "Anti"

Phrase: "--ID IgG Titer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0475208:Titer [Quantitative Concept]

Phrase: "Detected by ELISA"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   882   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   783   C2717977:Enzyme Assay [Laboratory Procedure]
   753   C0005507:Assay [Laboratory Procedure]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   753   C0243073:assay [Qualitative Concept]
   753   C0442726:Detected [Finding]
   753   C1510438:Assay [Laboratory Procedure]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   719   C1517892:Link [Intellectual Product]
   719   C1704666:Link [Intellectual Product]

Phrase: "in Serum Samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0444266:Serum sample [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "From MPS I Dogs Postinfusion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0012984:Dogs [Mammal]
   804   C1280551:Dogs [Mammal]
   717   C0023786:Mucopolysaccharidosis Type I [Disease or Syndrome]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(21K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig 6."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]
Processing 00000000.tx.233: Detection of serum IgG specific for -ID (ID), HS, FBS, and bovine serum albumin (BSA) in dog M2 by ELISA. 

Phrase: "Detection of serum IgG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "specific for -ID"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205369:Specific [Qualitative Concept]
   790   C1552740:specific [Intellectual Product]

Phrase: "(ID"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600091:ID [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "HS,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1518416:Serum, Horse [Immunologic Factor]
   861   C0019944:Horse [Mammal]
   861   C0229671:Serum [Body Substance]
   861   C0242616:Horse [Mammal]
   861   C1265527:Horse [Mammal]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "FBS,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0007452:Bovine [Mammal]
   827   C0015965:Fetal [Embryonic Structure]
   827   C0229671:Serum [Body Substance]
   827   C0521457:Fetal [Functional Concept]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "bovine serum albumin (BSA) in dog M2"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   833   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   820   C1440561:Dog serum albumin [Immunologic Factor]
   790   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   790   C0728877:serum albumin [Laboratory or Test Result]
   783 E C0523465:Albumin - serum [Laboratory Procedure]
   753   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0007452:Bovine [Mammal]
   753   C0229671:Serum [Body Substance]
   753   C1140701:bovine [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]

Phrase: "by ELISA."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   902   C2717977:Enzyme Assay [Laboratory Procedure]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
   779   C1517892:Link [Intellectual Product]
   779   C1704666:Link [Intellectual Product]
   729 E C0014445:enzymes [Functional Concept]
Processing 00000000.tx.234: Titers are shown as the dilution of serum that gave a corrected OD reading of greater than two times the dog's preinfusion serum. 

Phrase: "Titers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0475208:Titer [Quantitative Concept]

Phrase: "are"

Phrase: "shown as the dilution of serum"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0079240:Dilution [Laboratory Procedure]
   753   C0229671:Serum [Body Substance]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   753   C1948037:Dilution [Functional Concept]
   719   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "a corrected OD reading of greater"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0034754:Reading [Daily or Recreational Activity]
   753   C1705179:Reading [Finding]

Phrase: "than"

Phrase: "two times"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1948050:Two Times [Quantitative Concept]
   861   C0040223:times [Temporal Concept]
   861   C0205448:Two [Quantitative Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "the dog's preinfusion serum."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0229671:Serum [Body Substance]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
Processing 00000000.tx.235: Analysis of anti-FBS, -HS, and -BSA antibodies was not evaluated before 3months. 

Phrase: "Analysis of anti-FBS, -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "HS,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1518416:Serum, Horse [Immunologic Factor]
   861   C0019944:Horse [Mammal]
   861   C0229671:Serum [Body Substance]
   861   C0242616:Horse [Mammal]
   861   C1265527:Horse [Mammal]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "and -"

Phrase: "BSA antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   756   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "evaluated before 3months."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0220825:Evaluated [Functional Concept]
Processing 00000000.tx.236: The timing of infusions and initiation of treatment with cyclosporine A are shown with arrows. 

Phrase: "The timing of infusions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0449243:Timing [Temporal Concept]
   770   C1704250:Timing [Conceptual Entity]

Phrase: "and"

Phrase: "initiation of treatment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0589507:Initiation [Mental Process]
   790   C1158830:Initiation [Genetic Function]
   790   C1704686:Initiation [Functional Concept]

Phrase: "with cyclosporine A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010592:Cyclosporin A [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Ciclosporin

Phrase: "are"

Phrase: "shown with arrows."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0336721:arrows [Manufactured Object]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.237: Cellular immune responses to autologous transduced cells were evaluated by peripheral blood mononuclear cell proliferation assays. 

Phrase: "Cellular immune responses to autologous transduced cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   814   C1817908:Immune Responses, Cellular [Cell Function]
   778   C0301872:immune responses [Organ or Tissue Function]
   748   C0007634:Cellular [Cell]
   748   C0178539:Cellular [Functional Concept]
   748   C0439662:Immune [Functional Concept]
   748   C0871261:responses [Organism Attribute]
   714 E C1704632:Response [Finding]
   714 E C1706817:Response [Intellectual Product]
   714 E C2911692:Response [Mental Process]

Phrase: "were"

Phrase: "evaluated by peripheral blood mononuclear cell proliferation assays."
Meta Candidates (Total=28; Excluded=2; Pruned=0; Remaining=26)
   869   C2246305:peripheral blood mononuclear cell proliferation [Cell Function]
   839   C0201595:Peripheral blood mononuclear cell assay [Laboratory Procedure]
   833   C1321301:Peripheral blood mononuclear cell [Cell]
   800   C2246303:mononuclear cell proliferation [Cell Function]
   793   C0005773:Peripheral blood cell [Cell]
           Blood cell
   789   C2347293:Mononuclear Blood Cell [Cell]
   770   C0229664:peripheral blood [Body Substance]
           Blood
   770   C0596290:Cell Proliferation [Cell Function]
   770   C0806987:mononuclear cell [Cell]
   744   C0005767:Blood [Tissue]
   744   C0005768:blood [Body Substance]
   744   C0007634:Cell [Cell]
   744   C0205100:Peripheral [Spatial Concept]
   744   C0220825:Evaluated [Functional Concept]
   744   C0334094:Proliferation [Pathologic Function]
   744   C1269647:Cell [Cell]
   744   C1513475:Mononuclear [Clinical Attribute]
   744   C1514485:Proliferation [Functional Concept]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   739 E C2328697:Hemal cell [Cell]
   729 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   717   C0700080:Vascular proliferation [Pathologic Function]
   711   C0005507:Assay [Laboratory Procedure]
   711   C0243073:assay [Qualitative Concept]
   711   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.238: Two experiments were performed with blood mononuclear samples from dog M2 2and 6weeks after the third infusion of LTMC cells. 

Phrase: "Two experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed with blood mononuclear samples"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   797   C0178913:blood samples [Body Substance]
   760   C0005767:Blood [Tissue]
   760   C0005768:blood [Body Substance]
   760   C0229664:Blood [Body Substance]
   760   C0884358:Performed [Functional Concept]
   760   C1513475:Mononuclear [Clinical Attribute]
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "from dog M2 2and 6weeks"

Phrase: "after the third infusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0574032:Infusion [Therapeutic or Preventive Procedure]
   861   C1827465:Infusion [Functional Concept]

Phrase: "of LTMC cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.239: In these experiments peripheral blood mononuclear cells were overlaid on transduced and control autologous stroma and the cell proliferation under each condition was measured by incorporation of [3H]-thymidine and reported as mean cpmstandard deviation. 

Phrase: "In these experiments peripheral blood mononuclear cells"
Meta Candidates (Total=24; Excluded=12; Pruned=0; Remaining=12)
   937   C1321301:Peripheral Blood Mononuclear Cells [Cell]
   872   C0005773:Peripheral blood cell [Cell]
           Blood Cells
   840   C0229664:peripheral blood [Body Substance]
           Blood
   840   C0806987:Mononuclear cells [Cell]
   808 E C2328697:Hemal cell [Cell]
   804   C0005767:Blood [Tissue]
   804   C0005768:blood [Body Substance]
   804   C0007634:Cells [Cell]
   804   C0205100:Peripheral [Spatial Concept]
   804   C1513475:Mononuclear [Clinical Attribute]
   804   C3282337:Cells [Cell]
   798 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   733 E C0333275:Bloody [Qualitative Concept]
   721 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   721 E C0392895:Bloods [Population Group]
   721 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   721 E C1511228:VESSEL, BLOOD [Tissue]
   704 E C1558950:VASCULAR [Finding]
   704 E C1801960:Vascular [Qualitative Concept]

Phrase: "were"

Phrase: "overlaid on transduced"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0444456:Overlay [Spatial Concept]
   756   C1706359:Overlay [Medical Device]

Phrase: "and"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "autologous stroma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0927195:Stroma [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "the cell proliferation under each condition"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0007634:THE CELL [Cell]
           Cell
   790   C0596290:Cell Proliferation [Cell Function]
   753   C0334094:Proliferation [Pathologic Function]
   753   C1269647:Cell [Cell]
   753   C1514485:Proliferation [Functional Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "measured by incorporation of [3H]-thymidine"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0040077:Thymidine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0243126:incorporation [Functional Concept]
   753   C0444706:Measured [Qualitative Concept]
   753   C1442460:3H [Temporal Concept]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]

Phrase: "and"

Phrase: "reported as mean cpmstandard deviation."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   797   C1828170:Mean deviation [Clinical Attribute]
   760   C0012727:Deviation [Spatial Concept]
   760   C0205419:Deviation [Qualitative Concept]
   760   C0444504:Mean [Quantitative Concept]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C1705236:Deviation [Finding]
   760   C2347634:Mean [Quantitative Concept]
   760   C2348143:Mean [Quantitative Concept]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.240: In the first experiment, fresh peripheral blood mononuclear cells from 2weeks after the third infusion were exposed to LCIDSN-transduced and untransduced control stroma. 

Phrase: "In the first experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: "fresh peripheral blood mononuclear cells from 2weeks"
Meta Candidates (Total=18; Excluded=5; Pruned=0; Remaining=13)
   853   C1321301:Peripheral Blood Mononuclear Cells [Cell]
   789   C2347293:Mononuclear Blood Cell [Cell]
   788   C0005773:Peripheral blood cell [Cell]
           Blood Cells
   778   C0229664:peripheral blood [Body Substance]
           Blood
   778   C0806987:Mononuclear cells [Cell]
   748   C0005767:Blood [Tissue]
   748   C0005768:blood [Body Substance]
   748   C0007634:Cells [Cell]
   748   C0205100:Peripheral [Spatial Concept]
   748   C1513475:Mononuclear [Clinical Attribute]
   748   C3282337:Cells [Cell]
   737 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   729 E C2328697:Hemal cell [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "after the third infusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0574032:Infusion [Therapeutic or Preventive Procedure]
   861   C1827465:Infusion [Functional Concept]

Phrase: "were"

Phrase: "exposed to LCIDSN-transduced"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed

Phrase: "and"

Phrase: "untransduced control stroma."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0927195:Stroma [Body Part, Organ, or Organ Component]
Processing 00000000.tx.241: There was an approximately threefold increase in [3H]-thymidine incorporation in LCIDSN-transduced stroma over untransduced controls at blood mononuclear cells to stroma ratios of 10:1 (7,020719cpm LCIDSN transduced stroma v 1,850383.1cpm untransduced stroma; P<.005; Fig 7A). 

Phrase: "There"

Phrase: "was"

Phrase: "an approximately threefold increase in [3H]-thymidine incorporation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0243126:incorporation [Functional Concept]

Phrase: "in LCIDSN-transduced stroma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0927195:Stroma [Body Part, Organ, or Organ Component]

Phrase: "over untransduced controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "at blood mononuclear cells"
Meta Candidates (Total=19; Excluded=11; Pruned=0; Remaining=8)
   913   C0005773:Blood Cells [Cell]
   901   C0806987:Mononuclear cells [Cell]
   869 E C2328697:Hemal cell [Cell]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0007634:Cells [Cell]
   827   C0229664:Blood [Body Substance]
   827   C1513475:Mononuclear [Clinical Attribute]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "to stroma ratios"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0456603:Ratios [Quantitative Concept]
   861   C1610540:*Ratios [Quantitative Concept]
   827 E C1547037:Ratio [Intellectual Product]

Phrase: "of 10"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(7,"

Phrase: "020719cpm LCIDSN"

Phrase: "transduced"

Phrase: "stroma v 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1423644:V-1 [Gene or Genome]
   827   C0927195:Stroma [Body Part, Organ, or Organ Component]

Phrase: "850383.1cpm untransduced stroma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0927195:Stroma [Body Part, Organ, or Organ Component]

Phrase: "; P<.005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "; Fig 7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.242: In the second experiment, three separate stimulatory autologous stromal cells were used: untransduced, transduced with LNc11 (a neor only containing vector), and M48ID (the vector containing only -ID). 

Phrase: "In the second experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: "three separate stimulatory autologous stromal cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   827   C0162597:Stromal Cells [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   774 E C0596291:stroma cell [Cell Component]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
   727   C0927195:Stroma [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ":"

Phrase: "untransduced,"

Phrase: "transduced with LNc11"

Phrase: "("

Phrase: "a neor only"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "M48ID"

Phrase: "("

Phrase: "the vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "only -ID"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")."
Processing 00000000.tx.243: Cryopreserved blood mononuclear cells from 6weeks after the third infusion of LTMC cells were used as responders. 

Phrase: "Cryopreserved blood mononuclear cells from 6weeks"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   803   C2347293:Mononuclear Blood Cell [Cell]
   790   C0806987:Mononuclear cells [Cell]
   783   C0005773:Blood Cells [Cell]
   767   C1511548:Cryopreserved Cell [Cell]
   753   C0005767:Blood [Tissue]
   753   C0005768:blood [Body Substance]
   753   C0007634:Cells [Cell]
   753   C0229664:Blood [Body Substance]
   753   C1513475:Mononuclear [Clinical Attribute]
   753   C3282337:Cells [Cell]
   739 E C2328697:Hemal cell [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "after the third infusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0574032:Infusion [Therapeutic or Preventive Procedure]
   861   C1827465:Infusion [Functional Concept]

Phrase: "of LTMC cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "used as responders."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.244: There was approximately twofold higher proliferation when blood mononuclear cells were stimulated with M48ID-transduced autologous stroma versus control untransduced stroma (5,3671792cpm M48ID-transduced stroma v 3,053812cpm untransduced stroma; P<.05) or versus LNc11-transduced stroma (5,3671,792cpm M48ID-transduced stroma v 2,635487cpm LNc11-transduced stroma; P<.05; Fig 7B). 

Phrase: "There"

Phrase: "was"

Phrase: "approximately twofold higher proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0334094:Proliferation [Pathologic Function]
   812   C1514485:Proliferation [Functional Concept]

Phrase: "when"

Phrase: "blood mononuclear cells"
Meta Candidates (Total=19; Excluded=11; Pruned=0; Remaining=8)
   913   C0005773:Blood Cells [Cell]
   901   C0806987:Mononuclear cells [Cell]
   869 E C2328697:Hemal cell [Cell]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0007634:Cells [Cell]
   827   C0229664:Blood [Body Substance]
   827   C1513475:Mononuclear [Clinical Attribute]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "were"

Phrase: "stimulated with M48ID-transduced autologous stroma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439859:Autologous [Qualitative Concept]
   753   C0927195:Stroma [Body Part, Organ, or Organ Component]
   753   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "versus"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "untransduced stroma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0927195:Stroma [Body Part, Organ, or Organ Component]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "3671792cpm M48ID-transduced stroma v 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0927195:Stroma [Body Part, Organ, or Organ Component]

Phrase: "053812cpm untransduced stroma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0927195:Stroma [Body Part, Organ, or Organ Component]

Phrase: "; P<.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "or"

Phrase: "versus"

Phrase: "LNc11-transduced stroma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0927195:Stroma [Body Part, Organ, or Organ Component]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "3671,"

Phrase: "792cpm M48ID-transduced stroma v 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0445362:V 2 [Intellectual Product]
   799   C0927195:Stroma [Body Part, Organ, or Organ Component]

Phrase: "635487cpm LNc11-transduced stroma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0927195:Stroma [Body Part, Organ, or Organ Component]

Phrase: "; P<.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "; Fig 7B"

Phrase: ")."
Processing 00000000.tx.245: There was no significant difference between stimulation with LNc11-transduced stroma or untransduced stroma (P=.167). 

Phrase: "There"

Phrase: "was"

Phrase: "no significant difference between stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "with LNc11-transduced stroma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0927195:Stroma [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "untransduced stroma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0927195:Stroma [Body Part, Organ, or Organ Component]

Phrase: "(P=.167"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.246: The results from these two experiments are consistent with a cellular immune response to -ID but not to neor-transduced cells. 

Phrase: "The results from these two experiments"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   725   C2825142:Experimental Result [Finding]
           Result
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]

Phrase: "are"

Phrase: "consistent with a cellular immune response to -ID"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "but"

Phrase: "not to neor-transduced cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0007634:Cells [Cell]
   760   C1518422:Not [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.247: The higher rate of cell proliferation in the second experiment than the first may be due to a dampening of the immune response with time. 

Phrase: "The higher rate of cell proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]

Phrase: "in the second experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: "than the first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "may"

Phrase: "be due to a dampening of the immune response"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C0301872:Immune response [Organ or Tissue Function]
   764   C0678226:Due to [Functional Concept]
           due
   742   C0439662:Immune [Functional Concept]
   742   C0871261:Response [Organism Attribute]
   742   C1704632:Response [Finding]
   742   C1706817:Response [Intellectual Product]
   742   C2911692:Response [Mental Process]
   742   C2987476:Be [Conceptual Entity]
   742   C3146286:Due [Idea or Concept]

Phrase: "with time."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.248: View larger version (32K): [in this window] [in a new window]  Fig 7. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(32K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig 7."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]
Processing 00000000.tx.249: Peripheral blood mononuclear cell (MNC) proliferative response to autologous LCIDSN-transduced stroma in dog M2. 

Phrase: "Peripheral blood mononuclear cell (MNC) proliferative response to autologous LCIDSN-transduced stroma"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   738   C0871261:Response [Organism Attribute]
   738   C1704632:Response [Finding]
   738   C1706817:Response [Intellectual Product]
   738   C2911692:Response [Mental Process]

Phrase: "in dog M2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0457242:m2 [Quantitative Concept]
Processing 00000000.tx.250: Blood MNCs from dog M2, which received infusions of both LCIDSN and M48ID transduced LTMC cells, were cocultured in vitro with 1.5103 autologous LCIDSN transduced () and untransduced () stroma. 

Phrase: "Blood MNCs from dog M2,"

Phrase: "which"

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "infusions of both LCIDSN"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0574032:infusions [Therapeutic or Preventive Procedure]
   737 E C1827465:Infusion [Functional Concept]

Phrase: "and"

Phrase: "M48ID"

Phrase: "transduced"

Phrase: "LTMC cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cocultured"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0282547:Coculture [Laboratory Procedure]

Phrase: "in vitro with 1.5103 autologous LCIDSN"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0021135:In Vitro [Intellectual Product]
   778   C1533691:in vitro [Qualitative Concept]
           vitro
   778   C2827718:In Vitro [Functional Concept]

Phrase: "transduced"

Phrase: "("

Phrase: ")"

Phrase: "and"

Phrase: "untransduced"

Phrase: "("

Phrase: ")"

Phrase: "stroma."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0927195:Stroma [Body Part, Organ, or Organ Component]
Processing 00000000.tx.251: MNC proliferation is measured by the incorporation of [3H]-thymidine and reported as the mean counts per minute (cpm) of triplicate wells with standard errors shown. 

Phrase: "MNC proliferation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2246303:mononuclear cell proliferation [Cell Function]
   901   C0596290:Cell Proliferation [Cell Function]
   827   C0334094:Proliferation [Pathologic Function]
   827   C1514485:Proliferation [Functional Concept]
   734   C0806987:mononuclear cell [Cell]

Phrase: "is"

Phrase: "measured by the incorporation of [3H]-thymidine"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   748   C0040077:Thymidine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0243126:incorporation [Functional Concept]
   748   C0444706:Measured [Qualitative Concept]
   748   C1442460:3H [Temporal Concept]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]

Phrase: "and"

Phrase: "reported as the mean"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0444504:Mean [Quantitative Concept]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C2347634:Mean [Quantitative Concept]
   770   C2348143:Mean [Quantitative Concept]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "counts per minute (cpm) of triplicate wells"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C0392412:Count per Minute [Quantitative Concept]
           Count/Minute
   753   C0205174:Triplicate [Quantitative Concept]
   753   C0439157:counts [Quantitative Concept]
   753   C0439232:minute [Temporal Concept]
   753   C0700321:minute [Quantitative Concept]
   753   C0702093:/minute [Temporal Concept]
   753   C0750480:Count [Activity]
   753   C1282918:Minute [Quantitative Concept]
   753   C1705566:Count [Quantitative Concept]
   753   C2347166:Minute [Quantitative Concept]
   719   C0205170:Well [Qualitative Concept]
   719   C3146287:Well [Manufactured Object]

Phrase: "with standard errors"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   966   C1710181:Standard Error [Quantitative Concept]
   861   C0743559:errors [Qualitative Concept]
   861   C1442989:Standard [Qualitative Concept]
   861   C2828392:Standard [Intellectual Product]
   827 E C1608199:Error [Functional Concept]

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.252: The times after third infusion were (A) 2weeks and (B) 6weeks. 

Phrase: "The times after third infusion"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "were"

Phrase: "(A) 2weeks"

Phrase: "and ("

Phrase: "B) 6weeks."
Processing 00000000.tx.253: *P<.005and P<.05. 

Phrase: "*P<.005and P<.05."
Processing 00000000.tx.254: The demonstration of immune responses against -ID, the serum components of the LTMC media, and autologous cells expressing -ID in dog M2 after multiple infusions led to the treatment of dogs M3 through M6 with fewer infusions of transduced cells and immunosuppressive therapy to abrogate immune responses against -ID and transduced cells. 

Phrase: "The demonstration of immune responses"

Phrase: "against -ID,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "the serum components of the LTMC media,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0449432:Components [Manufactured Object]
   714 E C1705248:Component [Conceptual Entity]

Phrase: "and"

Phrase: "autologous cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing -ID"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in dog M2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0457242:m2 [Quantitative Concept]

Phrase: "after multiple infusions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0574032:infusions [Therapeutic or Preventive Procedure]
   827 E C1827465:Infusion [Functional Concept]

Phrase: "led to the treatment of dogs M3"
Meta Candidates (Total=16; Excluded=5; Pruned=0; Remaining=11)
   748   C0012984:Dogs [Mammal]
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1280551:Dogs [Mammal]
   748   C1300554:m3 [Quantitative Concept]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C1708698:LED [Manufactured Object]
   748   C3484373:M3 [Intellectual Product]
   748   C3538994:TREATMENT [Research Activity]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C1522538:Lead [Functional Concept]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "through M6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412828:M6 [Gene or Genome]
  1000   C2986885:M6 [Gene or Genome]

Phrase: "with fewer infusions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0574032:infusions [Therapeutic or Preventive Procedure]
   827 E C1827465:Infusion [Functional Concept]

Phrase: "of transduced cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "immunosuppressive therapy to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0021079:Immunosuppressive therapy [Therapeutic or Preventive Procedure]
   827   C0021081:immunosuppressive [Immunologic Factor,Pharmacologic Substance]
   827   C0039798:therapy [Functional Concept]
   827   C0087111:Therapy [Therapeutic or Preventive Procedure]
   827   C1363945:Therapy [Finding]

Phrase: "abrogate"

Phrase: "immune responses against -ID"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0301872:immune responses [Organ or Tissue Function]
   770   C0439662:Immune [Functional Concept]
   770   C0871261:responses [Organism Attribute]
   737 E C1704632:Response [Finding]
   737 E C1706817:Response [Intellectual Product]
   737 E C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "transduced cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.255: Three dogs received standard cyclosporine A doses during the immediate posttransplant period. 

Phrase: "Three dogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0012984:Dogs [Mammal]
   861   C1280551:Dogs [Mammal]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "standard cyclosporine A doses during the immediate posttransplant period."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   745   C0366433:Cyclosporin Dose [Clinical Attribute]
   742   C0178602:Doses [Quantitative Concept]
   708 E C0869039:Dose [Quantitative Concept]
   708 E C1114758:Dose # [Clinical Attribute]
   708 E C1428722:DOS [Gene or Genome]
Processing 00000000.tx.256: As expected, the titers of -ID-specific IgG were lower than those for M2, were at 1:100 in M3 and M5 receiving one infusion, and peaked at 1:400 in M4 after a second infusion (Table 4). 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "the titers of -ID-specific IgG"

Phrase: "were"

Phrase: "lower than those"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0441994:Lower [Spatial Concept]
   790   C1548802:Lower [Body Location or Region]
   790   C2003888:Lower [Activity]

Phrase: "for M2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0457242:m2 [Quantitative Concept]

Phrase: "were"

Phrase: "at 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: ":"

Phrase: "100 in M3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1300554:m3 [Quantitative Concept]
   790   C3484373:M3 [Intellectual Product]

Phrase: "and"

Phrase: "M5 receiving one infusion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0574032:Infusion [Therapeutic or Preventive Procedure]
   812   C1827465:Infusion [Functional Concept]

Phrase: "and"

Phrase: "peaked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444505:peaked [Quantitative Concept]

Phrase: "at 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: ":"

Phrase: "400 in M4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1550077:M4 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   790   C1561479:M4 [Intellectual Product]

Phrase: "after a second infusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0574032:Infusion [Therapeutic or Preventive Procedure]
   861   C1827465:Infusion [Functional Concept]

Phrase: "(Table 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.257: The humoral immune response was further reduced to background levels in dog M6 treated with one infusion of cells and both cyclosporine A and methotrexate, because titers were less than 1:100. 

Phrase: "The humoral immune response"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0020967:Humoral Immune Response [Organism Function]
  1000   C1155229:Humoral immune response [Cell Function]
   901   C0301872:Immune response [Organ or Tissue Function]
   827   C0439662:Immune [Functional Concept]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "reduced to background levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0392756:Reduced [Qualitative Concept]
   770   C0441889:Levels [Qualitative Concept]
   770   C1706907:Background [Conceptual Entity]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in dog M6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1412828:M6 [Gene or Genome]
   861   C2986885:M6 [Gene or Genome]

Phrase: "treated with one infusion of cells"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C0007634:Cells [Cell]
   753   C0205447:One [Quantitative Concept]
   753   C0574032:Infusion [Therapeutic or Preventive Procedure]
   753   C1522326:Treated [Functional Concept]
   753   C1827465:Infusion [Functional Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1292734:TREAT [Functional Concept]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "both cyclosporine A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010592:Cyclosporin A [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Ciclosporin

Phrase: "and"

Phrase: "methotrexate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025677:Methotrexate [Organic Chemical,Pharmacologic Substance]

Phrase: "because"

Phrase: "titers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0475208:Titer [Quantitative Concept]

Phrase: "were"

Phrase: "less than 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0439092:Less Than [Intellectual Product]
           less
   790   C0547044:Less [Qualitative Concept]

Phrase: ":"

Phrase: "100."
Processing 00000000.tx.258: Pathology.  

Phrase: "Pathology."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030664:Pathology [Biomedical Occupation or Discipline]
  1000   C0205469:pathology [Functional Concept]
  1000   C0677042:pathology [Pathologic Function]
   928 E C1521733:Pathologic [Functional Concept]
Processing 00000000.tx.259: Three MPS I dogs (M3, M5, and M6) were euthanized at 12to 24months postadoptive transfer due to worsening clinical status and increased morbidity, whereas dog M2 died naturally from disease-related causes at 42months postinfusion. 

Phrase: "Three MPS I dogs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0012984:Dogs [Mammal]
   804   C1280551:Dogs [Mammal]
   717   C0023786:Mucopolysaccharidosis Type I [Disease or Syndrome]

Phrase: "(M3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1300554:m3 [Quantitative Concept]
  1000   C3484373:M3 [Intellectual Product]

Phrase: "M5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1550079:M5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
  1000   C1561481:M5 [Intellectual Product]

Phrase: "and"

Phrase: "M6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412828:M6 [Gene or Genome]
  1000   C2986885:M6 [Gene or Genome]

Phrase: ")"

Phrase: "were"

Phrase: "euthanized at 12to 24months postadoptive transfer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0040671:Transfer [Mental Process]
   753   C1705822:Transfer [Activity]

Phrase: "due to worsening clinical status"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0449440:Clinical status [Qualitative Concept]
   827   C0449438:Status [Qualitative Concept]

Phrase: "and"

Phrase: "increased morbidity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026538:Morbidity [Quantitative Concept]
   861   C0220880:morbidity [Intellectual Product]

Phrase: "whereas"

Phrase: "dog M2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0457242:m2 [Quantitative Concept]

Phrase: "died"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
  1000   C0011065:Died [Organism Function]
  1000   C1546956:Died [Finding]
   928 E C0231800:Expired [Organ or Tissue Function]
   928 E C1704631:Expire [Idea or Concept]
   907 E C0184532:dying [Organism Function]
   907 E C1553404:terminated [Idea or Concept]
   907 E C2348570:Terminated [Functional Concept]

Phrase: "naturally from disease-related causes"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   781   C1314792:disease cause [Functional Concept]
           Causes
   760   C0012634:Disease [Disease or Syndrome]
   760   C0015127:causes [Functional Concept]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   726 E C1524003:Cause [Conceptual Entity]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "at 42months postinfusion."
Processing 00000000.tx.260: Pathologic examination of all euthanized affected dogs was consistent with normal progression of MPS I disease. 

Phrase: "Pathologic examination of all euthanized affected dogs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   728   C2984704:PATHOLOGICAL EXAMINATION [Functional Concept]

Phrase: "was"

Phrase: "consistent with normal progression of MPS I disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0332290:Consistent with [Idea or Concept]
           Consistent
   726   C0332530:Normal consistency [Qualitative Concept]
Processing 00000000.tx.261: Vacuolated cells were prominent in the connective tissues from skin, gastrointestinal tract, liver, pancreas, heart and arteries, respiratory system, reproductive system, and urinary and hemolymphatic systems. 

Phrase: "Vacuolated cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0007634:Cells [Cell]
   861   C1980010:Vacuolated [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "prominent in the connective tissues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205402:Prominent [Qualitative Concept]

Phrase: "from skin,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0444099:Skin [Body Substance]
  1000   C1123023:Skin [Body System]
  1000   C1278993:Skin [Body System]
   944 E C0221912:Cutaneous [Spatial Concept]
   944 E C0221928:Dermal [Qualitative Concept]
   944 E C1522447:Cutaneous [Functional Concept]
   877 E C0011646:Dermis [Tissue]

Phrase: "gastrointestinal tract,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0017189:Gastrointestinal Tract [Body System]
  1000   C1281182:Gastrointestinal tract [Body System]
   861   C0521362:gastrointestinal [Spatial Concept]
   861   C1185740:Tract [Body Part, Organ, or Organ Component]

Phrase: "liver,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "pancreas,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030274:Pancreas [Body Part, Organ, or Organ Component]
  1000   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "heart"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018787:Heart [Body Part, Organ, or Organ Component]
  1000   C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "arteries,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0003842:Arteries [Body Part, Organ, or Organ Component]
  1000   C0226004:arteries [Body System]
   916 E C0221464:Arterial [Spatial Concept]

Phrase: "respiratory system,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0035237:Respiratory System [Body System]
  1000   C0425442:RESPIRATORY SYSTEM [Finding]
  1000   C1269561:Respiratory system [Body System]
   861   C0449913:System [Functional Concept]
   861   C0521346:respiratory [Functional Concept]
   861   C1546767:Respiratory [Intellectual Product]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "reproductive system,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0178828:Reproductive system [Body System]
  1000   C0559522:Reproductive system [Body System]
  1000   C1261210:Reproductive system [Body System]
  1000   C1335757:REPRODUCTIVE SYSTEM [Finding]
   861   C0035150:Reproductive [Organism Function]
   861   C0449913:System [Functional Concept]
   861   C0748342:REPRODUCTIVE [Classification]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "and"

Phrase: "urinary"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042027:Urinary [Body Part, Organ, or Organ Component]
  1000   C1524119:urinary [Qualitative Concept]

Phrase: "and"

Phrase: "hemolymphatic systems."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   777 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.262: Dog M3 is alive at 28months postinfusion, with advanced but stable disease.  

Phrase: "Dog M3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1300554:m3 [Quantitative Concept]
   861   C3484373:M3 [Intellectual Product]

Phrase: "is"

Phrase: "alive at 28months postinfusion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0376558:Alive [Idea or Concept]
   770   C2584946:Alive [Finding]

Phrase: "with advanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205179:Advanced [Qualitative Concept]

Phrase: "but"

Phrase: "stable disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0677946:Stable Disease [Finding]
  1000   C3538874:Stable Disease [Finding]
   861   C0012634:Disease [Disease or Syndrome]
   861   C0205360:Stable [Qualitative Concept]
   861   C1547311:Stable [Intellectual Product]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.263: DISCUSSION Canine -ID deficiency was first described in 1982as a new mutation in three Plott hound dogs from Tennessee.16 Through thoughtful breeding programs, colonies were established and arising affected dogs have been the subjects of several important experiments designed to learn more about the comparable human condition, Hurler syndrome or MPS I.

Phrase: "DISCUSSION Canine -ID deficiency"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0011155:Deficiency [Functional Concept]
   812   C0162429:Deficiency [Disease or Syndrome]
   812   C1623416:deficiency [Qualitative Concept]
   741 E C1636779:% deficient [Quantitative Concept]

Phrase: "was"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "described in 1982as"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]

Phrase: "a new mutation in three Plott hound dogs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C2985439:new mutation [Cell or Molecular Dysfunction]
   744   C0026882:Mutation [Genetic Function]
   744   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "from Tennessee.16"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039514:Tennessee [Geographic Area]

Phrase: "Through thoughtful breeding programs,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0376691:Programs [Intellectual Product]
   827   C3484370:Programs [Functional Concept]
   793 E C1709697:Program [Conceptual Entity]
   793 E C2728259:Program [Pharmacologic Substance]

Phrase: "colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0439158:colonies [Quantitative Concept]
   966 E C1947989:Colony [Cell]

Phrase: "were"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "and"

Phrase: "arising affected dogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0012984:Dogs [Mammal]
   827   C1280551:Dogs [Mammal]

Phrase: "have"

Phrase: "been"

Phrase: "the subjects of several important experiments"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "learn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023185:learn [Mental Process]

Phrase: "more about the comparable human condition,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0012634:condition [Disease or Syndrome]
   753   C0086418:Human [Human]
   753   C0205172:More [Functional Concept]
   753   C0348080:Condition [Qualitative Concept]
   753   C1705253:Condition [Conceptual Entity]

Phrase: "Hurler syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0086795:Hurler Syndrome [Disease or Syndrome]
           hurler
  1000   C2700525:HURLER SYNDROME [Gene or Genome]
   861   C0039082:Syndrome [Disease or Syndrome]

Phrase: "or"

Phrase: "MPS I."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0023786:Mucopolysaccharidosis Type I [Disease or Syndrome]
           Mucopolysaccharidosis I
   901   C0441729:Type I [Classification]
   827   C0021966:I- [Inorganic Chemical]
   827   C0026703:Mucopolysaccharidosis [Disease or Syndrome]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.264: Allogeneic bone marrow transplantation in 5-month-old affected pups was shown to result in increased -ID levels in cerebral cortex, liver, and cerebrospinal fluid and reduced GAG storage in liver, neurons, glial cells, and blood vessels.20 In transplanted pups, urinary GAG excretion decreased to normal levels by 5months posttransplant. 

Phrase: "Allogeneic bone marrow transplantation in 5-month-old affected pups"
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   806   C0149615:Allogeneic bone marrow transplantation [Therapeutic or Preventive Procedure]
   782   C0005961:Bone Marrow Transplantation [Therapeutic or Preventive Procedure]
           Marrow Transplantation
   760   C0005953:Bone Marrow [Tissue]
   757   C0005976:Bone Transplantation [Therapeutic or Preventive Procedure]
   757   C0040739:Transplantation, Allogeneic [Therapeutic or Preventive Procedure]
   739   C0029216:Transplantation [Therapeutic or Preventive Procedure]
   739   C0040732:Transplantation [Therapeutic or Preventive Procedure]
   739   C0040733:transplantation [Functional Concept]
   739   C0086590:Marrow [Food]
   739   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   739   C0376152:Marrow [Body Part, Organ, or Organ Component]
   739   C0391978:Bone [Tissue]
   739   C1266908:Bone [Body Part, Organ, or Organ Component]
   739   C1266909:Bone [Body System]
   739   C1515895:Allogeneic [Qualitative Concept]
   739   C1546708:Marrow [Intellectual Product]
   730 E C1708973:Medullary Bone [Tissue]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "result in increased -ID levels"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0205217:Increased [Quantitative Concept]
   760   C0441889:Levels [Qualitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "in cerebral cortex,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "liver,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "and"

Phrase: "cerebrospinal fluid"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007806:Cerebrospinal Fluid [Body Substance]
  1000   C0007807:cerebrospinal fluid [Functional Concept]
   861   C0005889:FLUID [Body Substance]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]

Phrase: "and"

Phrase: "reduced GAG storage in liver,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0337174:Storage [Spatial Concept]
   760   C1698986:Storage [Functional Concept]
   760   C1753314:storage [Cell Component]

Phrase: "neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "glial cells,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0027836:Glial Cells [Cell]
           Glial
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789 E C1087003:Glia [Plant]

Phrase: "and"

Phrase: "blood vessels.20 In transplanted pups,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   804   C0278429:Transplanted blood vessel [Body Part, Organ, or Organ Component]
   804   C1282857:Transplanted blood vessel [Body Part, Organ, or Organ Component]
   790   C0005847:Blood Vessels [Body Part, Organ, or Organ Component]
           Vessels
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
       E   Vessel
   753   C0040732:transplanted [Therapeutic or Preventive Procedure]
   753   C0332835:transplanted [Tissue]
   753   C0700106:Transplanted [Functional Concept]
   718 E C1558950:VASCULAR [Finding]
   718 E C1801960:Vascular [Qualitative Concept]

Phrase: "urinary GAG excretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0221102:Excretion [Physiologic Function]
   827   C0504085:Excretion [Body Substance]
   827   C2699704:EXCRETION [Regulation or Law]

Phrase: "decreased to normal levels"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   770   C0205216:Decreased [Quantitative Concept]
   770   C0205307:Normal [Qualitative Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C0441889:Levels [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   770   C2347086:% Normal [Quantitative Concept]
   737 E C0456079:Level [Classification]
   737 E C0547047:Decrease [Quantitative Concept]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "by 5months"

Phrase: "posttransplant."
Processing 00000000.tx.265: Enzyme replacement studies have also been undertaken in affected dogs using recombinant human -L-iduronidase.21,22 Intravenous administration of purified enzyme to three affected pups for up to 13months21,22 resulted in normalization of lysosomal storage in liver, spleen, and kidney glomeruli. 

Phrase: "Enzyme replacement studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "also"

Phrase: "been"

Phrase: "undertaken in affected dogs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0012984:Dogs [Mammal]
   770   C0392760:Affected [Functional Concept]
   770   C1280551:Dogs [Mammal]
   770   C1314939:Affected [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "recombinant human -L-iduronidase.21,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   888   C1443679:Recombinant l-iduronidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   804   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0086418:Human [Human]
   804   C1514798:recombinant [Organism]

Phrase: "22 Intravenous administration of purified enzyme"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0013125:intravenous administration [Spatial Concept]
   790   C0021440:intravenous administration [Therapeutic or Preventive Procedure]
   753   C0001554:Administration [Occupational Activity]
   753   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "to three affected pups"

Phrase: "for"

Phrase: "up to 13months21,"

Phrase: "22"

Phrase: "resulted in normalization of lysosomal storage"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0337174:Storage [Spatial Concept]
   753   C0521450:Lysosomal [Body Location or Region]
   753   C1698986:Storage [Functional Concept]
   753   C1753314:storage [Cell Component]
   753   C1882115:Normalization [Research Activity]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "in liver,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "spleen,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037993:Spleen [Body Part, Organ, or Organ Component]
  1000   C0771377:SPLEEN [Tissue]
  1000   C1278932:Spleen [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "kidney glomeruli."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0022663:Kidney Glomerulus [Body Part, Organ, or Organ Component]
           Glomerulus
   777 E C0268731:GLOMERULAR [Disease or Syndrome]
Processing 00000000.tx.266: There was no improvement in brain tissue GAG storage, and all dogs developed complement-activating antibodies against the human protein. 

Phrase: "There"

Phrase: "was"

Phrase: "no improvement in brain tissue GAG storage,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2986411:Improvement [Conceptual Entity]

Phrase: "and"

Phrase: "all dogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012984:Dogs [Mammal]
  1000   C1280551:Dogs [Mammal]

Phrase: "developed"

Phrase: "complement-activating antibodies against the human protein."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   757   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   714 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.267: The promising results of allogeneic bone marrow transplantation20 and evidence for clinical improvement in recombinant enzyme infusion studies, despite the presence of an immune response,21,22 suggested that -ID-deficient dogs might be ideal for developing and evaluating therapies delivered by genetically corrected HSCs. 

Phrase: "The promising results of allogeneic bone marrow transplantation20"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0427694:bone marrow results [Laboratory or Test Result]
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711   C2825142:Result [Finding]

Phrase: "and"

Phrase: "evidence for clinical improvement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]

Phrase: "in recombinant enzyme infusion studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0947630:studies [Laboratory Procedure]
   779 E C0557651:Study [Manufactured Object]
   779 E C2603343:Study [Research Activity]

Phrase: "despite the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of an immune response,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0301872:Immune response [Organ or Tissue Function]
   861   C0439662:Immune [Functional Concept]
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "21,"

Phrase: "22"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that -ID-deficient dogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0012984:Dogs [Mammal]
   827   C1280551:Dogs [Mammal]

Phrase: "might"

Phrase: "be"

Phrase: "ideal for developing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1512612:Ideal [Qualitative Concept]

Phrase: "and"

Phrase: "evaluating therapies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0087111:therapies [Therapeutic or Preventive Procedure]
   827 E C0039798:therapy [Functional Concept]
   827 E C1363945:Therapy [Finding]

Phrase: "delivered by genetically"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1705822:Delivered [Activity]
   756 E C0308779:DELIVER [Organic Chemical,Pharmacologic Substance]
   756 E C1874964:DELIVER [Pharmacologic Substance]

Phrase: "corrected"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205202:Corrected [Qualitative Concept]
   966 E C2349182:Correct [Qualitative Concept]

Phrase: "HSCs."
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0018956:Hematopoietic stem cells [Cell]
   901   C0038250:Stem cells [Cell]
   896   C2323499:Hematopoietic cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0018957:Haematopoietic [Body System]
   827   C0229601:Hematopoietic [Functional Concept]
   827   C0242767:Stem [Plant]
   827   C1186763:Stem [Body Part, Organ, or Organ Component]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0018951:Haematopoiesis [Organ or Tissue Function]
Processing 00000000.tx.268: The need for such model systems was heightened by the generally poor results obtained in several large animal and human studies of HSC gene transfer. 

Phrase: "The need for such model systems"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0027552:Need [Qualitative Concept]
   753   C0686904:need [Functional Concept]

Phrase: "was"

Phrase: "heightened by the generally poor results"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0032854:Poor [Group Attribute]
   753   C0442803:Heightened [Qualitative Concept]
   753   C0442805:Heightened [Functional Concept]
   753   C0542537:Poor [Qualitative Concept]
   753   C2700379:Poor [Qualitative Concept]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "obtained in several large animal"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0003062:Animal [Animal]
   760   C0549177:Large [Quantitative Concept]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "studies of HSC gene transfer."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C1517499:Gene Transfer [Molecular Biology Research Technique]
   797   C1273305:Gene studies [Laboratory Procedure]
   760   C0017337:Gene [Gene or Genome]
   760   C0040671:Transfer [Mental Process]
   760   C0557651:Study [Manufactured Object]
   760   C0947630:studies [Laboratory Procedure]
   760   C1523748:HSC [Cell Component]
   760   C1705576:HSC [Therapeutic or Preventive Procedure]
   760   C1705822:Transfer [Activity]
   760   C2603343:Study [Research Activity]
Processing 00000000.tx.269: Studies in cats,35 dogs,10,36 nonhuman primates,5,37 humans,2,38,39 and surrogate human systems40,41 suggested that only a small proportion of in vivo repopulating HSCs are genetically modified using methods that gave high levels of HSC gene transfer in murine systems. 

Phrase: "Studies in cats,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0947630:studies [Laboratory Procedure]
   756 E C0557651:Study [Manufactured Object]
   756 E C2603343:Study [Research Activity]

Phrase: "35 dogs,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0012984:Dogs [Mammal]
   861   C1280551:Dogs [Mammal]

Phrase: "10,"

Phrase: "36 nonhuman primates,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0237798:Nonhuman Primates [Mammal]
   827   C0033147:Primates [Mammal]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "37 humans,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086418:Humans [Human]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "38,"

Phrase: "39"

Phrase: "and"

Phrase: "surrogate human systems40,"

Phrase: "41"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a small proportion of in vivo repopulating HSCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1709707:Proportion [Quantitative Concept]

Phrase: "are"

Phrase: "genetically"

Phrase: "modified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "that"

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "high levels of HSC gene transfer"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "in murine systems."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   777 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.270: Furthermore, there still is no clear evidence for a therapeutic benefit of genetically modified HSCs in any large animal or human system.3,42 We reasoned that the demonstration of significant disease amelioration in affected -ID-deficient dogs receiving genetically corrected HSCs would represent a much-needed proof of principle in the arena of HSC gene therapy. 

Phrase: "Furthermore,"

Phrase: "there still"

Phrase: "is"

Phrase: "no clear evidence for a therapeutic benefit of genetically"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "modified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]

Phrase: "HSCs in any large animal"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   814   C0018956:Hematopoietic stem cells [Cell]
   778   C0038250:Stem cells [Cell]
   757   C2323499:Hematopoietic cell [Cell]
   748   C0007634:Cells [Cell]
   748   C0018957:Haematopoietic [Body System]
   748   C0229601:Hematopoietic [Functional Concept]
   748   C0242767:Stem [Plant]
   748   C1186763:Stem [Body Part, Organ, or Organ Component]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "human system.3,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0086418:Human [Human]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "42"

Phrase: "We"

Phrase: "reasoned"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0392360:Reason [Idea or Concept]

Phrase: "that"

Phrase: "the demonstration of significant disease amelioration"

Phrase: "in affected -ID-deficient dogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0012984:Dogs [Mammal]
   812   C1280551:Dogs [Mammal]

Phrase: "receiving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514756:Receive [Qualitative Concept]

Phrase: "genetically"

Phrase: "corrected"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205202:Corrected [Qualitative Concept]
   966 E C2349182:Correct [Qualitative Concept]

Phrase: "HSCs"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0018956:Hematopoietic stem cells [Cell]
   901   C0038250:Stem cells [Cell]
   896   C2323499:Hematopoietic cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0018957:Haematopoietic [Body System]
   827   C0229601:Hematopoietic [Functional Concept]
   827   C0242767:Stem [Plant]
   827   C1186763:Stem [Body Part, Organ, or Organ Component]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0018951:Haematopoiesis [Organ or Tissue Function]

Phrase: "would"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a much-needed proof of principle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0556981:% proof [Quantitative Concept]

Phrase: "in the arena"

Phrase: "of HSC gene therapy."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0017296:gene therapy [Therapeutic or Preventive Procedure]
   827   C0017337:Gene [Gene or Genome]
   827   C0039798:therapy [Functional Concept]
   827   C0087111:Therapy [Therapeutic or Preventive Procedure]
   827   C1363945:Therapy [Finding]
Processing 00000000.tx.271: We performed large volume marrow harvests from five affected -ID-deficient dogs and exposed hematopoietic cells with known long-term in vivo repopulating potential to two retroviral vectors bearing the normal canine -ID cDNA. 

Phrase: "We"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "large volume marrow"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0086590:Marrow [Food]
   827   C0376152:Marrow [Body Part, Organ, or Organ Component]
   827   C1546708:Marrow [Intellectual Product]
   771 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   771 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   771 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   743 E C0330477:Marrows [Plant]

Phrase: "harvests from five"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205451:Five [Quantitative Concept]
   790   C1512335:Harvest [Health Care Activity]

Phrase: "affected -ID-deficient dogs"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0011155:Deficient [Functional Concept]
   812   C0012984:Dogs [Mammal]
   812   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0392760:Affected [Functional Concept]
   812   C1280551:Dogs [Mammal]
   812   C1314939:Affected [Functional Concept]
   812   C1636779:% deficient [Quantitative Concept]
   779 E C0001721:Affect [Mental Process]

Phrase: "and"

Phrase: "exposed hematopoietic cells with known long-term in vivo"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   748   C2323499:Hematopoietic cell [Cell]
   742   C0007634:Cells [Cell]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "repopulating"

Phrase: "potential to two retroviral vectors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3245505:Potential [Qualitative Concept]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "the normal canine -ID cDNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.272: One vector, LCIDSN, expressed -ID from the LTR and neor from the SV40 promoter/enhancer. 

Phrase: "One vector,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: "LCIDSN,"

Phrase: "expressed -ID"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "from the LTR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023978:LTR [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "neor from the SV40 promoter/enhancer."
Processing 00000000.tx.273: In the M48ID vector, -ID was expressed from the murine PGK promoter. 

Phrase: "In the M48ID vector, -ID"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0150312:In [Quantitative Concept]
   804   C0332285:In [Spatial Concept]
   804   C0442335:Vector [Spatial Concept]
   804   C1705099:Vector [Idea or Concept]

Phrase: "was"

Phrase: "expressed from the murine PGK promoter."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0026809:Murine [Mammal]
   753   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   753   C1150521:PGK [Molecular Function]
   753   C1418929:PGK [Gene or Genome]
Processing 00000000.tx.274: Both vectors were evaluated by us and independently by others and shown to be excellent vectors as determined by in vitro assays of transduction.43 Adoptive transfers of transduced LTMCs to autologous recipients were performed under conditions shown in prior studies to give rise to genetically modified hematopoietic cells with capacities to generate committed progenitors in vivo for up to 3years and at levels comprising approximately 5% of all committed progenitors.11 Our particular approach to gene transfer has relied heavily on the use of stromal-based culture systems, because data from several sources suggest that such in vitro microenvironments may facilitate both maintenance of and gene transfer into HSCs.10-14,44 There was good evidence that a high proportion of LTMC-derived committed progenitors carried and expressed the proviral -ID, as well as the bulk LTMC cells that expressed up to 200times the normal -ID enzyme levels in vitro. 

Phrase: "Both vectors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vectors [Spatial Concept]
   966 E C1705099:Vector [Idea or Concept]

Phrase: "were"

Phrase: "evaluated by us"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0220825:Evaluated [Functional Concept]

Phrase: "and"

Phrase: "independently by others"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1955473:Others [Finding]

Phrase: "and"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "excellent vectors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vectors [Spatial Concept]
   827 E C1705099:Vector [Idea or Concept]

Phrase: "as"

Phrase: "determined by in vitro assays of transduction.43 Adoptive transfers"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   760   C0021135:In Vitro [Intellectual Product]
   760   C0376518:Adoptive Transfers [Therapeutic or Preventive Procedure]
   760   C1533691:in vitro [Qualitative Concept]
           vitro
   760   C2827718:In Vitro [Functional Concept]
   748   C1515653:In Vitro Assay [Research Activity]
   739   C0728827:Transfers [Finding]
   739   C1160185:transduction [Organism Function]
   706   C0005507:Assay [Laboratory Procedure]
   706 E C0040671:Transfer [Mental Process]
   706   C0243073:assay [Qualitative Concept]
   706   C1510438:Assay [Laboratory Procedure]
   706 E C1705822:Transfer [Activity]

Phrase: "of transduced LTMCs"
Meta Candidates (Total=18; Excluded=4; Pruned=0; Remaining=14)
   827   C0443252:Long-term [Temporal Concept]
   799   C0010453:Culture [Idea or Concept]
   799   C0086590:Marrow [Food]
   799   C0205166:Long [Qualitative Concept]
   799   C0220814:culture [Functional Concept]
   799   C0332285:Of [Spatial Concept]
   799   C0376152:Marrow [Body Part, Organ, or Organ Component]
   799   C0430400:Culture [Laboratory Procedure]
   799   C1515273:Term [Temporal Concept]
   799   C1546708:Marrow [Intellectual Product]
   799   C1705313:Term [Idea or Concept]
   799   C1706317:Long [Qualitative Concept]
   799   C2242979:Culture [Laboratory Procedure]
   799   C2826302:TERM [Intellectual Product]
   743 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   743 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   743 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   716 E C0330477:Marrows [Plant]

Phrase: "to autologous recipients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1709854:Recipient [Human]

Phrase: "were"

Phrase: "performed under conditions"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C0884358:Performed [Functional Concept]
   756   C0012634:condition [Disease or Syndrome]
   756   C0348080:Condition [Qualitative Concept]
   756   C1705253:Condition [Conceptual Entity]
   756 E C2947996:Perform [Pharmacologic Substance]
   706 E C0009647:Conditioned [Mental Process]
   706 E C1701901:Conditional [Qualitative Concept]
   706 E C1963686:Conditional [Functional Concept]

Phrase: "shown in prior studies to"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   797   C0332152:Prior to [Temporal Concept]
           Prior
   760   C0947630:studies [Laboratory Procedure]
   760   C2826257:PRIOR [Event]
   726 E C0557651:Study [Manufactured Object]
   726   C1547282:Show [Intellectual Product]
   726 E C2603343:Study [Research Activity]

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "rise to genetically"

Phrase: "modified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]

Phrase: "hematopoietic cells with capacities to"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C2323499:Hematopoietic cell [Cell]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "generate"

Phrase: "committed progenitors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0870134:Progenitor [Family Group]

Phrase: "in vivo for"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   882   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "up to 3years"

Phrase: "and at levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0441889:Levels [Qualitative Concept]
   790   C1515981:And [Idea or Concept]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]

Phrase: "comprising"

Phrase: "approximately 5% of all committed progenitors.11"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0332232:Approximately [Qualitative Concept]
   748   C1171947:committed [Organic Chemical,Pharmacologic Substance]
   714   C0870134:Progenitor [Family Group]

Phrase: "Our particular approach to gene transfer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449445:Approach [Spatial Concept]

Phrase: "has"

Phrase: "relied"

Phrase: "heavily on the use of stromal-based culture systems,"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   764   C1524063:Use of [Functional Concept]
   742   C0010453:Culture [Idea or Concept]
   742   C0042153:use [Functional Concept]
   742   C0220814:culture [Functional Concept]
   742   C0430400:Culture [Laboratory Procedure]
   742   C0457083:Use [Functional Concept]
   742   C1527178:Based [Functional Concept]
   742   C1705938:Based [Idea or Concept]
   742   C1947944:Use [Intellectual Product]
   742   C2242979:Culture [Laboratory Procedure]
   708 E C0002055:base [Inorganic Chemical]
   708 E C0178499:Base [Chemical Viewed Functionally]
   708   C0449913:System [Functional Concept]
   708   C1553451:System [Manufactured Object]
   708   C1704459:System [Medical Device]
   708 E C1880279:Base [Biomedical or Dental Material]

Phrase: "because"

Phrase: "data from several sources"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0011001:Data Sources [Quantitative Concept]
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "such in vitro microenvironments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "may"

Phrase: "facilitate"

Phrase: "both maintenance of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0024501:Maintenance [Activity]

Phrase: "and"

Phrase: "gene transfer into HSCs.10-14,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1517499:Gene Transfer [Molecular Biology Research Technique]
   750   C1861886:CELL Gene [Gene or Genome]
   744   C0017337:Gene [Gene or Genome]
   744   C0040671:Transfer [Mental Process]
   744   C1705822:Transfer [Activity]

Phrase: "44 There"

Phrase: "was"

Phrase: "good evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "a high proportion of LTMC-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709707:Proportion [Quantitative Concept]

Phrase: "derived"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1441547:Derived [Qualitative Concept]
  1000   C3245521:derived [Idea or Concept]

Phrase: "committed progenitors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0870134:Progenitor [Family Group]

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "and"

Phrase: "expressed"

Phrase: "the proviral -ID,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "as well as"

Phrase: "the bulk LTMC cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "expressed up to 200times"

Phrase: "the normal -ID enzyme levels"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   861   C0014440:enzyme levels [Laboratory Procedure]
   861   C1287349:enzyme levels [Laboratory or Test Result]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.275: Monitoring of engraftment for up to 2years by PCR amplification of proviral sequences demonstrated that up to 6% of hematopoietic progenitors and 0.01% to 1% of blood and marrow leukocytes of affected dogs were gene marked. 

Phrase: "Monitoring of engraftment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0150369:Monitoring [Health Care Activity]
   790   C1516647:monitoring [Research Activity]

Phrase: "for"

Phrase: "up to 2years"

Phrase: "by PCR amplification"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0337112:Chain [Manufactured Object]
   812   C0443286:Reaction [Functional Concept]
   812   C1114821:Reaction [Clinical Attribute]
   812   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1517480:Amplification [Molecular Biology Research Technique]
   812   C1521871:Amplification [Phenomenon or Process]
   812   C1524075:Chain [Idea or Concept]
   812   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "of proviral sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "demonstrated"

Phrase: "that up to 6% of hematopoietic progenitors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0018957:Haematopoietic [Body System]
   748   C0229601:Hematopoietic [Functional Concept]
   714   C0870134:Progenitor [Family Group]

Phrase: "and"

Phrase: "0.01% to 1% of blood"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0005767:Blood [Tissue]
   753   C0005768:blood [Body Substance]
   753   C0229664:Blood [Body Substance]

Phrase: "and"

Phrase: "marrow leukocytes of affected dogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0023516:Marrow leukocyte [Cell]
           Leukocytes

Phrase: "were"

Phrase: "gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "marked."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]
Processing 00000000.tx.276: These data confirm prior results from our center.11 The higher level of marking in hematopoietic progenitors than differentiated cells observed in these dogs has also been seen in both our studies of LTMC gene transfer studies in human patients on a stem cell gene marking trial15 and in studies by others.2,45 The reason for this phenomenon is unknown but possibly involves an inability of transduced progenitors to undergo natural processes of proliferation and differentiation or immune responses to differentiated hematopoietic cells presenting foreign antigens. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "prior results from our center.11"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "The higher level of marking"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "in hematopoietic progenitors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0870134:Progenitor [Family Group]

Phrase: "than differentiated cells"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   861   C0007589:Differentiated [Cell Function]
   861   C0007634:Cells [Cell]
   861   C0205615:Differentiated [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789 E C1511938:Differentiation [Clinical Attribute]
   789 E C2945687:Differentiation [Functional Concept]

Phrase: "observed in these dogs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0012984:Dogs [Mammal]
   770   C1280551:Dogs [Mammal]
   770   C1441672:Observed [Functional Concept]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "seen in both"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0205397:Seen [Qualitative Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "our studies of LTMC gene transfer studies"

Phrase: "in human patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "on a stem cell gene marking trial15"

Phrase: "and in studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0947630:studies [Laboratory Procedure]
   790   C1515981:And [Idea or Concept]
   756 E C0557651:Study [Manufactured Object]
   756 E C2603343:Study [Research Activity]

Phrase: "by others.2,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1955473:Others [Finding]
   827 E C0205394:Other [Qualitative Concept]

Phrase: "45"

Phrase: "The reason for this phenomenon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392360:Reason [Idea or Concept]

Phrase: "is"

Phrase: "unknown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]

Phrase: "but"

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "involves"

Phrase: "an inability of transduced progenitors to"

Phrase: "undergo"

Phrase: "natural processes of proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1184743:Process [Body Part, Organ, or Organ Component]
   737   C1522240:Process [Phenomenon or Process]

Phrase: "and"

Phrase: "differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "or"

Phrase: "immune responses to differentiated hematopoietic cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0301872:immune responses [Organ or Tissue Function]
   779   C1817973:immune cell differentiation [Cell Function]
   753   C0439662:Immune [Functional Concept]
   753   C0871261:responses [Organism Attribute]
   719 E C1704632:Response [Finding]
   719 E C1706817:Response [Intellectual Product]
   719 E C2911692:Response [Mental Process]

Phrase: "presenting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presenting [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "foreign antigens."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003320:Antigens [Immunologic Factor]
   755 E C2698667:ANTIGENICITY [Regulation or Law]
Processing 00000000.tx.277: Despite the documentation of engraftment of up to 1% of blood and marrow leukocytes and 10% of progenitors carrying the provirus, we observed no -ID activity in blood or marrow leukocytes. 

Phrase: "Despite the documentation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0175636:documentation [Health Care Activity]
  1000   C0920316:Documentation [Intellectual Product]

Phrase: "of engraftment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0301944:Engraftment [Physiologic Function]

Phrase: "of"

Phrase: "up to 1%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "of blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "marrow leukocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0023516:Marrow leukocyte [Cell]
           Leukocytes

Phrase: "and"

Phrase: "10% of progenitors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0870134:Progenitor [Family Group]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "the provirus,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033755:Provirus [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1527278:provirus [Cell Component]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "no -ID activity in blood"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "or"

Phrase: "marrow leukocytes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0023516:Marrow leukocyte [Cell]
           Leukocytes
Processing 00000000.tx.278: At the time of infusion, LTMC cells expressed up to 200times the normal level of -ID protein and an average of 15% of individual hematopoietic colonies had proviral -ID enzyme activity. 

Phrase: "At the time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "of infusion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0574032:Infusion [Therapeutic or Preventive Procedure]
  1000   C1827465:Infusion [Functional Concept]

Phrase: "LTMC cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressed up to 200times"

Phrase: "the normal level of -ID protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   897   C0860902:normal protein [Finding]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "an average of 15% of individual hematopoietic colonies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1510992:Average [Quantitative Concept]
   744   C2825518:AVERAGE [Quantitative Concept]

Phrase: "had"

Phrase: "proviral -ID enzyme activity."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0243102:enzyme activity [Molecular Function]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   729 E C0014445:enzymes [Functional Concept]
Processing 00000000.tx.279: After infusion, -ID activity was not detected in blood or marrow leukocytes and only 1of a total of 592CFU-GM from dogs M2 and M5 was found to be expressing -ID, suggesting that proviral gene expression had been silenced in our vectors. 

Phrase: "After infusion, -ID activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   812   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0205177:Activity [Functional Concept]
   812   C0231290:After [Temporal Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C0574032:Infusion [Therapeutic or Preventive Procedure]
   812   C0687676:After [Temporal Concept]
   812   C1561536:*Activity [Idea or Concept]
   812   C1827465:Infusion [Functional Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected in blood"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   790   C0005767:Blood [Tissue]
   790   C0005768:blood [Body Substance]
   790   C0229664:Blood [Body Substance]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   718 E C0333275:Bloody [Qualitative Concept]
   706 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   706 E C0392895:Bloods [Population Group]
   706 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   706 E C1511228:VESSEL, BLOOD [Tissue]

Phrase: "or"

Phrase: "marrow leukocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0023516:Marrow leukocyte [Cell]
           Leukocytes

Phrase: "and"

Phrase: "only 1of"

Phrase: "a total of 592CFU-GM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]

Phrase: "from dogs M2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0457242:m2 [Quantitative Concept]

Phrase: "and"

Phrase: "M5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1550079:M5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
  1000   C1561481:M5 [Intellectual Product]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "expressing -ID,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that proviral gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0017262:Gene Expression [Genetic Function]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "had"

Phrase: "been"

Phrase: "silenced in our vectors."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0442335:Vectors [Spatial Concept]
   737   C0858952:silence [Mental or Behavioral Dysfunction]
   737 E C1705099:Vector [Idea or Concept]
Processing 00000000.tx.280: Silencing of Moloney murine leukemia virus (MMLV)-based promoters, such as that used in these vectors, has been described in other in vitro and in vivo studies.46-48 In our own previous canine gene transfer studies with the LN vector that has a similar vector backbone to these studies, expression of neor was maintained in approximately 5% of CFU-GM for up to 2years postinfusion. 

Phrase: "Silencing of Moloney murine leukemia virus (MMLV)-based promoters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C0858952:silence [Mental or Behavioral Dysfunction]

Phrase: "such as that"

Phrase: "used in these vectors,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0442335:Vectors [Spatial Concept]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1705099:Vector [Idea or Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "described in other in vitro"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0021135:In Vitro [Intellectual Product]
   797   C1533691:in vitro [Qualitative Concept]
           vitro
   797   C2827718:In Vitro [Functional Concept]
   760   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "in vivo studies.46-48"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   867   C0681829:in vivo study [Research Activity]
   840   C1515655:In Vivo [Spatial Concept]
           vivo
   804   C0947630:studies [Laboratory Procedure]
   771 E C0557651:Study [Manufactured Object]
   771 E C2603343:Study [Research Activity]

Phrase: "In our own previous canine gene transfer studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   839   C1273305:Gene studies [Laboratory Procedure]
   799   C0947630:studies [Laboratory Procedure]
   766 E C0557651:Study [Manufactured Object]
   766 E C2603343:Study [Research Activity]

Phrase: "with the LN vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: "that"

Phrase: "has"

Phrase: "a similar vector backbone to these studies,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0037949:Backbone [Body Part, Organ, or Organ Component]
   748   C1267072:Backbone [Body Part, Organ, or Organ Component]

Phrase: "expression of neor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "maintained in approximately 5% of CFU-GM"
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
   820   C0314589:Colony-forming unit, granulocyte-macrophage [Cell]
   799   C0314587:Colony-forming unit, granulocyte [Cell]
   799   C0314592:Colony-forming unit, macrophage [Cell]
   782   C0553561:Colony-forming unit [Quantitative Concept]
   739   C0018183:granulocyte [Cell]
   739   C0024432:macrophage [Cell]
   739   C0205431:Forming [Functional Concept]
   739   C0332232:Approximately [Qualitative Concept]
   739   C0439148:Unit [Quantitative Concept]
   739   C0439158:colony [Quantitative Concept]
   739   C1314677:Maintained [Functional Concept]
   739   C1519795:Unit [Quantitative Concept]
   739   C1522492:Forming [Functional Concept]
   739   C1704753:Unit [Manufactured Object]
   739   C1880519:Unit [Quantitative Concept]
   739   C1947989:Colony [Cell]
   706 E C0024501:Maintain [Activity]
   706 E C0348078:Form [Qualitative Concept]
   706 E C0376315:Form [Manufactured Object]

Phrase: "for"

Phrase: "up to 2years postinfusion."
Processing 00000000.tx.281: The lack of -ID proviral expression in MPS I dogs may be due to the presence of two genes in the LCIDSN vector, a phenomenon that has been associated with decreased expression of both genes.46 Alternatively silenced proviral -ID expression in MPS I dogs, but not neor in normal dogs, might be the result of the anti--ID immune response noted in MPS I dogs. 

Phrase: "The lack of -ID proviral expression in MPS I dogs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "be due to the presence of two genes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0678226:Due to [Functional Concept]
           due
   744   C0017337:Genes [Gene or Genome]
   744   C0205448:Two [Quantitative Concept]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C2987476:Be [Conceptual Entity]
   744   C3146286:Due [Idea or Concept]

Phrase: "in the LCIDSN vector,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: "a phenomenon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882365:Phenomenon [Phenomenon or Process]

Phrase: "that"

Phrase: "has"

Phrase: "been"

Phrase: "associated with decreased expression"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   770   C0205216:Decreased [Quantitative Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   737 E C0547047:Decrease [Quantitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "of both genes.46 Alternatively silenced proviral -ID expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   876   C0017262:Gene Expression [Genetic Function]
   795   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in MPS I dogs,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0012984:Dogs [Mammal]
   812   C1280551:Dogs [Mammal]
   756   C0023786:Mucopolysaccharidosis Type I [Disease or Syndrome]
           Mucopolysaccharidosis I

Phrase: "but"

Phrase: "not neor in normal dogs,"

Phrase: "might"

Phrase: "be"

Phrase: "the result of the anti"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]

Phrase: "--ID immune response"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0301872:Immune response [Organ or Tissue Function]
   827   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0439662:Immune [Functional Concept]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "noted in MPS I dogs."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C0023786:Mucopolysaccharidosis Type I [Disease or Syndrome]
           Mucopolysaccharidosis I
   790   C0441729:Type I [Classification]
   753   C0012984:Dogs [Mammal]
   753   C0021966:I- [Inorganic Chemical]
   753   C0026703:Mucopolysaccharidosis [Disease or Syndrome]
   753   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0332307:Type [Qualitative Concept]
   753   C1280551:Dogs [Mammal]
   753   C1547052:*Type [Quantitative Concept]
   719   C1316572:Note [Clinical Attribute]
   719   C1317574:Note [Intellectual Product]
   719   C1369612:Note [Clinical Attribute]
Processing 00000000.tx.282: Inflammatory cytokines such as tumor necrosis factor- (TNF-) and interferon- (IFN-) induced by immune responses have been shown to inhibit expression of MMLV-based promoters.49,50 We also investigated the role of humoral and cellular immune responses against -ID, LTMC media components, and -ID-transduced cells. 

Phrase: "Inflammatory cytokines such as tumor necrosis factor-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "interferon-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "induced by immune responses"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0301872:immune responses [Organ or Tissue Function]
   770   C0205263:Induced [Functional Concept]
   770   C0439662:Immune [Functional Concept]
   770   C0871261:responses [Organism Attribute]
   737 E C1704632:Response [Finding]
   737 E C1706817:Response [Intellectual Product]
   737 E C2911692:Response [Mental Process]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "expression of MMLV-based promoters.49,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "50"

Phrase: "We also"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the role of humoral"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "cellular immune responses against -ID,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   862   C1817908:Immune Responses, Cellular [Cell Function]
   806   C0301872:immune responses [Organ or Tissue Function]
   760   C0007634:Cellular [Cell]
   760   C0178539:Cellular [Functional Concept]
   760   C0439662:Immune [Functional Concept]
   760   C0871261:responses [Organism Attribute]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]

Phrase: "LTMC media components,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0449432:Components [Manufactured Object]
   793 E C1705248:Component [Conceptual Entity]

Phrase: "and -ID-transduced cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   812   C0007634:Cells [Cell]
   812   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1515981:And [Idea or Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.283: Strong immune responses to -ID enzyme, HS, and FBS components and -ID-transduced autologous cells were detected in dog M2 after three infusions of transduced cells. 

Phrase: "Strong immune responses to -ID enzyme,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0014442:Enzyme [Enzyme,Organic Chemical]
   716 E C0014445:enzymes [Functional Concept]

Phrase: "HS,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1518416:Serum, Horse [Immunologic Factor]
   861   C0019944:Horse [Mammal]
   861   C0229671:Serum [Body Substance]
   861   C0242616:Horse [Mammal]
   861   C1265527:Horse [Mammal]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "FBS components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0449432:Components [Manufactured Object]
   779 E C1705248:Component [Conceptual Entity]

Phrase: "and -ID-transduced autologous cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   804   C0007634:Cells [Cell]
   804   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0439859:Autologous [Qualitative Concept]
   804   C1515981:And [Idea or Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "detected in dog M2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0012984:Dog [Mammal]
   770   C0442726:Detected [Finding]
   770   C0457242:m2 [Quantitative Concept]
   770   C1280551:Dog [Mammal]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "after three infusions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0574032:infusions [Therapeutic or Preventive Procedure]
   827 E C1827465:Infusion [Functional Concept]

Phrase: "of transduced cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.284: All subsequently infused dogs (M3 through M6) were treated with posttransplant immunosuppression and received fewer infusions in an attempt to abrogate the immune responses. 

Phrase: "All subsequently infused dogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0012984:Dogs [Mammal]
   827   C1280551:Dogs [Mammal]

Phrase: "(M3 through M6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1300554:m3 [Quantitative Concept]
   790   C3484373:M3 [Intellectual Product]

Phrase: ")"

Phrase: "were"

Phrase: "treated with posttransplant immunosuppression"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0021079:Immunosuppression [Therapeutic or Preventive Procedure]
   770   C0021080:Immunosuppression [Organism Function]
   770   C1373218:Immunosuppression [Pathologic Function]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "fewer infusions in an attempt to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0574032:infusions [Therapeutic or Preventive Procedure]
   719 E C1827465:Infusion [Functional Concept]

Phrase: "abrogate"

Phrase: "the immune responses."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0301872:immune responses [Organ or Tissue Function]
   861   C0439662:Immune [Functional Concept]
   861   C0871261:responses [Organism Attribute]
   827 E C1704632:Response [Finding]
   827 E C1706817:Response [Intellectual Product]
   827 E C2911692:Response [Mental Process]
Processing 00000000.tx.285: The humoral anti--ID and antiserum immune responses in these dogs, although somewhat lower than those of M2, were still present. 

Phrase: "The humoral anti"

Phrase: "--ID"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "antiserum immune responses in these dogs,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0301872:immune responses [Organ or Tissue Function]
   753   C0439662:Immune [Functional Concept]
   753   C0871261:responses [Organism Attribute]
   719 E C1704632:Response [Finding]
   719 E C1706817:Response [Intellectual Product]
   719 E C2911692:Response [Mental Process]

Phrase: "although"

Phrase: "somewhat lower than those of M2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0441994:Lower [Spatial Concept]
   753   C1548802:Lower [Body Location or Region]
   753   C2003888:Lower [Activity]

Phrase: "were"

Phrase: "still"

Phrase: "present."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]
Processing 00000000.tx.286: Humoral immune responses have been detected against a variety of nontherapeutic antigens presented by genetically modified cells such as adenoviral vector proteins51 or serum components of culture media,52 whereas cellular responses have been detected against marker genes, such as a thymidine kinase-neor fusion protein.53 However, few gene transfer studies have used animal models of human disease to evaluate gene therapy strategies. 

Phrase: "Humoral immune responses"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C1155229:Immune Responses, Humoral [Cell Function]
   983 E C0020967:Humoral Immune Response [Organism Function]
   901   C0301872:immune responses [Organ or Tissue Function]
   827   C0439662:Immune [Functional Concept]
   827   C0871261:responses [Organism Attribute]
   793 E C1704632:Response [Finding]
   793 E C1706817:Response [Intellectual Product]
   793 E C2911692:Response [Mental Process]

Phrase: "have"

Phrase: "been"

Phrase: "detected against a variety of nontherapeutic antigens"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0003320:Antigens [Immunologic Factor]
   748   C0442726:Detected [Finding]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]
   748   C1883525:Variety [Conceptual Entity]
   748   C2346866:Variety [Conceptual Entity]

Phrase: "presented by genetically modified cells"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   797   C0205349:Modified By [Qualitative Concept]
   760   C0007634:Cells [Cell]
   760   C0392747:Modified [Functional Concept]
   760   C0449450:Presented [Idea or Concept]
   760   C3282337:Cells [Cell]
   726 E C0150312:Present [Quantitative Concept]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "such as adenoviral vector proteins51"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1510800:Adenoviral Vector [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "or"

Phrase: "serum components of culture media,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0449432:Components [Manufactured Object]
   726 E C1705248:Component [Conceptual Entity]

Phrase: "52"

Phrase: "whereas"

Phrase: "cellular responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0871261:responses [Organism Attribute]
   827 E C1704632:Response [Finding]
   827 E C1706817:Response [Intellectual Product]
   827 E C2911692:Response [Mental Process]

Phrase: "have"

Phrase: "been"

Phrase: "detected against marker genes,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0005516:Marker [Clinical Attribute]
   770   C0017337:Genes [Gene or Genome]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "such as a thymidine kinase-neor fusion protein.53 However,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   845   C0033640:kinase protein [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0040078:Thymidine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   795   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0040077:Thymidine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0332466:Fusion [Functional Concept]
   795   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "few gene transfer studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   875   C1273305:Gene studies [Laboratory Procedure]
   812   C0947630:studies [Laboratory Procedure]
   779 E C0557651:Study [Manufactured Object]
   779 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "used animal models of human disease to"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   829   C0012644:Animal Model of Disease [Experimental Model of Disease]
           Animal Disease Models
   778   C0599779:Models, Animal [Animal]
   774   C0003047:animal disease [Disease or Syndrome]
   774   C0683033:disease models [Intellectual Product]
   774   C0684309:disease models [Experimental Model of Disease]
   748   C0003062:Animal [Animal]
   748   C3161035:Models [Intellectual Product]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "gene therapy strategies."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0679199:strategies [Mental Process]
   734   C0017296:gene therapy [Therapeutic or Preventive Procedure]
Processing 00000000.tx.287: This study in dogs with -ID deficiency demonstrated significant humoral immune responses against the normal canine -ID and LTMC culture media serum components. 

Phrase: "This study in dogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]

Phrase: "with -ID deficiency"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0011155:Deficiency [Functional Concept]
   861   C0162429:Deficiency [Disease or Syndrome]
   861   C1623416:deficiency [Qualitative Concept]
   789 E C1636779:% deficient [Quantitative Concept]

Phrase: "demonstrated"

Phrase: "significant humoral immune responses against the normal canine -ID"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C1155229:Immune Responses, Humoral [Cell Function]
   773 E C0020967:Humoral Immune Response [Organism Function]
   764   C0301872:immune responses [Organ or Tissue Function]
   742   C0439662:Immune [Functional Concept]
   742   C0871261:responses [Organism Attribute]
   708 E C1704632:Response [Finding]
   708 E C1706817:Response [Intellectual Product]
   708 E C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "LTMC culture media serum components."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0449432:Components [Manufactured Object]
   771 E C1705248:Component [Conceptual Entity]
Processing 00000000.tx.288: As expected, the strongest immune responses in our study were detected after multiple infusions of cells in the absence of immunosuppressive therapy. 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "the strongest immune responses in our study"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   778   C0301872:immune responses [Organ or Tissue Function]
   748   C0439662:Immune [Functional Concept]
   748   C0871261:responses [Organism Attribute]
   714 E C1704632:Response [Finding]
   714 E C1706817:Response [Intellectual Product]
   714 E C2911692:Response [Mental Process]

Phrase: "were"

Phrase: "detected after multiple infusions of cells"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   753   C0007634:Cells [Cell]
   753   C0439064:Multiple [Quantitative Concept]
   753   C0442726:Detected [Finding]
   753   C0574032:infusions [Therapeutic or Preventive Procedure]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1827465:Infusion [Functional Concept]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of immunosuppressive therapy."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021079:Immunosuppressive therapy [Therapeutic or Preventive Procedure]
   861   C0021081:immunosuppressive [Immunologic Factor,Pharmacologic Substance]
   861   C0039798:therapy [Functional Concept]
   861   C0087111:Therapy [Therapeutic or Preventive Procedure]
   861   C1363945:Therapy [Finding]
Processing 00000000.tx.289: To our knowledge, this is the first demonstration of both humoral and cellular immune responses against a potentially therapeutic, normal canine enzyme in dogs deficient for this protein. 

Phrase: "To our knowledge,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376554:Knowledge [Intellectual Product]

Phrase: "this"

Phrase: "is"

Phrase: "the first demonstration of both humoral"

Phrase: "and"

Phrase: "cellular immune responses against a potentially therapeutic, normal canine enzyme"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   782   C1817908:Immune Responses, Cellular [Cell Function]
   760   C0301872:immune responses [Organ or Tissue Function]
   741   C0521982:Therapeutic response [Clinical Attribute]
   739   C0007634:Cellular [Cell]
   739   C0178539:Cellular [Functional Concept]
   739   C0439662:Immune [Functional Concept]
   739   C0871261:responses [Organism Attribute]
   706 E C1704632:Response [Finding]
   706 E C1706817:Response [Intellectual Product]
   706 E C2911692:Response [Mental Process]

Phrase: "in dogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012984:Dogs [Mammal]
  1000   C1280551:Dogs [Mammal]

Phrase: "deficient for this protein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011155:Deficient [Functional Concept]
   770   C1636779:% deficient [Quantitative Concept]
Processing 00000000.tx.290: Both the presence of cellular immune responses and lack of detectable -ID expression in vivo may indicate that only cells that have silenced proviral expression survived. 

Phrase: "Both"

Phrase: "the presence of cellular immune responses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "lack of detectable -ID expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332268:lack [Qualitative Concept]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "may"

Phrase: "indicate"

Phrase: "that only cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "have"

Phrase: "silenced proviral expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "survived."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0310255:SURVIVE [Pharmacologic Substance]
Processing 00000000.tx.291: However, further investigation is needed to confirm this. 

Phrase: "However,"

Phrase: "further investigation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C1261322:Investigation [Health Care Activity]
   861   C1552578:investigation [Idea or Concept]
   789 E C1517586:Investigational [Qualitative Concept]
   789 E C3245491:investigational [Intellectual Product]

Phrase: "is"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "this."
Processing 00000000.tx.292: Two mechanisms may account for the lack of sustained enzyme production: silencing of proviral gene expression and immune responses against -ID produced in vivo and/or cells expressing proviral antigens. 

Phrase: "Two mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "may"

Phrase: "account for the lack of sustained enzyme production"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0033268:production [Occupational Activity]
   744   C0332268:lack [Qualitative Concept]
   744   C0443318:Sustained [Functional Concept]
   744   C1551359:account [Idea or Concept]
   744   C2741673:Account # [Clinical Attribute]
   744   C2981730:Account [Classification]

Phrase: ":"

Phrase: "silencing of proviral gene expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0598496:Gene Silencing [Genetic Function]
   726   C0858952:silence [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "immune responses against -ID"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0301872:immune responses [Organ or Tissue Function]
   770   C0439662:Immune [Functional Concept]
   770   C0871261:responses [Organism Attribute]
   737 E C1704632:Response [Finding]
   737 E C1706817:Response [Intellectual Product]
   737 E C2911692:Response [Mental Process]

Phrase: "produced"

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and/or"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "proviral antigens."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003320:Antigens [Immunologic Factor]
   755 E C2698667:ANTIGENICITY [Regulation or Law]
Processing 00000000.tx.293: In ongoing studies, transduced LTMC grafts have been infused into preimmune fetal MPS I recipients to evaluate the therapeutic potential of HSC gene transfer for -ID-deficient dogs in the absence of immune responses.54 Retroviral vectors that have been modified to optimize long-term transgene expression, such as the MND,48 MFG,55 and MSCV56 vectors, will be evaluated in future studies. 

Phrase: "In ongoing studies,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0549178:ONGOING [Idea or Concept]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "transduced LTMC grafts"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0332835:Grafts [Tissue]
   827   C1527362:grafts [Qualitative Concept]
   793 E C0181074:{Graft} [Biomedical or Dental Material]
   793 E C1961139:Graft, NOS [Therapeutic or Preventive Procedure]

Phrase: "have"

Phrase: "been"

Phrase: "infused into preimmune fetal MPS I recipients to"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0023786:Mucopolysaccharidosis Type I [Disease or Syndrome]
           Mucopolysaccharidosis I
   764   C0441729:Type I [Classification]
   742   C0015965:Fetal [Embryonic Structure]
   742   C0021966:I- [Inorganic Chemical]
   742   C0026703:Mucopolysaccharidosis [Disease or Syndrome]
   742   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0332307:Type [Qualitative Concept]
   742   C0521457:Fetal [Functional Concept]
   742   C1547052:*Type [Quantitative Concept]
   708   C1709854:Recipient [Human]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the therapeutic potential of HSC gene transfer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3245505:Potential [Qualitative Concept]

Phrase: "for -ID-deficient dogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0012984:Dogs [Mammal]
   827   C1280551:Dogs [Mammal]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of immune responses.54 Retroviral vectors"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   840   C1514926:retroviral vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0035366:Retroviral [Virus]
   804   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0442335:Vectors [Spatial Concept]
   771 E C1705099:Vector [Idea or Concept]

Phrase: "that"

Phrase: "have"

Phrase: "been"

Phrase: "modified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "optimize"

Phrase: "long-term transgene expression,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   812   C0282641:Transgene [Gene or Genome]

Phrase: "such as the MND,48 MFG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0913150:MFG [Organic Chemical,Pharmacologic Substance]

Phrase: "55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "and"

Phrase: "MSCV56 vectors,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vectors [Spatial Concept]
   827 E C1705099:Vector [Idea or Concept]

Phrase: "will"

Phrase: "be"

Phrase: "evaluated in future studies."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0016884:Future [Temporal Concept]
   770   C0220825:Evaluated [Functional Concept]
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]
Processing 00000000.tx.294: These and other approaches may enable a definitive evaluation of the therapeutic potential of genetically corrected HSCs in the canine -ID deficiency model system.  

Phrase: "These"

Phrase: "and"

Phrase: "other approaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449445:Approaches [Spatial Concept]
  1000   C1292724:Approaches [Functional Concept]

Phrase: "may"

Phrase: "enable"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562342:enable [Mental Process]
  1000   C1171285:enable [Mental Process]

Phrase: "a definitive evaluation of the therapeutic potential of genetically"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1293088:Therapeutic evaluation [Diagnostic Procedure]
   742   C0220825:Evaluation [Functional Concept]
   742   C1261322:Evaluation [Health Care Activity]

Phrase: "corrected"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205202:Corrected [Qualitative Concept]
   966 E C2349182:Correct [Qualitative Concept]

Phrase: "HSCs in the canine -ID deficiency model system."
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   782   C0018956:Hematopoietic stem cells [Cell]
   760   C0038250:Stem cells [Cell]
   757   C0018957:Haematopoietic system [Body System]
           Haematopoietic
   757   C1292123:HEMATOPOIETIC SYSTEM [Finding]
   741   C2323499:Hematopoietic cell [Cell]
   739   C0007634:Cells [Cell]
   739   C0229601:Hematopoietic [Functional Concept]
   739   C0242767:Stem [Plant]
   739   C1186763:Stem [Body Part, Organ, or Organ Component]
   739   C3282337:Cells [Cell]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.295: ACKNOWLEDGMENT The authors express our appreciation to Dr Margaret Hough, Yongjun Zhao, Xiaochen Lu, and the staff of S.D. 

Phrase: "ACKNOWLEDGMENT"

Phrase: "The authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "express"

Phrase: "our appreciation to Dr Margaret Hough,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2346843:Appreciation [Conceptual Entity]

Phrase: "Yongjun Zhao,"

Phrase: "Xiaochen Lu,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024171:LU [Body System]
   861   C0024176:LU [Geographic Area]
   861   C2697939:LU [Quantitative Concept]

Phrase: "and"

Phrase: "the staff of S.D."
Processing 00000000.tx.296: Laboratories Ltd (Toronto, Ontario, Canada) for their assistance and cooperation. 

Phrase: "Laboratories Ltd (Toronto,"

Phrase: "Ontario,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029040:Ontario [Geographic Area]

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")"

Phrase: "for their assistance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018896:Assistance [Social Behavior]

Phrase: "and"

Phrase: "cooperation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392337:cooperation [Social Behavior]
Processing 00000000.tx.297: We are grateful to Drs Anna Salvetti and Olivier Danos for providing us with retroviral producer lines and to Dr Emil D.Kakkis for providing the canine -ID cDNA and purified -ID enzyme and for his generous assistance with the 4MUID and ELISA assays.  

Phrase: "We"

Phrase: "are"

Phrase: "grateful to Drs Anna Salvetti"

Phrase: "and"

Phrase: "Olivier Danos for providing"

Phrase: "us with retroviral producer lines"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0035366:Retroviral [Virus]
   760   C0205132:lines [Spatial Concept]
   760   C1709696:Producer [Human]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]

Phrase: "and to Dr Emil"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0031831:DR [Professional or Occupational Group]
   770   C1515981:And [Idea or Concept]
   770   C1707664:DR [Biomedical or Dental Material]
   770   C2348314:Dr. [Conceptual Entity]
   770   C3540849:DR [Idea or Concept]

Phrase: "D."

Phrase: "Kakkis for providing"

Phrase: "the canine -ID cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "purified -ID enzyme"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0020818:Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1998793:Purified [Functional Concept]
   743 E C0014445:enzymes [Functional Concept]
   734 E C1947930:Cleanse [Activity]

Phrase: "and for his generous assistance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0018896:Assistance [Social Behavior]
   760   C0019602:His [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C1412323:HIS [Gene or Genome]
   760   C1515981:And [Idea or Concept]

Phrase: "with the 4MUID"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0048509:4-methylumbelliferyl iduronide [Organic Chemical]

Phrase: "and"

Phrase: "ELISA assays."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   933   C0014441:Immunosorbent Assays, Enzyme-Linked [Laboratory Procedure]
           Enzyme-Linked Immunosorbent Assay
   897   C2717977:Enzyme Assays [Laboratory Procedure]
           Enzyme Assay
Processing 00000000.tx.298: FOOTNOTES Submitted March 5,1998; 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "Submitted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515023:Submitted [Functional Concept]

Phrase: "March 5,"

Phrase: "1998"

Phrase: ";"
Processing 00000000.tx.299: accepted November 10,1998. 

Phrase: "accepted November 10,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "1998."
Processing 00000000.tx.300: Supported by grants from the Medical Research Council of Canada. 

Phrase: "Supported by grants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0018173:Grants [Quantitative Concept]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from the Medical Research Council"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0079816:Medical Research [Research Activity]
   901   C1556038:Medical Research [Professional or Occupational Group]
   827   C0035168:research [Research Activity]
   827   C0205476:Medical [Functional Concept]
   827   C0242481:Research [Research Activity]
   827   C1551807:Council [Population Group]

Phrase: "of Canada."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]
Processing 00000000.tx.301: The publication costs of this article were defrayed in part by page charge payment. 

Phrase: "The publication"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034036:Publication [Intellectual Product,Manufactured Object]
  1000   C0034037:Publication [Occupational Activity]
  1000   C1704324:Publication [Intellectual Product]

Phrase: "costs of this article"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010186:Cost [Quantitative Concept]
   770   C0220812:Costs [Quantitative Concept]
   770   C1706852:Article [Intellectual Product]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by page charge payment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0220808:payment [Quantitative Concept]
   827   C0680264:payment [Quantitative Concept]
Processing 00000000.tx.302: This article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. section 1734solely to indicate this fact. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C. section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.303: Address reprint requests to Ian D.Dub, PhD, Department of Laboratory Medicine, Sunnybrook Health Science Center, 2075Bayview Ave (Room E346), Toronto, Ontario, Canada M4N 3M5; 

Phrase: "Address reprint"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3273171:Reprint [Intellectual Product]

Phrase: "requests to Ian"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0686900:request [Functional Concept]
   790   C1272683:Request [Functional Concept]
   790   C1522634:Request [Intellectual Product]

Phrase: "D."

Phrase: "Dub,"

Phrase: "PhD,"

Phrase: "Department of Laboratory Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "Sunnybrook Health Science Center,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C0475309:Health center [Health Care Related Organization,Manufactured Object]
   812   C0205099:Center [Spatial Concept]

Phrase: "2075Bayview Ave (Room E346"

Phrase: ")"

Phrase: ","

Phrase: "Toronto,"

Phrase: "Ontario,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029040:Ontario [Geographic Area]

Phrase: "Canada M4N 3M5"

Phrase: ";"
Processing 00000000.tx.304: e-mail: ian.dube{at}utoronto.ca .  REFERENCES TOP ABSTRACT INTRODUCTION REFERENCES 1. 

Phrase: "e-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "ian.dube{at}utoronto.ca ."

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1293116:Introduction [Health Care Activity]
   827   C1875307:INTRODUCTION [Manufactured Object]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.305: Karlsson S: Treatment of genetic defects in hematopoietic cell function by gene transfer. 

Phrase: "Karlsson S"

Phrase: ":"

Phrase: "Treatment of genetic defects"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "in hematopoietic cell function"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   901   C0007613:Cell Function [Cell Function]
   901   C2323499:Hematopoietic cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1705273:Function [Intellectual Product]
   827   C1948049:Cell [Spatial Concept]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]

Phrase: "by gene transfer."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1517499:Gene Transfer [Molecular Biology Research Technique]
   861   C0017337:Gene [Gene or Genome]
   861   C0040671:Transfer [Mental Process]
   861   C1705822:Transfer [Activity]
Processing 00000000.tx.306: Blood 78:2481, 1991[Medline] [OrderarticleviaInfotrieve] 2. 

Phrase: "Blood 78"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: ":"

Phrase: "2481,"

Phrase: "1991"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.307: Kohn DB, Hershfield MS, Carbonaro D, Shigeoka A, Brooks J, Smogorzewska EM, Barsky LW, Chan R, Burotto F, Annett G, Nolta JA, Crooks G, Kapoor N, Elder M, Wara D, Bowen T, Madsen E, Snyder FF, Bastian J, Muul L, Blaese RM, Weinberg K, Parkman R: T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates. 

Phrase: "Kohn DB,"

Phrase: "Hershfield MS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]

Phrase: "Carbonaro D,"

Phrase: "Shigeoka A,"

Phrase: "Brooks J,"

Phrase: "Smogorzewska EM,"

Phrase: "Barsky LW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1415842:LW [Gene or Genome]

Phrase: "Chan R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Burotto F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Annett G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Nolta JA,"

Phrase: "Crooks G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Kapoor N,"

Phrase: "Elder M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Wara D,"

Phrase: "Bowen T,"

Phrase: "Madsen E,"

Phrase: "Snyder FF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539653:FF [Idea or Concept]

Phrase: "Bastian J,"

Phrase: "Muul L,"

Phrase: "Blaese RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Weinberg K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Parkman R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ":"

Phrase: "T lymphocytes with a normal ADA gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0039194:T-Lymphocytes [Cell]
   748   C0024264:Lymphocytes [Cell]

Phrase: "accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells"
Meta Candidates (Total=35; Excluded=5; Pruned=0; Remaining=30)
   792   C0935850:umbilical cord blood transplantation [Therapeutic or Preventive Procedure]
           cord blood transplantation
   775   C0162371:Umbilical Cord Blood [Tissue]
           Cord Blood
   756   C0041633:Umbilical Cord [Embryonic Structure]
   756   C0882849:cd34 cells [Cell]
   756   C1281286:Umbilical cord [Embryonic Structure]
   756   C1546555:Cord blood [Intellectual Product]
   754   C0005773:Blood Cells [Cell]
   754   C0040736:Transplantation, Autologous [Therapeutic or Preventive Procedure]
   754   C0206153:cells transplantation [Therapeutic or Preventive Procedure]
   754   C0694698:Umbilical Blood [Tissue]
   754   C1547941:Umbilical blood [Intellectual Product]
   754 E C1550613:Blood - cord [Body Substance]
   754   C1550673:Umbilical blood [Body Substance]
   744   C0189736:Transplantation of blood vessel [Therapeutic or Preventive Procedure]
           blood vessel transplantation
   738   C0005767:Blood [Tissue]
   738   C0005768:blood [Body Substance]
   738   C0007634:Cells [Cell]
   738   C0029216:Transplantation [Therapeutic or Preventive Procedure]
   738   C0040732:Transplantation [Therapeutic or Preventive Procedure]
   738   C0040733:transplantation [Functional Concept]
   738   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   738   C0229664:Blood [Body Substance]
   738   C0439859:Autologous [Qualitative Concept]
   738   C1550235:Cord [Body Part, Organ, or Organ Component]
   738   C1552938:cord [Quantitative Concept]
   738   C1706500:Cord [Manufactured Object]
   738   C3282337:Cells [Cell]
   738   C3538723:CD34 [Laboratory Procedure]
   709 E C2328697:Hemal cell [Cell]
   704 E C1269647:Cell [Cell]
   704 E C1704653:Cell [Medical Device]
   704 E C1948049:Cell [Spatial Concept]

Phrase: "in ADA-deficient SCID neonates."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0021289:Neonates [Age Group]
   779 E C2239178:Neonate [Finding]
   779 E C2939425:Neonate, NOS [Temporal Concept]
   708   C1863236:ADA-SCID [Disease or Syndrome]
Processing 00000000.tx.308: Nat Med 4:775, 1998[Medline] [OrderarticleviaInfotrieve] 3. 

Phrase: "Nat Med 4"

Phrase: ":"

Phrase: "775,"

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.309: Verma IM, Somia N: Gene therapyPromises, problems and prospects. 

Phrase: "Verma IM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539078:IM [Idea or Concept]

Phrase: "Somia N"

Phrase: ":"

Phrase: "Gene therapyPromises,"

Phrase: "problems"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1546466:Problems [Idea or Concept]
   966 E C0033213:Problem [Finding]

Phrase: "and"

Phrase: "prospects."
Processing 00000000.tx.310: Nature 389:239, 1997[Medline] [OrderarticleviaInfotrieve] 4. 

Phrase: "Nature 389"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "239,"

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 4."
Processing 00000000.tx.311: Malech HL, Maples PB, Whiting-Theobald N, Linton GF, Sekhsaria S, Vowells SJ, Li F, Miller JA, DeCarlo E, Holland SM, Leitman SF, Carter CS, Butz RE, Read EJ, Fleisher TA, Schneiderman RD, Van Epps DE, Spratt SK, Maack CA, Rokovich JA, Cohen LK, Gallin JI: Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease. 

Phrase: "Malech HL,"

Phrase: "Maples PB,"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0229664:Blood [Body Substance]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "Whiting-Theobald N,"

Phrase: "Linton GF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0016703:GF [Geographic Area]
   861   C1551081:gf [Quantitative Concept]

Phrase: "Sekhsaria S,"

Phrase: "Vowells SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Li F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Miller JA,"

Phrase: "DeCarlo E,"

Phrase: "Holland SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Leitman SF,"

Phrase: "Carter CS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540510:cs [Quantitative Concept]

Phrase: "Butz RE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986904:RE [Idea or Concept]

Phrase: "Read EJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1718783:Ej [Immunologic Factor]

Phrase: "Fleisher TA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]

Phrase: "Schneiderman RD,"

Phrase: "Van Epps DE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0011198:DE [Geographic Area]
   827   C0017480:DE [Geographic Area]
   827   C3541240:DE [Idea or Concept]

Phrase: "Spratt SK,"

Phrase: "Maack CA,"

Phrase: "Rokovich JA,"

Phrase: "Cohen LK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038088:LK [Geographic Area]
   861   C2681928:LK [Gene or Genome]

Phrase: "Gallin JI"

Phrase: ":"

Phrase: "Prolonged production of NADPH oxidase-corrected granulocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0302090:Granulocyte production [Organ or Tissue Function]
   748   C0033268:production [Occupational Activity]

Phrase: "after gene therapy"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0017296:gene therapy [Therapeutic or Preventive Procedure]
   861   C0017337:Gene [Gene or Genome]
   861   C0039798:therapy [Functional Concept]
   861   C0087111:Therapy [Therapeutic or Preventive Procedure]
   861   C1363945:Therapy [Finding]

Phrase: "of chronic granulomatous disease."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
  1000   C0018203:Chronic granulomatous disease [Disease or Syndrome]
   913   C0008679:Chronic disease [Disease or Syndrome]
   901   C0332214:Chronic granulomatous [Functional Concept]
   901   C0740451:Granulomatous disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0205191:chronic [Temporal Concept]
   827   C0439667:Granulomatous [Qualitative Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.312: Proc Natl Acad Sci USA 94:12133, 1997[Abstract/Free FullText] 5. 

Phrase: "Proc Natl Acad Sci USA 94"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "12133,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "] 5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.313: Bodine DM, Moritz T, Donahue RE, Luskey BD, Kessler SW, Martin DI, Orkin SH, Nienhuis AW, Williams DA: Long-term in vivo expression of a murine adenosine deaminase gene in rhesus monkey hematopoietic cells of multiple lineages after retroviral mediated gene transfer into CD34+ bone marrow cells. 

Phrase: "Bodine DM,"

Phrase: "Moritz T,"

Phrase: "Donahue RE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986904:RE [Idea or Concept]

Phrase: "Luskey BD,"

Phrase: "Kessler SW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1420193:SW [Gene or Genome]
   861   C1832169:SW [Body System]
   861   C3538902:SW [Gene or Genome]

Phrase: "Martin DI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3538902:DI [Gene or Genome]
   861   C3541881:DI [Idea or Concept]

Phrase: "Orkin SH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038108:SH [Geographic Area]

Phrase: "Nienhuis AW,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0282379:AW [Geographic Area]
   861   C0332281:AW [Qualitative Concept]

Phrase: "Williams DA"

Phrase: ":"

Phrase: "Long-term in vivo expression of a murine adenosine deaminase gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C0017262:Gene Expression [Genetic Function]
   738   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in rhesus monkey hematopoietic cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   844   C2323499:Hematopoietic cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "of multiple lineages"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881379:Lineage [Conceptual Entity]

Phrase: "after retroviral mediated gene transfer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1517499:Gene Transfer [Molecular Biology Research Technique]
   812   C0017337:Gene [Gene or Genome]
   812   C0040671:Transfer [Mental Process]
   812   C1705822:Transfer [Activity]

Phrase: "into CD34+ bone marrow cells."
Meta Candidates (Total=22; Excluded=9; Pruned=0; Remaining=13)
   923   C0005955:Bone Marrow Cells [Cell]
   902   C0882849:cd34 cells [Cell]
   875   C0222677:Bone cells [Cell]
   861   C0005953:Bone Marrow [Tissue]
   858 E C0029432:Bone cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0086590:Marrow [Food]
   812   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   812   C0376152:Marrow [Body Part, Organ, or Organ Component]
   812   C0391978:Bone [Tissue]
   812   C1266908:Bone [Body Part, Organ, or Organ Component]
   812   C1266909:Bone [Body System]
   812   C1546708:Marrow [Intellectual Product]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   756 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   756 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   741 E C0443157:Bony [Functional Concept]
   729 E C0330477:Marrows [Plant]
Processing 00000000.tx.314: Blood 82:1975, 1993[Abstract] 6. 

Phrase: "Blood 82"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: ":"

Phrase: "1975,"

Phrase: "1993"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 6."
Processing 00000000.tx.315: Conneally E, Bardy P, Eaves CJ, Thomas T, Chappel S, Shpall EJ, Humphries RK: Rapid and efficient selection of human hematopoietic cells expressing murine heat-stable antigen as an indicator of retroviral-mediated gene transfer. 

Phrase: "Conneally E,"

Phrase: "Bardy P,"

Phrase: "Eaves CJ,"

Phrase: "Thomas T,"

Phrase: "Chappel S,"

Phrase: "Shpall EJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1718783:Ej [Immunologic Factor]

Phrase: "Humphries RK"

Phrase: ":"

Phrase: "Rapid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439831:Rapid [Qualitative Concept]

Phrase: "and"

Phrase: "efficient selection of human hematopoietic cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0036576:selection [Genetic Function]

Phrase: "expressing"

Phrase: "murine heat-stable antigen as an indicator"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0003320:Antigen [Immunologic Factor]

Phrase: "of retroviral-mediated gene transfer."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1517499:Gene Transfer [Molecular Biology Research Technique]
   812   C0017337:Gene [Gene or Genome]
   812   C0040671:Transfer [Mental Process]
   812   C1705822:Transfer [Activity]
Processing 00000000.tx.316: Blood 87:456, 1996[Abstract/Free FullText] 7. 

Phrase: "Blood 87"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: ":"

Phrase: "456,"

Phrase: "1996"

Phrase: "[Abstract/Free FullText"

Phrase: "] 7."
Processing 00000000.tx.317: Orlic D, Girard LJ, Jordan CT, Anderson SM, Cline A, Bodine DM: The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction. 

Phrase: "Orlic D,"

Phrase: "Girard LJ,"

Phrase: "Jordan CT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540513:CT [Gene or Genome]

Phrase: "Anderson SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Cline A,"

Phrase: "Bodine DM"

Phrase: ":"

Phrase: "The level of mRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the amphotropic retrovirus receptor in mouse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "human hematopoietic stem cells"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   923   C0018956:Hematopoietic stem cells [Cell]
   902   C0427861:Human cells [Laboratory or Test Result]
   861   C0038250:Stem cells [Cell]
   858   C2323499:Hematopoietic cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0018957:Haematopoietic [Body System]
   812   C0229601:Hematopoietic [Functional Concept]
   812   C0242767:Stem [Plant]
   812   C1186763:Stem [Body Part, Organ, or Organ Component]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   741 E C0018951:Haematopoiesis [Organ or Tissue Function]

Phrase: "is"

Phrase: "low"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "and"

Phrase: "correlates with the efficiency of retrovirus transduction."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0013682:Efficiency [Quantitative Concept]
   748   C0035366:Retrovirus [Virus]
   748   C1160185:transduction [Organism Function]
Processing 00000000.tx.318: Proc Natl Acad Sci USA 93:11097, 1996[Abstract/Free FullText] 8. 

Phrase: "Proc Natl Acad Sci USA 93"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "11097,"

Phrase: "1996"

Phrase: "[Abstract/Free FullText"

Phrase: "] 8."
Processing 00000000.tx.319: Hodgson GS, Bradley TR: Properties of haematopoietic stem cells surviving 5-fluorouracil treatment: Evidence for a pre-CFU-S cell? 

Phrase: "Hodgson GS,"

Phrase: "Bradley TR"

Phrase: ":"

Phrase: "Properties of haematopoietic stem cells"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0871161:properties [Qualitative Concept]
   760   C1292721:properties [Functional Concept]
   726 E C1882134:Property [Conceptual Entity]
   726 E C2347695:Property [Entity]

Phrase: "surviving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0310255:SURVIVE [Pharmacologic Substance]

Phrase: "5-fluorouracil treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0016360:5-Fluorouracil [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: ":"

Phrase: "Evidence for a pre-CFU-S cell?"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0332120:Evidence [Functional Concept]
Processing 00000000.tx.320: Nature 281:381, 1979[Medline] [OrderarticleviaInfotrieve] 9. 

Phrase: "Nature 281"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "381,"

Phrase: "1979"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 9."
Processing 00000000.tx.321: Abkowitz JL, Catlin SN, Guttorp P: Evidence that hematopoiesis may be a stochastic process in vivo. 

Phrase: "Abkowitz JL,"

Phrase: "Catlin SN,"

Phrase: "Guttorp P"

Phrase: ":"

Phrase: "Evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that hematopoiesis"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0018951:Haematopoiesis [Organ or Tissue Function]
   928 E C0018957:Haematopoietic [Body System]
   928 E C0229601:Hematopoietic [Functional Concept]

Phrase: "may"

Phrase: "be"

Phrase: "a stochastic process"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0038347:Stochastic Process [Quantitative Concept]
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.322: Nat Med 2:190, 1996[Medline] [OrderarticleviaInfotrieve] 10. 

Phrase: "Nat Med 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0796518:NAT-2 [Gene or Genome]
   913   C1261253:NAT-2 [Amino Acid, Peptide, or Protein,Enzyme]
   913   C1705514:NAT-2 [Gene or Genome]

Phrase: ":"

Phrase: "190,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 10."
Processing 00000000.tx.323: Carter RF, Abrams-Ogg AC, Dick JE, Kruth SA, Valli VE, Kamel-Reid S, Dub ID: Autologous transplantation of canine long-term marrow culture cells genetically marked by retroviral vectors. 

Phrase: "Carter RF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035448:RF [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0201660:RF [Laboratory Procedure]
   861   C0748398:RF [Finding]

Phrase: "Abrams-Ogg AC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1412573:AC [Gene or Genome]
   827   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   827   C3539770:AC [Gene or Genome]

Phrase: "Dick JE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0454673:JE [Geographic Area]
   861   C1550752:JE [Temporal Concept]

Phrase: "Kruth SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Valli VE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0042469:VE [Geographic Area]

Phrase: "Kamel-Reid S,"

Phrase: "Dub ID"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600091:ID [Intellectual Product]

Phrase: ":"

Phrase: "Autologous transplantation of canine long-term marrow culture cells genetically"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   775   C0194037:Autologous Marrow Transplantation [Therapeutic or Preventive Procedure]
   760   C0040736:Transplantation, Autologous [Therapeutic or Preventive Procedure]
   757   C0005961:Marrow Transplantation [Therapeutic or Preventive Procedure]
   757   C0206153:cells transplantation [Therapeutic or Preventive Procedure]
   739   C0029216:Transplantation [Therapeutic or Preventive Procedure]
   739   C0040732:Transplantation [Therapeutic or Preventive Procedure]
   739   C0040733:transplantation [Functional Concept]

Phrase: "marked by retroviral vectors."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C1514926:retroviral vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0035366:Retroviral [Virus]
   770   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0442335:Vectors [Spatial Concept]
   770   C0522501:Marked [Qualitative Concept]
   770   C1706089:Marked [Qualitative Concept]
   737 E C1705099:Vector [Idea or Concept]
Processing 00000000.tx.324: Blood 79:356, 1992[Abstract] 11. 

Phrase: "Blood 79"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: ":"

Phrase: "356,"

Phrase: "1992"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 11."
Processing 00000000.tx.325: Bienzle D, Abrams-Ogg AC, Kruth SA, Ackland-Snow J, Carter RF, Dick JE, Jacobs RM, Kamel-Reid S, Dub ID: Gene transfer into hematopoietic stem cells: Long-term maintenance of in vitro activated progenitors without marrow ablation. 

Phrase: "Bienzle D,"

Phrase: "Abrams-Ogg AC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1412573:AC [Gene or Genome]
   827   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   827   C3539770:AC [Gene or Genome]

Phrase: "Kruth SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Ackland-Snow J,"

Phrase: "Carter RF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035448:RF [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0201660:RF [Laboratory Procedure]
   861   C0748398:RF [Finding]

Phrase: "Dick JE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0454673:JE [Geographic Area]
   861   C1550752:JE [Temporal Concept]

Phrase: "Jacobs RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Kamel-Reid S,"

Phrase: "Dub ID"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600091:ID [Intellectual Product]

Phrase: ":"

Phrase: "Gene transfer into hematopoietic stem cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1517499:Gene Transfer [Molecular Biology Research Technique]
   767   C1861886:CELL Gene [Gene or Genome]
   753   C0017337:Gene [Gene or Genome]
   753   C0040671:Transfer [Mental Process]
   753   C1705822:Transfer [Activity]

Phrase: ":"

Phrase: "Long-term maintenance of in vitro activated progenitors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0024501:Maintenance [Activity]

Phrase: "without marrow ablation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0547070:Ablation [Therapeutic or Preventive Procedure]
   861   C1261381:ablation [Therapeutic or Preventive Procedure]
Processing 00000000.tx.326: Proc Natl Acad Sci USA 91:350, 1994[Abstract] 12. 

Phrase: "Proc Natl Acad Sci USA 91"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "350,"

Phrase: "1994"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 12."
Processing 00000000.tx.327: Moore KA, Deisseroth AB, Reading CL, Williams DE, Belmont JW: Stromal support enhances cell-free retroviral vector transduction of human bone marrow long-term culture-initiating cells. 

Phrase: "Moore KA,"

Phrase: "Deisseroth AB,"

Phrase: "Reading"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034754:Reading [Daily or Recreational Activity]
  1000   C1705179:Reading [Finding]

Phrase: "CL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "Williams DE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: "Belmont JW"

Phrase: ":"

Phrase: "Stromal support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0183683:Support [Medical Device]
   861   C1521721:Support [Conceptual Entity]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "cell-free retroviral vector transduction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1160185:transduction [Organism Function]

Phrase: "of human bone marrow long-term culture-initiating cells."
Meta Candidates (Total=23; Excluded=4; Pruned=0; Remaining=19)
   892   C0427861:Human cells [Laboratory or Test Result]
   883   C0005955:Bone Marrow Cells [Cell]
   878   C0222677:Bone cells [Cell]
   861 E C0029432:Bone cell [Cell]
   855   C1254426:Bone marrow culture [Laboratory Procedure]
   812   C0443252:Long-term [Temporal Concept]
   806   C0007585:culture cell [Laboratory Procedure]
   793   C0007634:Cells [Cell]
   793   C0010453:Culture [Idea or Concept]
   793   C0205166:Long [Qualitative Concept]
   793   C0220814:culture [Functional Concept]
   793   C0430400:Culture [Laboratory Procedure]
   793   C1515273:Term [Temporal Concept]
   793   C1705313:Term [Idea or Concept]
   793   C1706317:Long [Qualitative Concept]
   793   C2242979:Culture [Laboratory Procedure]
   793   C2826302:TERM [Intellectual Product]
   793   C3282337:Cells [Cell]
   760 E C1269647:Cell [Cell]
   760   C1548602:Initiate [Idea or Concept]
   760 E C1704653:Cell [Medical Device]
   760   C1704686:Initiate [Functional Concept]
   760 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.328: Blood 79:1393, 1992[Abstract] 13. 

Phrase: "Blood 79"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: ":"

Phrase: "1393,"

Phrase: "1992"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 13."
Processing 00000000.tx.329: Wells S, Malik P, Pensiero M, Kohn DB, Nolta JA: The presence of an autologous marrow stromal cell layer increases glucocerebrosidase gene transduction of long-term culture initiating cells (LTCICs) from the bone marrow of a patient with Gaucher disease. 

Phrase: "Wells S,"

Phrase: "Malik P,"

Phrase: "Pensiero M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kohn DB,"

Phrase: "Nolta JA"

Phrase: ":"

Phrase: "The presence of an autologous marrow stromal cell layer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "glucocerebrosidase gene transduction of long-term culture initiating cells (LTCICs)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C1519598:Transduction Gene [Gene or Genome]
   742   C1160185:transduction [Organism Function]

Phrase: "from the bone marrow"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
  1000   C0005953:Bone Marrow [Tissue]
   861   C0086590:Marrow [Food]
   861   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   861   C0376152:Marrow [Body Part, Organ, or Organ Component]
   861   C0391978:Bone [Tissue]
   861   C1266908:Bone [Body Part, Organ, or Organ Component]
   861   C1266909:Bone [Body System]
   861   C1546708:Marrow [Intellectual Product]
   805 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   805 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   805 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   789 E C0443157:Bony [Functional Concept]
   777 E C0330477:Marrows [Plant]

Phrase: "of a patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "with Gaucher disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0017205:Gaucher Disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.330: Gene Ther 2:512, 1995[Medline] [OrderarticleviaInfotrieve] 14. 

Phrase: "Gene Ther 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Gene [Gene or Genome]

Phrase: ":"

Phrase: "512,"

Phrase: "1995"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 14."
Processing 00000000.tx.331: Xu LC, Kluepfel-Stahl S, Blanco M, Schiffmann R, Dunbar C, Karlsson S: Growth factors and stromal support generate very efficient retroviral transduction of peripheral blood CD34+ cells from Gaucher patients. 

Phrase: "Xu LC,"

Phrase: "Kluepfel-Stahl S,"

Phrase: "Blanco M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Schiffmann R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Dunbar C,"

Phrase: "Karlsson S"

Phrase: ":"

Phrase: "Growth factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "stromal support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0183683:Support [Medical Device]
   861   C1521721:Support [Conceptual Entity]

Phrase: "generate"

Phrase: "very efficient retroviral transduction of peripheral blood CD34+ cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1160185:transduction [Organism Function]

Phrase: "from Gaucher patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.332: Blood 86:141, 1995[Abstract/Free FullText] 15. 

Phrase: "Blood 86"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: ":"

Phrase: "141,"

Phrase: "1995"

Phrase: "[Abstract/Free FullText"

Phrase: "] 15."
Processing 00000000.tx.333: Stewart AK, Sutherland DR, Nanji S, Zhao Y, Ruedy C, Lutzko C, Nayar R, Peck B, McGarrity G, Tisdale J, Dub ID: Gene marked long term culture cells contribute at low levels to hematopoiesis after autologous transplant. 

Phrase: "Stewart AK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001905:AK [Geographic Area]
   861   C1412243:AK [Gene or Genome]

Phrase: "Sutherland DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031831:DR [Professional or Occupational Group]
   861   C1707664:DR [Biomedical or Dental Material]
   861   C2348314:Dr. [Conceptual Entity]
   861   C3540849:DR [Idea or Concept]

Phrase: "Nanji S,"

Phrase: "Zhao Y,"

Phrase: "Ruedy C,"

Phrase: "Lutzko C,"

Phrase: "Nayar R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Peck B,"

Phrase: "McGarrity G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Tisdale J,"

Phrase: "Dub ID"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600091:ID [Intellectual Product]

Phrase: ":"

Phrase: "Gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: "long term culture cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   844   C0007585:culture cell [Laboratory Procedure]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "contribute at low levels"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0205251:low [Qualitative Concept]
   770   C0441889:Levels [Qualitative Concept]
   770   C1299352:Low [Qualitative Concept]
   770   C1550472:low [Idea or Concept]
   770   C1880177:Contribute [Activity]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "to hematopoiesis"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0018951:Haematopoiesis [Organ or Tissue Function]
   928 E C0018957:Haematopoietic [Body System]
   928 E C0229601:Hematopoietic [Functional Concept]

Phrase: "after autologous transplant."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0559189:Transplant, Autologous [Biomedical or Dental Material]
   861   C0040732:Transplant [Therapeutic or Preventive Procedure]
   861   C0332835:Transplant [Tissue]
Processing 00000000.tx.334: (submitted) 16. 

Phrase: "(submitted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515023:Submitted [Functional Concept]

Phrase: ")"

Phrase: "16."
Processing 00000000.tx.335: Shull RM, Munger RJ, Spellacy E, Hall CW, Constantopoulos G, Neufeld EF: Canine alpha-L-iduronidase deficiency. 

Phrase: "Shull RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Munger RJ,"

Phrase: "Spellacy E,"

Phrase: "Hall CW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0454665:CW [Geographic Area]

Phrase: "Constantopoulos G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Neufeld EF"

Phrase: ":"

Phrase: "Canine alpha-L-iduronidase deficiency."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   937   C0023786:Alpha-L-iduronidase deficiency [Disease or Syndrome]
   937   C2713321:alpha-L-Iduronidase Deficiency [Disease or Syndrome]
   884   C0020818:alpha-L-Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]
           Iduronidase
   884   C1442485:ALPHA-L-IDURONIDASE [Gene or Genome]
   804   C0011155:Deficiency [Functional Concept]
   804   C0162429:Deficiency [Disease or Syndrome]
   804   C0439095:Alpha [Intellectual Product]
   804   C1623416:deficiency [Qualitative Concept]
   804   C2003941:Alpha [Intellectual Product]
   804   C2350010:Alpha [Qualitative Concept]
   733 E C1636779:% deficient [Quantitative Concept]
Processing 00000000.tx.336: A model of mucopolysaccharidosis I. 

Phrase: "A model of mucopolysaccharidosis I."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]
Processing 00000000.tx.337: Am J Pathol 109:244, 1982[Medline] [OrderarticleviaInfotrieve] 17. 

Phrase: "Am"

Phrase: "J Pathol 109"

Phrase: ":"

Phrase: "244,"

Phrase: "1982"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 17."
Processing 00000000.tx.338: Menon KP, Tieu PT, Neufeld EF: Architecture of the canine IDUA gene and mutation underlying canine mucopolysaccharidosis I. 

Phrase: "Menon KP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022772:KP [Geographic Area]
   861   C1881334:kp [Quantitative Concept]

Phrase: "Tieu PT,"

Phrase: "Neufeld EF"

Phrase: ":"

Phrase: "Architecture of the canine IDUA gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0003737:Architecture [Occupation or Discipline]

Phrase: "and"

Phrase: "mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "underlying"

Phrase: "canine mucopolysaccharidosis I."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0023786:Mucopolysaccharidosis 1 [Disease or Syndrome]
   827   C0021966:I- [Inorganic Chemical]
   827   C0026703:Mucopolysaccharidosis [Disease or Syndrome]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.339: Genomics 14:763, 1992[Medline] [OrderarticleviaInfotrieve] 18. 

Phrase: "Genomics 14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0887950:Genomics [Biomedical Occupation or Discipline]

Phrase: ":"

Phrase: "763,"

Phrase: "1992"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 18."
Processing 00000000.tx.340: Shull RM, Lu X, McEntee MF, Bright RM, Pepper KA, Kohn DB: Myoblast gene therapy in canine mucopolysaccharidosis. 

Phrase: "Shull RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Lu X,"

Phrase: "McEntee MF,"

Phrase: "Bright RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Pepper KA,"

Phrase: "Kohn DB"

Phrase: ":"

Phrase: "Myoblast gene therapy in canine mucopolysaccharidosis."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0017296:gene therapy [Therapeutic or Preventive Procedure]
   753   C0017337:Gene [Gene or Genome]
   753   C0039798:therapy [Functional Concept]
   753   C0087111:Therapy [Therapeutic or Preventive Procedure]
   753   C1363945:Therapy [Finding]
Processing 00000000.tx.341: I: Abrogation by an immune response to alpha-L-iduronidase. 

Phrase: "I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ":"

Phrase: "Abrogation by an immune response"

Phrase: "to alpha-L-iduronidase."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020818:alpha-L-Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]
           Iduronidase
  1000   C1442485:ALPHA-L-IDURONIDASE [Gene or Genome]
Processing 00000000.tx.342: Hum Gen Ther 7:1595, 1996[Medline] [OrderarticleviaInfotrieve] 19. 

Phrase: "Hum Gen Ther 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1704351:GEN [Quantitative Concept]
   812   C2239486:Gen [Gene or Genome]

Phrase: ":"

Phrase: "1595,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 19."
Processing 00000000.tx.343: Shull RM, Helman RG, Spellacy E, Constantopoulos G, Munger RJ, Neufeld EF: Morphologic and biochemical studies of canine mucopolysaccharidosis I. 

Phrase: "Shull RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Helman RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Spellacy E,"

Phrase: "Constantopoulos G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Munger RJ,"

Phrase: "Neufeld EF"

Phrase: ":"

Phrase: "Morphologic"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   928   C0332437:Morphology [Qualitative Concept]
   928   C0543482:morphology [Spatial Concept]
   928   C0700329:Morphology, NOS [Finding]
   928   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "biochemical studies of canine mucopolysaccharidosis I."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0205474:Biochemical [Functional Concept]
   753   C0947630:studies [Laboratory Procedure]
   719 E C0557651:Study [Manufactured Object]
   719 E C2603343:Study [Research Activity]
Processing 00000000.tx.344: Am J Pathol 114:487, 1984[Abstract] 20. 

Phrase: "Am"

Phrase: "J Pathol 114"

Phrase: ":"

Phrase: "487,"

Phrase: "1984"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 20."
Processing 00000000.tx.345: Shull RM, Hastings NE, Selcer RR, Jones JB, Smith JR, Cullen WC, Constantopoulos G: Bone marrow transplantation in canine mucopolysaccharidosis I.

Phrase: "Shull RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Hastings NE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538705:NE [Gene or Genome]

Phrase: "Selcer RR,"

Phrase: "Jones JB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550751:JB [Temporal Concept]

Phrase: "Smith JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "Cullen WC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: "Constantopoulos G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: ":"

Phrase: "Bone marrow transplantation in canine mucopolysaccharidosis I."
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   814   C0005961:Bone Marrow Transplantation [Therapeutic or Preventive Procedure]
           Marrow Transplantation
   778   C0005953:Bone Marrow [Tissue]
   774   C0005976:Bone Transplantation [Therapeutic or Preventive Procedure]
   748   C0029216:Transplantation [Therapeutic or Preventive Procedure]
   748   C0040732:Transplantation [Therapeutic or Preventive Procedure]
   748   C0040733:transplantation [Functional Concept]
   748   C0086590:Marrow [Food]
   748   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   748   C0376152:Marrow [Body Part, Organ, or Organ Component]
   748   C0391978:Bone [Tissue]
   748   C1266908:Bone [Body Part, Organ, or Organ Component]
   748   C1266909:Bone [Body System]
   748   C1546708:Marrow [Intellectual Product]
   746 E C1708973:Medullary Bone [Tissue]
Processing 00000000.tx.346: Effects within the central nervous system. 

Phrase: "Effects within the central nervous system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   864   C0683212:central nervous system effects [Organ or Tissue Function]
   793   C1518287:neurologic effects [Physiologic Function]
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.347: J Clin Invest 79:435, 1987[Medline] [OrderarticleviaInfotrieve] 21. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "79"

Phrase: ":"

Phrase: "435,"

Phrase: "1987"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 21."
Processing 00000000.tx.348: Shull RM, Kakkis ED, McEntee MF, Kania SA, Jonas AJ, Neufeld EF: Enzyme replacement in a canine model of Hurler syndrome. 

Phrase: "Shull RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Kakkis ED,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538926:ED [Idea or Concept]

Phrase: "McEntee MF,"

Phrase: "Kania SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Jonas AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "Neufeld EF"

Phrase: ":"

Phrase: "Enzyme replacement in a canine model of Hurler syndrome."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0035139:Replacement [Therapeutic or Preventive Procedure]
   742   C0559956:Replacement [Functional Concept]
   742   C1555302:Replacement [Idea or Concept]
Processing 00000000.tx.349: Proc Natl Acad Sci USA 91:12937, 1994[Abstract/Free FullText] 22. 

Phrase: "Proc Natl Acad Sci USA 91"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "12937,"

Phrase: "1994"

Phrase: "[Abstract/Free FullText"

Phrase: "] 22."
Processing 00000000.tx.350: Kakkis ED, McEntee MF, Schmidtchen A, Neufeld EF, Ward DA, Gompf RE, Kania S, Bedolla C, Chien SL, Shull RM: Long-term and high-dose trials of enzyme replacement therapy in the canine model of mucopolysaccharidosis I. 

Phrase: "Kakkis ED,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538926:ED [Idea or Concept]

Phrase: "McEntee MF,"

Phrase: "Schmidtchen A,"

Phrase: "Neufeld EF,"

Phrase: "Ward DA,"

Phrase: "Gompf RE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986904:RE [Idea or Concept]

Phrase: "Kania S,"

Phrase: "Bedolla C,"

Phrase: "Chien SL,"

Phrase: "Shull RM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: ":"

Phrase: "Long-term"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0443252:Long-term [Temporal Concept]
   861   C0205166:Long [Qualitative Concept]
   861   C1515273:Term [Temporal Concept]
   861   C1705313:Term [Idea or Concept]
   861   C1706317:Long [Qualitative Concept]
   861   C2826302:TERM [Intellectual Product]

Phrase: "and"

Phrase: "high-dose trials of enzyme replacement therapy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0008976:Trial [Research Activity]

Phrase: "in the canine model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "of mucopolysaccharidosis I."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023786:Mucopolysaccharidosis 1 [Disease or Syndrome]
   861   C0021966:I- [Inorganic Chemical]
   861   C0026703:Mucopolysaccharidosis [Disease or Syndrome]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.351: Biochem Mol Med 58:156, 1996[Medline] [OrderarticleviaInfotrieve] 23. 

Phrase: "Biochem Mol Med 58"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1456781:mole [Neoplastic Process]
   812   C1824986:mol [Gene or Genome]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "156,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.352: Guild BC, Finer MH, Housman DE, Mulligan RC: Development of retrovirus vectors useful for expressing genes in cultured murine embryonal cells and hematopoietic cells in vivo. 

Phrase: "Guild BC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2984916:BC [Quantitative Concept]

Phrase: "Finer MH,"

Phrase: "Housman DE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: "Mulligan RC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: ":"

Phrase: "Development of retrovirus vectors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]

Phrase: "useful for expressing genes"

Phrase: "in cultured murine embryonal cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   902   C0007600:cultured cells [Cell]
   902   C0007635:Cultured Cells [Cell]
   902   C3282338:Cells, Cultured [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   794   C1947950:Embryonic Cell [Embryonic Structure]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "hematopoietic cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C2323499:Hematopoietic cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.353: J Virol 62:3795, 1988[Medline] [OrderarticleviaInfotrieve] 24. 

Phrase: "J Virol 62"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0965991:virol [Lipid]

Phrase: ":"

Phrase: "3795,"

Phrase: "1988"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 24."
Processing 00000000.tx.354: Adra CN, Boer PH, McBurney MW: Cloning and expression of the mouse pgk-1 gene and the nucleotide sequence of its promoter. 

Phrase: "Adra CN,"

Phrase: "Boer PH,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "McBurney MW"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024548:MW [Geographic Area]
   861   C0026385:mw [Quantitative Concept]
   861   C0556966:mW [Quantitative Concept]

Phrase: ":"

Phrase: "Cloning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009015:Cloning [Research Activity]

Phrase: "and"

Phrase: "expression of the mouse pgk-1 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0017262:Gene Expression [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "the nucleotide sequence of its promoter."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0004793:Nucleotide Sequence [Nucleotide Sequence]
           Sequence
   753   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.355: Gene 60:65, 1987[Medline] [OrderarticleviaInfotrieve] 25. 

Phrase: "Gene 60"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: ":"

Phrase: "65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "1987"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 25."
Processing 00000000.tx.356: Stoltzfus LJ, Sosa-Pineda B, Moskowitz SM, Menon KP, Dlott B, Hooper L, Teplow DB, Shull RM, Neufeld EF: Cloning and characterization of cDNA encoding canine alpha-L-iduronidase. 

Phrase: "Stoltzfus LJ,"

Phrase: "Sosa-Pineda B,"

Phrase: "Moskowitz SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Menon KP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022772:KP [Geographic Area]
   861   C1881334:kp [Quantitative Concept]

Phrase: "Dlott B,"

Phrase: "Hooper L,"

Phrase: "Teplow DB,"

Phrase: "Shull RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Neufeld EF"

Phrase: ":"

Phrase: "Cloning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009015:Cloning [Research Activity]

Phrase: "and"

Phrase: "characterization of cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1880022:Characterization [Activity]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "canine alpha-L-iduronidase."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0020818:alpha-L-Iduronidase [Amino Acid, Peptide, or Protein,Enzyme]
           Iduronidase
   923   C1442485:ALPHA-L-IDURONIDASE [Gene or Genome]
Processing 00000000.tx.357: mRNA deficiency in mucopolysaccharidosis I dog. 

Phrase: "mRNA deficiency in mucopolysaccharidosis I dog."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0011155:Deficiency [Functional Concept]
   753   C0162429:Deficiency [Disease or Syndrome]
   753   C1623416:deficiency [Qualitative Concept]
Processing 00000000.tx.358: J Biol Chem 267:6570, 1992[Abstract/Free FullText] 26. 

Phrase: "J Biol Chem 267"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "6570,"

Phrase: "1992"

Phrase: "[Abstract/Free FullText"

Phrase: "] 26."
Processing 00000000.tx.359: Miller AD, Rosman GJ: Improved retroviral vectors for gene transfer and expression. 

Phrase: "Miller AD,"

Phrase: "Rosman GJ"

Phrase: ":"

Phrase: "Improved retroviral vectors for gene transfer"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C1514926:retroviral vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0035366:Retroviral [Virus]
   753   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0442335:Vectors [Spatial Concept]
   719 E C1705099:Vector [Idea or Concept]

Phrase: "and"

Phrase: "expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.360: Biotechniques 7:980, 1989[Medline] [OrderarticleviaInfotrieve] 27. 

Phrase: "Biotechniques 7"

Phrase: ":"

Phrase: "980,"

Phrase: "1989"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 27."
Processing 00000000.tx.361: Miller AD, Buttimore C: Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. 

Phrase: "Miller AD,"

Phrase: "Buttimore C"

Phrase: ":"

Phrase: "Redesign of retrovirus packaging cell lines to"

Phrase: "avoid"

Phrase: "recombination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034865:Recombination [Genetic Function]

Phrase: "leading to helper virus production."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   806   C0018895:Virus, Helper [Virus]
   760   C0033268:production [Occupational Activity]
   760   C0042776:Virus [Virus]
   760   C0319157:virus [Virus]
   760   C0332152:Leading [Temporal Concept]
   760   C1522538:Leading [Functional Concept]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.362: Mol Cell Biol 6:2895, 1986[Medline] [OrderarticleviaInfotrieve] 28. 

Phrase: "Mol Cell Biol 6"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   812   C0007634:Cell [Cell]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1269647:Cell [Cell]
   812   C1456781:mole [Neoplastic Process]
   812   C1704653:Cell [Medical Device]
   812   C1824986:mol [Gene or Genome]
   812   C1948049:Cell [Spatial Concept]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "2895,"

Phrase: "1986"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 28."
Processing 00000000.tx.363: Danos O, Mulligan RC: Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. 

Phrase: "Danos O,"

Phrase: "Mulligan RC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: ":"

Phrase: "Safe"

Phrase: "and"

Phrase: "efficient generation of recombinant retroviruses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079411:Generation [Temporal Concept]
   760   C3146294:Generation [Activity]

Phrase: "with amphotropic"

Phrase: "and"

Phrase: "ecotropic host ranges."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C2936413:Ranges, Host [Natural Phenomenon or Process]
   827   C1167395:Host [Organism]
   827   C1514721:*Ranges [Quantitative Concept]
   793 E C2348147:Range [Quantitative Concept]
   793 E C3542016:Range [Intellectual Product]
Processing 00000000.tx.364: Proc Natl Acad Sci USA 85:6460, 1988[Abstract] 29. 

Phrase: "Proc Natl Acad Sci USA 85"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "6460,"

Phrase: "1988"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 29."
Processing 00000000.tx.365: Dub ID, Kruth S, Abrams-Ogg A, Kamel-Reid S, Lutzko C, Nanji S, Ruedy C, Singaraja R, Wild A, Krygsman P, Chu P, Messner H, Reddy V, McGarrity G, Stewart AK: Preclinical assessment of human hematopoietic progenitor cell transduction in long-term marrow cultures. 

Phrase: "Dub ID,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600091:ID [Intellectual Product]

Phrase: "Kruth S,"

Phrase: "Abrams-Ogg A,"

Phrase: "Kamel-Reid S,"

Phrase: "Lutzko C,"

Phrase: "Nanji S,"

Phrase: "Ruedy C,"

Phrase: "Singaraja R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Wild A,"

Phrase: "Krygsman P,"

Phrase: "Chu P,"

Phrase: "Messner H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Reddy V,"

Phrase: "McGarrity G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Stewart AK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001905:AK [Geographic Area]
   861   C1412243:AK [Gene or Genome]

Phrase: ":"

Phrase: "Preclinical assessment of human hematopoietic progenitor cell transduction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1261322:Assessment [Health Care Activity]
   744   C1516048:Assessment [Activity]

Phrase: "in long-term marrow cultures."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0010453:Cultures [Idea or Concept]
   779 E C0220814:culture [Functional Concept]
   779 E C0430400:Culture [Laboratory Procedure]
   779 E C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.366: Hum Gen Ther 7:2089, 1996[Medline] [OrderarticleviaInfotrieve] 30. 

Phrase: "Hum Gen Ther 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1704351:GEN [Quantitative Concept]
   812   C2239486:Gen [Gene or Genome]

Phrase: ":"

Phrase: "2089,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 30."
Processing 00000000.tx.367: Allan DS, De Koven A, Wild A, Kamel-Reid S, Dub ID: Endogenous murine leukemia virus DNA sequences in murine cell lines: Implications for gene therapy safety testing by PCR. 

Phrase: "Allan DS,"

Phrase: "De Koven A,"

Phrase: "Wild A,"

Phrase: "Kamel-Reid S,"

Phrase: "Dub ID"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600091:ID [Intellectual Product]

Phrase: ":"

Phrase: "Endogenous murine leukemia virus DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0012923:Virus-DNA [Virus]
   840   C0012939:virus DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   717   C0026626:Murine leukaemia virus [Virus]

Phrase: "sequences in murine cell lines"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   806   C0007600:Cell lines [Cell]
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0007634:Cell [Cell]
   760   C0026809:Murine [Mammal]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C0205132:lines [Spatial Concept]
   760   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   760   C1269647:Cell [Cell]
   760   C1519249:Sequence [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]

Phrase: ":"

Phrase: "Implications for gene therapy safety testing"

Phrase: "by PCR."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0337112:Chain [Manufactured Object]
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
   827   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1524075:Chain [Idea or Concept]
Processing 00000000.tx.368: Leuk Lymphoma 23:375, 1996[Medline] [OrderarticleviaInfotrieve] 31. 

Phrase: "Leuk Lymphoma 23"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0024299:Lymphoma [Neoplastic Process]
   827   C0450348:23 [Quantitative Concept]

Phrase: ":"

Phrase: "375,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.369: Carter RF, Kruth SA, Valli VE, Dub ID: Long-term culture of canine marrow: Cytogenetic evaluation of purging of lymphoma and leukemia. 

Phrase: "Carter RF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035448:RF [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0201660:RF [Laboratory Procedure]
   861   C0748398:RF [Finding]

Phrase: "Kruth SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Valli VE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0042469:VE [Geographic Area]

Phrase: "Dub ID"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600091:ID [Intellectual Product]

Phrase: ":"

Phrase: "Long-term culture of canine marrow"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0443252:Long-term [Temporal Concept]
   753   C0010453:Culture [Idea or Concept]
   753   C0205166:Long [Qualitative Concept]
   753   C0220814:culture [Functional Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C1515273:Term [Temporal Concept]
   753   C1705313:Term [Idea or Concept]
   753   C1706317:Long [Qualitative Concept]
   753   C2242979:Culture [Laboratory Procedure]
   753   C2826302:TERM [Intellectual Product]

Phrase: ":"

Phrase: "Cytogenetic evaluation of purging of lymphoma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0220825:Evaluation [Functional Concept]
   753   C1261322:Evaluation [Health Care Activity]

Phrase: "and"

Phrase: "leukemia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023418:Leukaemia [Neoplastic Process]
Processing 00000000.tx.370: Exp Hematol 18:995, 1990[Medline] [OrderarticleviaInfotrieve] 32. 

Phrase: "Exp Hematol 18"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "995,"

Phrase: "1990"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 32."
Processing 00000000.tx.371: Abrams-Ogg AC, Kruth SA, Carter RF, Valli VE, Kamel-Reid S, Dub ID: Preparation and transfusion of canine platelet concentrates. 

Phrase: "Abrams-Ogg AC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1412573:AC [Gene or Genome]
   827   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   827   C3539770:AC [Gene or Genome]

Phrase: "Kruth SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Carter RF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035448:RF [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0201660:RF [Laboratory Procedure]
   861   C0748398:RF [Finding]

Phrase: "Valli VE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0042469:VE [Geographic Area]

Phrase: "Kamel-Reid S,"

Phrase: "Dub ID"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600091:ID [Intellectual Product]

Phrase: ":"

Phrase: "Preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0455052:Preparation [Health Care Activity]
  1000   C1521827:Preparation [Functional Concept]

Phrase: "and"

Phrase: "transfusion of canine platelet concentrates."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   879   C1293886:Transfusion of platelet concentrate [Therapeutic or Preventive Procedure]
   816   C0086818:Transfusion of platelets [Therapeutic or Preventive Procedure]
           Platelet Transfusion
   760   C0005841:Transfusion [Therapeutic or Preventive Procedure]
   760   C0199960:Transfusion [Functional Concept]
   760   C0455012:Transfusion [Therapeutic or Preventive Procedure]
   760   C1879316:Transfusion [Therapeutic or Preventive Procedure]
Processing 00000000.tx.372: Am J Vet Res 54:635, 1993[Medline] [OrderarticleviaInfotrieve] 33. 

Phrase: "Am"

Phrase: "J Vet Res 54"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0242856:Vet [Professional or Occupational Group]
   812   C2347379:RES [Finding]

Phrase: ":"

Phrase: "635,"

Phrase: "1993"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 33."
Processing 00000000.tx.373: Coulombel L, Eaves AC, Eaves CJ: Enzymatic treatment of long-term human marrow cultures reveals the preferential location of primitive hemopoietic progenitors in the adherent layer. 

Phrase: "Coulombel L,"

Phrase: "Eaves AC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1412573:AC [Gene or Genome]
   861   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539770:AC [Gene or Genome]

Phrase: "Eaves CJ"

Phrase: ":"

Phrase: "Enzymatic treatment of long-term human marrow cultures"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   793   C0023977:long-term treatment [Health Care Activity]
   744   C0039798:treatment [Functional Concept]
   744   C0087111:Treatment [Therapeutic or Preventive Procedure]
   744   C1522326:Treatment [Functional Concept]
   744   C1533734:Treatment [Therapeutic or Preventive Procedure]
   744   C1705169:Treatment [Conceptual Entity]
   744   C3538994:TREATMENT [Research Activity]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "the preferential location of primitive hemopoietic progenitors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0450429:Location [Spatial Concept]
   748   C1515974:Location [Body Location or Region]

Phrase: "in the adherent layer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0934502:Layer [Body Part, Organ, or Organ Component]
   861   C1522408:Layer [Qualitative Concept]
   861   C1561599:Layer [Intellectual Product]
Processing 00000000.tx.374: Blood 62:291, 1983[Abstract] 34. 

Phrase: "Blood 62"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: ":"

Phrase: "291,"

Phrase: "1983"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 34."
Processing 00000000.tx.375: Nash RA, Pepe MS, Storb R, Longton G, Pettinger M, Anasetti C, Appelbaum FR, Bowden RA, Deeg HJ, Doney K, Martin PJ, Sullivan KM, Sanders J, Witherspoon RP: Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. 

Phrase: "Nash RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Pepe MS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]

Phrase: "Storb R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Longton G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Pettinger M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Anasetti C,"

Phrase: "Appelbaum FR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2348513:Fr. [Conceptual Entity]
   861   C3538902:FR [Gene or Genome]

Phrase: "Bowden RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Deeg HJ,"

Phrase: "Doney K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Martin PJ,"

Phrase: "Sullivan KM,"

Phrase: "Sanders J,"

Phrase: "Witherspoon RP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1538326:RP [Gene or Genome]
   861   C3541325:RP [Idea or Concept]

Phrase: ":"

Phrase: "Acute graft-versus-host disease"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
  1000   C0856825:Acute graft-versus-host disease [Disease or Syndrome]
   937   C0018133:Graft-Versus-Host Disease [Disease or Syndrome]
   937   C2984293:Graft-versus-host disease [Functional Concept]
   897   C0001314:Acute Disease [Disease or Syndrome]
   804   C0012634:Disease [Disease or Syndrome]
   804   C0181074:{Graft} [Biomedical or Dental Material]
   804   C0332835:Graft [Tissue]
   804   C1167395:Host [Organism]
   804   C1961139:Graft, NOS [Therapeutic or Preventive Procedure]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "analysis of risk factors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C0085801:analysis factors [Quantitative Concept]
   819   C0814767:risk analysis [Qualitative Concept]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "after allogeneic marrow transplantation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0040739:Transplantation, Allogeneic [Therapeutic or Preventive Procedure]
   901   C0005961:Marrow Transplantation [Therapeutic or Preventive Procedure]
   827   C0029216:Transplantation [Therapeutic or Preventive Procedure]
   827   C0040732:Transplantation [Therapeutic or Preventive Procedure]
   827   C0040733:transplantation [Functional Concept]

Phrase: "and"

Phrase: "prophylaxis with cyclosporine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0033107:prophylaxis [Intellectual Product]
   790   C0199176:Prophylaxis [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "methotrexate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025677:Methotrexate [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.376: Blood 80:1838, 1992[Abstract] 35. 

Phrase: "Blood 80"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: ":"

Phrase: "1838,"

Phrase: "1992"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 35."
Processing 00000000.tx.377: Lothrop CD J, al-Lebban ZS, Niemeyer GP, Jones JB, Peterson MG, Smith JR, Baker HJ, Morgan RA, Eglitis MA, Anderson WF: Expression of a foreign gene in cats reconstituted with retroviral vector infected autologous bone marrow. 

Phrase: "Lothrop CD J,"

Phrase: "al-Lebban ZS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0043459:ZS [Congenital Abnormality,Disease or Syndrome]

Phrase: "Niemeyer GP,"

Phrase: "Jones JB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550751:JB [Temporal Concept]

Phrase: "Peterson MG,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "Smith JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "Baker HJ,"

Phrase: "Morgan RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Eglitis MA,"

Phrase: "Anderson WF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043021:WF [Geographic Area]

Phrase: ":"

Phrase: "Expression of a foreign gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0017262:Gene Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in cats"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0007450:Cats [Mammal]
  1000   C0325089:cats [Mammal]
  1000   C1825121:CATS [Gene or Genome]
   966 E C0325090:Cat [Mammal]
   966 E C0524517:Cat [Mammal]

Phrase: "reconstituted with retroviral vector"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1514926:Retroviral Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0035366:Retroviral [Virus]
   770   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0442335:Vector [Spatial Concept]
   770   C1705099:Vector [Idea or Concept]

Phrase: "infected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439663:Infected [Functional Concept]

Phrase: "autologous bone marrow."
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
  1000   C2986504:Autologous Bone Marrow [Body Substance]
   901   C0005953:Bone Marrow [Tissue]
   827   C0086590:Marrow [Food]
   827   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   827   C0376152:Marrow [Body Part, Organ, or Organ Component]
   827   C0391978:Bone [Tissue]
   827   C0439859:Autologous [Qualitative Concept]
   827   C1266908:Bone [Body Part, Organ, or Organ Component]
   827   C1266909:Bone [Body System]
   827   C1546708:Marrow [Intellectual Product]
   771 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   771 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   771 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   755 E C0443157:Bony [Functional Concept]
   743 E C0330477:Marrows [Plant]
Processing 00000000.tx.378: Blood 78:237, 1991[Abstract] 36. 

Phrase: "Blood 78"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: ":"

Phrase: "237,"

Phrase: "1991"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 36."
Processing 00000000.tx.379: Kiem HP, Darovsky B, Von Kalle C, Goehle S, Graham T, Miller AD, Storb R, Schuening FG: Long-term persistence of canine hematopoietic cells genetically marked by retrovirus vectors. 

Phrase: "Kiem HP,"

Phrase: "Darovsky B,"

Phrase: "Von Kalle C,"

Phrase: "Goehle S,"

Phrase: "Graham T,"

Phrase: "Miller AD,"

Phrase: "Storb R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Schuening FG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: ":"

Phrase: "Long-term persistence of canine hematopoietic cells genetically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0546816:Persistence [Mental Process]

Phrase: "marked by retrovirus vectors."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0035366:Retrovirus [Virus]
   770   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0442335:Vectors [Spatial Concept]
   770   C0522501:Marked [Qualitative Concept]
   770   C1706089:Marked [Qualitative Concept]
   737 E C1705099:Vector [Idea or Concept]
Processing 00000000.tx.380: Hum Gen Ther 7:89, 1995[Medline] [OrderarticleviaInfotrieve] 37. 

Phrase: "Hum Gen Ther 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1704351:GEN [Quantitative Concept]
   812   C2239486:Gen [Gene or Genome]

Phrase: ":"

Phrase: "89,"

Phrase: "1995"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 37."
Processing 00000000.tx.381: Dunbar CE, Seidel NE, Doren S, Sellers S, Cline AP, Metzger ME, Agricola BA, Donahue RE, Bodine DM: Improved retroviral gene transfer into murine and Rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor. 

Phrase: "Dunbar CE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827664:CE [Idea or Concept]

Phrase: "Seidel NE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538705:NE [Gene or Genome]

Phrase: "Doren S,"

Phrase: "Sellers S,"

Phrase: "Cline AP,"

Phrase: "Metzger"

Phrase: "ME,"

Phrase: "Agricola BA,"

Phrase: "Donahue RE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986904:RE [Idea or Concept]

Phrase: "Bodine DM"

Phrase: ":"

Phrase: "Improved retroviral gene transfer into murine"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1517499:Gene Transfer [Molecular Biology Research Technique]
   753   C0017337:Gene [Gene or Genome]
   753   C0040671:Transfer [Mental Process]
   753   C1705822:Transfer [Activity]

Phrase: "and"

Phrase: "Rhesus peripheral blood"
Meta Candidates (Total=13; Excluded=8; Pruned=0; Remaining=5)
   901   C0229664:peripheral blood [Body Substance]
           Blood
   859 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0205100:Peripheral [Spatial Concept]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "or"

Phrase: "bone marrow repopulating cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   923   C0005955:Bone Marrow Cells [Cell]
   902   C0222677:Bone cells [Cell]
   886 E C0029432:Bone cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "primed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:primed [Functional Concept]

Phrase: "in vivo with stem cell factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "granulocyte colony-stimulating factor."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0079459:Granulocyte Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   923   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0018183:granulocyte [Cell]
   812   C0439158:colony [Quantitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1947989:Colony [Cell]
   812   C1948023:Stimulating [Natural Phenomenon or Process]
   812   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.382: Proc Natl Acad Sci USA 93:11871, 1996[Abstract/Free FullText] 38. 

Phrase: "Proc Natl Acad Sci USA 93"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "11871,"

Phrase: "1996"

Phrase: "[Abstract/Free FullText"

Phrase: "] 38."
Processing 00000000.tx.383: Brenner MK, Rill DR, Holladay MS, Heslop HE, Moen RC, Buschle M, Krance RA, Santana VM, Anderson WF, Ihle JN: Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. 

Phrase: "Brenner MK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539059:MK [Idea or Concept]

Phrase: "Rill DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031831:DR [Professional or Occupational Group]
   861   C1707664:DR [Biomedical or Dental Material]
   861   C2348314:Dr. [Conceptual Entity]
   861   C3540849:DR [Idea or Concept]

Phrase: "Holladay MS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]

Phrase: "Heslop"

Phrase: "HE,"

Phrase: "Moen RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: "Buschle M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Krance RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Santana VM,"

Phrase: "Anderson WF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043021:WF [Geographic Area]

Phrase: "Ihle JN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1428813:JN [Gene or Genome]

Phrase: ":"

Phrase: "Gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "marking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:marking [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "autologous marrow infusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0574032:Infusion [Therapeutic or Preventive Procedure]
   827   C1827465:Infusion [Functional Concept]

Phrase: "restores"

Phrase: "long-term haemopoiesis in cancer patients."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0018951:Hemopoiesis [Organ or Tissue Function]
   737   C0376544:Hematopoietic Cancer [Neoplastic Process]
Processing 00000000.tx.384: Lancet 342:1134, 1993[Medline] [OrderarticleviaInfotrieve] 39. 

Phrase: "Lancet 342"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0777169:Lancet [Medical Device]

Phrase: ":"

Phrase: "1134,"

Phrase: "1993"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 39."
Processing 00000000.tx.385: Dunbar CE, Cottler-Fox M, O'Shaughnessy JA, Doren S, Carter C, Berenson R, Brown S, Moen RC, Greenblatt J, Stewart FM, Leitman SF, Wilson WH, Cowan K, Young NS, Neinhuis A: Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. 

Phrase: "Dunbar CE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827664:CE [Idea or Concept]

Phrase: "Cottler-Fox M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "O'Shaughnessy JA,"

Phrase: "Doren S,"

Phrase: "Carter C,"

Phrase: "Berenson R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Brown S,"

Phrase: "Moen RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: "Greenblatt J,"

Phrase: "Stewart FM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540627:FM [Gene or Genome]

Phrase: "Leitman SF,"

Phrase: "Wilson WH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2349143:Wh [Quantitative Concept]

Phrase: "Cowan K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Young NS,"

Phrase: "Neinhuis A"

Phrase: ":"

Phrase: "Retrovirally"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: "CD34-enriched peripheral blood"
Meta Candidates (Total=13; Excluded=8; Pruned=0; Remaining=5)
   861   C0229664:peripheral blood [Body Substance]
           Blood
   819 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   812   C0005767:Blood [Tissue]
   812   C0005768:blood [Body Substance]
   812   C0205100:Peripheral [Spatial Concept]
   741 E C0333275:Bloody [Qualitative Concept]
   729 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   729 E C0392895:Bloods [Population Group]
   729 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   729 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C1558950:VASCULAR [Finding]
   712 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "bone marrow cells"
Meta Candidates (Total=21; Excluded=9; Pruned=0; Remaining=12)
  1000   C0005955:Bone Marrow Cells [Cell]
   913   C0222677:Bone cells [Cell]
   901   C0005953:Bone Marrow [Tissue]
   896 E C0029432:Bone cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0086590:Marrow [Food]
   827   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   827   C0376152:Marrow [Body Part, Organ, or Organ Component]
   827   C0391978:Bone [Tissue]
   827   C1266908:Bone [Body Part, Organ, or Organ Component]
   827   C1266909:Bone [Body System]
   827   C1546708:Marrow [Intellectual Product]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   771 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   771 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   771 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   755 E C0443157:Bony [Functional Concept]
   743 E C0330477:Marrows [Plant]

Phrase: "contribute to long-term engraftment"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0443252:Long-term [Temporal Concept]
   760   C0205166:Long [Qualitative Concept]
   760   C0301944:Engraftment [Physiologic Function]
   760   C1515273:Term [Temporal Concept]
   760   C1705313:Term [Idea or Concept]
   760   C1706317:Long [Qualitative Concept]
   760   C1880177:Contribute [Activity]
   760   C2826302:TERM [Intellectual Product]

Phrase: "after autologous transplantation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040736:Transplantation, Autologous [Therapeutic or Preventive Procedure]
   861   C0029216:Transplantation [Therapeutic or Preventive Procedure]
   861   C0040732:Transplantation [Therapeutic or Preventive Procedure]
   861   C0040733:transplantation [Functional Concept]
Processing 00000000.tx.386: Blood 85:3048, 1995[Abstract/Free FullText] 40. 

Phrase: "Blood 85"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: ":"

Phrase: "3048,"

Phrase: "1995"

Phrase: "[Abstract/Free FullText"

Phrase: "] 40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.387: Nolta JA, Dao MA, Wells S, Smogorzewska EM, Kohn DB: Transduction of pluripotent human hematopoietic stem cells demonstrated by clonal analysis after engraftment in immune-deficient mice. 

Phrase: "Nolta JA,"

Phrase: "Dao MA,"

Phrase: "Wells S,"

Phrase: "Smogorzewska EM,"

Phrase: "Kohn DB"

Phrase: ":"

Phrase: "Transduction of pluripotent human hematopoietic stem cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1160185:transduction [Organism Function]

Phrase: "demonstrated by clonal analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C1880109:Clonality Analysis [Molecular Biology Research Technique]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1522642:Clonal [Tissue]
   770   C1524024:analysis [Functional Concept]
   770   C1704387:Clonal [Qualitative Concept]

Phrase: "after engraftment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0301944:Engraftment [Physiologic Function]

Phrase: "in immune-deficient mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.388: Proc Natl Acad Sci USA 93:2414, 1996[Abstract/Free FullText] 41. 

Phrase: "Proc Natl Acad Sci USA 93"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "2414,"

Phrase: "1996"

Phrase: "[Abstract/Free FullText"

Phrase: "] 41."
Processing 00000000.tx.389: Larochelle A, Vormoor J, Hanenberg H, Wang JC, Bhatia M, Lapidot T, Moritz T, Murdoch B, Xiao XL, Kato I, Williams DA, Dick JE: Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy. 

Phrase: "Larochelle"

Phrase: "A,"

Phrase: "Vormoor J,"

Phrase: "Hanenberg H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Wang JC,"

Phrase: "Bhatia M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lapidot T,"

Phrase: "Moritz T,"

Phrase: "Murdoch B,"

Phrase: "Xiao XL,"

Phrase: "Kato I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Williams DA,"

Phrase: "Dick JE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0454673:JE [Geographic Area]
   861   C1550752:JE [Temporal Concept]

Phrase: ":"

Phrase: "Identification of primitive human hematopoietic cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0242954:Human Identification [Diagnostic Procedure]
   753   C0020792:Identification [Mental Process]
   753   C0205396:Identification [Qualitative Concept]

Phrase: "capable of repopulating NOD/SCID mouse bone marrow"

Phrase: ":"

Phrase: "Implications for gene therapy."
Processing 00000000.tx.390: Nat Med 2:1329, 1996[Medline] [OrderarticleviaInfotrieve] 42. 

Phrase: "Nat Med 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0796518:NAT-2 [Gene or Genome]
   913   C1261253:NAT-2 [Amino Acid, Peptide, or Protein,Enzyme]
   913   C1705514:NAT-2 [Gene or Genome]

Phrase: ":"

Phrase: "1329,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 42."
Processing 00000000.tx.391: Ross G, Erickson R, Knorr D, Motulsky AG, Parkman R, Samulski J, Straus SE, Smith BR: Gene therapy in the United States: A five-year status report. 

Phrase: "Ross G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Erickson R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Knorr D,"

Phrase: "Motulsky AG,"

Phrase: "Parkman R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Samulski J,"

Phrase: "Straus SE,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1710181:Standard Error [Quantitative Concept]
   827   C0743559:error [Qualitative Concept]
   827   C1442989:Standard [Qualitative Concept]
   827   C1608199:Error [Functional Concept]
   827   C2828392:Standard [Intellectual Product]

Phrase: "Smith BR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1704648:Br. [Conceptual Entity]

Phrase: ":"

Phrase: "Gene therapy in the United States"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0017296:gene therapy [Therapeutic or Preventive Procedure]
   753   C0017337:Gene [Gene or Genome]
   753   C0039798:therapy [Functional Concept]
   753   C0087111:Therapy [Therapeutic or Preventive Procedure]
   753   C1363945:Therapy [Finding]

Phrase: ":"

Phrase: "A five-year status report."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0586177:status report [Finding]
   812   C0684224:Report [Intellectual Product]
   812   C0700287:Report [Health Care Activity]
   812   C3273238:Report [Intellectual Product]
Processing 00000000.tx.392: Hum Gen Ther 7:1781, 1996[Medline] [OrderarticleviaInfotrieve] 43. 

Phrase: "Hum Gen Ther 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1704351:GEN [Quantitative Concept]
   812   C2239486:Gen [Gene or Genome]

Phrase: ":"

Phrase: "1781,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 43."
Processing 00000000.tx.393: Shull RM, Lu X, Dub I, Lutzko C, Kruth S, Abrams-Ogg A, Kiem HP, Goehle S, Schuening F, Millan C, Carter R: Humoral immune response limits gene therapy in canine MPS I. 

Phrase: "Shull RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Lu X,"

Phrase: "Dub I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Lutzko C,"

Phrase: "Kruth S,"

Phrase: "Abrams-Ogg A,"

Phrase: "Kiem HP,"

Phrase: "Goehle S,"

Phrase: "Schuening F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Millan C,"

Phrase: "Carter R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ":"

Phrase: "Humoral immune response"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0020967:Humoral Immune Response [Organism Function]
  1000   C1155229:Humoral immune response [Cell Function]
   901   C0301872:Immune response [Organ or Tissue Function]
   827   C0439662:Immune [Functional Concept]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "limits"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439801:limit [Functional Concept]
  1000   C1549649:Limit [Idea or Concept]
  1000   C2349209:Limit [Conceptual Entity]

Phrase: "gene therapy in canine MPS I."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0017296:gene therapy [Therapeutic or Preventive Procedure]
   774   C0314611:Gene type [Genetic Function]
   748   C0017337:Gene [Gene or Genome]
   748   C0039798:therapy [Functional Concept]
   748   C0087111:Therapy [Therapeutic or Preventive Procedure]
   748   C1363945:Therapy [Finding]
Processing 00000000.tx.394: Blood 88:377, 1996[Free FullText] 44. 

Phrase: "Blood 88"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: ":"

Phrase: "377,"

Phrase: "1996"

Phrase: "[Free FullText"

Phrase: "] 44."
Processing 00000000.tx.395: Barnett MJ, Eaves CJ, Phillips GL, Gascoyne RD, Hogge DE, Horsman DE, Humphries RK, Klingemann HG, Lansdorp PM, Nantel SH, Reece DE, Shepherd JD, Spinelli JJ, Sutherland HJ, Eaves AJ: Autografting with cultured marrow in chronic myeloid leukemia: Results of a pilot study. 

Phrase: "Barnett MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Eaves CJ,"

Phrase: "Phillips GL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0018229:GL [Geographic Area]
   861   C1423073:GL [Gene or Genome]
   861   C1427674:GL [Gene or Genome]

Phrase: "Gascoyne RD,"

Phrase: "Hogge DE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: "Horsman DE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: "Humphries RK,"

Phrase: "Klingemann HG,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0025424:Hg [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   861   C2347108:Hg+ [Element, Ion, or Isotope]
   861   C2347109:Hg++ [Element, Ion, or Isotope]
   861   C2348272:Hg [Element, Ion, or Isotope]

Phrase: "Lansdorp PM, Nantel SH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0038108:SH [Geographic Area]

Phrase: "Reece DE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: "Shepherd JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "Spinelli JJ,"

Phrase: "Sutherland HJ,"

Phrase: "Eaves AJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: ":"

Phrase: "Autografting with cultured marrow"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040736:Autografting [Therapeutic or Preventive Procedure]
   770   C0559189:autografting [Biomedical or Dental Material]

Phrase: "in chronic myeloid leukemia"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0023473:Chronic myeloid leukaemia [Neoplastic Process]
  1000   C2984277:Chronic myeloid leukemia [Functional Concept]
   913   C1279296:Chronic leukaemia [Neoplastic Process]
   901   C0023470:Myeloid Leukemia [Neoplastic Process]
   827   C0023418:Leukaemia [Neoplastic Process]
   827   C0205191:chronic [Temporal Concept]
   827   C0439677:Myeloid [Qualitative Concept]

Phrase: ":"

Phrase: "Results of a pilot study."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0683954:results study [Finding]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]
Processing 00000000.tx.396: Blood 84:724, 1994[Abstract/Free FullText] 45. 

Phrase: "Blood 84"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: ":"

Phrase: "724,"

Phrase: "1994"

Phrase: "[Abstract/Free FullText"

Phrase: "] 45."
Processing 00000000.tx.397: Brenner MK, Rill DR, Moen RC, Krance RA, Mirro J Jr, Anderson WF, Ihle JN: Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. 

Phrase: "Brenner MK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539059:MK [Idea or Concept]

Phrase: "Rill DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031831:DR [Professional or Occupational Group]
   861   C1707664:DR [Biomedical or Dental Material]
   861   C2348314:Dr. [Conceptual Entity]
   861   C3540849:DR [Idea or Concept]

Phrase: "Moen RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: "Krance RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Mirro J Jr,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708595:Jr [Idea or Concept]
   827   C3280986:JR [Disease or Syndrome]

Phrase: "Anderson WF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043021:WF [Geographic Area]

Phrase: "Ihle JN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1428813:JN [Gene or Genome]

Phrase: ":"

Phrase: "Gene-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "marking to trace origin of relapse"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   753   C0035020:Relapse [Phenomenon or Process]
   753   C0079946:origin [Classification]
   753   C0205336:relapse [Temporal Concept]
   753   C0277556:Relapse [Disease or Syndrome]
   753   C0439659:Origin [Temporal Concept]
   753   C0442822:Trace [Quantitative Concept]
   753   C0522501:marking [Qualitative Concept]
   753   C1524031:Trace [Qualitative Concept]
   753   C1550512:origin [Intellectual Product]
   753   C1883002:Trace [Functional Concept]
   725   C0852910:Birth mark [Congenital Abnormality]

Phrase: "after autologous bone-marrow transplantation."
Meta Candidates (Total=24; Excluded=5; Pruned=0; Remaining=19)
  1000   C0194037:autologous bone marrow transplantation [Therapeutic or Preventive Procedure]
           Autologous Marrow Transplantation
   923   C0005961:Bone Marrow Transplantation [Therapeutic or Preventive Procedure]
           Marrow Transplantation
   923   C2986504:Autologous Bone Marrow [Body Substance]
   902   C0040736:Transplantation, Autologous [Therapeutic or Preventive Procedure]
   875   C0005976:Bone Transplantation [Therapeutic or Preventive Procedure]
   861   C0005953:Bone Marrow [Tissue]
   812   C0029216:Transplantation [Therapeutic or Preventive Procedure]
   812   C0040732:Transplantation [Therapeutic or Preventive Procedure]
   812   C0040733:transplantation [Functional Concept]
   812   C0086590:Marrow [Food]
   812   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   812   C0376152:Marrow [Body Part, Organ, or Organ Component]
   812   C0391978:Bone [Tissue]
   812   C0439859:Autologous [Qualitative Concept]
   812   C1266908:Bone [Body Part, Organ, or Organ Component]
   812   C1266909:Bone [Body System]
   812   C1546708:Marrow [Intellectual Product]
   756 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   756 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   756 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   741 E C0443157:Bony [Functional Concept]
   729 E C0330477:Marrows [Plant]
Processing 00000000.tx.398: Lancet 341:85, 1993[Medline] [OrderarticleviaInfotrieve] 46. 

Phrase: "Lancet 341"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0777169:Lancet [Medical Device]

Phrase: ":"

Phrase: "85,"

Phrase: "1993"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 46."
Processing 00000000.tx.399: Bowtell DD, Cory S, Johnson GR, Gonda TJ: Comparison of expression in hemopoietic cells by retroviral vectors carrying two genes. 

Phrase: "Bowtell DD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538867:DD [Gene or Genome]

Phrase: "Cory S,"

Phrase: "Johnson GR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552950:[gr] [Quantitative Concept]

Phrase: "Gonda TJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039247:TJ [Geographic Area]

Phrase: ":"

Phrase: "Comparison of expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Comparison [Activity]

Phrase: "in hemopoietic cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C2323499:Hemopoietic cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "by retroviral vectors"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1514926:retroviral vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0035366:Retroviral [Virus]
   861   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vectors [Spatial Concept]
   827 E C1705099:Vector [Idea or Concept]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "two genes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]
Processing 00000000.tx.400: J Virol 62:2464, 1988[Medline] [OrderarticleviaInfotrieve] 47. 

Phrase: "J Virol 62"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0965991:virol [Lipid]

Phrase: ":"

Phrase: "2464,"

Phrase: "1988"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 47."
Processing 00000000.tx.401: Challita PM, Kohn DB: Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. 

Phrase: "Challita PM, Kohn DB"

Phrase: ":"

Phrase: "Lack of expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332268:lack [Qualitative Concept]

Phrase: "from a retroviral vector"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1514926:Retroviral Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0035366:Retroviral [Virus]
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: "after transduction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1160185:transduction [Organism Function]

Phrase: "of murine hematopoietic stem cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   923   C0018956:Hematopoietic stem cells [Cell]
   861   C0038250:Stem cells [Cell]
   858   C2323499:Hematopoietic cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0018957:Haematopoietic [Body System]
   812   C0229601:Hematopoietic [Functional Concept]
   812   C0242767:Stem [Plant]
   812   C1186763:Stem [Body Part, Organ, or Organ Component]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   741 E C0018951:Haematopoiesis [Organ or Tissue Function]

Phrase: "is"

Phrase: "associated with methylation"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0025723:Methylation [Molecular Function]
   790   C1159269:Methylation [Molecular Function]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
   718 E C0746574:methylated [Pharmacologic Substance]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.402: Proc Natl Acad Sci USA 91:2567, 1994[Abstract] 48. 

Phrase: "Proc Natl Acad Sci USA 91"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "2567,"

Phrase: "1994"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 48."
Processing 00000000.tx.403: Robbins PB, Skelton DC, Yu XJ, Halene S, Leonard EH, Kohn DB: Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells. 

Phrase: "Robbins PB,"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0229664:Blood [Body Substance]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "Skelton DC,"

Phrase: "Yu XJ,"

Phrase: "Halene S,"

Phrase: "Leonard EH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1520135:EH [Geographic Area]

Phrase: "Kohn DB"

Phrase: ":"

Phrase: "Consistent, persistent expression from modified retroviral vectors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0599566:expression vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in murine hematopoietic stem cells."
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   923   C0018956:Hematopoietic stem cells [Cell]
   861   C0038250:Stem cells [Cell]
   858   C2323499:Hematopoietic cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0018957:Haematopoietic [Body System]
   812   C0229601:Hematopoietic [Functional Concept]
   812   C0242767:Stem [Plant]
   812   C1186763:Stem [Body Part, Organ, or Organ Component]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   741 E C0018951:Haematopoiesis [Organ or Tissue Function]
Processing 00000000.tx.404: Proc Natl Acad Sci USA 95:10182, 1998[Abstract/Free FullText] 49. 

Phrase: "Proc Natl Acad Sci USA 95"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "10182,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "] 49."
Processing 00000000.tx.405: Harms JS, Splitter GA: Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter. 

Phrase: "Harms"

Phrase: "JS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: "Splitter GA"

Phrase: ":"

Phrase: "Interferon-gamma"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0021740:Interferon Gamma [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0021745:Interferon-gamma [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C1149405:interferon-gamma [Molecular Function]
  1000   C2757040:Interferon gamma [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0017011:Gamma [Natural Phenomenon or Process]
   861   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C1552644:Gamma [Intellectual Product]
   861   C2349976:Gamma [Quantitative Concept]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "transgene expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
   861   C0282641:Transgene [Gene or Genome]

Phrase: "driven by SV40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0038975:SV 40 [Virus]
   756   C0013126:Drive [Mental Process]

Phrase: "or"

Phrase: "CMV promoters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:promoters [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "but"

Phrase: "augments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:augment [Quantitative Concept]

Phrase: "expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "driven by the mammalian MHC I promoter."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0021966:I- [Inorganic Chemical]
   748   C0024660:Mammalian [Mammal]
   748   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   714   C0013126:Drive [Mental Process]
Processing 00000000.tx.406: Hum Gene Ther 6:1291, 1995[Medline] [OrderarticleviaInfotrieve] 50. 

Phrase: "Hum Gene Ther 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017337:Gene [Gene or Genome]

Phrase: ":"

Phrase: "1291,"

Phrase: "1995"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 50."
Processing 00000000.tx.407: Qin L, Ding Y, Pahud DR, Chang E, Imperiale MJ, Bromberg JS: Promoter attenuation in gene therapy: Interferon- and tumor necrosis factor- inhibit transgene expression. 

Phrase: "Qin L,"

Phrase: "Ding Y,"

Phrase: "Pahud DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031831:DR [Professional or Occupational Group]
   861   C1707664:DR [Biomedical or Dental Material]
   861   C2348314:Dr. [Conceptual Entity]
   861   C3540849:DR [Idea or Concept]

Phrase: "Chang E,"

Phrase: "Imperiale MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Bromberg JS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "Promoter attenuation in gene therapy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0599946:Attenuation [Activity]

Phrase: ":"

Phrase: "Interferon-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "tumor necrosis factor-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1323304:tumor necrosis factor [Molecular Function]
  1000   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0333516:Tumor necrosis [Neoplastic Process]
   827   C0027540:Necrosis [Organ or Tissue Function]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1334928:Necrosis [Finding]
   827   C1521761:Factor [Functional Concept]
   827   C1578706:Tumor [Intellectual Product]
   827   C2827422:Factor [Conceptual Entity]
   827   C3273930:Tumor [Finding]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "transgene expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
   861   C0282641:Transgene [Gene or Genome]
Processing 00000000.tx.408: Hum Gen Ther 8:2019, 1997[Medline] [OrderarticleviaInfotrieve] 51. 

Phrase: "Hum Gen Ther 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1704351:GEN [Quantitative Concept]
   812   C2239486:Gen [Gene or Genome]

Phrase: ":"

Phrase: "2019,"

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 51."
Processing 00000000.tx.409: Fang B, Eisensmith RC, Wang H, Kay MA, Cross RE, Landen CN, Gordon G, Bellinger DA, Read MS, Hu PC, Brinkhous KM, Woo SLC: Gene therapy for hemophilia B: Host immunosuppression prolongs the therapeutic effect of adenovirus-mediated factor IX expression. 

Phrase: "Fang B,"

Phrase: "Eisensmith RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: "Wang H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Kay MA,"

Phrase: "Cross RE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986904:RE [Idea or Concept]

Phrase: "Landen CN,"

Phrase: "Gordon G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Bellinger DA,"

Phrase: "Read MS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]

Phrase: "Hu PC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540812:PC [Gene or Genome]

Phrase: "Brinkhous KM,"

Phrase: "Woo SLC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1332684:SLC [Gene or Genome]
   861   C1705075:SLC [Gene or Genome]

Phrase: ":"

Phrase: "Gene therapy for hemophilia B"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0017296:gene therapy [Therapeutic or Preventive Procedure]
   760   C0017337:Gene [Gene or Genome]
   760   C0039798:therapy [Functional Concept]
   760   C0087111:Therapy [Therapeutic or Preventive Procedure]
   760   C1363945:Therapy [Finding]

Phrase: ":"

Phrase: "Host immunosuppression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0021079:Immunosuppression [Therapeutic or Preventive Procedure]
   861   C0021080:Immunosuppression [Organism Function]
   861   C1373218:Immunosuppression [Pathologic Function]

Phrase: "prolongs"

Phrase: "the therapeutic effect of adenovirus-mediated factor IX expression."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1527144:Therapeutic Effect [Health Care Activity]
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.410: Hum Gene Ther 6:1039, 1995[Medline] [OrderarticleviaInfotrieve] 52. 

Phrase: "Hum Gene Ther 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017337:Gene [Gene or Genome]

Phrase: ":"

Phrase: "1039,"

Phrase: "1995"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 52."
Processing 00000000.tx.411: Muul L: Production and evaluation of retroviral vectors for clinical gene therapy. 

Phrase: "Muul L"

Phrase: ":"

Phrase: "Production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "evaluation of retroviral vectors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0220825:Evaluation [Functional Concept]
   770   C1261322:Evaluation [Health Care Activity]

Phrase: "for clinical gene therapy."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0017296:gene therapy [Therapeutic or Preventive Procedure]
   827   C0017337:Gene [Gene or Genome]
   827   C0039798:therapy [Functional Concept]
   827   C0087111:Therapy [Therapeutic or Preventive Procedure]
   827   C1363945:Therapy [Finding]
Processing 00000000.tx.412: 2nd Conference on Stem Cell Gene Therapy: Biology and Technology. 

Phrase: "2nd Conference on Stem Cell Gene Therapy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0086047:Conference [Human-caused Phenomenon or Process]

Phrase: ":"

Phrase: "Biology"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0005532:Biology [Biomedical Occupation or Discipline]
   928 E C0205460:Biologic [Qualitative Concept]
   928 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "Technology."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039421:Technology [Occupation or Discipline]
Processing 00000000.tx.413: Orcas Island, WA, 1998. 

Phrase: "Orcas Island,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022130:Island [Geographic Area]

Phrase: "WA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043038:WA [Geographic Area]

Phrase: "1998."
Processing 00000000.tx.414: 53. 

Phrase: "53."
Processing 00000000.tx.415: Riddell SR, Elliott M, Lewinsohn DA, Gilbert MJ, Wilson L, Manley SA, Lupton SD, Overell RW, Reynolds TC, Corey L, Greenberg PD: T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. 

Phrase: "Riddell SR,"

Phrase: "Elliott M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lewinsohn DA,"

Phrase: "Gilbert MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Wilson L,"

Phrase: "Manley SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Lupton SD,"

Phrase: "Overell RW,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035978:RW [Geographic Area]
   861   C2700310:RW [Fish]

Phrase: "Reynolds TC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041405:TC [Geographic Area]
   861   C1824670:TC [Gene or Genome]
   861   C3272447:TC [Gene or Genome]

Phrase: "Corey L,"

Phrase: "Greenberg PD"

Phrase: ":"

Phrase: "T-cell"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0039194:T-cell [Cell]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "rejection of gene-modified HIV-specific cytotoxic T lymphocytes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0035015:Rejection [Social Behavior]
   742   C1548437:Rejection [Idea or Concept]
   742   C1882923:REJECTION [Phenomenon or Process]
   742   C2700401:Rejection [Activity]

Phrase: "in HIV-infected patients."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C1549592:HIV(+) patient [Intellectual Product]
   827   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.416: Nat Med 2:216, 1996[Medline] [OrderarticleviaInfotrieve] 54. 

Phrase: "Nat Med 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0796518:NAT-2 [Gene or Genome]
   913   C1261253:NAT-2 [Amino Acid, Peptide, or Protein,Enzyme]
   913   C1705514:NAT-2 [Gene or Genome]

Phrase: ":"

Phrase: "216,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 54."
Processing 00000000.tx.417: Lutzko C, Omori F, Abrams-Ogg ACG, Shull RM, Liheng L, Lau K, Ruedy C, Nanji S, Gartley C, Dobson H, Foster R, Kruth S, Dub ID: Gene therapy for canine -L-iduronidase deficiency: In utero adoptive transfer of genetically corrected hematopoietic progenitors results in engraftment but not amelioration of disease. 

Phrase: "Lutzko C,"

Phrase: "Omori F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Abrams-Ogg ACG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0050397:AcG [Amino Acid, Peptide, or Protein]
   827   C1428097:ACG [Gene or Genome]

Phrase: "Shull RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Liheng L,"

Phrase: "Lau K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Ruedy C,"

Phrase: "Nanji S,"

Phrase: "Gartley C,"

Phrase: "Dobson H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Foster R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Kruth S,"

Phrase: "Dub ID"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600091:ID [Intellectual Product]

Phrase: ":"

Phrase: "Gene therapy for canine -L-iduronidase deficiency"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0017296:gene therapy [Therapeutic or Preventive Procedure]
   748   C0017337:Gene [Gene or Genome]
   748   C0039798:therapy [Functional Concept]
   748   C0087111:Therapy [Therapeutic or Preventive Procedure]
   748   C1363945:Therapy [Finding]

Phrase: ":"

Phrase: "In utero adoptive transfer of genetically"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0376518:Adoptive Transfer [Therapeutic or Preventive Procedure]
   753   C0040671:Transfer [Mental Process]
   753   C1705822:Transfer [Activity]

Phrase: "corrected"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205202:Corrected [Qualitative Concept]
   966 E C2349182:Correct [Qualitative Concept]

Phrase: "hematopoietic progenitors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0870134:Progenitor [Family Group]

Phrase: "results in engraftment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0301944:Engraftment [Physiologic Function]
   790   C1274040:Result [Functional Concept]
   790   C1546471:Result [Idea or Concept]
   790   C2825142:Result [Finding]

Phrase: "but"

Phrase: "not amelioration of disease."
Processing 00000000.tx.418: (submitted) 55. 

Phrase: "(submitted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515023:Submitted [Functional Concept]

Phrase: ")"

Phrase: "55."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]
Processing 00000000.tx.419: Riviere I, Brose K, Mulligan RC: Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. 

Phrase: "Riviere I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Brose K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Mulligan RC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: ":"

Phrase: "Effects of retroviral vector design"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of human adenosine deaminase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C2933084:adenosine deaminase, human [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0001457:ADENOSINE DEAMINASE [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1412179:ADENOSINE DEAMINASE [Gene or Genome]
   827   C0001443:Adenosine [Nucleic Acid, Nucleoside, or Nucleotide,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   827   C0086418:Human [Human]
   827   C0582118:Deaminase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in murine bone marrow transplant recipients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0376387:Transplant Recipients [Patient or Disabled Group]
   771   C1709854:Recipient [Human]
   717   C0005961:Bone Marrow Transplant [Therapeutic or Preventive Procedure]

Phrase: "engrafted with genetically modified cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0007634:Cells [Cell]
   760   C0392747:Modified [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.420: Proc Natl Acad Sci USA 92:6733, 1995[Abstract] 56. 

Phrase: "Proc Natl Acad Sci USA 92"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "6733,"

Phrase: "1995"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 56."
Processing 00000000.tx.421: Hawley RG, Lieu FH, Fong AZ, Hawley TS: Versatile retroviral vectors for potential use in gene therapy. 

Phrase: "Hawley RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Lieu FH,"

Phrase: "Fong AZ,"

Phrase: "Hawley TS"

Phrase: ":"

Phrase: "Versatile retroviral vectors for potential use"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C1514926:retroviral vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0035366:Retroviral [Virus]
   753   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0442335:Vectors [Spatial Concept]
   719 E C1705099:Vector [Idea or Concept]

Phrase: "in gene therapy."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0017296:gene therapy [Therapeutic or Preventive Procedure]
   861   C0017337:Gene [Gene or Genome]
   861   C0039798:therapy [Functional Concept]
   861   C0087111:Therapy [Therapeutic or Preventive Procedure]
   861   C1363945:Therapy [Finding]
Processing 00000000.tx.422: Gen Ther 1:136, 1994[Medline] [OrderarticleviaInfotrieve]  1999 by The American Society of Hematology.  

Phrase: "Gen Ther 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704351:GEN [Quantitative Concept]
   827   C2239486:Gen [Gene or Genome]

Phrase: ":"

Phrase: "136,"

Phrase: "1994"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]  1999 by The American Society of Hematology."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C1515949:American Society of Hematology [Professional Society]
   748   C0018943:Haematology NOS [Biomedical Occupation or Discipline]
   748   C0037455:society [Organization]
   748   C0200627:HEMATOLOGY [Laboratory Procedure]
   748   C0596070:American [Population Group]
Processing 00000000.tx.423: 0006-4971/99/9306-0002$3.00/0

Phrase: "0006-4971/99/9306-0002$3.00/0"

